,VAERS_ID,RECVDATE,STATE,AGE_YRS,CAGE_YR,CAGE_MO,SEX,RPT_DATE,SYMPTOM_TEXT,DIED,DATEDIED,L_THREAT,ER_VISIT,HOSPITAL,HOSPDAYS,X_STAY,DISABLE,RECOVD,VAX_DATE,ONSET_DATE,NUMDAYS,LAB_DATA,V_ADMINBY,V_FUNDBY,OTHER_MEDS,CUR_ILL,HISTORY,PRIOR_VAX,SPLTTYPE,FORM_VERS,TODAYS_DATE,BIRTH_DEFECT,OFC_VISIT,ER_ED_VISIT,ALLERGIES,Covid
0,916710,01/01/2021,MO,23.0,23.0,,F,,"Acute appendicitis, onset morning of 1/1/2021  (Reporting this because Pfizer covid vaccine had 3-4x higher risk of appendicitis, although data not reported for Moderna covid vaccine)",,,Y,,Y,,,,U,12/29/2020,01/01/2021,3.0,"WBCs 13k, 4% Bands, CT with acute appendicitis- taken to surgery",PVT,,Synthroid,,Hypothyroidism,,,2,01/01/2021,,,Y,NKDA,True
15,917122,01/01/2021,NY,35.0,35.0,,M,,"A little over ab hour after receiving the vaccine I noticed a burning sensation in my sinuses. By 130am 1/1/2021 I awoke from my sleep terribly dizzy, shaking violently and experiencing a fever of 101.3 F. I took advil and tylenol and fell asleep about an hour later. I woke up with similar symptoms at approximately 830am on 1/1/2021 took an additional dose of advil and tylenol and slept till 12p. I woke up with a bad headache and coughing fits similar to when I had covid back in March. I went to an urgent care who assessed me and ordered me to the ER. medical center administered IV fluids, an inhaler, steroids, epinephrine and benadryl and a few hours later my symptoms had subsided for the most part and a dose of IV antibiotics was administered. I am currently admitted for observation with likely discharge on 1/2/2021.",,,,,Y,2.0,,,U,12/31/2020,12/31/2020,0.0,"1/1/2021 covid test, bloodwork, CT scan, chest x ray, bloodgas test",PVT,,"Networking, Januvia, amlodopine, losartan",None,"Crohns disease, diabetes, high blood pressure, sleep apnea",,,2,01/01/2021,,Y,Y,None,True
56,918075,01/04/2021,FL,67.0,67.0,,F,,"about 1 hour and 15 minutes post injection (I waited in area as recommended for thirty minutes because of hx), I had the sudden onset of  itchy runny nose and  chest tightness and wheezing of significant intensity that I  needed to use inhaler then and again later in the day. Noteworthy, I had  as a precaution taken prednisone 20mg p.o  about 2 hours before the injection.  I had to take more  later that afternoon because of symptoms. I then seem better but several times since the vaccine I have needed to uses the inhaler  and take prednisone  more than I have except after an infection about 6 years ago that precipitated similar symptoms to now. Today I had a flare significant enough that except for covid I might have gone to the ER or urgent care.",,,,,,,,,N,12/21/2020,12/21/2020,0.0,none,OTH,,Prednisone Alupent inhaler,"Hx mild asthma, not on tx at the time  of reactions but always  keep medicines handy, last  attack requiring ongoing steroids  about 6  years  prior, last SOB of that intensity about 6 years prior","allergic asthma, episodic, usually in association of URI or exposure to cats, this attack worse in about 6 years .",,,2,01/04/2021,,,,"Foods: Shell fish, Peaches, Strawberries  Medications, Pcn, Sulfa, ?Clindamycin  airborne: multiple trees, wees, grasses on skin testing many years ago,  significant allergy to cats - allergic rhinitis, wheezing, itchy eyes etc.",True
115,918210,01/04/2021,VA,31.0,31.0,,F,,Patient experienced feeling flushed and nauseated after receiving covid vaccine injection. Declines ED evaluation. No further symptoms reported on 12/19 follow-up,,,,,,,,,Y,12/18/2020,12/18/2020,0.0,none,PVT,,,,,,,2,01/04/2021,,,,,True
133,918229,01/04/2021,MA,39.0,39.0,,F,,12/26/20 started to experience covid -19 symptoms.,,,,,,,,,N,12/23/2020,12/26/2020,3.0,"(+)Covid-19 test taken 12/30/20, confirmed positive 12/31/20",WRK,,,,,,,2,01/04/2021,,Y,Y,,True
146,918242,01/04/2021,NY,37.0,37.0,,F,,"I got moderna COVID19 vaccine on 12/26/2020. Day 1-3 local pain and swelling, no redness. All resolved after day 3-4. Very tired all week post vaccine,.  Day 5-6 noticed ipsilateral axillary lymph node swelling.  On day 7 post vaccine I got a localized area of itching swelling and redness as if I had been bitten by a few mosquitoes at injection site that was new. Milder on day 8, less itchy and swollen, but still red and a little raised.  Mild shortness of breath.",,,,,,,,,N,12/26/2020,01/02/2021,7.0,,OTH,,"lexapro 10mg daily, magnesium 400mg daily, fish oil, vit D 1000iu, biotin",none,anticardiolipin antibodies (asymptomatic),,,2,01/04/2021,,,,"penicillin (rash in childhood), latex sensitive",True
173,918283,01/04/2021,TX,47.0,47.0,,F,,Modern a covid 19,,,,,,,,,N,12/24/2020,12/25/2020,1.0,None,PHM,,75 mg amitriptyline Doxipen,None,Insomnia,,,2,01/04/2021,,,,Procardia Macrobid,True
174,918284,01/04/2021,NY,23.0,23.0,,F,,Moderna vaccine received on 12/21 from my workplace. Rash (reddened skin not raised) appeared after vaccine was given (within 24hrs) the size of a quarter and was gone 3 days later.  Now on 1/3 the rash (red bullseye not raised) came back the size of a baseball and is warm to the touch. Went to urgent care and physician called it a delayed adverse reaction to the moderna vaccine 1st dose,,,,,,,,,N,12/21/2020,01/03/2021,13.0,,WRK,,Junel birth control,None,None,,,2,01/04/2021,,Y,,None,True
199,918409,01/04/2021,CA,38.0,38.0,,M,,"Patient complained of increased shortness of breath, generalized weakness and fatigue with mild cough worsening today and was admitted on 12/25/20. Patient is an employee of the hospital in the ICU and received the covid-19 vaccine on 12/25/20.  Patient believes symptoms started after the vaccination. On admission, patient was in sinus tachycardia with O2 saturation 91% on room air. Tested SARs CoV 2 RNA, RT PCR positive on 12/24/20. Transferred to ICU for closer monitoring after transitioning to high flow nasal cannula on 12/26. Patient recovered and discharged on 12/31/20.",,,,,Y,7.0,,,,12/18/2020,12/25/2020,7.0,"12/24: SARs CoV 2 RNA, RT PCR (+)",PVT,,,,,,,2,01/04/2021,,,,no known allergies,True
209,918742,01/04/2021,TN,38.0,,,F,,"Allergic reaction; Diarrhea; Chills; Palpitation; Tongue and throat swelling; Tongue and throat swelling; This is a spontaneous report from a contactable other healthcare professional (patient). A 38-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number: ELO141), via an unspecified route of administration on 21Dec2020 at a single dose for covid-19 immunization. The patient's medical history included asthma and allergy. Concomitant medication included levosalbutamol hydrochloride (XOPENEX) for asthma and cetirizine hydrochloride (ZYRTEC) for allergy. About hour and a half to two hours after the vaccine, on 21Dec2020, the patient experienced had an allergic reaction with symptoms set of diarrhea, chills, palpitations, and tongue and throat swelling. The patient took diphenhydramine (BENADRYL) 25 mg as treatment. It helped some. She woke up this morning (22Dec2020) and still had the symptoms. So, she went to the emergency room. They gave her diphenhydramine 25 mg IV, methylprednisolone (SOLUMEDROL), and famotidine (PEPCID). The patient underwent lab tests and procedures which included blood count and chemistry and lab work which showed normal on 22Dec2020. Outcome of the events was unknown. The patient thinks that the product had causality to the events.  Information on the lot/batch number has been requested.; Sender's Comments: The patient's medical history included asthma and allergy. Based on information available, the reported allergic reaction with symptoms set of diarrhea, chills, palpitations, and tongue and throat swelling was likely related to the use of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), due to temporal relationship and clinical course.  The case will be reassessed should additional information become available.  The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.",,,,,,,,,U,12/21/2020,12/21/2020,0.0,Test Date: 20201222; Test Name: Blood count; Result Unstructured Data: Test Result:Normal; Test Date: 20201222; Test Name: blood chemistry/lab test; Result Unstructured Data: Test Result:Normal,UNK,,XOPENEX; ZYRTEC [CETIRIZINE HYDROCHLORIDE],,Medical History/Concurrent Conditions: Allergy; Asthma,,USPFIZER INC2020509635,2,01/03/2021,,,Y,,True
211,918744,01/04/2021,KS,38.0,,,F,,"Have a fever with a high of 99.6 Fahrenheit; felt winded like she has exerted herself more than expected/shortness of air; Coughing/cough got worse; She is covid positive/Tested positive for COVID 19; She is covid positive/Tested positive for COVID 19; Shortness of breath/Shortness of breath was reported as worsened/feels winded; Tachycardia; Has been sick ever since; Felt like she was in a fog, on a cloud, heavy and out of it; She felt hot and weird but had no fever; Headache; Burning sensations in her legs; Extreme fatigue, want to go to bed; headache went away and she felt like the congestion was clearing up some; Arm was sore; This is a spontaneous report from a contactable ICU nurse (patient [Registered nurse ADN]) via Pfizer-sponsored program. A 38-year-old female patient received single dose of BNT162B2 (lot number: EK5730) , via an unspecified route of administration (right arm) on 16Dec2020 20:30 for immunization (for front line health care worker). Medical history included allergies; acid reflux; patent foramen ovale (PFO); supraventricular tachycardia (SVT) without treatment, vitamin D low and ongoing smoker. The patient had no other history/family history. Concomitant medication included loratadine (CLARITIN) taken for at least 5 years for allergy, famotidine from Dec2020 for acid reflex, and vitamin D taken for 5 or more years for vitamin D low; all given orally and were ongoing. The patient had no other prior vaccines within 4 weeks of Covid vaccination. Patient had been taking Covid tests on and off due to her immunocompromised daughter. On 15Dec2020 she took the PTR that took three to four days for results; she tested negative for Covid and was completely asymptomatic. She then received the COVID 19 vaccine 16Dec2020. Her test was positive for COVID 19 on 18Dec2020 and she had been sick ever since. She received the vaccine at the hospital where she works. The vaccine was not administered at facility. She further reported she was fine after getting the COVID 19 vaccine. Her right arm was sore/ started to hurt about four or five hours later on 16Dec2020 but then was fully after 24 to 48 hours. She started to feel sick on 18Dec2020 (Friday evening). States she went to bed Friday morning after the night shift. She felt fine, better than normal. That same day (18Dec2020) she woke up at 1700 and felt like she was in a fog, on a cloud, heavy and out of it. She walked around for a while and that sensation didn't go away. She felt hot and weird but had no fever. Then at 1830 she got the alert on her phone that told her she was positive for COVID 19. She started to feel other symptoms on 18Dec2020 including headache, shortness of breath, tachycardia, burning sensations in her legs; extreme fatigue, wanting to go to bed that persisted from Friday to Sunday. Then on 20Dec2020, Sunday afternoon, her headache went away and she felt like the congestion was clearing up some. Mentions she did have a fever (onset date unspecified) with a high of 99.6 Fahrenheit; but it went back down to 99.0 Fahrenheit (date/s unspecified). On 20Dec2020 the patient experienced coughing. On 21Dec2020 (Monday) she started coughing more but states her O2 was fine and her breathing was okay. However, when walking around she felt winded like she has exerted herself more than expected. She then clarified that on 21Dec2020, she experienced shortness of air and the cough got worse but it has now plateaued. She did call her HCP and they were holding off on treatment at the time. No investigation assessment was performed. The patient was not admitted to an Intensive Care Unit. The patient did not display clinical signs at rest indicative of severe systemic illness nor did she require supplemental oxygen or receive mechanical ventilation. No preexisting diseases worsened during the SARS-CoV2 infection. The patient considered shortness of breath, and tachycardia as serious: medically significant while the events headache, burning sensations in her legs, fatigue, Coughing, and feels winded were considered as not serious. The events headache, shortness of breath, tachycardia, burning sensations in her legs, fatigue, Coughing, and feels winded were ongoing at the time of reporting. Shortness of breath worsened. The patient recovered from arm was sore on an unspecified date in Dec2020; and was recovering from tachycardia, sick, headache and congestion. The outcome of felt like she was in a fog, on a cloud, heavy and out of it; felt hot, and fever was unknown while not recovered for the other events.; Sender's Comments: Based on available information, a possible contributory role of the subject product, BNT162B2 vaccine, cannot be excluded for the reported events due to temporal relationship.  However, the reported events may possibly represent intercurrent medical conditions in this patient.  There is limited information provided in this report.  Additional information is needed to better assess the case, including complete medical history, diagnostics including chest x-ray, counteractive treatment measures and concomitant medications.  This case will be reassessed once additional information is available.  The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.",,,,,,,,,N,12/16/2020,12/16/2020,0.0,Test Name: have a fever; Result Unstructured Data: Test Result:99.6 Fahrenheit; Test Name: have a fever; Result Unstructured Data: Test Result:99.0 Fahrenheit; Test Date: 20201221; Test Name: O2; Result Unstructured Data: Test Result:fine; Test Date: 20201215; Test Name: PTR/COVID/COVID 19; Result Unstructured Data: Test Result:negative; Comments: she tested negative for covid and completely asymptomatic; Test Date: 20201218; Test Name: PTR/COVID/COVID 19; Result Unstructured Data: Test Result:Positive,PVT,,CLARITIN [LORATADINE];  ; VIT D,"Smoker (Is the patient a smoker/former smoker? Yes, current.)",Medical History/Concurrent Conditions: Acid reflux (oesophageal) (allergies; acid reflux; PFO; SVT without treatment); Allergy (allergies; acid reflux; PFO; SVT without treatment); Foramen ovale patent (allergies; acid reflux; PFO; SVT without treatment); Supraventricular tachycardia (allergies; acid reflux; PFO; SVT without treatment); Vitamin D low,,USPFIZER INC2020510479,2,01/04/2021,,,,,True
212,918745,01/04/2021,AL,33.0,,,F,,"General weakness requiring assistance to stand.; General weakness requiring assistance to stand; Rash on chest/neck; This is a spontaneous report from a contactable Pharmacist. A 33-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) (lot number EK5730), intramuscularly on 22Dec2020 13:15 at single dose for covid-19 immunization. Vaccine location was right arm and it was the first dose. The facility type vaccine was hospital. None medical history. No known allergies. Patient was not diagnosed with COVID-19 prior to vaccination nor tested for COVID-19 since the vaccination. There were no concomitant medications. The patient didn't receive any other vaccines within 4 weeks prior to the COVID vaccine nor received any other medications within 2 weeks of vaccination. The patient experienced rash on chest/neck. General weakness requiring assistance to stand on 22Dec2020 17:00 with outcome of recovered in Dec2020. The date report was first received from source was 23Dec2020. Patient received Fluid bolus, IV benadryl, IV steroid as treatment for the adverse events. The action taken in response to the events for BNT162B2 was not applicable. The events were reported as non-serious.; Sender's Comments: The reported events rash on chest/neck and general weakness requiring assistance to stand were likely related to the use of first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), due to temporal relationship and clinical course.  The case will be reassessed should additional information become available.  The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.",,,,,,,,,Y,12/22/2020,12/22/2020,0.0,,PVT,,,,Comments: List of non-encoded Patient Relevant History: Patient Other Relevant History 1: None,,USPFIZER INC2020510588,2,01/03/2021,,,Y,,True
217,918751,01/04/2021,CA,37.0,,,F,,"severe fever; chills; severe night sweats; hives throughout my body; a rash on my face; This is a spontaneous report from a contactable nurse. This nurse reported for helf that the 37-year-old female patient received first dose of bnt162b2 (BNT162B2, product: COVID 19, brand: Pfizer), via an unspecified route of administration on Left Arm on 19Dec2020 10:30AM at single dose for covid-19 immunisation. No Pregnant at the time of vaccination. Medical history included Known Allergies to medications, food, or other products:Cocoa butter. Concomitant medications were unknown. Facility where the most recent COVID-19 vaccine was administered was Hospital. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient reported that ""Starting seven hours after the vaccine, I experienced severe fever and chills. The next morning, despite multiple anti-pyretics, the fevers/chills were worse. Also I experienced severe night sweats, likely related to the fevers. Three days after the vaccine, I began to have hives throughout my body and a rash on my face. Responds to Benadryl, but eventually reappears."" The event started from 19Dec2020 05:30 PM. Treatment was received for the adverse event included Anti-pyretics, anti-inflammatories, anti-histamine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. Facility type vaccine was hospital. No other vaccine in four weeks. The patient recovered with lasting effects. No Covid prior vaccination. No Covid tested post: vaccination. The outcome of the event was recovered/resolved with sequel in Dec2020.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.; Sender's Comments: The reported events severe fever and chills, severe night sweats, and hives and a rash on face were likely related to the use of first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), due to temporal relationship and clinical course.  The case will be reassessed should additional information become available.  The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.",,,,,,,,,N,12/19/2020,12/19/2020,0.0,,PVT,,,,Medical History/Concurrent Conditions: Food allergy,,USPFIZER INC2020511813,2,01/04/2021,,,,,True
221,918759,01/04/2021,NC,35.0,,,F,,"burst blood vessel in left eye/blood in her eye; This is a spontaneous report from a contactable physician (patient). A 35-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) (lot number EH9899, expiry date 01Mar2021), via an unspecified route of administration on 23Dec2020 at single dose for covid-19 immunization. Vaccine location was left deltoid. The facility type vaccine was hospital. Medical history included ongoing rheumatoid arthritis for about 8 years. No known allergies. Patient didn't do relevant test. Concomitant medication included duloxetine hydrochloride (CYMBALTA) for rheumatoid arthritis for 2 years, sulfasalazine for rheumatoid arthritis for 4 months, it's unknown if they were ongoing. The patient didn't receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient received the vaccine yesterday (23Dec2020), which she was very excited about, but today (24Dec2020) she woke up with a burst blood vessel in her left eye, she appears to have blood in her eye. This has never happened to her before. She knows this can occur with patients that have COVID but didn't know if it was a side effect to receiving the vaccine. Patient didn't receive treatment for the adverse event. The action taken in response to the event for BNT162B2 was not applicable. The outcome of event was not recovered. The relatedness between COVID vaccine and event ""burst blood vessel in left eye"" was related by reporter.  Pfizer is a marketing authorization holder of [BNT162B2] in the country of incidence or the country where the product was purchased (if different). This may be a duplicate report if another marketing authorization holder of [BNT162B2] has submitted the same report to the regulatory authorities.; Sender's Comments: ""Burst blood vessel in eye"" is not uncommon in general population, and there are many causes of the event.  Considering temporal relationship, a contribution role of the injection of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) to the reported Eye haemorrhage cannot be excluded.  The case will be reassessed should additional information become available.  The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.",,,,,,,,,N,12/23/2020,12/24/2020,1.0,,PVT,,CYMBALTA;,Rheumatoid arthritis (for about 8 years),,,USPFIZER INC2020513310,2,01/03/2021,,,,,True
222,918760,01/04/2021,FL,27.0,,,M,,"Tachycardia; Intermittent palpitations; Low grade fever/fever; muscle aches; This is a spontaneous report from a contactable physician. A 27-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), intramuscularly in unknown arm on 17Dec2020 at single dose for routine mass immunizations (covid-19 immunization). The COVID-19 vaccine was administered at Hospital. Not a military facility. The patient's medical history was reported as none and concomitant medications was none (he was on no other medications). The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient experienced tachycardia, intermittent palpitations, low grade fever/fever all started somewhere in the morning of 18Dec2020 and muscle aches on 17Dec2020. Physician assessed tachycardia and intermittent palpitations as serious due to medically significant. Physician stated that one of his workers had the vaccine and proceeded to have tachycardia and low grade fever. He would like to know if patient should get the second dose. The patient had mostly tachycardia with some intermittent palpitations. Patient was seen in his office on 18Dec2020, and got the COVID vaccine on 17Dec2020. He also reported fever and muscle aches, although the fever was subjective and was not documented. Tachycardia improved and sent him to cardiology on 21Dec2020. It was not life threatening and they did an Electrocardiogram (EKG). His initial heart rate was 130. When he was seen again in their office on 21Dec2020, it was 93, which was baseline. It improved. He never got his temperature. The highest in office was 99.5 degrees Fahrenheit. He had some muscle aches. The physician just sent patient to cardiology because he was having intermittent tachycardia and intermittent palpitations. Two visits to physician office. He was seen on 18Dec2020 and again on 21Dec2020. Relevant tests: they did testing for tachycardia but not related specifically. They did thyroid and EKG in office and he did not know if test were back. EKG was ok. The Thyroid, Complete blood count (CBC) and lipid (all were on an unknown date in Dec2020) were not back and were just done to make sure there were no cardiac issues. The outcome of the events was recovering. The lot/batch number has been requested.; Sender's Comments: Based on temporal association, the causal relationship between BNT162B2 and the events tachycardia and palpitations cannot be excluded. This case will be reassessed once additional information becomes available. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees, and Investigators, as appropriate.",,,,,,,,,N,12/17/2020,12/17/2020,0.0,Test Date: 20201221; Test Name: temperature; Result Unstructured Data: Test Result:99.5 Fahrenheit; Test Date: 20201221; Test Name: EKG; Result Unstructured Data: Test Result:ok; Test Date: 202012; Test Name: CBC; Result Unstructured Data: Test Result:unknown results; Test Date: 20201221; Test Name: heart rate; Result Unstructured Data: Test Result:93; Comments: baseline. It improved.; Test Date: 20201221; Test Name: heart rate; Result Unstructured Data: Test Result:130; Comments: initial heart rate; Test Date: 202012; Test Name: lipid; Result Unstructured Data: Test Result:unknown results; Test Date: 202012; Test Name: Thyroid; Result Unstructured Data: Test Result:unknown results,PVT,,,,Comments: List of non-encoded Patient Relevant History: Patient Other Relevant History 1: None,,USPFIZER INC2020513318,2,01/04/2021,,Y,,,True
225,918763,01/04/2021,FL,,,,F,,"She was hospitalized for a month Occurred after a flu two months prior and a stomach flu 2-3 weeks prior; She was hospitalized for a month Occurred after a flu two months prior and a stomach flu 2-3 weeks prior; This is a spontaneous report from a contactable consumer. A 75-year-old female patient received bnt162b2 (BNT162B2, lot number and expiry date were not reported), via an unspecified route of administration on an unspecified date at a single dose for covid-19 vaccination. Medical history included guillain-barre syndrome from 2011 at the age of 65 and Levaquin allergy. The patient's concomitant medications were not reported. On an unspecified date, the patient was hospitalized for a month that occurred after a flu two months prior and a stomach flu 2-3 weeks prior. The outcome of the events was unknown.  Information about lot/batch number has been requested.",,,,,Y,,,,U,,,,,UNK,,,,Medical History/Concurrent Conditions: Guillain Barre syndrome (Caller had Guillain Barre in 2011 at age 65),,USPFIZER INC2020513681,2,12/31/2020,,,,,True
230,918768,01/04/2021,NY,51.0,,,F,,"Diarrhea persisted 24 hours with mucous and bloody mucous after all fecal material was exhausted.; Did have one episode of chills; This is a spontaneous report from a contactable physician.  A 51-year-old female patient received the first dose of bnt162b2 (BNT162B2) lot no: EK9231, intramuscular on 23Dec2020 09:45 at a single dose for COVID-19 immunization in workplace clinic. Medical history included hypothyroid, allergies from bee sting, and covid-19 from Apr2020, all unknown if ongoing. Concomitant medication included levothyroxine sodium (SYNTHROID). The patient did not receive other vaccine in four weeks. On 25Dec2020, in the late evening at 11:45 PM-almost midnight, the patient experienced diarrhea, severe, without nausea or vomiting. Did have one episode of chills that resolved. Diarrhea persisted 24 hours with mucous and bloody mucous after all fecal material was exhausted. The patient had COVID-19 in Apr2020 and had positive antibodies in Jun2020 with high titers. She confirmed with their ID chief that she should proceed to receive the vaccine. Diarrhea resolved in 24 hours. Some lingering increased GI activity. No fever (temp 99.0F) (Dec2020). The patient recovered from events without treatment in Dec2020. The events were reported as non-serious. The patient was not tested for COVID-19 post vaccination.; Sender's Comments: A possible causal association between administration of BNT162B2 and the onset of diarrhea, severe cannot be excluded, considering the plausible temporal relationship and the known adverse profile of the suspect product.  The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate",,,,,,,,,Y,12/23/2020,12/25/2020,2.0,Test Date: 202012; Test Name: fever; Result Unstructured Data: Test Result:99.0 Fahrenheit; Test Date: 202006; Test Name: COVID-19; Result Unstructured Data: Test Result:positive antibodies; Comments: high titers,WRK,,SYNTHROID,,Medical History/Concurrent Conditions: Bee sting hypersensitivity; COVID-19; Hypothyroidism,,USPFIZER INC2020514021,2,01/04/2021,,,,,True
236,918776,01/04/2021,OK,40.0,,,F,,"I had seizure like 3 times; Vasovagal reaction; Fever; Headache; Weakness; It's just little bit shaky and breathless; It's just little bit shaky and breathless; allergic reaction; This is a spontaneous report from a contactable consumer. A 40-year-old female patient received bnt162b2 (BNT162B2, lot number: EK5730), via an unspecified route of administration on 24Dec2020 at a single dose for covid-19 vaccination. There were no relevant medical history and concomitant medications. The patient reported that on an unspecified date, she had an allergic reaction. She had vasovagal reaction and seizures. Vasovagal was an allergic reaction that happened, and added that basically it's an allergic reaction. The patient experienced fever, headache, and weakness like right now. It was just little bit shaky, ever since yesterday and she had been way off like she take it as instruction yesterday, weakness, headache and breathless did not stopped from yesterday. The patient had been taking Tylenol for fever and headache. The patient reported that the events persisted. On 24Dec2020, lab work was done at the  hospital, and she was told that the lab work was okay and they did CT scan of head because she developed seizure. She had seizure like 3 times so they scanned her brain. The outcome of the events was not recovered.",,,,,,,,,N,12/24/2020,,,Test Date: 20201224; Test Name: CT scan; Result Unstructured Data: Test Result:Unknown results; Test Date: 20201224; Test Name: lab work; Result Unstructured Data: Test Result:okay,PVT,,,,Comments: List of non-encoded Patient Relevant History: Patient Other Relevant History 1: None,,USPFIZER INC2020514618,2,12/31/2020,,,,,True
240,918782,01/04/2021,NY,,,,F,,"extreme muscle ache that she couldn't move; I couldn't take the pain/severe body ache severe like I couldn't walk; I couldn't take the pain/severe body ache severe like I couldn't walk; extreme muscle ache that she couldn't move; High fever; Lot of chills; Itchiness; Hives; she was crying; This is a spontaneous report from a contactable Nurse (patient). A 44-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiry date unknown), intramuscular on an unspecified date at single dose for covid-19 immunization. Patient history was no and investigation assessment was no. There were no concomitant medications. The patient had hives and itchiness and then that was the first day that was after 8 minutes and then the next day the patient had severe body ache severe like I couldn't walk, she cried. The patient took Tylenol and Ibuprofen as she couldn't take the pain (further clarification was unknown). The patient had high fever 102.4 and was having a lot of chills. Start date of event was 24th, the 23rd she had the hives and the 24th she had the extreme muscle ache that she couldn't move and she was crying and she had the chills and the fever on the 24th. So it on started 23rd with the hives so then it started with the body aches and the fever on the 24th. Outcome of the events was recovered. The causality between the events and drug was considered as related by the reporter via Global Introspection.   Information on the batch/lot number has been requested.; Sender's Comments: The Company cannot completely exclude the possible causality between the reported body ache severe like I couldn't walk, extreme muscle ache that she couldn't move, and the administration of  BNT162B2, based on the reasonable temporal association.  The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to RA, IEC, as appropriate.",,,,,,,,,Y,,,,Test Name: body temperature; Result Unstructured Data: Test Result:102.4,UNK,,,,Comments: List of non-encoded Patient Relevant History: Patient Other Relevant History 1: None,,USPFIZER INC2020515992,2,01/04/2021,,,,,True
242,918784,01/04/2021,CT,42.0,,,F,,"Left sided hearing loss; This is a spontaneous report from a contactable physician who was also the patient. A 42-year-old non-pregnant female patient received bnt162b2, lot number and expiration date were unknown, via an unspecified route of administration on 16Dec2020 , 8:30 at a single dose for covid-19 immunization. The patient's medical history included antiphospholipid antibody from an unknown date and unknown if ongoing. The patient's concomitant medications were not reported. On 22Dec2020, the patient experienced left sided hearing loss. It was unknown if patient received treatment for the event. The outcome of the event was not recovered. The patient was not diagnosed with COVID prior to vaccination and has not been tested for COVID-19 since vaccination. Patient has no allergies. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine.   Information on the lot/batch number has been requested.; Sender's Comments: As an individual case report there is not enough evidence to establish a causal relationship with the suspect vaccine. Currently there is no clear biological plausibility between the vaccine use and the even onset.  More information such as complete medical history and concomitant medications are needed for fully medical assessment.  The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.",,,,,,,,,N,12/16/2020,12/22/2020,6.0,,UNK,,,,Medical History/Concurrent Conditions: Antiphospholipid syndrome,,USPFIZER INC2020516171,2,01/04/2021,,,,,True
243,918785,01/04/2021,,,,,F,,"severe hearing loss; This is a spontaneous report from a contactable physician (patient). A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration on 16Dec2020 at single dose for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient experienced severe hearing loss on Dec2020 and was inquiring if it was a reported side effect of the vaccine. Outcome of event was unknown.  Information about lot/batch number has been requested.; Sender's Comments: A causal association between BNT162 and the reported event cannot be excluded based on a compatible temporal relation. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to RAs, Ethics Committees, and Investigators, as appropriate.",,,,,,,,,U,12/16/2020,12/01/2020,,,UNK,,,,,,USPFIZER INC2020516250,2,01/04/2021,,,,,True
244,918786,01/04/2021,RI,23.0,,,F,,"tightness in throat and lump in throat/had a tightness and lump in her throat; tightness in throat and lump in throat/had a tightness and lump in her throat; allergic reaction like rash, tightness in throat, and lump in throat; allergic reaction like rash/red rash on her chest and rash was on her arms too; cheeks were flushed; This is a spontaneous report from a contactable nurse (patient). This nurse reported similar events for 3 patients. This is the first of 3 reports.  A 23-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE) lot number: EK9231, intramuscular in the right deltoid, first dose on 27Dec2020 14:15 at a single dose for covid-19 prevention. Medical history included ongoing asthma and reactive airway which she was diagnosed when she was like 5 years old (2002). Concomitant medication included albuterol [salbutamol] for asthma which started when she was 8 years old or so. The patient wanted to know if she can receive the second dose of covid vaccine after experiencing symptoms of allergic reaction like rash, tightness in throat, and lump in throat. She wanted to know the ingredients and specific proteins in the covid vaccine. The patient received the COVID Vaccine and she developed a reaction. On 27Dec2020, she had a red rash on her chest, and her cheeks were flushed, and the rash was on her arms too, and she had a tightness and lump in her throat, it was not painful to swallow but she could feel the pressure with swallowing. She stated that she did not experience shortness of breath, but regardless, she was seen in the ER and she was given IV SOLUMEDROL, and BENADRYL, and she was watched for 5 or 6 hours and then she was sent home with an Epi Pen, around the clock Benadryl, and prednisone. She asked the ER doctors if they thought it was okay for her to receive the second dose of the product, and they told her to contact employee health for that question. She mentioned that she contacted that employee health and was told to contact her primary care provide which she did. Her primary care doctor instructed the caller to call Pfizer and gather some more information regarding ingredients, as the she may have had the reaction to a particular protein filler. She was also wondering if this is a known reaction to the product. She received the vaccine on 27Dec2020 at 2:15 PM. She reported that the red rash on her chest and arms, and her cheeks being flushed, resolved yesterday after receiving IV BENADRYL. Had a tightness and lump in her throat which was still ongoing, and it was kind of off and on and when the she takes Benadryl it goes away. She reported that this one is medically significant because even though she did not have shortness of breath, it could have affected her airway. She confirmed that she received no other vaccines on the same day as the COVID vaccine. The outcome of the events 'had a tightness and lump in her throat', allergic reaction was not recovered (a s reported); while recovered on 27Dec2020 for allergic reaction like rash/red rash on her chest and rash was on her arms too and cheeks were flushed.; Sender's Comments: Based on temporal association, the causal relationship between bnt162b2 and the events throat tightness, sensation of foreign body, allergy to vaccine, rash erythematous and flushing cannot be excluded. This case will be reassessed once additional information becomes available. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees, and Investigators, as appropriate.,Linked Report(s) : US-PFIZER INC-2020517134 different patient, same drug and same event;US-PFIZER INC-2020517133 different patient, same drug and same event.",,,,,,,,,N,12/27/2020,12/27/2020,0.0,,UNK,,ALBUTEROL [SALBUTAMOL],Asthma; Reactive airways disease,,,USPFIZER INC2020516277,2,01/04/2021,,,Y,,True
245,918787,01/04/2021,AZ,25.0,,,F,,"Fever up to 120F; Bodyaches; Headache; dulled taste and smell; dulled taste and smell; Pain at the injection site; This is a spontaneous report from a contactable other HCP. A 25-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) (reported as COVID 19 vaccine), intramuscular on 27Dec2020 12:00PM at single dose for covid-19 immunization. Vaccine location was left arm and it was the first dose. The patient medical history was not reported. Concomitant medication included influenza vaccine (FLU) on 16Dec2020 at right arm. Patient was not diagnosed with COVID-19 prior to vaccination nor tested for COVID-19 since the vaccination. The patient didn't receive any other medications within 2 weeks of vaccination. The patient experienced fever up to 120F, bodyaches, headache, dulled taste and smell, pain at the injection site on 27Dec2020. Patient didn't receive treatment for the adverse events. The action taken in response to the events for BNT162B2 was not applicable. The outcome of events was not recovered. The events were reported as non-serious.  Pfizer is a marketing authorization holder of [BNT162B2] in the country of incidence or the country where the product was purchased (if different). This may be a duplicate report if another marketing authorization holder of [BNT162B2] has submitted the same report to the regulatory authorities.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.; Sender's Comments: A causal association between BNT162B2 and the event hyperpyrexia cannot be excluded based on compatible temporal relation. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to RAs, Ethics Committees, and Investigators, as appropriate.",,,,,,,,,N,12/27/2020,12/27/2020,0.0,Test Date: 20201227; Test Name: Fever; Result Unstructured Data: Test Result:120 Fahrenheit; Comments: Fever up to 120F,UNK,,,,,,USPFIZER INC2020516279,2,01/04/2021,,,,,True
249,918791,01/04/2021,MA,58.0,,,F,,"30 minutes after receiving vaccine, patient reported heart racing, dizziness, flushing, burning pain in her chest, dizziness. tachycardia, nausea and throat tightness; 30 minutes after receiving vaccine, patient reported heart racing, dizziness, flushing, burning pain in her chest, dizziness. tachycardia, nausea and throat tightness; 30 minutes after receiving vaccine, patient reported heart racing, dizziness, flushing, burning pain in her chest, dizziness. tachycardia, nausea and throat tightness; 30 minutes after receiving vaccine, patient reported heart racing, dizziness, flushing, burning pain in her chest, dizziness. tachycardia, nausea and throat tightness; 30 minutes after receiving vaccine, patient reported heart racing, dizziness, flushing, burning pain in her chest, dizziness. tachycardia, nausea and throat tightness; 30 minutes after receiving vaccine, patient reported heart racing, dizziness, flushing, burning pain in her chest, dizziness. tachycardia, nausea and throat tightness; 30 minutes after receiving vaccine, patient reported heart racing, dizziness, flushing, burning pain in her chest, dizziness. tachycardia, nausea and throat tightness; This is a spontaneous report from a contactable pharmacist. A 58-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number= EH9899), intramuscular on 19Dec2020 07:00 at SINGLE DOSE at Left arm for covid-19 immunization. Medical history included breast cancer female and allergies to shell fish and Latex. The patient's concomitant medications were not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. 30 minutes after receiving vaccine on 19Dec2020 07:30 am, patient reported 'heart racing, dizziness, flushing, burning pain in her chest, dizziness. tachycardia, nausea and throat tightness. Patient was taken to the ED where she received IV Benadryl and was observed for 4 hours. Patient was discharged home and symptoms subsided. The events resulted in emergency room/department or urgent care. Prior to vaccination, the patient was not diagnosed with COVID-19 and since the vaccination, the patient was not been tested for COVID-19. Outcome of the events was recovered in Dec2020.; Sender's Comments: There is a plausible temporal relationship between immunization and onset of allergic reaction in a subject with a positive medical history for allergy to food (shellfish); causality cannot be completely excluded. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to regulatory authorities, Ethics Committees, and Investigators, as appropriate.",,,,,,,,,Y,12/19/2020,12/19/2020,0.0,,UNK,,,,Medical History/Concurrent Conditions: Breast cancer female; Latex allergy; Shellfish allergy,,USPFIZER INC2020516671,2,01/04/2021,,,Y,,True
251,918793,01/04/2021,NC,69.0,,,M,,"Sudden onset Acoustic Neuritis without Labyrinthitis, hyperacusis, loss of hearing, fullness in ears, dizziness and tinnitus.; Sudden onset Acoustic Neuritis without Labyrinthitis, hyperacusis, loss of hearing, fullness in ears, dizziness and tinnitus.; Sudden onset Acoustic Neuritis without Labyrinthitis, hyperacusis, loss of hearing, fullness in ears, dizziness and tinnitus.; Sudden onset Acoustic Neuritis without Labyrinthitis, hyperacusis, loss of hearing, fullness in ears, dizziness and tinnitus.; Sudden onset Acoustic Neuritis without Labyrinthitis, hyperacusis, loss of hearing, fullness in ears, dizziness and tinnitus.; sore arm; nerve related hearing loss; This is a spontaneous report from a contactable physician reporting for himself.  A 69-years-old male patient received bnt162b2 (BNT162B2; Lot : EKS730) vaccine , intramuscular in the left deltoid  on  21Dec2020 15:30 at single dose for covid-19 immunisation .  Medical history included atrial fibrillation from 2009.  There were no concomitant medications.  The patient stated he experienced sore arm on the same day 21Dec2020 and this was not a big deal. On 26Dec2020 the patient experienced sudden onset of acoustic neuritis without labyrinthitis, hyperacusis,  fullness in ears, dizziness and tinnitus . The patient also experienced nerve related hearing loss from Dec2020. Sore arm was considered non serious events, while the remaining were considered Important Medical Events. The outcome of nerve related hearing loss was recovered, the outcome of sore arm was unknown, while the outcome of the remaining events was recovering.; Sender's Comments: Based on the temporal association, it cannot be fully excluded that the vaccination with BNT162B2 might play a contributory role in the events onset.  The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.",,,,,,,,,N,12/21/2020,12/01/2020,,,PVT,,,,Medical History/Concurrent Conditions: Atrial fibrillation (Verbatim: Atrial fibrillation),,USPFIZER INC2020516832,2,01/01/2021,,,,,True
252,918794,01/04/2021,TN,58.0,,,F,,"I have lost hearing in my right ear; the right side of my face was numb; This is a spontaneous report from a contactable consumer (patient). A 58-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) Batch/lot number number EJ1685, expiration date Mar2021, on 25Dec2020 09:30 at single dose on left arm for Covid-19 vaccination. Medical history and concomitant medications were none. The patient had not received other vaccine in four weeks. The patient had no covid prior vaccination. The patient had no covid tested post vaccination. The patient received her first Covid-19 vaccination on Christmas morning. She worked at a medical center. Within an hour of when she got home, she lost hearing in one ear and also had some numbness on the same side of her face, She was wondering if that was something she should be concerned and she still didn't have hearing in her right ear. Treatment received for the events included Tylenol. The outcome of the events was not resolved.",,,,,,,,,N,12/25/2020,12/25/2020,0.0,,PVT,,,,Comments: List of non-encoded Patient Relevant History: Patient Other Relevant History 1: None,,USPFIZER INC2020517995,2,01/04/2021,,,,,True
253,918795,01/04/2021,CA,43.0,,,F,,"She suspected that she had an undiagnosed autoimmune disease.; Spinal pain that elicits nausea; spinal pain that elicits nausea; Headache that is worse at night/Headache worse at night time, sometimes gets better during the day/bad head ache; Body aches; Feeling crappy; Low grade fever; Pressure in the head; Terrible pain; Neck pain; This is a spontaneous report from a contactable other health professional (patient). A 43-yearsold female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 19Dec2020 at single dose for covid-19 immunization. The patient's medical history and concomitant medications were not reported. The patient received Covid19 vaccine on 19Dec2020 and reported that at 36 hours she had body aches, feeling crappy, and low grade fever in Dec2020, she had since developed at headache that is worse at night, and spinal pain that elicits nausea. She suspected that she had an undiagnosed autoimmune disease. She was inquiring about duration of the reported AE's from clinical trials, and tried to decide how long she will feel this way. And going on 10 days and she's just struggling, bad headache and neck pain headache worse at night time, sometimes gets better during the day. Terrible pain and nausea. Any info on length of side effects: 36 hours- body aches feeling crappy. Low grade fever. Nausea with the spinal pain, pressure in the head. Difference in people with autoimmune issues- infertility - suspected autoimmune. The outcome of the events was unknown.  Information on the lot/batch number has been requested.; Sender's Comments: Based on the information currently available, there is no biological plausibility to implicate the suspect vaccine to the occurrence of the serious event autoimmune disease. More information such as medical history and concomitant medications and confirmative diagnostic workups are needed for full medial assessment.  The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.",,,,,,,,,U,12/19/2020,12/01/2020,,,UNK,,,,,,USPFIZER INC2020518140,2,01/01/2021,,,,,True
256,918799,01/04/2021,NY,67.0,,,F,,"disoriented; hit her head and cut herself; hit her head and cut herself; Passed out at night; This is a spontaneous report from a contactable consumer (patient). A 67-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EK5730), via an unspecified route of administration on 23Dec2020 at single dose at left arm for COVID-19 immunization. Medical history included Atrial fibrillation/heart problems diagnosed prior to the vaccine, got the COVID virus on 18Nov2020, disoriented in Nov2020. Concomitant medications included her heart medication every day and vitamins, nothing out of the normal. Caller stated she had heart problems. The heart problems were diagnosed prior to the vaccine. Caller also stated that she got the COVID virus this year before the vaccine as well and she was off, of work for like a month. On 23Dec2020 she got the vaccine. Then on Thursday 24Dec2020 and Friday 25Dec2020 she had a reaction. She had passed out in the night, hit her head and cut herself, she was then disoriented for 1 full day. Caller stated that the last time she was disoriented like this was when she had the COVID Virus, because she had heart problems. Caller stated that she was fine now. Caller stated that she had been off, of work so much. The heart problem she had was Atrial Fibrillation. Caller clarified that she had the COVID virus this year in Nov2020, it was before thanksgiving, on 18Nov2020 she had the virus, then on 19Nov2020 she got tested and it was positive. She got the vaccine on the 23Dec2020 Wednesday then on 24Dec2020 at night she passed out and on 25Dec2020 she was disoriented all day. Investigation Assessment: No. On 24Dec2020 she was going to bathroom, and found herself on the floor, then the following day 25Dec2020 was when she was disoriented. She knew this because when she had the actual COVID virus previous in Nov2020 this happened previously. When queried outcome of being disoriented she stated that she still felt a little weird but if getting better very, very slow. The Second dose was schedule for 13Jan2021. Caller confirmed that she did have a Positive Test for Covid Previously. Her treatment at the time was in the Emergency Room, they gave her an Antibody infusion, she had to schedule it because it was actually a clinical trial. Caller was asked if she knew the name of covid test, she stated that she does not know, she only recalled that she opened her mouth and they test her that way. The outcome of the event ""disoriented"" was recovering, of the other events was unknown.",,,,,,,,,N,12/23/2020,12/24/2020,1.0,Test Date: 20201119; Test Name: Test for Covid; Test Result: Positive,UNK,,,,Medical History/Concurrent Conditions: Atrial fibrillation (diagnosed prior to the vaccine); COVID-19; Disorientated,,USPFIZER INC2020518909,2,01/04/2021,,,,,True
258,918801,01/04/2021,MD,,,,U,,"Bell's Palsy; This is a spontaneous report from a contactable consumer or other non HCP. This consumer reported same events for three patients (nurses). This is 2nd of 3 reports. A patient of an unknown age and gender received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, also reported as COMIRNATY), via an unspecified route of administration on unknown date in Dec2020 at single dose for covid-19 immunization. The patient's medical history and concomitant medications were unknown. Healthcare worker reported that 3 nurses who work in her facility received Pfizer's COVID vaccine last week (Dec2020) came in with Bell's Palsy in Dec2020. Event took place after use of product. The outcome of event was unknown.   No follow-up attempts are possible. Information about batch/Lot number cannot be obtained.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2020519105 same reporter, same drug, same event, different patients;US-PFIZER INC-2020519119 same reporter, same drug, same event, different patients",,,,,,,,,U,12/01/2020,12/01/2020,0.0,,UNK,,,,,,USPFIZER INC2020519118,2,01/04/2021,,,,,True
263,918974,01/04/2021,MO,,,,F,,"being tested positive; being tested positive; felt very sick; congestion; This is a spontaneous report from a contactable other healthcare professional (patient herself). A female patient of an unspecified age received her first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiration date not reported), via an unspecified route of administration on an unspecified date at single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient felt very sick and that's not her normal. The patient felt great after getting the vaccine she hadn't felt that in a while. Today (23Dec2020) the patient had this congestion and 4 -5 people came back positive post covid-19 vaccination on unknown date. All of them sent home after being tested positive. The patient just someone to keep track, she just wanted Pfizer to know. She didn't have any problems, she was working COVID patients. They had a lot new cases. She just didn't feel 100%. The patient wanted to know if it's safe for her to get the second dose after being tested COVID positive post vaccination. The outcome of events was unknown.; Sender's Comments: The information available in this report is limited and does not allow a medically meaningful assessment of the case. The company cannot completely exclude a causal relationship between the reported events and vaccination with BNT162B2. Additional information regarding therapy vaccination date, lot number and investigation results will aid in comprehensive assessment of the case.",,,,,,,,,U,,12/23/2020,,Test Name: COVID-19; Result Unstructured Data: Test Result:positive,UNK,,,,,,USPFIZER INC2020510637,2,01/03/2021,,,,,True
267,918980,01/04/2021,AL,39.0,,,M,,"guillain barre syndrome; stroke; left thigh burning; Left b/l gluteal burning/bilateral gluteal burning; paresthesia; mid back burning; right side burning / right thigh burning; b/l hand numbness/bilateral hand numbness; left facial numbness; b/l foot numbness/bilateral foot numbness; This is a spontaneous report from a contactable physician (patient). A 39-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/lot number: EK5730), via an unspecified route of administration on 19Dec2020 at single dose for prevention.  Medical history included none. There were no concomitant medications. Caller states, he received the covid vaccine 19Dec2020 and on 25Dec2020 he was experiencing left facial numbness, b/l foot numbness, b/l hand numbness on 26Dec2020, right side burning on 28Dec2020, Today (29Dec2020) he has had left thigh burning, and Left b/l gluteal burning and paresthesia. No motor issues and no tendon issues, all intact. Also had mid back burning on 28Dec2020 that comes and goes. He has heard that there is a described neuropathy with the virus and/or with the vaccine and wants more information on that. Curious if anyone has anything similar? and makes mention of possible Gillian Barre Syndrome. States that he has had a potential reaction. He had his dose on 19Dec2020. On 25Dec2020 he developed left facial numbness, then later that day he developed bilateral foot numbness. On 26Dec2020, he developed bilateral hand numbness, on 28Dec2020 he developed right thigh burning, and today (29Dec2020) he has developed left thigh burning, and bilateral gluteal burning and paresthesia. States that he has been kind of freaking out about it. He doesn't have any motor issues. States that he heard that there is a described neuropathy with the virus, but not with the vaccine, is that true? The left facial numbness resolved on either 26Dec2020 or 27Dec2020. States that the symptoms were concerning because it could have been a stroke. States his symptoms were moderate. States that due to the bilateral foot and hand numbness, he had a LP, brain and spine MRI, and blood work done on 26Dec2020. All came back completely normal. When asked about causality, caller states that it makes the most sense for his symptoms to be caused by the vaccine due to his age and the fact that all his testing was completely normal. Reporter seriousness for left facial numbness, bilateral foot numbness, bilateral hand numbness, right thigh burning, left thigh burning and bilateral gluteal burning and paresthesia: Medically significant. The outcome of the event left facial numbness was recovered in Dec2020. The outcome of the events guillain barre syndrome, stroke and mid back burning was unknown. The outcome of the other events was not recovered.; Sender's Comments: Based on the temporal relationship the association between the reported serious adverse events with BNT162b2 can not be fully excluded.  The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to regulatory authorities, Ethics Committees, and Investigators, as appropriate.",,,,,,,,,N,12/19/2020,12/25/2020,6.0,Test Date: 20201226; Test Name: Blood work; Result Unstructured Data: Test Result:Normal; Test Date: 20201226; Test Name: LP; Result Unstructured Data: Test Result:Normal; Test Date: 20201226; Test Name: Brain and spine MRI; Result Unstructured Data: Test Result:Normal; Test Date: 20201226; Test Name: Brain and spine MRI; Result Unstructured Data: Test Result:Normal,UNK,,,,Comments: List of non-encoded Patient Relevant History: Patient Other Relevant History 1: None,,USPFIZER INC2020518534,2,01/04/2021,,,,,True
270,919022,01/04/2021,MD,28.0,28.0,,M,,Complete loss of vision in the left eye 12 hours after receiving second dose (Moderna mRNA-1273) while having a fever of 102 F for 6 hours.  Loss of vision lasted for 1 minute.  Loss of vision occurred while standing.  Referral to primary care and ophthalmology specialist found normal eye exam and MRI of orbits but  presence of tachycardia especially while standing (fluctuations between 60 beats at rest/laying down to 130 beats per minute standing).   Postural tachycardia syndrome (POTS)  is suspected.  Currently pursuing cardiac workup with cardiologist and Covid POTS specialist.  POTS specialist believes autoantibody development after vaccination could be suspected as recovering covid patients similarly present to clinic with POTS like symptoms.,,,,,,,,Y,N,09/02/2020,09/02/2020,0.0,"Eye exam, MRI of brain and orbits, Holter monitor, EKG, Echocardiogram, CT cardiac calcium score.",PVT,,"Dutastride 0.5 mg/day, Wellbutrin XL 300 mg/day, Truvada (emtricitabine 200 mg and tenofovir disoproxil fumarate 300 mg)/day.",,,,,2,01/04/2021,,Y,,doxycycline-gastrointestinal.,True
284,919444,01/04/2021,NY,34.0,34.0,,F,,"12/21 had covid vaccine (dose 1). On evening of 12/29 had sudden onset of mild neck pain and significant weakness and numbness of left arm, weak hand grip, clumsiness in hand . Did not improve after trying to shake arm/move around , and took prednisone 40mg oral. Went to ER and had CT Cspine which did not show evidence of cervical pathology. Continued with corticosteroids, sought consultation with PMR and neurology specialists, and steroid dose increased to 60mg/day.   Some improvement in strength , but still have diminished sensation and strength in left hand/arm. Unable to perform full job tasks as I am left hand dominant.  Likely brachial neuritis / parsonage turner syndrome per both specialists seen. Continuing with corticosteroids at this time, pending bloodwork and OT evaluation",,,,,,,,Y,N,12/21/2020,12/29/2020,8.0,12/30 - ct cspine,PVT,,Balziva ( birth control ),None,"Scoliosis, IBS",,,2,01/04/2021,,Y,Y,None,True
307,919818,01/05/2021,CA,33.0,33.0,,F,,"Received covid vaccine 1/2 at 2pm. Around 7pm that night, left arm pain and slight itching of whole body. did not think much of it.  woke up once in middle of night at 4am with racing heart but went back to sleep.  Around 9 am next morning started getting chills, initially mild then severe and developed severe myalgias; could not get out of bed or lift arms or limbs.  having chest tightness and shortness of breath. pressing on chest wall hurts, hard to take deep breath.  Temps of 99.5 most of morning.  started taking tylenol total of 1 gram.  1 hour after tylenol shaking and rigors with sweating. had temp of 101 after tylenol. HR 110 at this time (my baseline is around 60s).  O2 sat remained normal.  Went to ER for testing for covid in case this was covid--test negative.   Felt a little better morning of 1/4--no fever.  tried to work 1/2 day; called out sick.  lots of brain fog, fatigue mental slowing.  still having intermittent chest tightness and sob; feel like i cannot expand my lungs.  deep breath makes me cough. had few small red bumps on left antecubital fossa that resolved.  i'm a physician, i'm concerned this was a severe reaction and was advised to report this.",,,,,,,,,N,01/02/2021,01/03/2021,1.0,ER 1/3 Covid nasopharyngeal swab  PCP visit 1/3  UC visit for CXR 1/4--awaiting results,PVT,,none,none,none,"HPV vaccine, swelling of joints in fingers (dactylitis)--10/6/2013",,2,01/05/2021,,Y,Y,"Keflex, HPV vaccine",True
340,919906,01/05/2021,MO,,,,F,,"tested positive for covid; tested positive for covid; coughing; congestion; could not sleep that night; her temperature is still low/temperature was lower around 96 or 97; fever; This is a spontaneous report from a contactable consumer (patient). A female patient of an unspecified age received first dose of BNT162B2 (Pfizer-BIONTECH Covid-19 Vaccine, lot number: EH9899), via an unspecified route of administration on 15Dec2020 at a single dose, for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient received the Covid-19 shot 8 days ago on 15Dec2020. She tested positive for COVID on 23Dec2020. She worked in the emergency room, clarified she was a certified Nurse Assistant (CNA). She was hesitant about taking the COVID-19 vaccine. She was curious since she has been around the virus 24/7 since the pandemic started since she works in the emergency room. When she took the COVID-19 shot, stated she felt great the next day and could not sleep at night in Dec2020 which is not normal for her. It's nothing like the flu shot. It was strange since she has been around the virus all this time, she felt like she had COVID in Feb2020, but she was not tested then. She does not ever get sick and she was down for two days with a fever in Dec2020. After those two days, she always had a low-grade fever of 98 or 99 which was constant. After she took the COVID vaccine her temperature was normal, her temperature was lower around 96 or 97 in Dec2020. She woke up on 23Dec2020 and she had congestion and her temperature was still low. She went to work, and she was told she looked like she had no sleep. She was coughing 23Dec2020 morning, but she did not have any symptoms as far as temperature. She realized that the COVID 19 shot is only 50% effective. She is asking if she should get the second dose. The outcome of events was unknown.",,,,,,,,,U,12/15/2020,12/01/2020,,"Test Date: 202012; Test Name: Temperature; Result Unstructured Data: Test Result:98 or 99; Comments: had a low grade fever of 98 or 99 which was constant; Test Date: 202012; Test Name: Temperature; Result Unstructured Data: Test Result:96 or 97; Comments: she took the covid vaccine her temperature was normal, clarifies her temperature was lower around 96 or 97; Test Date: 202012; Test Name: Temperature; Result Unstructured Data: Test Result:low; Comments: her temperature is still low; Test Date: 20201223; Test Name: COVID; Result Unstructured Data: Test Result:Positive; Comments: She just tested positive for covid as of today",UNK,,,,,,USPFIZER INC2020511220,2,01/04/2021,,,,,True
341,919907,01/05/2021,,,,,U,,"30 mins after vaccination caller was notified patient tested positive for covid; 30 mins after vaccination caller was notified patient tested positive for covid; This is a spontaneous report from a contactable pharmacist. A patient of unspecified age and gender received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on an unspecified date at single dose for immunization. The patient's medical history and concomitant medications were not reported. 30 mins after vaccination caller was notified patient tested positive for covid on an unspecified date with outcome of unknown.    Information on the lot/batch number has been requested.; Sender's Comments: Based on the information currently available (30 mins after vaccination Covid test found positive), no effect of the suspect vaccine could be reasonably achieved to protect from the targeted infection/disease due to the very short time lag.  Instead, the positive COVID represents the pre-existing infection prior to vaccine use.  Further information like confirmative COVID 19 Nucleic acid/ PCR test together with any associated symptoms are needed for full medical assessment.",,,,,,,,,U,,,,Test Name: Covid; Test Result: Positive,UNK,,,,,,USPFIZER INC2020511373,2,01/04/2021,,,,,True
343,919909,01/05/2021,CA,33.0,,,M,,"Tested positive for covid; Tested positive for covid; This is a spontaneous report from a contactable nurse (patient). A 33-year-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EH9899) intramuscularly at right arm on 18Dec2020 14:30 at single dose for COVID-19 immunization. Medical history included asthma. No allergies to medications, food, or other products. The patient's concomitant medications were not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient developed severe nasal burning sensation the first two days of injection along with severe headache that lasted for 4 days. He lost his sense of taste and smell (23Dec2020) 5 days after vaccine was administered, tested positive for Covid (23Dec2020 16:30) with use of ABBOTT rapid test which was performed at his employment. Pending Covid nasal swab fulgent which was obtained on 23Dec2020 and sent out to reference lab. Patient was just wondering if any of these symptoms and/or testing positive after administration was a rare side effect. The adverse event resulted in doctor or other healthcare professional office/clinic visit. No treatment received for the adverse events. Prior to vaccination, the patient was not diagnosed with COVID-19. The outcome of the events was not recovered.; Sender's Comments: Vaccine BNT162B2 provides protection to COVID-19 after at least 7 days have elapsed from the second dose (21 days post first injection). These conditions are not met in the present report. The reported symptoms are compatible with COVID-19 illness.",,,,,,,,,N,12/18/2020,12/23/2020,5.0,Test Date: 20201223; Test Name: ABBOTT rapid test; Test Result: Positive  ; Test Date: 20201223; Test Name: Nasal swab fulgent; Result Unstructured Data: Test Result:Pending,PVT,,,,Medical History/Concurrent Conditions: Asthma,,USPFIZER INC2020511668,2,01/03/2021,,Y,,,True
344,919910,01/05/2021,MN,68.0,,,F,,"positive for Covid with symptoms; positive for Covid with symptoms; positive for streph; positive for influenza; This is a spontaneous report from a contactable physician and nurse. A 68-year-old female patient received bnt162b2, via an unspecified route of administration on 17Dec2020 at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient experienced positive for COVID with symptoms, positive for streph and positive for influenza in Dec2020. Additional Context: caller stated that she had a patient that got Covid vaccine on 17Dec2020 who was complaining of muscle aches, no fever, sudden loss of taste and smell in the last 24 hours, sore throat and a cough. Stated that she cannot attribute the cough to the vaccine. Stated that she was screened for COVID, streph and influenza. Stated that she was positive for covid and streph. Stated that she does not think that and wanted to know if the vaccine would cause a positive from a rapid test. Outcome of the events was unknown.  The Lot/Batch and expiry date has been requested.; Sender's Comments: The reported positive for COVID with symptoms after immunization with BNT162B2 is considered related to the suspect, BNT162B2.",,,,,,,,,U,12/17/2020,12/01/2020,,Test Date: 202012; Test Name: influenza test; Test Result: Positive  ; Test Date: 202012; Test Name: covid test; Test Result: Positive  ; Test Date: 202012; Test Name: streph test; Test Result: Positive,OTH,,,,,,USPFIZER INC2020511919,2,01/03/2021,,,,,True
346,919917,01/05/2021,NY,43.0,,,F,,"had another COVID test with positive results on 23Dec; had another COVID test with positive results on 23Dec; This is a spontaneous report from a contactable consumer. A 43-year-old female patient received bnt162b2 (BNT162B2, lot number and expiry date were not reported), via an unspecified route of administration on 18Dec2020 at a single dose for covid-19 vaccination. The vaccination was done in the hospital. The patient's medical history and concomitant medications were not reported. The patient was initially tested negative for covid-19 on 13Dec2020. The patient was not pregnant. The patient believed she may have been infected with COVID as early as 13Dec2020 based on symptoms but test results at that time came back negative. She had vaccine on 18Dec2020 and when symptoms hadn't resolved had another COVID test with positive results on 23Dec2020. The event resulted to a doctor or other healthcare professional office/clinic visit. There was not treatment for the event. The reporter considered the events as non-serious. The outcome of the event was recovering.   Information about batch/lot number has been requested.",,,,,,,,,N,12/18/2020,12/23/2020,5.0,Test Date: 20201213; Test Name: COVID test; Test Result: Negative  ; Test Date: 20201223; Test Name: COVID test; Test Result: Positive,PVT,,,,,,USPFIZER INC2020513078,2,12/31/2020,,Y,,,True
348,919934,01/05/2021,NM,,,,F,,"Received the vaccine and tested positive for Covid today; Received the vaccine and tested positive for Covid today; This is a spontaneous report from a contactable nurse. This Nurse reported similar events for two different patients. This is second of two reports.  A female patient of an unspecified age received bnt162b2, via an unspecified route of administration on 21Dec2020 at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient received the vaccine and tested positive for covid today (24Dec2020).It was further reported that the patient showed up positive today (24Dec2020) and her symptoms have been on and off, she just got her vaccine 21Dec2020. The outcome of the event was unknown.   Information on the lot/batch number has been requested.; Sender's Comments: Preventive effect of BNT162b2 is documented after 7 days from the second dosing. This case does not match this requirement.,Linked Report(s) : US-PFIZER INC-2020513367 same reporter/drug. different patient and event.",,,,,,,,,U,12/21/2020,12/24/2020,3.0,Test Date: 20201224; Test Name: Covid; Test Result: Positive,UNK,,,,,,USPFIZER INC2020513377,2,01/03/2021,,,,,True
349,919938,01/05/2021,NM,,,,F,,"Drug ineffective; tested positive; chills; fever; headache; This is a spontaneous report from a contactable nurse. This nurse reported similar events for two patients. This is 2nd of two reports.   A female patient of an unspecified age (30-40 year-old)started to receive bnt162b2 (BNT162B2) , via an unspecified route of administration on 02Dec2020 at single dose for covid-19 immunisation .  The patient medical history and concomitant medications were not reported.  The patient was tested positive to COVID-19 on 24Dec2020 after having chills, fever and a headache. The outcome of the events was unknown. The reporter stated that these were worse than just side effects. The reporter is wondering if the patient can receive the second dose.  Information on the lot/batch number has been requested.; Sender's Comments: Preventive effect of BNT162b2 is documented 7 days after the 2 dose. This case does not match this requirement,Linked Report(s) : US-PFIZER INC-2020512742 different patient, same drug and event",,,,,,,,,U,12/02/2020,12/01/2020,,Test Date: 20201224; Test Name: COVID-19; Test Result: Positive,UNK,,,,,,USPFIZER INC2020513401,2,01/04/2021,,,,,True
350,919949,01/05/2021,,,,,F,,"tested positive for covid; tested positive for covid; This is a spontaneous report from a Pfizer-sponsored program, Pfizer First Connect. A contactable consumer (patient) reported that a female patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number and expiration date were not reported), via an unspecified route of administration on 23Dec2020 at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient received the COVID vaccine on Wednesday this week (23Dec2020) and she tested positive for COVID yesterday (25Dec2020). She wanted to know if she should take the second dose of the vaccine. Outcome of the events was unknown.  Information on the lot/batch number has been requested.",,,,,,,,,U,12/23/2020,12/25/2020,2.0,Test Date: 20201225; Test Name: covid test; Test Result: Positive,UNK,,,,,,USPFIZER INC2020513575,2,12/31/2020,,,,,True
351,919951,01/05/2021,,,,,F,,"I received the covid-19 vaccine and then afterwards contracted covid-19; I received the covid-19 vaccine and then afterwards contracted covid-19; This is a spontaneous report from a contactable nurse.  A female patient of an unspecified age received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on an unspecified date at single dose for covid-19 vaccine.  The patient medical history and concomitant medications were not reported.  The patient stated on an unspecified date, ""I received the covid-19 vaccine and then afterwards contracted covid-19. I was told by my hospital that because of this I needed to defer the second dose for 90 days. Is this best practice? Or should I take the second dose in 3 weeks as scheduled?"". The outcome of the events was unknown.    Information on the batch/lot number has been requested.; Sender's Comments: BNT162b2 provides protection against COVID-19 seven days after the second dose is administered. This case does not match this condition",,,,,,,,,U,,,,Test Name: COVID-19; Test Result: Positive,PVT,,,,,,USPFIZER INC2020513592,2,01/03/2021,,,,,True
355,919984,01/05/2021,TX,46.0,,,F,,"tested positive for COVID with symptoms such as nasal congestion, sore throat, weakness, and flu-like symptoms; tested positive for COVID with symptoms such as nasal congestion, sore throat, weakness, and flu-like symptoms; This is a spontaneous report from a contactable physician (patient). A 46-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) (lot number EJ1685), via an unspecified route of administration on 20Dec2020 at single dose for covid-19 immunization. Vaccine location was left deltoid. The facility type vaccine was hospital. Medical history included polycystic ovarian diseases from an unknown date. Concomitant medication included metformin, omeprazole, apremilast (OTEZLA). Patient stated she got the vaccine on the 18th. She took the vaccine on 20Dec2020. Yesterday (25Dec2020) she started to feeling sick and today (26Dec2020) patient got tested and she have Covid. She reported to have tested positive for COVID today (26Dec2020) with symptoms such as nasal congestion, sore throat, weakness, and flu-like symptoms yesterday at around 4:00pm. This was the first time she has taken the Covid test. The physician stated she didn't know the causality between the event and vaccine. The action taken in response to the events for BNT162B2 was not applicable. The outcome of events was unknown.; Sender's Comments: Based on the information available, a possible contributory role of the suspect BNT162B2 cannot be excluded for the reported event positive test for COVID based on the known safety profile. However the short duration of 5 days since the vaccine first dose is given it is unlikely patient would have fully developed immunity.",,,,,,,,,U,12/20/2020,12/25/2020,5.0,Test Date: 20201226; Test Name: COVID test; Result Unstructured Data: Test Result:positive,PVT,,;  ; OTEZLA,,Medical History/Concurrent Conditions: Polycystic ovarian syndrome,,USPFIZER INC2020513763,2,12/31/2020,,,,,True
359,920004,01/05/2021,,,,,U,,"Coworker who received the shot is positive too; Coworker who received the shot is positive too; This is a spontaneous report from a contactable consumer. This consumer reporter similar events for two patients. This is the second of two reports. A patient of unspecified age and gender received bnt162b2 (BNT162B2, lot number and expiry date were not reported), via an unspecified route of administration on an unspecified date at a single dose for covid-19 vaccination. The patient's medical history  concomitant medications were not reported. The reporter's coworker who received the shot was positive too. The outcome of the event was unknown.  Information about lot/batch number has been requested.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2020513735 same reporter/product, different patient, similar event",,,,,,,,,U,,,,Test Name: COVID test; Test Result: Positive,UNK,,,,,,USPFIZER INC2020513859,2,12/31/2020,,,,,True
360,920015,01/05/2021,,,,,F,,"Caller stated that she received covid vaccine on Tuesday and was tested positive on Friday.; Caller stated that she received covid vaccine on Tuesday and was tested positive on Friday.; This is a spontaneous report from a contactable nurse reporting for herself.  A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE lot number and expiration date not reported), via an unspecified route of administration on Dec2020 at single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient stated that she received the vaccine on Tuesday (Dec2020) and was tested positive on Friday (Dec2020). The patient stated she was told that vaccine was contraindicated in people who have COVID-19. The outcome of the events was unknown.  Information on the Lot/Batch number has been requested.; Sender's Comments: Based on the information currently available, a lack of efficacy with BNT162B2 in this patient might not be completely excluded.",,,,,,,,,U,12/01/2020,12/01/2020,0.0,Test Date: 202012; Test Name: covid; Test Result: Positive  ; Comments: tested positive on Friday,UNK,,,,,,USPFIZER INC2020514008,2,01/04/2021,,,,,True
363,920043,01/05/2021,NC,29.0,,,F,,"All of a sudden I did not have any taste or smell; All of a sudden I did not have any taste or smell; Tested positive; Tested positive; This is a spontaneous report from a contactable nurse reported for herself. A 29-year-old female patient received bnt162b2 ((PFIZER-BIONTECH COVID-19 VACCINE, batch/lot EH9899), via an unspecified route of administration on 22Dec2020 at single dose for covid-19 immunisation. Medical history included seasonal allergy. Concomitant medication included cetirizine hydrochloride (ZYRTEC [CETIRIZINE HYDROCHLORIDE]). The patient was taking a multivitamin a day. The patient experienced typical symptoms no taste, smell on 22Dec2020, Slight tingling, body aches, chills, all the other symptoms for Covid and now positive for Covid in Dec2020. Outcome of events was unknown.; Sender's Comments: Based on the information available, a possible contributory role of the suspect BNT162B2 cannot be excluded for the reported event positive for Covid based on the known safety profile.",,,,,,,,,U,12/22/2020,12/01/2020,,Test Date: 202012; Test Name: tested; Test Result: Positive  ; Test Name: weight; Result Unstructured Data: Test Result:179,PVT,,ZYRTEC [CETIRIZINE HYDROCHLORIDE],,Medical History/Concurrent Conditions: Seasonal allergy,,USPFIZER INC2020514155,2,12/31/2020,,,,,True
364,920059,01/05/2021,NY,35.0,,,F,,"I am not feeling well; had a Covid PCR done swapped on yesterday and I am Covid positive; had a Covid PCR done swapped on yesterday and I am Covid positive; This is a spontaneous report from a contactable nurse. This nurse reported for herself that the 35-year-old female patient who received bnt162b2 (BNT162B2), via unknown route of administration on 23Dec2020 at single dose for covid-19 immunisation. Medical history was none. Concomitant medications were none. Nurse stated, ""I received the Pfizer Vaccine this Wednesday and right before getting the vaccine, I had a Covid test (captured as per verbatim) on before the vaccine on Tuesday (22Dec2020) was negative. I had a Covid PCR done swapped on yesterday (25Dec2020) and I am Covid positive. So I have the vaccine and I am Covid positive"" Nurse stated ""It's ""140"" ""130"" pounds (further bot clarified)."" The patient was not feeling well. The outcome of the events was unknown.   Information on the lot/batch number has been requested.; Sender's Comments: Based on the limited available information, the company considers that a causal relationship between the SARS-CoV-2 test positive and vaccination with BNT162B2 cannot be excluded.",,,,,,,,,U,12/23/2020,12/25/2020,2.0,Test Date: 20201222; Test Name: Covid test/Covid PCR; Result Unstructured Data: Test Result:Negative; Comments: I had a Covid test (captured as per verbatim) on before the vaccine on Tuesday (22Dec2020) was negative.; Test Date: 20201225; Test Name: COVID-19 PCR test; Result Unstructured Data: Test Result:Positive; Comments: I had a Covid PCR done swapped on yesterday and I am Covid positive.,PVT,,,,Comments: List of non-encoded Patient Relevant History: Patient Other Relevant History 1: none,,USPFIZER INC2020514561,2,01/01/2021,,,,,True
374,920130,01/05/2021,CA,40.0,,,F,,"Angioedema; This is a spontaneous report from a contactable Other Health Professional (patient). A 40-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE) lot number: EL1284, intramuscular in the right arm (also reported as right shoulder), first dose on 22Dec2020 00:30 at a single dose for Covid-19 immunization. The patient's relevant medical history included severe reaction to some animal dander and pollen, severe reactions to poison oak, possible drug induced reactions (unspecified) post C-section, mild rash with influenza vaccine this year (2020) (with no other hx of adverse reaction to a vaccine); had allergies to pollen, mold, some animals. The patient previously took influenza vaccine (split virion, inactivated) and experienced rash. The patient had no covid prior vaccination nor was she tested post vaccination. Adverse event reported was angioedema on 24Dec2020 with outcome of recovering. Systems started appearing on 23Dec2020 evening with slight rash and fluid collection under right eye. Developed more rash on 24Dec2020. In the evening to early morning of 25Dec2020, symptoms worsened significantly. Rapid swelling to face occurred. Swelling was concentrated around eyes and cheeks the most. Both right and left side of the face and neck were affected. However, the right side face had a more pronounced reaction. MD ordered oral prednisone and Benadryl as treatment plan. Also, ordered episode-pen for a worst case scenario. Symptoms have been improving under treatment but still persist some. The events were reported as non-serious. The adverse event start date was 24Dec2020 (as reported). The event resulted in doctor or other healthcare professional office/clinic visit.; Sender's Comments: There is a reasonable possibility that the event angioedema was related to BNT162b2 based on known drug safety profile and temporal relationship.  The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to regulatory authorities, Ethics Committees, and Investigators, as appropriate.",,,,,,,,,N,12/22/2020,12/24/2020,2.0,,PVT,,,,Medical History/Concurrent Conditions: Allergy to animal; Allergy to animal dander; Allergy to molds; C-section; Poison oak rash; Pollen allergy,,USPFIZER INC2020516168,2,01/04/2021,,Y,,,True
376,920146,01/05/2021,CO,,,,F,,"tested positive; tested positive; Symptoms experiencing include having no taste, smell and slight bodyache; Symptoms experiencing include having no taste, smell and slight bodyache; Symptoms experiencing include having no taste, smell and slight bodyache; This is a spontaneous report from a Pfizer-sponsored program IBCC (Inbound Call Center for HCPs). A contactable other-healthcare professional (patient) reported that a female patient of an unspecified age received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 17Dec2020 at single dose for covid-19 immunization. The patient's medical history and concomitant medications were not reported. The patient was tested positive on 24Dec2020, and symptoms experiencing include having no taste, smell and slight body ache in Dec2020. The patient asked if she could get the second dose. The outcome of the events was unknown.   Information about the Lot/batch number has been requested.; Sender's Comments: Based on the limited available information, the company considers that a causal relationship between the COVID-19, with symptoms of having no taste, smell and slight body ache, and vaccination with BNT162B2 cannot be excluded.",,,,,,,,,U,12/17/2020,12/01/2020,,Test Date: 20201224; Test Name: tested; Test Result: Positive,UNK,,,,,,USPFIZER INC2020516267,2,01/01/2021,,,,,True
379,920156,01/05/2021,,,,,U,,"tested positive for covid; tested positive for covid; This is a spontaneous report from a Pfizer-sponsored program Pfizer First Connect. A contactable Pharmacist reported similar events for 2 patients. This is the first of two reports. A patient of unspecified age and gender received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration on 14Dec2020 at single dose for covid-19 immunization. The patient medical history and concomitant medications were not reported. Caller is a pharmacist asked if there is a contraindication for administering antibody therapy to a person after they have received the first dose of the covid vaccine. He reported that there are 2 patients that received the covid vaccine the week of 14Dec and subsequently tested positive for covid on the 23rd and 24th of December. He was trying to determine the safety of administering antibody therapy for those patients even though they already got the first vaccine dose. He reported this question has some urgency and needed the information within 48 hours. Attempted to warm transfer but caller reported that he does not have any patient specific information or identifiers at this time. Escalating Urgently for additional research. Outcome of event was unknown.   Information on the lot/batch number has been requested.; Sender's Comments: Based on the limited available information, the company considers that a causal relationship between the event ""tested positive for COVID"" and vaccination with BNT162B2 cannot be excluded.,Linked Report(s) : US-PFIZER INC-2020516661 same reporter/ drug/ AE, different patient",,,,,,,,,U,12/14/2020,12/01/2020,,Test Date: 20201223; Test Name: covid; Result Unstructured Data: Test Result:positive; Test Date: 20201224; Test Name: covid; Result Unstructured Data: Test Result:positive,UNK,,,,,,USPFIZER INC2020516319,2,01/01/2021,,,,,True
386,920183,01/05/2021,,,,,U,,"tested positive for covid; tested positive for covid; This is a spontaneous report from a Pfizer-sponsored program Pfizer First Connect. A contactable Pharmacist reported similar events for 2 patients. This is a 2nd of two reports. A patient of unspecified age and gender received BNT162B2, via an unspecified route of administration on 14Dec2020 at single dose for covid-19 immunization.  The patient medical history was not reported.  The patient's concomitant medications were not reported.  The reporter was a pharmacist asking if there was a contraindication for administering antibody therapy to a person after they had received the first dose of the covid vaccine. He reported that there was a patient that received the covid vaccine the week of 14Dec and subsequently tested positive for covid on the 23rd and 24th of December. The reporter was trying to determine the safety of administering antibody therapy for the patient even though the patient already got the first vaccine dose.  The reporter reported this question had some urgency and needed the information within 48 hours. The patient underwent lab tests and procedures which included covid test: positive on 23Dec2020, positive on 24Dec2020. The outcome of the events was unknown.   Information on the lot/batch number has been requested.; Sender's Comments: Based on the limited available information, the company considers that a causal relationship between the COVID test positive and vaccination with BNT162B2 cannot be excluded.,Linked Report(s) : US-PFIZER INC-2020516319 same reporter/ drug/ AE, different patient",,,,,,,,,U,12/14/2020,12/23/2020,9.0,Test Date: 20201223; Test Name: covid test; Test Result: Positive  ; Test Date: 20201224; Test Name: covid test; Test Result: Positive,UNK,,,,,,USPFIZER INC2020516661,2,12/31/2020,,,,,True
388,920212,01/05/2021,TN,,,,U,,"Received the first dose of the vaccine; Have now tested positive; Received the first dose of the vaccine; Have now tested positive; This is a spontaneous report from a  pharmacist. It was reported that a patient of unspecified age and gender received bnt162b2 (BNT162B2) vaccine , via an unspecified route of administration on an unspecified date at single dose for covid-19 immunisation .  The patient medical history  and concomitant medications were not reported.  The patient  received the first dose of the vaccine; and have now tested positive.  The patient underwent lab tests and procedures which included sars-cov-2 test: positive  No follow-up attempts are possible; information about lot/batch number cannot be obtained.; Sender's Comments: Based on the limited available information, the company considers that a causal relationship between the reported events and vaccination with BNT162B2 cannot be excluded.",,,,,,,,,U,,,,Test Name: tested; Result Unstructured Data: Test Result:positive,UNK,,,,,,USPFIZER INC2020517772,2,12/31/2020,,,,,True
389,920224,01/05/2021,TX,35.0,,,M,,"had a positive COVID test; had a positive COVID test; O2 Saturation of 80% / Hypoxia; shortness of breath; He has a CT scan which showed extensive infiltration in the lungs; muscle pain; chills; body aches; low grade fever; cough; This is a spontaneous report from a contactable physician (pulmonary medicine). This physician reported similar events for 2 patients. This is 1st of 2 reports.   A 35-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 18Dec2020 at single dose for covid-19 immunization. There were no medical history and concomitant medications. Caller stated that his close friend who was ER physician (front line worker) and within 24 hours after receiving the COVID vaccine, developed COVID or symptoms of COVID. Patient received the COVID vaccine on 18Dec2020 and the same night patient started with a low grade fever, body aches, chills, muscle pain, shortness of breath, cough, O2 saturation of 80% (hypoxia) and was in the intensive care unit now. Patient swore this was related to the vaccine. This patient tested positive for COVID. He had a CT (computerised tomogram) scan which showed extensive infiltration in the lungs in Dec2020. Patient was admitted to the hospital on 24Dec2020 and then was moved to the ICU 2 days later, on 26Dec2020. Caller thought patient had a positive COVID test at another hospital. Caller did know that tested positive at the current hospital on 26Dec2020 which was done to confirm the previous positive test. Caller thought patient had his first positive COVID test either the same day or the next day after receiving the vaccine. Event of O2 Saturation of 80% / hypoxia was reported as hospitalization from 24Dec2020 and life threatening; infiltration in the lungs and shortness of breath caused hospitalization from 24Dec2020, muscle pain, chills and positive COVID test was reported as medically significant; and other events were reported as non-serious.  Outcome of O2 saturation of 80% / hypoxia and shortness of breath was not recovered, outcome of cough was recovering; and outcome of other events were unknown.    Information about lot/batch number has been requested. ; Sender's Comments: Based on the information currently available, a lack of efficacy with suspected vaccine BNT162B2 in this patient cannot be completely excluded.,Linked Report(s) : US-PFIZER INC-2020519020 same reporter/drug , different patient/AE.",,,Y,,Y,,,,N,12/18/2020,12/01/2020,,Test Date: 202012; Test Name: CT scan; Result Unstructured Data: Test Result:showed extensive infiltration in the lungs; Test Date: 20201218; Test Name: O2 saturation; Result Unstructured Data: Test Result:80%; Test Date: 20201226; Test Name: COVID test; Test Result: Positive,UNK,,,,Comments: List of non-encoded Patient Relevant History: Patient Other Relevant History 1: None,,USPFIZER INC2020518143,2,01/03/2021,,,Y,,True
391,920236,01/05/2021,,,,,F,,"patient received the first dose of COVID 19 vaccine on 16Dec2020. She got tested positive on 20Dec2020; patient received the first dose of COVID 19 vaccine on 16Dec2020. She got tested positive on 20Dec2020; This is a spontaneous report from a contactable nurse (patient).  A female patient of an unspecified age received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration on 16Dec2020 at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient received the first dose of COVID 19 vaccine on 16Dec2020. She got tested positive on 20Dec2020. The patient wanted to know if it's safe for her to get the second dose of covid-19 vaccine scheduled for 07Jan2021. Outcome of the event was unknown.  Information on the Batch/Lot number has been requested.; Sender's Comments: Based on the information currently available, a lack of efficacy with BNT162B2 in this patient might not be completely excluded.",,,,,,,,,U,12/16/2020,12/20/2020,4.0,,UNK,,,,,,USPFIZER INC2020518548,2,01/04/2021,,,,,True
392,920239,01/05/2021,,,,,M,,"anaphylactic shock/numb throat; high heart rate; light headed; anaphylactic shock/numb throat; This is a spontaneous report from a contactable consumer (patient himself).  A male patient of an unspecified age (reported as 39: unknown unit) received bnt162b2 (BNT162B2 also reported as PFIZER-BIONTECH COVID-19 VACCINE, lot/batch number and expiry date were not reported), via an unspecified route of administration on 22Dec2020 at single dose, for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient experienced anaphylactic shock, numb throat, high heart rate and light headed on an on 22Dec2020. The outcome of events was unknown.    Information on the lot/batch number has been requested.",,,,,,,,,U,12/22/2020,12/22/2020,0.0,,UNK,,,,,,USPFIZER INC2020518612,2,01/04/2021,,,,,True
393,920247,01/05/2021,IN,,,,M,,"tested positive for COVID-19; tested positive for COVID-19; feeling sick; This is a spontaneous report from a consumer or other non hcp.    A male patient of an unspecified age received bnt162b2 (BNT162B2) vaccine, via an unspecified route of administration on  22Dec2020 at single dose for covid-19 immunisation .  The patient medical history and concomitant medications were not reported.  On 24Dec2020   the patient was sick and was  tested positive for covid-19, the outcome of the event was unknown.   Information about Lot/Batch number has been requested.",,,,,,,,,U,12/22/2020,12/24/2020,2.0,Test Name: COVID-19; Result Unstructured Data: Test Result:positive,UNK,,,,,,USPFIZER INC2020519031,2,12/31/2020,,,,,True
417,920961,01/05/2021,CA,39.0,,,F,,"result back w positive covid; positive COVID-19 test with symptoms; This is a spontaneous report from a contactable nurse reporting for herself.  A 39-years-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), via an unspecified route of administration on 19Dec2020 11:00 (at age 39 years old) as a single dose (Dose 1) in the left arm for COVID-19 vaccination. The patient was not pregnant at the time of vaccination. The patient was not administered any other vaccine in the 4 weeks prior to COVID-19 vaccination.  Medical history was none. There were no allergies to medication, food, or other products. The patient's concomitant medications were not reported; however the patient had not received any other medications in the last 2 weeks. The patient experienced a sore throat, voice loss on day 4, loss of smell on day 5, went to test, and the result came back with positive COVID. The events resulted in a Doctor's office visit. The patient was tested post vaccination on 22Dec2020 via NAAT-PCR (nasal swab), with a positive result. The patient had not been diagnosed with COVID-19 prior to vaccination. There was no treatment received for the event(s). The clinical outcome of the event positive COVID was unknown The event was reported as non-serious.  The lot number for the vaccine, BNT162B2, was not provided and will be requested during follow up.; Sender's Comments: The association between the event drug ineffective (COVID-19 infection) with BNT162b2 can not be fully excluded.",,,,,,,,,U,12/19/2020,12/22/2020,3.0,Test Date: 20201222; Test Name: NAAT-PCR; Test Result: Positive,PVT,,,,Comments: List of non-encoded Patient Relevant History: Patient Other Relevant History 1: None,,USPFIZER INC2020513662,2,01/04/2021,,Y,,,True
418,920964,01/05/2021,,,,,F,,"tested positive for covid19/diagnosed with Covid; tested positive for covid19/diagnosed with Covid; she had SOB the day of her first vaccination; I am very sick; I feel bad; This is a spontaneous report from a contactable consumer (patient). A female patient of an unspecified age received 1st dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EH9899), via an unspecified route of administration on 21Dec2020 at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient got the first dose of COVID-19 vaccine on Monday, 21Dec2020 and then was diagnosed with COVID-19 on 23Dec2020. Added that she was very sick and wondering if he'll get her second dose or not. The patient feel bad and is due for her second dose on 11Jan2021. The patient also reported that she had shortness of breath (SOB) the day of her first vaccination on 21Dec2020 and then tested positive for COVID-19 later. She posits she may have received the vaccine when she had an active COVID-19 infection. She is wondering if she can still get her second vaccination. Outcome of the events was unknown.",,,,,,,,,U,12/21/2020,12/01/2020,,Test Date: 20201223; Test Name: Covid 19; Test Result: Positive,UNK,,,,,,USPFIZER INC2020514073,2,01/05/2021,,,,,True
419,920965,01/05/2021,PA,58.0,,,F,,"tested positive for COVID-19; headache; cough; voice being hoarse; Drug ineffective; This is a spontaneous report from a Pfizer Sponsored Program Pfizer First Connect from a Contactable nurse reporting for herself.  A 58-years-old female patient received bnt162b2 (BNT162B2; Lot # EK5730) vaccine , via an unspecified route of administration on 18Dec2020 10:30 at single dose for covid-19 immunisation .  Medical history included hypertension from an unknown date and blood cholesterol increased.  Concomitant medication included losartan (LOSARTAN), hctz (HCTZ), ezetimibe (ZETIA), famotidine (PEPCID).  The patient  started having a headache and cough on 25Dec2020 and these symptoms worsened on 26Dec2020 in addition to her voice being hoarse. On 26Dec2020 she went to get tested at an urgent center and tested positive for Covid-19. The outcome of the event was not recovered.; Sender's Comments: The association between the event ""tested positive for COVID-19, headache, cough, and dysphonia"" with BNT162b2 can not be fully excluded.  The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to regulatory authorities, Ethics Committees, and Investigators, as appropriate.",,,,,,,,,N,12/18/2020,12/25/2020,7.0,Test Date: 20201226; Test Name: covid_tested_post_vaccination; Test Result: Positive,PVT,,; HCTZ; ZETIA; PEPCID,,Medical History/Concurrent Conditions: High cholesterol; Hypertension,,USPFIZER INC2020514087,2,01/04/2021,,,Y,,True
420,920968,01/05/2021,CT,30.0,,,F,,"It looks like one of the ingredients may have an animal cell lipid; Syncope; Dizziness; feeling faint; like going to pass out now and then; overall achiness, severe headaches, fever; overall achiness, severe headaches, fever; overall achiness, severe headaches, fever; This is a spontaneous report from a contactable nurse reporting for herself.  This A 30-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) (Lot # EH9899), intramuscular at single dose in the left arm on 22Dec2020 09:00 for covid-19 immunisation. Medical history included reaction to pork, porsine and/or if she ever was exposed to exposed to heparin. There were no concomitant medications. On 23Dec2020, the patient experienced syncope (medically significant), dizziness (medically significant), feeling faint; like going to pass out now and then (medically significant), overall achiness, severe headaches, fever. The outcome of the events syncope, dizziness, feeling faint; like going to pass out now was recovering and outcome of overall achiness, severe headaches, fever was recovered on 24Dec2020. The patient ask: are there any animal products, pork gelatin or a lipid form of that contain in the vaccine?   The events were described as follows: She experienced a significant amount of syncope and dizziness, for greater than 4 or 5 days post-receiving the vaccination. Also feeling faint like she is going to pass out every now and then. Has a more important question, wondering along with the doctors if one of the ingredients may have an animal product, like pork gelatin or a lipid form of that. It looks like one of the ingredients may have an animal cell lipid and was wondering if she was having a reaction to that. Declines to provide primary care provider details. States she received this first dose at occupational health in her workplace. Received the vaccine on the 22Dec2020 at 9am. 24 hours post vaccination, 1 day after, the syncope, dizziness, feeling faint started. Also the other symptoms, overall achiness, severe headaches, and fever were also experienced, but they stopped after that 24 hours. Those were expected since it was listed as side effects that popped up, so she expected those and they stopped after 24 hours. The syncope, dizziness, and faint feeling are not any worse and are very slowly improving, but she still has it and had to call out of work today because of it. That's consistent. Mentions it takes her a while to get down the stairs when getting product details for the COVID-19 vaccine. Unable to provide the vaccine NDC or expiry, or dose. Did not have any other vaccines at time of this one and none 4 weeks prior. Had to call a (company withheld) doctor and has to go to occupational health tomorrow to be seen. Declines having COVID virus. No further details provided.; Sender's Comments: Based on the compatible time association, the events syncope and dizziness are possibly related to suspect BNT162B2 administration. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.",,,,,,,,,N,12/22/2020,12/23/2020,1.0,,PVT,,,,Medical History/Concurrent Conditions: Allergy to animal; Food allergy,,USPFIZER INC2020515878,2,01/05/2021,,,,,True
421,920970,01/05/2021,VA,51.0,,,M,,"positive COVID-19 antigen test with symptoms (ache, cough, fever); positive COVID-19 antigen test with symptoms (ache, cough, fever); This is a spontaneous report from a contactable physician (patient). A 51-year-old male patient received the first dose bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number EH9899), via an unspecified route of administration on 17Dec2020 at 10:30 at single dose in left arm for covid-19 immunization. Medical history included borderline diabetes, ongoing hypertension, ongoing hyperlipidemia, ongoing rhinitis allergic, and currently ill. Concomitant medication included ongoing fexofenadine hydrochloride (ALLEGRA, strength: 180 mg) at 180mg once daily by mouth for Rhinitis allergic taking for years, ongoing lisinopril (strength: 40 mg) at 40 mg once daily by mouth for hypertension taking for two or three years, ongoing atorvastatin (strength: 40 mg) at 40 mg once daily by mouth for hyperlipidemia taking for a year. The patient experienced positive covid-19 antigen test with symptoms (ache, cough, fever) from 19Dec2020. Event details: The patient received the COVID 19 Vaccine on 17Dec2020 10:30AM in the left arm. Tested for COVID 19 with the antigen test, on 20Dec2020 and his result was positive, he experienced ache and cough on 19Dec2020. Clarified he started having symptoms in the evening (19Dec2020) and then tested in the morning (20Dec2020). He experienced the low grade fever on 20Dec2020. His maximum temperature was 100.4 fahrenheit. He had only been treated with over the counter products. No further information provided for the over the counter products. He was not hospitalized. He will take the second dose of the COVID 19 vaccine on 07Jan2021. The patient didn't have SARS-CoV2 antibodies at diagnosis. The patient was not admitted to an Intensive Care Unit. The patient didn't display clinical signs at rest indicative of severe systemic illness. The patient didn't require supplemental oxygen (including high flow or ECMO) or receive mechanical ventilation. The patient didn't have any pre-existing diseases worsened during the SARS-CoV2 infection. The patient was not treated with immunomodulating or immunosuppressing medications or received any other vaccines around the time of COVID-19 vaccination. The outcome of all his symptoms was resolving.; Sender's Comments: The reported events drug ineffective and COVID-19 are likely intercurrent and are unrelated to suspect drug BNT162B2 based on short temporal relation between vaccination and onset of events.",,,,,,,,,N,12/17/2020,12/19/2020,2.0,Test Date: 20201220; Test Name: Fever; Result Unstructured Data: Test Result:100.4 Fahrenheit; Test Date: 20201220; Test Name: COVID-19 antigen test; Result Unstructured Data: Test Result:Positive,PVT,,ALLEGRA;  ;,Hyperlipidemia; Hypertension; Rhinitis allergic,Medical History/Concurrent Conditions: Borderline diabetes; Illness,,USPFIZER INC2020515927,2,01/05/2021,,,,,True
424,920974,01/05/2021,,43.0,,,F,,"developed rashes on the chest area, not spreading; This is a spontaneous report from a contactable nurse (patient).  A 43-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number EK5730), via an unspecified route of administration into the left deltoid on 18Dec2020 as the first single dose for covid-19 immunization.  Medical history was reported as none.  Concomitant medication included rosuvastatin calcium (CRESTOR).  The patient developed rashes on the chest area, not spreading on 22Dec2020.  The event as reported between not serious and medically significant by the reporter.  Details were as follows: and patient was a nurse  that had her vaccine through her workplace on 18Dec2020, so she was 10 days out, and noticed a rash on her chest on day 4, which was still present. It did not seem to be spreading, and she could not  think of any reason for the reaction. She was scheduled to receive the second dose in three weeks.  The outcome of developed rashes on the chest area, not spreading was not recovered. The relatedness of the event to the suspect drug was reported as unknown from the reporter.; Sender's Comments: Based on the information currently provided, the vaccination with BNT162B2 might play a contributory role in triggering the onset of rash. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.",,,,,,,,,N,12/18/2020,12/22/2020,4.0,,UNK,,CRESTOR,,Comments: List of non-encoded Patient Relevant History: Patient Other Relevant History 1: None,,USPFIZER INC2020516077,2,01/04/2021,,,,,True
442,921037,01/05/2021,AZ,21.0,,,F,,"nauseous; weak; no appetite; numbness on the skin of my arms and legs; I was post Ictal for 2+ hours; seizures/having 2 non epileptic seizures; dizzy and lightheaded; This is a spontaneous report from a contactable nurse (patient). A 21-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE. Batch/lot number: EK5730), intramuscularly on 28Dec2020 07:45 AM at right arm, at single dose for covid-19 immunization. Medical history was none. There were no concomitant medications. The patient was not pregnant at the time of vaccination. The patient received vaccine around 7:45 AM. Within 2 minutes she felt extremely dizzy and lightheaded on 28Dec2020. She sat down and drank some Gatorade and took deep breaths. The feelings persisted 5 minutes later. She then woke up after having 2 non epileptic seizures while still in 15m waiting period, (This included posturing and color change) a rapid response was called and she was taken to the ER. She was post Ictal for 2+ hours. Dizzy and nauseous, weak and no appetite for the rest of the day. She had no history of epilepsy. She also have numbness on the skin of my arms and legs within 24 hours of the vaccine. Onset date of all events (except dizzy and lightheaded) was reported as 28Dec2020 08:00AM. Treatment fluids, Zofran was received for all events. All event resulted in emergency room. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The outcome of the events was recovered with sequel.; Sender's Comments: A possible contributory effect of suspect BNT162BW on reported seizures cannot be excluded.  The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to regulatory authorities, Ethics Committees, and Investigators, as appropriate.",,,,,,,,,N,12/28/2020,12/28/2020,0.0,,PVT,,,,Comments: List of non-encoded Patient Relevant History: Patient Other Relevant History 1: None,,USPFIZER INC2020518338,2,01/05/2021,,Y,Y,,True
444,921057,01/05/2021,AZ,48.0,,,M,,"Hypertensive crisis; Numbness to my left ear; progressively it went down to my mandible, my face and my left  shoulder numbness; Radial blood pressure cough; This is a spontaneous report from a contactable nurse reporting for himself. A 48-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EH9899), via an unspecified route of administration on 28Dec2020 at single dose for covid-19 immunization. Medical history reported as none. There were no concomitant medications. During the administration the patient did experience some types of reaction where it wanted medical supervision. So, basically when he did got the injection he was waiting for his 15 minute prolapse. But within probably he would say 7 to 8 minutes he started to experiencing some numbness to his left ear and usually he thought it was secondary to the that he had (not clarified) but progressively it went down to his mandible, his face and his left  shoulder numbness and he was experiencing some numbness that radiate towards his fingertips only to the left side. At that time he waived to the Nurse to supervise and at that time he wait again and a Physician came over. He checked his pulse and noted that he had normal rhythm during the pulse check and at that time and he had Emergency medical technician (EMT) come over. The EMT checked his blood pressure he thought multiple times through the left and to the right brachial. He was having what they would consider a hypertensive crisis where systolic were in 170's, 180's, diastolic numbers were between like 120's and 130's and his heart rate was in 70's. So, initially it was not anxiety induced. But he do not have no blood pressure. They wanted he to go to the hospital to treat the hypertensive crisis that was in. The patient opted not to. So he went home in a quieter environment he did have a radial blood pressure cough that he had been checking his blood pressure rigorously, tried different techniques and now he was back to normal state to 120-130 systolic and his diastolic was 70-80. This instance was weird that he did not see as a part of one of the side effects listed with Pfizer BioNTech Vaccine. No treatment received for the events, because he had no history of hypertension it was just more of decreasing the ambient around he. At that time he wanted to go to a quiet environment, took a shower and check his blood pressure. He did orthostatic while laying down sitting up, standing up and he was not hypertensive. For the causality, the nurse stated, ""I think it did. This is a fact I mean I was doing fine prior to administration and then this event is slowly subsiding."" The outcome of the events was recovering.; Sender's Comments: A possible contributory effect of suspect BNT162B2 on reported hypertensive crisis cannot be excluded.  The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to regulatory authorities, Ethics Committees, and Investigators, as appropriate.",,,,,,,,,N,12/28/2020,12/28/2020,0.0,"Test Date: 20201228; Test Name: blood pressure; Result Unstructured Data: Test Result:between like 120's and 130's; Test Date: 20201228; Test Name: blood pressure; Result Unstructured Data: Test Result:diastolic is 70-80; Test Date: 20201228; Test Name: blood pressure; Result Unstructured Data: Test Result:were in 170's, 180's; Test Date: 20201228; Test Name: blood pressure; Result Unstructured Data: Test Result:120-130 systolic; Test Date: 20201228; Test Name: heart rate; Result Unstructured Data: Test Result:70's; Test Date: 20201228; Test Name: pulse; Result Unstructured Data: Test Result:normal rhythm",UNK,,,,Comments: List of non-encoded Patient Relevant History: Patient Other Relevant History 1: None,,USPFIZER INC2020519036,2,01/05/2021,,,,,True
445,921058,01/05/2021,MI,,,,F,,"huge welt on her arm; This is a spontaneous report from a contactable nurse (patient). A female patient of an unspecified age received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration on an unspecified date at a single dose for covid-19 immunization. Medical history included covid-19 from end of Oct2020 to an unknown date. The patient's concomitant medications were not reported. The patient reported that she is an nurse in the ICU. She had received the 1st dose of the vaccine after she had covid the end of Oct2020. Her reaction to the vaccine was, she felt exactly how she did when she had covid. It lasted 3 days. She had a huge welt on her arm. Her pulmonologist suggested that she contact Pfizer for advice on if or when she should receive the 2nd dose, which is currently due 08Jan2021. Outcome of the event huge welt was unknown.  Information on the lot/batch number has been requested.; Sender's Comments: Based on available information, a possible contributory role of the subject product, BNT162B2 vaccine, cannot be excluded for the reported event of giant urticaria due to temporal relationship.  There is limited information provided in this report.  Additional information is needed to better assess the case, including complete medical history, diagnostics, counteractive treatment measures and concomitant medications.  This case will be reassessed once additional information is available.  The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.",,,,,,,,,U,,,,,UNK,,,,Medical History/Concurrent Conditions: COVID-19,,USPFIZER INC2020519776,2,01/04/2021,,,,,True
446,921060,01/05/2021,GA,,,,F,,Appendicitis / colic pain to her right midsection; This is a spontaneous report from a contactable Other-HCP (Nurse Practitioner).   A female patient of an unspecified age received bnt162b2 (BNT162B2) at single dose on 20Dec2020 for covid-19 immunisation.  The patient medical history and concomitant medications were not reported.  In Dec2020 3 days after vaccination she experienced colic pain to her right midsection. She was diagnosed with appendicitis. The outcome of events was unknown.  Information about lot/batch number has been requested.; Sender's Comments: The event appendicitis is most likely an intercurrent medical condition and is assessed as unrelated to BNT162B2.,,,,,,,,,U,12/20/2020,12/01/2020,,,UNK,,,,,,USPFIZER INC2020519876,2,01/05/2021,,,,,True
458,921249,01/05/2021,,51.0,,,M,,"Contracted Covid after receiving the first vaccine; Contracted Covid after receiving the first vaccine; This is a spontaneous report from a contactable consumer (patient). A 51-year-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 21Dec2020 at single dose for covid-19 immunisation.  Medical history included asthma, dry cough due to inhalation from fires over the years.  The patient's concomitant medications were not reported. Contracted Covid after receiving the first vaccine was reported. The patient received the first dose of the Covid vaccine, then contracted Covid. He now had the option to receive antibodies through plasma. Since he had the vaccine, was that still an option? Or was that a no-no? He received the vaccine at work on 21Dec2020. He got sick on 22Dec2020 and he was at home. He didn't feel like eating, and can't lay down because it made it worse to cough. He didn't know what vitamins they were giving him. The patient probably should be in a hospital, but was not. The outcome of events was not recovered.  Information on Lot/Batch number has been requested.",,,,,,,,,N,12/21/2020,12/22/2020,1.0,Test Date: 20201222; Test Name: Contracted Covid; Test Result: Positive,WRK,,,,Medical History/Concurrent Conditions: Asthma; Dry cough (due to inhalation from fires over the years.),,USPFIZER INC2020518851,2,01/05/2021,,,,,True
462,921293,01/05/2021,,,,,M,,"Tested positive for COVID-19; Tested positive for COVID-19; Sick; He got the chills and later came down with muscle aches and fatigue; He got the chills and later came down with muscle aches and fatigue; He got the chills and later came down with muscle aches and fatigue; His arm was sore for a day; This is a spontaneous report from a Pfizer-sponsored program Corporate (Pfizer) Social Media Platforms. A non-contactable consumer reported for a 45-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 18Dec2020 at single dose for covid-19 immunization. The patient's medical history and concomitant medications were not reported. The patient experienced his arm was sore for a day on 18Dec2020 but he suffered no other side effects. Six days later on Christmas Eve (24Dec2020), after working a shift in the COVID-19 unit, the patient became sick. He got the chills and later came down with muscle aches and fatigue. The day after Christmas (26Dec2020), he went to a drive-up hospital testing site and tested positive for COVID-19. The patient was feeling better since his symptoms peaked on Christmas Day but still felt fatigued. The outcome of event fatigue was not recovered, the outcome of the events sick, chills, muscle aches was recovering, the outcome of other events was unknown.  No follow-up attempts are possible. Information about lot/batch number cannot be obtained.; Sender's Comments: The efficacy of a drug varies from one patient to another and can be affected by different factors; however, a contributory role of the suspect drug BNT162B2 to the reported events drug ineffective and COVID-19 cannot be ruled out.",,,,,,,,,N,12/18/2020,12/18/2020,0.0,Test Date: 20201226; Test Name: COVID-19; Test Result: Positive,UNK,,,,,,USPFIZER INC2020520014,2,01/05/2021,,,,,True
467,921387,01/05/2021,,43.0,,,F,,"positive for covid; positive for covid; positive for covid; This is a spontaneous report from a contactable nurse (patient). A 43-year-old female patient received 1st dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 18Dec2020 at a single dose for COVID-19 immunization. completely excluded.  More information such as laboratory findings on nucleic acid /PCR test needed for meaningful medical assessment.The patient's medical history and concomitant medications were not reported. The patient tested positive for COVID on 20Dec2020. Outcome of the events was unknown.  Information on the lot/batch number has been requested.; Sender's Comments: Based on the information currently available, a lack of efficacy with the suspected vaccine BNT162B2 in this patient cannot be completely excluded.  More information such as virus genome /nucleic acid detection needed for meaningful medical assessment",,,,,,,,,U,12/18/2020,12/20/2020,2.0,Test Date: 20201220; Test Name: covid; Test Result: Positive,UNK,,,,,,USPFIZER INC2020520757,2,01/05/2021,,,,,True
469,921465,01/05/2021,RI,51.0,51.0,,F,,"51-year-old female with history of intermittent asthma presented to the ED with 1 week of intermittent fevers, myalgias, arthralgias and headache.  Patient reports receiving first dose of moderna vaccine last week.  She initially developed arm soreness followed by chills and body aches.  Subsequently developed frontal headache, photophobia, back pain, nausea and vomiting.  She was seen in the ER on 1/1/21, when her work-up including labs, CT spine, chest x-ray were negative therefore she was discharged home. She continued to have symptoms and also developed bilateral intermittent ear pain.  She also developed rash in her extremities and torso. Rash is pruritic but not painful. reports ongoing history of neck pain for which she sees PT.  Denies sore throat, cough, chest pain or shortness of breath.",,,,,Y,,,,N,12/27/2020,12/30/2020,3.0,,PVT,,,,,,,2,01/05/2021,,,,,True
489,922218,01/05/2021,CO,41.0,41.0,,F,,"3  Days after the covid vaccine. I Started  to have these symptoms around 1am:  fever, chills, body aches, cold sweats.  I took ibuprofen  fell asleep. Around 330am. Woke up with dizziness, headache, chills. Took tylenol. Fell asleep body was extremely cold esp hands and feet. Woke up around 7am.  Still had severe body aches and was extremely dizzy, headache worsening.  Took ibuprofen. Woke up around noon. Extremely dizzy with chills and body aches headache still severe. Took tylenol.  I was not getting better.  went to hospital . It was found I had extremely high wbc and had extremely low blood pressure.  Diagnosed as septic shock.",,,,,Y,4.0,,,Y,12/23/2020,12/26/2020,3.0,,PUB,,Entyvio,,Crohns disease,,,2,01/05/2021,,,Y,,True
514,922300,01/06/2021,MA,41.0,41.0,,F,,"EE starting with migraine about 5 minutes after receiving vaccine. That night had rash to trunk and back with the chills. Took benadryl that night. Next am, had swollen eyes and hands. Within 24 hours,those sx resolved- but then had 48 hours of sx similar to past covid infection.",,,,,,,,,Y,12/23/2020,12/23/2020,0.0,,WRK,,,,,,,2,01/06/2021,,,,,True
539,923278,01/06/2021,,,,,U,,"had covid and also received the Pfizer covid 19 vaccine.; had covid and also received the Pfizer covid 19 vaccine.; This is a spontaneous report from a contactable nurse. A patient of unspecified age and gender started received single dose of BNT162B2 (Solution for injection, batch/lot number and exp date not reported), via an unspecified route of administration on an unspecified date for immunization. The patient's medical history and concomitant medications were not reported. They have a patient that meets the criteria to receive product bamlanivimab. The patient had Covid and received the Pfizer covid 19 vaccine. The nurse asked if patient can still get the bamlanivimab after receiving vaccine. The outcome of the events was unknown.  No follow-up attempts are possible; information about batch number cannot be obtained.; Sender's Comments: Based on the information currently available, it is unclear if Covid developed after BNT162B2 Pfizer covid 19 vaccine, pending further clarification, at this moment, the Company would handle the reported COVID related to the suspect, BNT162B2, for reporting purpose.",,,,,,,,,U,,,,Test Name: COVID; Result Unstructured Data: Test Result:had Covid,UNK,,,,,,USPFIZER INC2020518219,2,01/05/2021,,,,,True
543,923290,01/06/2021,NY,,,,F,,"tested positive for COVID-19 by PCR the following day and developed covid symptoms; tested positive for COVID-19 by PCR the following day and developed covid symptoms; This is a spontaneous report from a contactable physician (patient). A female patient of an unspecified age received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on an unspecified date at single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient received the first dose of the Pfizer-biontech covid-19 vaccine and tested positive for COVID-19 by PCR the following day and developed COVID symptoms. The outcome of the events was unknown.  Information on the lot/batch number has been requested.; Sender's Comments: The reported tested positive for COVID-19 by PCR after COVID-19 immunization is considered ineffective of BNT162B2, and the Company cannot completely exclude the possible causality between the reported event and BNT162B2 administration.",,,,,,,,,U,,,,Test Name: COVID-19; Test Result: Positive,UNK,,,,,,USPFIZER INC2020518902,2,01/05/2021,,,,,True
545,923294,01/06/2021,CA,53.0,,,F,,"Tested positive for COVID after receiving the vaccine/runny nose and felt achy/coughing/ dizzy and weak. It was affecting her legs and she had no taste; Tested positive for COVID after receiving the vaccine/runny nose and felt achy/coughing/ dizzy and weak. It was affecting her legs and she had no taste; This is a spontaneous report from a Pfizer-sponsored program IBCC (Inbound Call Center for HCPs). A contactable consumer (patient) reported a 53-year-old female received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/lot number: Unknown, did not see this information on the vaccination card), via an unspecified route of administration in the left arm on 20Dec2020 at single dose for covid-19 immunization (certified nurse assistant in healthcare). Other products, patient history and investigation assessment was No. There were no concomitant medications. The patient was vaccinated with the COVID Vaccine on 20Dec2020 but tested positive afterwards on 27Dec2020. The patent thought she had COVID in the vaccine and COVID in her body. She was scheduled for next dose on 10Jan2021 and would like to know if she should get the scheduled dose or if she needs to wait longer and re-schedule it. She was now a COVID patient and sick. She was waiting to get better. Before the vaccine she tested negative and felt great. Then she got the vaccine. She had a runny nose and felt achy. She asked her coworker, and her coworker felt the same. She thought if it continued that maybe it was a side effect. Caller confirmed her symptoms were runny nose, feeling achy, and coughing. She took Tylenol and the aches went away. They then came back, and she had more aching and she was wondering why. Caller clarified that these symptoms did not start the next day after receiving the vaccine. Achiness/body aches was started on 23Dec2020 when she was at work. It would wake her up at night. She did have aches right now, but her fever had lowered down. She was also dizzy and weak. It was affecting her legs and she had no taste. She was not eating but needs to eat. If she did, she eat something sweet. Runny nose was started on 24Dec2020. She went back to work on 26Dec2020 but told them she could not work because she had symptoms of COVID. She went to her second job where they do COVID testing and asked her boss for a test. She tested positive on 27Dec2020. Dose was unknown. She said she thought she got 1 vial. The whole thing. The outcome of events ""tested positive for COVID after receiving the vaccine"" was not recovered.   Information on lot/batch number has been requested.",,,,,,,,,N,12/20/2020,12/01/2020,,Test Name: Covid; Result Unstructured Data: Test Result: negative; Test Date: 20201227; Test Name: Covid; Result Unstructured Data: Test Result:Positive,UNK,,,,Comments: List of non-encoded Patient Relevant History: Patient Other Relevant History 1: None,,USPFIZER INC2020519185,2,01/05/2021,,,,,True
549,923324,01/06/2021,MN,64.0,,,M,,"Bell's palsy on the left side of his face; Headaches; Overall was not feeling well; This is a spontaneous report from contactable consumers (including the patient). A 64-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number EH9899), via an unspecified route of administration in right arm on 18Dec2020 04:00 at a single dose for covid-19 vaccination. There were no relevant medical history and concomitant medications. On, 19Dec2020, the patient had headaches and overall was not feeling well.  On 28Dec2020, the patient experienced bell's palsy on the left side of his face. He said it was a little hard to talk as his mouth was not working at the moment. The provider he saw gave him steroids- Prednisone, and Valaciclovir. He was also told to get some eyedrops as one eye does not close very well. He laughed and said it was a little hard to drink his coffee. The outcome of the events headache and not feeling well was recovered on 21Dec2020 while the outcome of bell's palsy was not recovered.  The information on the batch/lot number and expiration date has been requested.",,,,,,,,,N,12/18/2020,12/19/2020,1.0,,UNK,,,,Comments: List of non-encoded Patient Relevant History: Patient Other Relevant History 1: None,,USPFIZER INC2020520004,2,01/06/2021,,,,,True
550,923325,01/06/2021,MA,43.0,,,F,,"positive COVID-19 test with symptoms; positive COVID-19 test with symptoms; This is a spontaneous report from a contactable physician reporting for a nurse (patient) from a Pfizer-sponsored program Pfizer First Connect.  A 43-year-old female patient received first dose of BNT162B2 (Pfizer Covid-19 vaccine), via an unspecified route of administration on 22Dec2020 at single dose for covid-19 immunisation.  There were no medical history and concomitant medications. The physician was reporting that a nurse received the vaccine and had a headache after receiving it. She also tested positive for Covid 6 days after getting the vaccine (on 28Dec2020). He was asking if there was any connection with getting the first shot and testing positive. She was very keen with social distancing and wearing a mask. The physician is a medical oncologist. He was reporting on one of the nurses that worked at the hospital. She also developed nasopharyngeal congestion 4-5 days later. The nurse was at work today. She was disappointed because she had to go home. The patient underwent lab tests and procedures which included SARS-CoV-2 test: positive on 28Dec2020. The outcome of the events was unknown.   Information on Lot/Batch number has been requested.; Sender's Comments: Based on the current available information and the plausible drug-event temporal association, a possible contributory role of the suspect product BNT162B2 to the development of events Drug ineffective and COVID-19  cannot be totally excluded.  The case will be reassessed if additional information becomes available.",,,,,,,,,U,12/22/2020,12/28/2020,6.0,Test Date: 20201228; Test Name: SARS-CoV-2 test; Result Unstructured Data: Test Result: positive,UNK,,,,Comments: List of non-encoded Patient Relevant History: Patient Other Relevant History 1: None,,USPFIZER INC2020520009,2,01/06/2021,,,,,True
554,923336,01/06/2021,,,,,F,,"tested positive; tested positive; This is a spontaneous report from a contactable Nurse. A female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on 27Dec2020 (reported as about 3 days ago, as of 30Dec2020) at single dose for covid-19 immunisation. Medical history, concomitant medications or past drug history were not provided. She received the vaccine about 3 days ago and later tested positive in Dec2020 and asked if the patient needs to restart the 2 doses series. Outcome of the events were unknown.  Lot/Batch and Expiration date has been requested.; Sender's Comments: The reported events drug ineffective and COVID-19 are likely intercurrent conditions and are unrelated to BNT162B2 based on the short temporal relation between vaccination and onset of event.",,,,,,,,,U,12/27/2020,12/01/2020,,Test Date: 202012; Test Name: test; Test Result: Positive,UNK,,,,,,USPFIZER INC2020520183,2,01/06/2021,,,,,True
555,923337,01/06/2021,,,,,F,,"Caller stated that a patient tested positive for covid 19 after the first dose of the vaccine; Caller stated that a patient tested positive for covid 19 after the first dose of the vaccine; This is a spontaneous report from a contactable Pharmacist. A female patient of an unspecified age (age: 74; unit- unknown) received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration on an unspecified date at single dose for COVID-19 immunization. The patient medical history was not reported. The patient's concomitant medications were not reported. The patient tested positive for COVID 19 after the first dose of the vaccine. Reporter wants to know if the patient can be treated with monoclonal antibodies after having received the vaccine. Reporter also wanted to know if the storage in the thermal shipper can be extended past the 30 days. Event outcome was unknown.  Information on the lot/batch number has been requested.; Sender's Comments: The information currently provided is too limited to make a meaningful medical assessment hence, the events drug ineffective and COVID-19 are conservatively assessed as related to the suspect drug BNT162B2 until further information becomes available.",,,,,,,,,U,,,,Test Name: covid 19; Result Unstructured Data: Test Result:Positive,UNK,,,,,,USPFIZER INC2020520184,2,01/06/2021,,,,,True
556,923338,01/06/2021,,,,,U,,"Patient who got the vaccine a week ago tested positive now for COVID; Patient who got the vaccine a week ago tested positive now for COVID; This is a spontaneous report from a contactable pharmacist. A patient of unspecified age and gender received first dose bnt162b2 (BNT162B2), via an unspecified route of administration on Dec2020 at single dose for covid-19 immunisation. The patient medical history was not reported. The patient's concomitant medications were not reported. The pharmacist reported the patient who got the vaccine a week ago tested positive now for covid on Dec2020 with outcome of unknown. The patient underwent lab tests and procedures which included covid: positive on Dec2020. the doctor is thinking of giving antibody. The event was reported at non-serious.  Information on lot/batch number has been requested.; Sender's Comments: The information currently provided is too limited to make a meaningful medical assessment hence, the events are conservatively assessed as related to the suspect drug BNT162B2 until further information becomes available.",,,,,,,,,U,12/01/2020,12/01/2020,0.0,Test Date: 202012; Test Name: COVID; Test Result: Positive,UNK,,,,,,USPFIZER INC2020520198,2,01/06/2021,,,,,True
564,923354,01/06/2021,,,,,M,,"acute pericarditis; This is a spontaneous report from a contactable physician. A male patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot/batch number not reported), via an unspecified route of administration on 23Dec2020 at a single dose for covid-19 immunization. The patient medical history and concomitant medications were not reported. It was unknown if other vaccines were given in four weeks and unknown if patient had Covid prior vaccination. The patient experienced acute pericarditis on 24Dec2020. Clinical course as follows: Doctor colleagues at the institution admitted (at Emergency room/department or urgent care) and treated a patient with acute pericarditis who received his first dose of Pfizer SARS-CoV-2 EUA vaccine on 23Dec2020. The physician (reporter) considered the event as non-serious. The outcome of the event was recovering.  Information about batch/lot number has been requested.; Sender's Comments: The causal relationship between BNT162B2 and the event acute pericarditis cannot be excluded as the information available in this report is limited and does not allow a medically meaningful assessment. This case will be reassessed once additional information becomes available. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees, and Investigators, as appropriate.",,,,,,,,,N,12/23/2020,12/24/2020,1.0,,UNK,,,,,,USPFIZER INC2020520292,2,01/06/2021,,Y,Y,,True
565,923355,01/06/2021,CA,30.0,,,F,,"received the vaccine last week and tested positive for covid this week; received the vaccine last week and tested positive for covid this week; This is a spontaneous report from a contactable other Healthcare Professional (patient). A 30-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/lot number: Unknown), via an unspecified route of administration on 23Dec2020 at single dose by injection in the right arm for COVID-19 immunization (to be protected and to protect her family with other conditions like diabetes). The patient's medical history and concomitant medications were none. The patient got the first dose of the COVID vaccine last week on 23Dec2020 and then she tested positive for COVID on Monday on 28Dec2020. She was asking if it was safe to get the second dose. Patient was a pharmacy technician. The outcome of the events was not recovered.  Information on the Lot/Batch number has been requested.; Sender's Comments: The causal relationship between BNT162B2 and the events drug ineffective and SARS-CoV-2 test positive cannot be excluded as the information available in this report is limited and does not allow a medically meaningful assessment. This case will be reassessed once additional information becomes available.",,,,,,,,,N,12/23/2020,12/28/2020,5.0,Test Date: 20201228; Test Name: COVID; Result Unstructured Data: Test Result:she tested positive for COVID,UNK,,,,Comments: List of non-encoded Patient Relevant History: Patient Other Relevant History 1: None,,USPFIZER INC2020520305,2,01/06/2021,,,,,True
587,923564,01/06/2021,NJ,,,,M,,"covid; covid; This is a spontaneous report from a contactable physician. A male patient of an unspecified age received single dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, batch/lot number and exp date not reported), via an unspecified route of administration on an unspecified date for immunization. The patient's medical history and concomitant medications were not reported. The physician inquired whether a person with previous history of COVID would experience more significant reaction to the COVID vaccine than a person without a previous diagnosis due to having already produced antibodies. Reporter's colleague (physician) had the vaccine 2 weeks ago, had a severe reaction (unspecified) wherein he got a shot of epi. Patient recovered and was okay. At the time of reporting, patient now had Covid or maybe he had Covid before, reporter was not sure. The outcome of the events was unknown.  Information on the Batch/Lot number has been requested.; Sender's Comments: Based on available information, a possible contributory role of suspect BNT162B2 vaccine cannot be completely excluded for event ""Covid"".",,,,,,,,,U,,,,,UNK,,,,,,USPFIZER INC2020518221,2,01/05/2021,,,,,True
588,923565,01/06/2021,PA,54.0,,,F,,"positive COVID-19 test with symptoms; positive COVID-19 test with symptoms, tested for COVID (PCR); night sweats; Soreness at injection site; slight temp 99.5 degrees/her temperature was 101 degrees Fahrenheit/it was 102.5 degrees Fahrenheit/99 degrees Fahrenheit and then 98 degrees Fahrenheit; Tiredness she related to giving blood; This is a spontaneous report from a contactable nurse (patient). A 54-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL0140) via intramuscular on 19Dec2020 15:45 on left deltoid at a single dose for prevention as frontline health worker at hospital (COVID-19 immunisation). The patient donated blood on 18th and no antibodies were present then. The patient was a former smoker and quit 2 or 3 years ago. Patient diagnosed Osteoporosis in 2015, benign heart arrhythmia in 2005. The patient took 70 mg alendronate sodium (FOSAMAX) once weekly and just a regular OTC daily multivitamin. Caller reported she was having the covid vaccine on 19Dec2020 and began having fever, night sweats, loss of taste and smell and then tested positive for covid. The patient received the Pfizer COVID 19 vaccine through work on 19Dec2020. She received it at 3:45 pm and should have taken temperature before, but she was afebrile the day before because she donated blood. At 7pm, she had slight temp 99.5 degrees Fahrenheit and by 10:30, her temperature was 101 degrees Fahrenheit and she still felt fine. She was surprised that it was that. She woke up at 2:30 am on 20Dec2020 and took her temperature and it was 102.5 degrees Fahrenheit. She took 2 Tylenol and went back to bed and felt fine. By morning it was 99 degrees Fahrenheit and then 98 degrees Fahrenheit a little later. She has been afebrile since then. She was a little tired because she gave blood and though it was related. She does not know if it was a side effect or not. It was not significant tiredness and was just not having energy in the evening of 19Dec2020. She also had soreness at injection site that night after 22:00 and the next day. It did not bother her until she woke up in the middle of night, and she noticed her left arm was sore. She received the vaccine at 3:45pm and started with low grade fever at 6:30 pm, earlier stated at 7:00 pm. There was no prescriber. She tested for COVID (PCR) on Saturday, 26Dec2020 at 14:50and it came back positive 28Dec2020 18:45. At 10pm on 19Dec2020, her temperature was 101 degrees Fahrenheit. If she had not been monitoring her temperature, she would not have known. She has been Afebrile since morning of 20Dec2020. Tiredness she related to giving blood and the holidays. She was a little stressed about the holidays and running around. It was very mild. Soreness at injection site was during the night after 10pm when she went to bed. On Wednesday, 23Dec2020, she woke up congested, sniffly, sneezy, with a runny nose. This persisted through Wednesday night. Her sense of taste was off. She had no problem with that on Tuesday. She had some horrible smell at work she recalled, so she knew her sense of smell was fine. On Thursday, 24Dec2020, she had no sense of taste or smell. She could not smell a pine candle. She was congested on Thursday and called employee health on 24Dec2020. This both improved and persisted. She is still congested but it has improved. She has never had a complete loss of sense of taste or smell before. Mild cough started yesterday morning. On the night of 20Dec2020, and 21Dec2020, she developed night sweats. She had not had any night sweats before this since menopause and she woke up really wet. The patient was not hospitalized and not admitted to an Intensive Care Unit. NO ER or physician's office required. She did not know if she was exposed on the day of the vaccine or if a couple of days later if the fever is from the vaccine. She stated what are the chances she goes 10 months and is super careful and then gets the vaccine and test positive. The patient did not display clinical signs at rest indicative of sever systemic illness. The patient did not require supplemental oxygen nor receive mechanical ventilation. No Multiorgan failure. The patient did not receive any additional therapies for COVID- 19. No initiation of new medication or other treatment or procedure. Not any preexisting diseases worsen during the SARS-CoV2 infection. She would like to know if there is a chance of false positive for this. It would just be her luck to be 10 months and not getting it. She has not gone anywhere without her N95 and then gets the vaccine and gets COVD. She wears mask and face shield at work always. She also wanted to know if she should get the second dose. The outcome of the event slight temperature was recovered on 20Dec2020 and the other event was recovering.; Sender's Comments: Based on the information currently available, a lack of efficacy with the suspected vaccine BNT162B2 in this patient cannot be completely excluded.",,,,,,,,,N,12/19/2020,12/19/2020,0.0,Test Date: 20201219; Test Name: temp; Result Unstructured Data: Test Result:99.5 Fahrenheit; Comments: 7pm; Test Date: 20201219; Test Name: temp; Result Unstructured Data: Test Result:101 Fahrenheit; Comments: 10pm and 10:30pm; Test Date: 20201220; Test Name: temp; Result Unstructured Data: Test Result:99 Fahrenheit; Comments: By morning it was 99 degrees Fahrenheit; Test Date: 20201220; Test Name: temp; Result Unstructured Data: Test Result:98 Fahrenheit; Comments: then 98 degrees Fahrenheit a little later; Test Date: 20201220; Test Name: temp; Result Unstructured Data: Test Result:102.5 Fahrenheit; Comments: 2:30 am; Test Date: 20201226; Test Name: PCR test; Test Result: Positive  ; Comments: at 14:50 and it came back positive 28Dec2020 18:45,PVT,,FOSAMAX,,Medical History/Concurrent Conditions: Arrhythmia; Blood donation (no antibodies were present then.); Osteoporosis; Smoker (Quit 2-3 years ago.),,USPFIZER INC2020518240,2,01/06/2021,,,,,True
591,923570,01/06/2021,,,,,U,,"got the COVID-19 vaccine last week and six days later tested positive for COVID-19; got the COVID-19 vaccine last week and six days later tested positive for COVID-19; This is a spontaneous report from a contactable pharmacist.  A patient of unspecified age and gender received bnt162b2 (BNT162B2 also reported as PFIZER-BIONTECH COVID-19 VACCINE, lot/batch number and expiry date were not reported), via an unspecified route of administration on unspecified date in Dec2020 at single dose, for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient got the covid-19 vaccine last week and six days later (Dec2020) tested positive for Covid-19. The outcome of event was unknown.  Information about Lot/Batch number has been requested.; Sender's Comments: The information currently provided is too limited to make a meaningful medical assessment hence, the events are conservatively assessed as related to the suspect drug BNT162B2 until further information becomes available.",,,,,,,,,U,12/01/2020,12/01/2020,0.0,Test Date: 202012; Test Name: COVID-19; Result Unstructured Data: Test Result:Positive; Comments: the COVID-19 vaccine last week and six days later tested positive for COVID-19,UNK,,,,,,USPFIZER INC2020518427,2,01/06/2021,,,,,True
596,923579,01/06/2021,MT,52.0,,,F,,"Asymptotic positive rapid COVID test 12 days post vaccination.  Close contact testing/Nasal Swab positive; Asymptotic positive rapid COVID test 12 days post vaccination.  Close contact testing/Nasal Swab positive; This is a spontaneous report from a contactable Other HCP (patient). A 52-year-old female (not pregnant) patient received first dose bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/lot number: EK5730), intramuscular in arm left on 17Dec2020 13:15 at single dose for COVID-19 immunisation. Medical history included seasonal allergies, depression and Allergies: Sulfa. Prior to vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included sertraline hydrochloride (ZOLOFT), cefixime (FLEXERIL), fluticasone propionate, salmeterol xinafoate (ADVAIR), montelukast sodium (SINGULAIR), omeprazole (PRILOSEC).  The patient previously took pethidine hydrochloride (DEMEROL) and experienced 'allergies: Demerol', codeine and experienced 'allergies: codeine'.  The patient experienced asymptotic positive rapid COVID test 12 days post vaccination. Close contact testing on 29Dec2020.  The patient underwent lab tests and procedures which included [{covid test type post vaccination= Nasal Swab, covid test date=29Dec2020, covid test result= Positive}].  Facility type vaccine was workplace clinic. No treatment received for the adverse event. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The outcome of the events was unknown.; Sender's Comments: Based on the information currently available, a lack of efficacy with the suspected vaccine BNT162B2 in this patient cannot be completely excluded.",,,,,,,,,U,12/17/2020,12/29/2020,12.0,Test Date: 20201229; Test Name: Nasal Swab; Test Result: Positive,WRK,,ZOLOFT; FLEXERIL [CEFIXIME]; ADVAIR; SINGULAIR; PRILOSEC [OMEPRAZOLE],,Medical History/Concurrent Conditions: Depression; Seasonal allergy; Sulfonamide allergy,,USPFIZER INC2020518842,2,01/06/2021,,,,,True
597,923583,01/06/2021,,,,,U,,"I got the Pfizer vaccine, the first shot; I tested positive for Covid; I got the Pfizer vaccine, the first shot; I tested positive for Covid; This is a spontaneous report from a contactable consumer (patient). A patient of unspecified age and gender received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/lot number: EH9899), via an unspecified route of administration on 18Dec2020 at single dose for covid-19 immunization. The patient medical history and concomitant medications were not reported.  Consumer stated, ""I had a question, I got the Pfizer vaccine, the first shot on the 18Dec but I tested positive for Covid on the 27Dec, so, my question is this and I asked my healthcare institution and they still haven't got back to me, so I just wanted to call you guys, what do I do about the second dose because I am scheduled to get the second dose net week?"" The outcome of event was unknown.",,,,,,,,,U,12/18/2020,12/27/2020,9.0,Test Date: 20201227; Test Name: Covid; Test Result: Positive,UNK,,,,,,USPFIZER INC2020519163,2,01/05/2021,,,,,True
603,923708,01/06/2021,MI,21.0,,,M,,"Lost sense of taste; Lost sense of smell; Whole body is sore; Rapid test came back positive for COVID; Rapid test came back positive for COVID; This is a spontaneous report from a Pfizer-sponsored program IBCC (Inbound Call Center for HCPs) via a contactable consumer (patient). A 21-year-old male patient received his first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number: EK5730, expiration date: 31Mar2021), via intramuscular on 29Dec2020 07:40 at 0.3 mL, single dose on his left deltoid for covid-19 immunization. Medical history included allergic to wasp stings. There were no concomitant medications. The patient had no additional vaccines administrated on the same date and no prior vaccinations were received within 4 weeks. Caller on the line calling about the COVID Vaccine he received on 29Dec2020. The day after receiving it he woke up and had a loss of sense of smell on 30Dec2020 12:00. That afternoon he went to get tested and the rapid test came back positive for COIVD on 30Dec2020. He was now waiting on the other one, clarified to be the PCR test, the lab test. The next day he also lost his sense of taste on 31Dec2020 11:00 and his whole body feels sore on 30Dec2020 around noon. Transfer agent stated the caller needs to be transferred to Medical Information as he was scheduled to get the next shot on 19Jan2021 and he was calling to ask if he should proceed with that. It was reported that the patient works in a hospital (not an HCP). No emergency room was visited and no physician office was visited. The outcome of the event ""rapid test came back positive for covid"" was unknown, the outcome of the other events ""lost sense of smell"", ""lost sense of taste"", ""whole body is sore"" were not recovered.",,,,,,,,,N,12/29/2020,12/30/2020,1.0,Test Name: Lab test; Result Unstructured Data: Test Result:Unknown results; Test Name: PCR test; Result Unstructured Data: Test Result:Unknown results; Test Date: 20201230; Test Name: Rapid Test for COVID; Test Result: Positive,PVT,,,,Medical History/Concurrent Conditions: Allergy to sting NOS (Allergic to wasp stings),,USPFIZER INC2021001409,2,01/06/2021,,,,,True
609,923935,01/06/2021,MA,62.0,62.0,,F,,"I got my shot on the 19th and that evening it was like a light switch and I was so tired I went to sleep at 730pm I had severe chills and fever and had to go to bed. The next day I still wasn't feeling well and I was called in to get covid tested and I went to the ER on the 21st and took a rapid covid test that was positive. I was stable and had good oxygenation and was discharged. I have fever nausea vomiting  I also had problems with O2 stat i was in the 80s and realized I was having respiratory failure so I was admitted on the 27th and I've been here ever since. I had kinetic storm and infusions my O2 stats were bad and I was sent to the covid unit and put on high flow oxygen and negative for a PE, I'm still on the covid unit but I feel much better today",,,,,Y,11.0,,,N,12/19/2020,12/19/2020,0.0,rapid covid  - positive labs  - all normal now,PVT,,tylenol for arthritis,none,arthritis,fever and chills post shingles shot,vsafe,2,01/06/2021,,,,"morphine, erythromycin, IV iron",True
630,924657,01/06/2021,OH,67.0,67.0,,F,,"5 minutes after injection, my feet and palms itched and I was lightheaded but I tried to shake it off and it faded over the next 10 minutes. I did report it and stayed longer and was ok. Then i went straight home and layed down because i did not sleep well night before (was on call ) i awoke 1 hour post injection dry heaving, very nauseated, mild headache, achy, itchy over different parts of my body and weak. Sat up and my face was getting itchier, lips started to swell, tongue started to swell and itch, throat felt like someone was strangling me, had trouble swallowing and trouble breathing. took 2 benadryls immediately and went out into cold air, thought about calling 911 but got better in 10-15 minutes. never have had a reaction like this in my life. have had hives  though in the past. If I would have had an epi pen I would have used it (never have had an epi pen) I was frightened but the benadryl worked and I slept due to the benadryl  for 5 hours, when I woke up the benadryl wore off and it started again. took more benadryl, and it improved. before bedtime, the benadryl wore off and I had a hard time swallowing my night time meds like my throat was swollen. Took 2 more benadryls, today I am weak and nauseated and ate very little and feel like my face is still red and itchy. I told my sister and she said she is allergic to PEG which i later noted was in the vaccine. i am very disappointed that I had this reaction- I have desparately wanted this vaccine as a medical worker with a lot of covid patients- I onlu hopr this one shot will protect me enough because it is clear to me that i cannot take this vaccine again.",,,Y,,,,,,N,01/05/2021,01/05/2021,0.0,none,PVT,,"atenolol 25 mg per day, claritin 10 mg per day, evamist one spray per day, pepcid 20 mg per day, vit b12 3000 mcg per day, vit d 5000 units per day, prenatal gummy vitamin one per day,tylenol 500 mg per day, benadryl 50 mg per day",none,"chronic gastritis, tachycardia, kidney stones. food allergies",swine flu vaccine 1978? was very sick and couldn't walk well,,2,01/06/2021,,,,"aspirin, NSAIDS, flexeril, percocet, thiomerosol in any product, caffeine or stimulants, allergic to milk, ?to eggs, ?to bluberries and strawberries, severe to cheese esp cheddar, ?to onions, ? to garlic, ?to grapes, severe intolerance to alcohol",True
653,924892,01/07/2021,FL,89.0,,,M,,"extremely lightheaded; like he was about to fall down; This is a spontaneous report from a contactable physician. This physician reported similar events for 2 patients. This is the 1st of 2 reports.  An 89-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number; EL0140), intramuscular on the right arm on 30Dec2020 10:10 at single dose for vaccination.  Medical history included covid-19 on Jul2020 and had it fairly severe and almost died and he mentions he was overweight.  There were no concomitant medications.  The patient previously took flu shot (INFLUENZA VACCINE), a couple of months ago. He mentions he was in the military so he had a lots of shots in his life but he has never had a reaction like this.  The patient stated that on 30Dec2020 10:30, ""he became extremely lightheaded, like he was about to fall down. He sat down and is currently sitting down. This lightheadedness started about 20 minutes after the injection. When probed for the outcome, the caller explains it might be improving a little. The lightheadedness is not still not gone, but it has not worsened.  When probed for seriousness criteria, the caller explains he is just resting and sitting. He would say its not serious but it could be medically significant. He states he isn't sure if this is something that happens to just people who have had COVID before. He states none of his friends or relatives have this type of reaction. He lives in a retirement home and everybody is getting the injection. This is the second day of injections. He doesn't know if anybody had a reaction to the COVID-19 vaccine here"". The outcome of the events were recovering.; Sender's Comments: Based on available information, a possible contributory role of the subject product, BNT162B2 vaccine, cannot be excluded for the reported events of lightheadedness and pre-syncope due to temporal relationship.  There is limited information provided in this report.  Additional information is needed to better assess the case, including complete medical history, diagnostics, counteractive treatment measures and concomitant medications.   This case will be reassessed once additional information is available.  The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.,Linked Report(s) : US-PFIZER INC-2020520862 same reporter/drug, similar event, different patient.",,,,,,,,,N,12/30/2020,12/30/2020,0.0,,UNK,,,,Medical History/Concurrent Conditions: COVID-19; Overweight,,USPFIZER INC2020520760,2,01/06/2021,,,,,True
656,924895,01/07/2021,PA,34.0,,,F,,"peripheral neuropathy type symptoms; tingling of the feet, legs, hands, arms; This is a spontaneous report from a contactable Other Health Professional (patient). A 34-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration at Left arm on 22Dec2020 10:00 at single dose for covid-19 immunization. The COVID-19 vaccine was administered at Hospital. Medical history included hypothyroidism. The patient had no known allergies. Concomitant medication included levothyroxine and multivitamin. No other vaccine in four weeks. The patient was not sure if this was related to the vaccine or not. The patient didn't know if anyone else was having peripheral neuropathy type symptoms such as tingling of the feet, legs, hands, arms. The symptoms started a few days ago. The patient did not even sure if it related to the vaccine. Adverse event start date was 27Dec2020. Covid was not tested post vaccination. The outcome of the events was not recovered.  No treatment received for the events.   Information on the lot/batch number has been requested.; Sender's Comments: The temporal relationship between the onset of the event and administration of the vaccine does not support a causal relationship. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to regulatory authorities, Ethics Committees, and Investigators, as appropriate.",,,,,,,,,N,12/22/2020,12/27/2020,5.0,,PVT,,,,Medical History/Concurrent Conditions: Hypothyroidism,,USPFIZER INC2020521273,2,01/06/2021,,,,,True
657,924898,01/07/2021,IN,34.0,,,F,,"tested positive for covid; tested positive for covid; fever; headache; runny nose; nasal congestion; This is a spontaneous report from a contactable consumer (patient).  A 34-year-old female patient received the first single dose of BNT162B2 (Solution for injection, lot number: EK5730, exp date: Mar2021), intramuscular (injected in left upper arm ) on 20Dec2020 12:30 to 20Dec2020 12:30 at 0.3 mL for immunisation. The vaccine was administered in a hospital and not in a military facility. Medical history included birth control. The patient had no other history. NO ER or physician's office required Prior Vaccinations (within 4 weeks). Patient had no relevant family history. Concomitant medication include unspecified birth control.There was no previous immunization. Patient, who was a Respiratory therapist, got the covid vaccine on 20Dec2020 (Sunday). She first stated she doesn't have any side effects and just had a question.  Patient had COVID Symptoms on 26Dec2020 21:00 which was minimal like a runny nose. She further reports that on 26Dec2020 she started to have nasal congestion. On 27Dec2020 the nasal congestion worsened, and she started having a headache. She then experienced a 102.6 fever on 28Dec2020 (Monday). She has since tested positive for Covid on 28Dec2020 11:30. Patient asked if it was ok that she received the 2nd dose after testing positive for covid. Investigation assessment was not performed. There was no prescriber. She received at work because she was a front line healthcare worker. The patient does not have SARS-CoV2 antibodies at diagnosis but never tested for antibodies. The patient was not in the hospital, nor was admitted in ICU. The patient did not display clinical signs at rest indicative of severe systemic illness. The patient did not require supplemental oxygen (including high flow or ECMO) or receive mechanical ventilation. No Multiorgan failure. The patient did not receive any additional therapies for COVID-19.  The patient did not require the initiation of new medication or other treatment or procedure. PCR on 28Dec2020 (Saturday) Results: just detected. No units available. No reference ranges provided. Standard range was not detected. It was just detected or not detected ranges. No other test or diagnostic imaging performed. The patient had not been treated with immune modulating or immunosuppressing medications or received any other vaccines around the time of COVID-19 vaccination. No pre-existing diseases worsened during the SARS-CoV2 infection. The patient was recovering from event positive for covid and runny nose; nasal congestion was not recovered and outcome of the other events was unknown.; Sender's Comments: Based on the information available, a possible contributory role of the suspect products cannot be excluded for the reported event of positive for corona virus infection for the lack of efficacy of the vaccine. However, based on the mechanism of action of the vaccine, it is unlikely the patient would have fully developed immunity for the vaccine to be effective, due to the number of days passed since the vaccine is given.",,,,,,,,,N,12/20/2020,12/26/2020,6.0,Test Date: 20201228; Test Name: fever; Result Unstructured Data: Test Result:102.6; Test Date: 20201228; Test Name: Covid/ PCR; Result Unstructured Data: Test Result:just detected,PVT,,,,Medical History/Concurrent Conditions: Birth control,,USPFIZER INC2020521584,2,01/06/2021,,,,,True
659,924900,01/07/2021,PA,35.0,,,F,,"had a reaction of bells palsy with mild symptoms 5 minutes of receiving covid vaccine; facial numbness right sided ear discomfort, difficulty closing right eye, only right side numbness and weakness of her face. It has gotten a lot better; facial numbness right sided ear discomfort, difficulty closing right eye, only right side numbness and weakness of her face. It has gotten a lot better; facial numbness right sided ear discomfort, difficulty closing right eye, only right side numbness and weakness of her face. It has gotten a lot better; This is a spontaneous report from a contactable Other Health Professional reported that a 35-year-old female  patient receives first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot/Batch Number and Expiration Date unknown) via an unspecified route of administration on 21Dec2020 at single dose for covid-19 immunization. The patient's medical history and concomitant medications was not reported. The patient experienced a reaction of bells palsy with mild symptoms 5 minutes of receiving Covid vaccine. ""facial numbness right sided ear discomfort, difficulty closing right eye, only right side numbness and weakness of her face. It has gotten a lot better, patient was vaccinated 10 days ago on 21Dec2020.  Patient was treated with 60mg of Prednisone for 5 days which was started today."" Question is regarding the 2nd dose of Covid vaccine, whether or not she should have it.  The outcome of events was recovering.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. .; Sender's Comments: There is a positive chronological association between vaccine administration and onset of the events. Causality cannot be completely excluded. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to regulatory authorities, Ethics Committees, and Investigators, as appropriate.",,,,,,,,,N,12/21/2020,12/21/2020,0.0,,PVT,,,,,,USPFIZER INC2020521770,2,01/06/2021,,,,,True
661,924906,01/07/2021,NY,46.0,,,F,,"Contracted covid 19 virus after receiving first dose of vaccine; Contracted covid 19 virus after receiving first dose of vaccine; This is a spontaneous report from a contactable nurse. A 46-year-old female patient received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number Eh9899), intramuscular in left arm on 17Dec2020 18:00 at a single dose for covid-19 vaccination. Vaccine was administered in the hospital. There were no relevant medical history. The patient had no known allergies. Concomitant medication included levothyroxine sodium (SYNTHROID). On 27Dec2020 20:00, the patient contracted covid 19 virus after receiving first dose of vaccine. The outcome of the event was recovering. The patient did not received any treatment. The event resulted in a doctor or other healthcare professional office/clinic visit. The patient did not have COVID prior to vaccination. The patient was tested for COVID post vaccination. The patient had nasal swab on 31Dec2020 and had a positive result.; Sender's Comments: Based on the information available, a possible contributory role of the suspect products cannot be excluded for the reported event of positive for corona virus infection for the lack of efficacy of the vaccine. However, based on the mechanism of action of the vaccine, it is unlikely the patient would have fully developed immunity for the vaccine to be effective, due to the number of days passed since the vaccine is given.",,,,,,,,,N,12/17/2020,12/27/2020,10.0,Test Date: 20201231; Test Name: Nasal Swab; Test Result: Positive,PVT,,SYNTHROID,,Comments: List of non-encoded Patient Relevant History: Patient Other Relevant History 1: None,,USPFIZER INC2021000202,2,01/06/2021,,Y,,,True
663,924913,01/07/2021,,,,,M,,"sore arm; aches and pains for a couple of days; a little headache; I received results yesterday and I am positive; I received results yesterday and I am positive; This is a spontaneous report from a non-contactable physician (patient). A male patient of an unspecified age started to receive bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), lot number and expiry date was unknown, via an unspecified route of administration on 19Dec2020 at single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient received his first covid vaccine dose on 19Dec2020, and due to get his second dose on 09Jan2021. The problem is he tested for the covid virus on Wednesday 26Dec2020 (was negative). He was tested again on the 30Dec2020, because his wife and son had tested positive on the 26Dec2020, he received the results yesterday and he is positive.  He asked if he should proceed with the 2nd dose, another test on the 30th and tested positive. He reports that, other than initial side effects from the vaccine administration, sore arm, aches and pains for a couple of days, never had fever, a little headache for a day or two, he feels fine. The outcome of the events ""a little headache"" was recovered on an unspecified date while outcome of the other events was unknown.    No follow-up attempts are possible. Information about lot/batch number cannot be obtained. No further information is expected.; Sender's Comments: Based on the information available, a possible contributory role of the suspect products cannot be excluded for the reported event of positive for corona virus infection for the lack of efficacy of the vaccine. However, based on the mechanism of action of the vaccine, it is unlikely the patient would have fully developed immunity for the vaccine to be effective, due to the number of days passed since the vaccine is given.",,,,,,,,,Y,12/19/2020,12/30/2020,11.0,Test Date: 20201226; Test Name: covid; Test Result: Negative  ; Test Date: 20201230; Test Name: covid; Test Result: Positive,UNK,,,,,,USPFIZER INC2021000483,2,01/06/2021,,,,,True
668,924928,01/07/2021,AZ,,,,U,,"anaphylaxis; This is a spontaneous report from a contactable other healthcare professional (patient). A patient of unspecified age and gender received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on an unspecified date at single dose for immunization. The patient's medical history and concomitant medications were not reported. Pfizer covid vaccine caused anaphylaxis on 30Dec2020 and landed patient in hospital. Patient was an anesthesiologist and had high IgG to thyroid with hashimotos. Patient thought he/she had IgG/neutrophil mediated anaphylaxis (not the typical IgE) as absolute neutrophil count elevated but everything else normal in labs. Had tachycardia into 140-150s and mild facial and throat edema. Still having sudden bouts of elevated heart rate in the morning of 31Dec2020. Heart tests all normal. Outcome of event elevated heart rate was not recovered, and outcome of other events was unknown.  Information on the Lot/Batch number has been requested.; Sender's Comments: A possible contributory role of the suspect products cannot be excluded for the reported events based on the known safety profile and temporal association. Case will be reevaluated based on follow-up information",,,,,Y,,,,U,,12/30/2020,,Test Name: IgG; Result Unstructured Data: Test Result:high; Test Name: Heart tests; Result Unstructured Data: Test Result:all normal; Test Name: heart rate; Result Unstructured Data: Test Result:Had tachycardia into 140-150s; Test Date: 20201231; Test Name: heart rate; Result Unstructured Data: Test Result:elevated; Test Name: absolute neutrophil count; Result Unstructured Data: Test Result:elevated,UNK,,,,,,USPFIZER INC2021001834,2,01/06/2021,,,,,True
682,925636,01/07/2021,MI,37.0,,,F,,"Moderate to severe headache 24-48 hours post injection. Complete sensorineural hearing loss in left ear 1 week after injection; Moderate to severe headache 24-48 hours post injection. Complete sensorineural hearing loss in left ear 1 week after injection; This is a spontaneous report from a contactable physician (patient). A 37-year-old female non-pregnant patient received her first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 22Dec2020 17:15 at single dose on her left arm for covid-19 immunization. Medical history included known allergies to penicillin. The patient had no other medical history. There were no concomitant medications. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine and the patient was not received list of any other medications within 2 weeks of vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient experienced moderate to severe headache 24-48 hours post injection. Complete sensorineural hearing loss in left ear 1 week after injection on 23Dec2020. These events resulted in doctor or other healthcare professional office/clinic visit, disability or permanent damage. The patient had received prednisone to treat the events. The outcome of the events was not recovered.; Sender's Comments: A possible contribution role of first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE) to the onset of sensorineural hearing loss in left ear and headache cannot be excluded due to temporal relationship.  The case will be reassessed should additional information become available. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics committees and Investigators, as appropriate.",,,,,,,,Y,N,12/22/2020,12/23/2020,1.0,,PVT,,,,Medical History/Concurrent Conditions: Penicillin allergy,,USPFIZER INC2020521789,2,01/07/2021,,Y,,,True
684,925638,01/07/2021,,29.0,,,F,,"Joint pain; loss of balance; increased drowsiness; Headaches induced by allergies; Limited neck mobility/lessened neck pain but still limited mobility; Scalp tenderness and sensitivity; Significant migraines/debilitating migraines (light & noise sensitivity, covers whole head, pulsating, sharp pain, loss of balance, increased drowsiness); Sharp pains in neck/Neck pain; Sharp pains in neck, ear, head pain (similar to an ear infection pain); head pain/sharp pains in lower head/covers whole head, pulsating, sharp pain/Increase in headaches but no longer centralized to back of head/ headaches induced by allergies; Nausea; Neck stiffness; This is a spontaneous report from a contactable Other Health Professional (patient). A 29-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) Solution for injection, lot number was unknown, via an unspecified route of administration in the right arm on 22Dec2020 07:30 at a single dose for COVID-19 immunization. Medical history was none. There were no concomitant medications. The patient was not pregnant. The patient had not receive any other vaccines within 4 weeks prior to the COVID vaccine. It was reported that the patient received vaccine in Tuesday (22Dec2020). The following Sunday (27Dec2020) at 12:00, she had nausea and neck stiffness. On Monday (28Dec2020), she had sharp pains in neck, ear, head pain (similar to an ear infection pain), and nausea. She used teledmed appt and got antibiotics (unspecified). On Tuesday (29Dec2020), she had significant migraines, limited neck mobility, sharp pains in neck and lower head, scalp tenderness and sensitivity which felt like whiplash when she moved her head w/ her head feeling ""swimmy"". She tried to see urgent care but was to go to ER. On Wednesday (30Dec2020), there was lessened neck pain but still limited mobility, increased in headaches but no longer centralized to back of head. She went to ER and they said that she had headaches induced by allergies. She mentioned that she never had migraines or allergies in her life. They also reported no ear infection. She did complete CT Scan with no concerning results on 30Dec2020. On Thursday (31Dec2020) & Friday, she no longer has neck pain but with continued nausea, joint pain, debilitating migraines (light & noise sensitivity, covers whole head, pulsating, sharp pain, loss of balance, increased drowsiness). The events were reported as non-serious. The treatment received for the adverse events included fluids, pain & nausea meds. The patient was not diagnosed with Covid prior to vaccination. She was tested for covid post vaccination on 30Dec2020 through a nasal swab with negative result. The outcome of the events neck stiffness, ear pain, scalp tenderness and sensitivity, and 'Headaches induced by allergies' was unknown; while neck pain was recovered on 31Dec2020. The outcome of the events 'significant migraines/debilitating migraines', nausea, limited neck mobility, head pain/Headache, joint pain, loss of balance, and increased drowsiness was not recovered.  Information on the lot/batch number has been requested.; Sender's Comments: A causal association between BNT162B2 and the event migraine cannot be excluded based on a compatible temporal relation between vaccination and onset of event. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to RAs, Ethics Committees, and Investigators, as appropriate.",,,,,,,,,N,12/22/2020,12/27/2020,5.0,Test Date: 20201230; Test Name: CT Scan; Result Unstructured Data: Test Result:No concerning results; Test Date: 20201230; Test Name: Nasal Swab; Test Result: Negative,PVT,,,,Comments: List of non-encoded Patient Relevant History: Patient Other Relevant History 1: None,,USPFIZER INC2021000163,2,01/07/2021,,,Y,,True
686,925640,01/07/2021,NJ,60.0,,,M,,"DVT left calf; This is a spontaneous report from a contactable Physician (patient). A 60-year-old male patient started to receive the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) Intramuscular on 20Dec2020 08:00 at single dose on right arm for COVID-19 immunization. Medical history included Gastric reflux. The patient had no known allergies. The patient had no covid prior vaccination. The patient had no covid tested post vaccination. Concomitant medications included omeprazole (PRILOSEC) and ergocalciferol (VIT D). The patient had not received other vaccine in four weeks. The patient experienced deep vein thrombosis (DVT) left calf on 27Dec2020 09:00 which resulted emergency room visit. Treatment received for the event included Xarelto. The outcome of the event was not resolved.   Information on the lot/batch number has been requested.; Sender's Comments: The information currently provided is too limited to make a meaningful medical assessment hence, the events are conservatively assessed as related to the suspect drug BNT162B2 until further information becomes available. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to RAs, Ethics Committees, and Investigators, as appropriate.",,,,,,,,,N,12/20/2020,12/27/2020,7.0,,PVT,,PRILOSEC [OMEPRAZOLE]; VIT D,,Medical History/Concurrent Conditions: Reflux gastritis,,USPFIZER INC2021000374,2,01/07/2021,,,Y,,True
691,925645,01/07/2021,PA,40.0,,,M,,"Patient was poorly responsive to her inhalers that she used for asthma; Persistent shortness of breath and chest tightness starting within a few days after vaccine; Persistent shortness of breath and chest tightness starting within a few days after vaccine; This is a spontaneous report from a contactable physician (patient). A 40-year-old male patient received the first single dose of BNT162B2 (Solution for injection, lot number: EK5730, exp date not reported), via an unspecified route of administration (vaccine location: left arm) on 18Dec2020 04:15 for COVID-19 immunization. Medical history included allergy induced asthma, allergies to cats and dust, and occasional seasonal allergies. Concomitant medication included other vaccine/s received within 4 weeks prior to the COVID vaccine: first dose of diphtheria vaccine toxoid, pertussis vaccine acellular 3-component, tetanus vaccine toxoid (BOOSTRIX, GlaxoSmithKline) administered as single dose via unspecified route of administration (vaccine location: left arm) on 08Dec2020. There were no other medications the patient received within 2 weeks of vaccination. The patient experienced persistent shortness of breath and chest tightness starting within a few days after vaccine (24Dec2020). Patient was poorly responsive to her inhalers that she used for asthma (onset date not reported). She rarely needed the, used about once or twice a year). It was constant, but with periods of improvement followed regression. Will likely seek medical evaluation as it's been over a week now and rather concerning. The patient did not consider the events shortness of breath and chest tightness as serious. Treatment for the adverse events shortness of breath and chest tightness included fluticasone propionate, almeterol (ADVAIR), albuterol, and unspecified anti-allergy medications. Patient did not have covid prior vaccination. Patient was tested for COVID post vaccination wherein patient tested negative for COVID via Covid test rapid on 30Dec2020. The adverse event resulted in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. The outcome of shortness of breath and chest tightness was not recovered and unknown for the other event.; Sender's Comments: Based on the time association, the possible contribution of BNT162B2 to the events shortness of breath , chest tightness and asthma aggravated cannot be excluded. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.",,,,,,,,,N,12/18/2020,12/24/2020,6.0,Test Date: 20201230; Test Name: Covid test rapid; Test Result: Negative  ; Comments: Nasal swab,PVT,,,,Medical History/Concurrent Conditions: Allergic asthma; Allergy to animal; Dust allergy; Seasonal allergy,,USPFIZER INC2021000948,2,01/07/2021,,Y,Y,,True
696,925650,01/07/2021,MI,,,,F,,"strong, whole body heat, and flushing; strong, whole body heat, and flushing; Tachycardia; Palpitations; This is a spontaneous report from a contactable Nurse. This Nurse reported for similar events for 6 patients. This is 2nd of 6 reports. A 49-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot/batch unknown), via an unspecified route of administration on 28Dec2020 at single dose for covid-19 immunization. The patient's medical history and concomitant medications were not reported. The reporter said her friend was a registered nurse, and received the COVID-19 Vaccine on Monday, 28Dec2020. She said her friend stated she, and 5 other registered nurses she works with, had a serious reaction right after receiving the COVID-19 Vaccine. The patient had a strong, whole body heat, and flushing. The patient said she became tachycardia and had palpitations that lasted a few minutes. She said the tachycardia and palpitations then slowly resolved in less than 5 minutes. She had no other symptoms after receiving the COVID-19 Vaccine. It was unknown whether the patient received the treatment or not. The outcome of the events was recovered on 28Dec2020. Information on lot/batch number has been requested.; Sender's Comments: The reported transient events of whole body heat, flushing, tachycardia and palpitations were likely related to BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) due to temporal relationship and clinic course. The case will be reassessed should additional information become available. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics committees and Investigators, as appropriate.,Linked Report(s) : US-PFIZER INC-2021001345 same reporter/drug/event, different patients.",,,,,,,,,Y,12/28/2020,12/28/2020,0.0,,UNK,,,,,,USPFIZER INC2021001329,2,01/07/2021,,,,,True
701,925742,01/07/2021,TN,23.0,,,F,,"Fatigue and overall lethargic feeling/Sore throat; Dark colored urine despite pushing fluids; Frequent urination; Migraine; Swollen joints and could not move arm that received vaccine in; Swollen joints and could not move arm that received vaccine in; Stomach pains, nausea, diarrhea, swollen lymph nodes; Stomach pains, nausea, diarrhea, swollen lymph nodes; Stomach pains, nausea, diarrhea, swollen lymph nodes; Stomach pains, nausea, diarrhea, swollen lymph nodes; Chills, body aches, spiked fever of 102.; Chills, body aches, spiked fever of 102.; Chills, body aches, spiked fever of 102.; Fatigue and overall lethargic feeling; Fatigue and overall lethargic feeling; Sore throat; The initial case was missing the following minimum criteria: Invalid for no adverse effect. Upon receipt of follow-up information on (31Dec2020), this case now contains all required information to be considered valid.   This is a spontaneous report from a contactable Nurse.  A female patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, batch/lot number EH9899, Expiry Date: Mar2021), intramuscular at Deltoid Left on 29Dec2020 07:20 at single dose for COVID-19 immunization.  Medical history included covid-19 from Nov2020 to an unknown date (had covid in the middle of November), surgeries from an unknown date and unknown if ongoing (She also had previous surgeries and has foreign objects in her body. Those areas were super hot. Those antibodies were like rejecting those foreign bodies because they were super hot.)  There were no concomitant medications.  Received call from RN calling about the Pfizer COVID vaccine. She got the vaccine on Tuesday and had a terrible reaction to it and she called a couple of different hotlines and spoke with the people who administered it. She confirmed that she did not report to Pfizer though. The people at her work that she spoke with told her to go to an Urgent care. They told her she should not get it within 90 days of having COVID. She had COVID in the middle of Nov2020. She went ahead and got it on Tuesday and had this terrible reaction. She would like to know if she should get the second dose or wait until 90 days after she had COVID and start again. There was no prescriber. She received it as part of the (hospital name withheld) front line health worker precaution. She thought that this was a normal reaction, but was told it was not. Fatigue and overall lethargic feeling happened exactly 12 hours after receiving. She works night shift and that is her base line. Pretty much everything hit after that within an hour. She was told low grade fever was normal, but not 102. She never spikes fevers, so it is medically significant. It persisted for 24 hours and is better today. She is on the 48 hour mark now. Stomach pains, nausea, diarrhea, lymph node swelling all over, including swelled armpits and groin area, Migraine, Frequent urination, were also listed as side effects. She was trying to push more fluids but her urine was dark color more than normal, despite pushing fluids. Swollen lymph nodes in her groin and armpits were concerning. Her head is lumpy. Meaning, she can feel swollen lymph nodes in back of neck area. Migraine was consistent through 24 hours and now has improved. Urine color remains dark and she will keep an eye on color. She had swollen joints, but really terrible swollen joints, and she could not move the arm that she got the vaccine in. She could not lift to above shoulder height. AE Details and time of onset: Sore Throat 12:00 on 29 Fatigue and overall lethargic feeling 20:00 Chills, body aches, spiked fever of 102: 21:00 Stomach pains, nausea, diarrhea, swollen lymph nodes- 21:00 Migraine- 21:00 Frequent Urination 23:00 Dark colored urine despite pushing fluids 23:00 Swollen joints and could not move arm that received vaccine in: 21:00. ER or physician's office required: Went to urgent care 36 hours after administration. No treatment given. She just wanted to make sure no additional infection was causing anything weird. All test were negative. Prior Vaccinations (within 4 weeks): none. Events Swollen joints and could not move arm that received vaccine in, Stomach pains, nausea, diarrhea, swollen lymph nodes, Chills, body aches, spiked fever of 102 were serious with criteria of medically significant, while the other events were non-serious. The outcome of the event Fatigue and overall lethargic feeling/Sore throat (Condition worsened) was unknown, the outcome of the events Swollen joints and could not move arm that received vaccine in, Chills, body aches, spiked fever of 102., Migraine, Dark colored urine despite pushing fluids, Frequent urination was recovering, while the outcome of the other events was not resolved.; Sender's Comments: Based on the information available, a possible contributory role of the suspect products cannot be excluded for the reported events due to temporal association. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators as appropriate.",,,,,,,,,N,12/29/2020,12/29/2020,0.0,Test Date: 20201229; Test Name: fever; Result Unstructured Data: Test Result:102; Test Date: 20201229; Test Name: Lab Test; Result Unstructured Data: Test Result:negative; Comments: All test were negative.,PVT,,,,Medical History/Concurrent Conditions: COVID-19 (had covid in the middle of November); Surgery,,USPFIZER INC2020521518,2,01/07/2021,,,,,True
753,927361,01/08/2021,AZ,61.0,61.0,,F,,Moderna covid 19 vaccine EAU,,,,,,,,,N,01/06/2021,01/06/2021,0.0,,PVT,,"Celebrex, estradiol, paxil, abilify, losartan, metformin, norco, morphine, phentermine, klonipin, modafinial, calcium, b complex, stool softener",None,"Diabetes, back pain, high cholesterol, obesity, depression, anxiety",,,2,01/08/2021,,,,"Ceftin, clindamycin, vancomycin, augmentin, ativan,",True
767,927496,01/08/2021,,,,,U,,"Reported to get the vaccine, and within a couple of hours or days, test positive for COVID; Reported to get the vaccine, and within a couple of hours or days, test positive for COVID; This is a spontaneous report from a contactable other HCP received from a Pfizer-sponsored program IBCC (Inbound Call Center for HCPs).  A patient of unspecified age and gender received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiry date were not reported), via an unspecified route of administration on an unspecified date at a single dose for covid-19 vaccination. The patient's medical history and concomitant medications were not reported. The patient reported to get the vaccine, and within a couple of hours or days, test positive for covid. The outcome of the event was unknown  Information on the lot/batch number has been requested.; Sender's Comments: Based on available information, a possible contributory role of the subject product, BNT162B2 vaccine, cannot be excluded for the reported events of SARS-CoV-2 test positive and LOE due to temporal relationship.  There is limited information provided in this report.  Additional information is needed to better assess the case, including complete medical history, diagnostics, counteractive treatment measures and concomitant medications.   This case will be reassessed once additional information is available.  The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.,Linked Report(s) : US-PFIZER INC-2020520145 different patients, same drug and event",,,,,,,,,U,,,,"Test Name: COVID; Result Unstructured Data: Test Result: Positive; Comments: Reported to get the vaccine, and within a couple of hours or days, test positive for COVID",UNK,,,,,,USPFIZER INC2020520610,2,01/06/2021,,,,,True
770,927499,01/08/2021,VA,,,,F,,"Test positive for COVID after the first vaccine dose; Test positive for COVID after the first vaccine dose; This is a spontaneous report from a contactable Physician. This Physician reported similar events for 2 patients. This is the 1st of 2 reports. A 42-year-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number EH9899), via an unspecified route of administration in left deltoid on 16Dec2020 at a single dose for COVID-19 vaccination. There were no relevant medical history and concomitant medications. The patient was test positive for covid after the first vaccine dose on 27Dec2020 with outcome of not recovered.; Sender's Comments: Based on available information, a possible contributory role of the subject product, BNT162B2 vaccine, cannot be excluded for the reported events of COVID 19 test positive and LOE due to temporal relationship.  There is limited information provided in this report.  Additional information is needed to better assess the case, including complete medical history, diagnostics, counteractive treatment measures and concomitant medications.   This case will be reassessed once additional information is available.  The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.,Linked Report(s) : US-PFIZER INC-2020520645 same reporter/product/event, different patient",,,,,,,,,N,12/16/2020,12/27/2020,11.0,Test Date: 20201227; Test Name: COVID; Result Unstructured Data: Test Result:Positive; Comments: Test positive for COVID after the first vaccine dose,UNK,,,,Comments: List of non-encoded Patient Relevant History: Patient Other Relevant History 1: None,,USPFIZER INC2020520651,2,01/06/2021,,,,,True
772,927503,01/08/2021,,,,,M,,"came out positive for Covid-19; came out positive for Covid-19; This is a spontaneous report from a contactable pharmacist.  A male patient of an unspecified age received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration in 29Dec2020 at a single dose for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported.  The patient came out positive for covid-19 on 30Dec2020 and inquired if he should still get the 2nd dose.   Information on the lot/batch number has been requested.",,,,,,,,,U,12/29/2020,12/30/2020,1.0,Test Date: 20201230; Test Name: Covid-19; Test Result: Positive,UNK,,,,,,USPFIZER INC2020521524,2,01/06/2021,,,,,True
773,927505,01/08/2021,KS,43.0,,,F,,"testing positive for covid/ they have had a patient have a positive COVID test after vaccine was given; testing positive for covid/ they have had a patient have a positive COVID test after vaccine was given; This is a spontaneous report from a contactable pharmacist via medical information team and a Pfizer-sponsored program IBCC (Inbound Call Center for HCPs).  A 43-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) (lot number EK5730, expiration date 31Mar2021), via an unspecified route of administration on 18Dec2020 at single dose for COVID-19 immunization. The patient's medical history included ongoing asthma.  The reporter was not aware of any allergies, adverse reactions to previous vaccines, significant medical history or any relevant family medical history of the patients. Concomitant medications were reported as none. It was reported that that they had a patient who had a positive COVID test after vaccine was given. The patient who received the vaccine on 18Dec2020 now testing positive for COVID. The patient received the first vaccine dose on 18Dec2020. She tested positive 30Dec2020. They wanted to give her monoclonal antibodies (Bamlanivimab) but they don't know how that would interact with the vaccine. Also, they didn't know how the product and the positive test would play into her already having the first dose and getting the second dose. The second shot would be due on 08Jan2020. The patient was not at the facility at the point of reporting, they had been talking to her by phone. The type of test done was unknown. No treatments known. The outcome of the event ""positive COVID test after vaccine was given"" was not recovered. The event was assessed as medically significant, and unrelated to vaccine by reporter. The seriousness assessment option was made due to her history of asthma.; Sender's Comments: Based on available information, a possible contributory role of suspect BNT162B2 cannot be completely excluded for reported ""positive COVID test after vaccine was given"".",,,,,,,,,N,12/18/2020,12/30/2020,12.0,Test Date: 20201230; Test Name: COVID test; Test Result: Positive,UNK,,,Asthma,,,USPFIZER INC2020521658,2,01/06/2021,,,,,True
780,927561,01/08/2021,FL,,,,F,,"She also complained of all the COVID signs and symptoms; She also complained of all the COVID signs and symptoms; left cervical, axillary, clavicular and periscapular lymphadenopathy; left arm and shoulder pain; left arm and shoulder pain; This is a spontaneous report from a contactable physician. An adult female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) Solution for injection, lot number was unknown, intramuscular in the left arm on 28Dec2020 at a single dose for COVID-19 immunization. Medical history included covid-19 from an unknown date and unknown if ongoing. The patient's concomitant medications were not reported. The patient is not pregnant. It was unknown if the patient received any other vaccines within 4 weeks prior to the COVID vaccine. It was reported that after receiving the Pfizer COVID-19 vaccine in the left deltoid, the patient experienced left cervical, axillary, clavicular and periscapular lymphadenopathy in Dec2020 with outcome of not recovered. She also complained of left arm and shoulder pain and all the COVID signs and symptoms in Dec2020 with outcome of not recovered. The onset was within a day of immunization. She has a history of COVID-19, she had Covid prior vaccination. It was unknown if the patient tested for Covid post vaccination. The onset date of the events was reported as Dec2020. The events was reported as non-serious and it was unknown if the patient received treatment for the events.  Information on the lot/batch number has been requested.; Sender's Comments: Based on available information, a possible contributory role of the subject product, BNT162B2 vaccine, cannot be excluded for the suspected LOE, COVID 19 and other reported events due to temporal relationship.  Of note, it is reported that the patient had a history of COVID-19, and she was diagnosed with  COVID 19 infection prior to the  vaccination.  There is limited information provided in this report.  Additional information is needed to better assess the case, including complete medical history, diagnostics , counteractive treatment measures and concomitant medications.   This case will be reassessed once additional information is available.  The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.",,,,,,,,,N,12/28/2020,12/01/2020,,,UNK,,,,Medical History/Concurrent Conditions: COVID-19 (She has a history of COVID-19),,USPFIZER INC2021000377,2,01/07/2021,,,,,True
787,927640,01/08/2021,,,,,F,,"became positive for covid 19; became positive for covid 19; This is a spontaneous report from a contactable other healthcare professional (patient). A female patient of an unspecified age received the first dose of bnt162b2 (Pfizer-Biontech Covid-19 Vaccine) via an unspecified route of administration on 22Dec2020 at a single dose for covid-19 immunization. The patient's medical history and concomitant medications were not reported. The patient she received covid vaccine on 22Dec2020 and on 30Dec2020 became positive for covid 19. The patient wanted to know when she can schedule her 2nd dose. Outcome of the event was unknown.  Information about Batch/Lot number has been requested.; Sender's Comments: Based on the current available information and the plausible drug-event temporal association, a possible contributory role of the suspect product BNT162B2 to the development of events Drug ineffective and COVID-19 cannot be totally excluded.  The case will be reassessed if additional information becomes available.",,,,,,,,,U,12/22/2020,12/30/2020,8.0,Test Date: 20201230; Test Name: covid test; Result Unstructured Data: Test Result:positive,UNK,,,,,,USPFIZER INC2021000799,2,01/07/2021,,,,,True
788,927641,01/08/2021,,44.0,,,F,,"slight cough; diarrhea; shortness of breath; no sense of smell; positive for covid 19 virus; positive for covid 19 virus; feel tired; sore arm; This is a spontaneous report from a non-contactable consumer (patient). A 44-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) first dose on 20Dec2020 at single dose for COVID-19 immunization. Medical history and concomitant medications were not reported. Patient was Diagnosed with covid 19 virus on the 31Dec2020, she was set to have the second vaccine on the 10Jan2021. She wanted to know if she can get the second dose and if so, when. Also asked if she should get tested before taking the 2nd dose of the covid 19 vaccine. Her Adverse effects are sore arm on vaccination day (20Dec2020), and she began to feel tired on 27Dec2020 and thought that was normal. She went to a Christmas eve party 24Dec2020 and no one was masked, friend had several people from work tested positive. was tested and was positive for covid 19 virus on 31Dec2020. She also was experiencing slight cough, diarrhea (which is normal for her), shortness of breath is improving and she had no sense of smell but she was able to taste. The outcome of event shortness of breath is recovering. The outcome of other events was unknown.  No follow-up attempts are possible. information about lot/batch number cannot be obtained.",,,,,,,,,N,12/20/2020,12/20/2020,0.0,Test Date: 20201231; Test Name: covid; Result Unstructured Data: Test Result:positive,UNK,,,,,,USPFIZER INC2021000801,2,01/07/2021,,,,,True
789,927648,01/08/2021,TX,62.0,,,F,,"Tested Positive for COVID-19/nausea, occasional dry cough, neck and lower back soreness, and sore throat; Tested Positive for COVID-19/nausea, occasional dry cough, neck and lower back soreness, and sore throat; Weakness/generalized weakness; This is a spontaneous report from a contactable nurse (patient). A 62-year-old female patient received first dose of BNT162b2 (Pfizer, Lot number: 5730), via an unspecified route of administration at right arm at 22Dec2020 21:00 at single dose for covid-19 immunization. Medical history included Mayonaise allergies. The patient's concomitant medications were not reported. The patient previously took codeine and experienced allergies. At 31Dec2020 06:00, the patient experienced Weakness, nausea, occasional dry cough, generalized weakness, neck and lower back soreness, and sore throat which has now dissipated. Tested Positive for COVID-19 on 02Jan2021 (also reported as 01Jan2021, pending clarification). The covid test type post vaccination was Nasal Swab, Covid test name post vaccination was COVID-19 PCR ROCHE c6800(NTX), RNA SARS CoV2 TGT1, PAN SARS RNA TGT2. No treatment received for events. The events result in Emergency room/department or urgent care. The patient was not pregnant. The outcome of the events were nor recovered.; Sender's Comments: Based on the current available information and the plausible drug-event temporal association, a possible contributory role of the suspect product BNT162B2 to the development of events Drug ineffective and COVID-19 cannot be totally excluded.  The case will be reassessed if additional information becomes available.",,,,,,,,,N,12/22/2020,12/31/2020,9.0,Test Date: 20210102; Test Name: Nasal Swab/COVID-19; Test Result: Positive,PVT,,,,Medical History/Concurrent Conditions: Food allergy,,USPFIZER INC2021000821,2,01/07/2021,,,Y,,True
790,927658,01/08/2021,,,,,U,,"Took the COVID vaccine; Rapid Antigen Test turned out positive, PCR test came out negative; Took the COVID vaccine; Rapid Antigen Test turned out positive, PCR test came out negative; This is a spontaneous report from a non-contactable consumer. A patient of unspecified age and gender received BNT162b2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration on an unspecified date at single dose for covid-19 immunization. The patient medical history and concomitant medications were not reported. The patient took the COVID vaccine, and a few days later they took the Rapid Antigen Test, the COVID test. And it turned out positive. The person took other tests as well, PCR test which came out negative. The reporter didn't know if there was any research or data if that was done maybe during clinical trials of whether it is possible to come out positive on an antigen test which tests for bio-protein. The reporter believe that was what in the vaccine. The reporter guess the vaccine causes the reaction in the body to make that protein in the body. The reporter wonder if it was possible it could be false positive on one of those tests because of the vaccine, because of the way that rapid test works. The outcome of the events was unknown.  No follow-up attempts are possible. Information about lot/batch number cannot be obtained. No further information is expected.",,,,,,,,,U,,,,Test Name: COVID PCR test; Test Result: Negative  ; Test Name: COVID Rapid Antigen Test; Test Result: Positive,UNK,,,,,,USPFIZER INC2021001146,2,01/07/2021,,,,,True
795,927667,01/08/2021,MN,,,,M,,"Tested positive for COVID after having received the vaccine; Tested positive for COVID after having received the vaccine; This is a spontaneous report from a contactable nurse. This nurse reported similar events for 2 patients. This is 1st of 2 reports. A 7-decade-old male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, batch/lot number: EJ1685, expiration date: Mar2021), via an unspecified route of administration on 18Dec2020 at left deltoid, at 0.3 mL, single for covid-19 immunization. Medical history included ongoing diabetic. Concomitant medication included insulin for diabetic; pioglitazone hydrochloride (ACTOS) for diabetic and all ongoing. The patient received the vaccine on 18Dec2020 and then less than a week later, on 23Dec2020 was positive for COVID. The reporter said that they had been vaccinating people at their work. The reporter had vaccinated two people now who within about a week after, they tested positive for COVID. The patient was exposed to COVID outside of work. This patient was a healthcare worker (Doctor) in his 60's, weight within normal limits. The reported stated that obviously this person was exposed prior to getting the vaccine and was not symptomatic. But she needed to know, should she stick with the 21 day time period for the second dose or wait 90 days. The patient described COVID as the flu with an attitude. He was staying home and resting. The reporter did not think, with either of these patients that them getting COVID had anything to do with the vaccine. She thought it was a coincidence and they were obviously exposed prior to receiving the vaccine. The event was assessed as non-serious, and unrelated to vaccine by reporter. The outcome of the events was not recovered.; Sender's Comments: There is not a reasonable possibility that event ""tested positive for COVID"" is related to BNT162B2 vaccine.  Patient most likely was exposed to SARS-CoV-2 virus prior vaccination.,Linked Report(s) : US-PFIZER INC-2021001199 Same drug and events, different patient",,,,,,,,,N,12/18/2020,12/23/2020,5.0,Test Date: 20201223; Test Name: COVID; Test Result: Positive  ; Test Name: weight; Result Unstructured Data: Test Result:within normal limits,UNK,,; ACTOS,Diabetic,,,USPFIZER INC2021001215,2,01/07/2021,,,,,True
798,927670,01/08/2021,FL,22.0,,,F,,"chills and not feeling very good; chills and not feeling very good; rapid COVID test positive; rapid COVID test positive; This is a spontaneous report from a contactable consumer. This consumer reported similar events for two patients. This is the first of two reports. This case is serious, the other one is non-serious.   A 22-year-old female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/Lot Number: EH9899) intramuscular at left deltoid on 22Dec2020 19:00 at single dose for covid-19 immunization. The patient medical history and concomitant medications were not reported. No other vaccines given at the same time. The patient received a flu shot back between 27th or 28th Nov2020 in her left deltoid. Caller reported getting the COVID vaccine on the 22Dec2020 and feeling fine before that. On the 28Dec2020 she started feeling chills and not feeling very good and that hasn't gone away. The patient went and got a rapid COVID test and it came back positive, not sure if it was because of the vaccine having antigens in it or she came into contact with it or if she just weakened immune system from the shot. The patient wanted to know if that was true. Then stated she and her mom got the COVID vaccine and her mom received it on the 23Dec. On the 29Dec her whole family started to get sick and experiencing the same things she experienced. The patient was not feeling well at the time of the call. The outcome of the events was not recovered.; Sender's Comments: Linked Report(s) : 2021001266 same reporter/ drug, different patient/event",,,,,,,,,N,12/22/2020,12/01/2020,,Test Date: 202012; Test Name: COVID test; Test Result: Positive,UNK,,,,,,USPFIZER INC2021001263,2,01/06/2021,,,,,True
799,927671,01/08/2021,PA,39.0,,,F,,"PCR was positive last night; PCR was positive last night; This is a spontaneous report from a contactable Other Health Professional (Patient) reported that a 39-year-old female patient receives first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot/Batch Number: EH9899  and Expiration Date unknown) via an unspecified route of administration on 18Dec2020 at single dose for covid-19 immunization. The patient's medical history was unknown. The concomitant medications were reported as none. The patient experienced received the Pfizer's COVID Vaccine on 18Dec2020 (later clarified) at work, at (Institution name) and she just wanted to report that on 23Dec2020, her husband developed symptoms, he was positive on the 26Dec2020 and then she was just converted and her PCR was positive last night on 30Dec2020 (later clarified).  Patient think her husband exposed then she was exposed. Treatment included Advair is twice a day and albuterol is three times a day. The outcome of events was unknown.; Sender's Comments: Based on the information available, a possible contributory role of the suspect BNT162B2 cannot be excluded for the reported COVID-19 PCR test positive  based on the known safety profile. However the short duration of 12 days since the vaccine first dose is given it is unlikely patient would have fully developed immunity. Of note, the patient was exposure to COVID-19 (her husband developed COVID-19).",,,,,,,,,U,12/18/2020,12/30/2020,12.0,Test Date: 20201230; Test Name: PCR; Test Result: Positive,PVT,,,,,,USPFIZER INC2021001308,2,01/07/2021,,,,,True
800,927677,01/08/2021,TX,,,,U,,"tested positive for the Covid antigen with no signs or symptoms; tested positive for the Covid antigen with no signs or symptoms; This is a spontaneous report from a contactable consumer(an administrator of skilled nursing facility).  A patient of unspecified age and gender received BNT162B2 (Covid vaccine) , via an unspecified route of administration on an unspecified date at single dose for covid-19 immunisation.  The patient medical history and concomitant medications were not reported.  The reporter stated the pharmacy did a Pfizer vaccine clinic at his facility, stated that after looking at the FAQs he would like to know if they should not expect a positive antigen test after the vaccine, states the reason he was asking was because the patient they tested today(31Dec2020) that got the vaccine tested positive for the Covid antigen with no signs or symptoms. Outcome of event was unknown. Information on the lot/batch number has been requested.",,,,,,,,,U,,12/31/2020,,Test Date: 20201231; Test Name: Covid; Test Result: Positive  ; Comments: tested positive for the Covid antigen with no signs or symptoms.,UNK,,,,,,USPFIZER INC2021001487,2,01/06/2021,,,,,True
803,927683,01/08/2021,CA,42.0,,,U,,"tested positive for Covid; tested positive for Covid; This is a spontaneous report from a contactable Nurse reported for self. This 42-year-old patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on an 22Dec2020 08:00 on Left arm at single dose (Lot # EH9899) for covid-19 immunisation. Medical history, concomitant medications were none. The patient tested positive for Covid in 25Dec2020. The patient was scheduled to receive the second dose in 08Jan2021 so should the patient get it. (Further clarified the dates and years). Outcome of the events were unknown.; Sender's Comments: A possible contributory effect of suspect BNT162B2 on reported event cannot be excluded.  The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to regulatory authorities, Ethics Committees, and Investigators, as appropriate.",,,,,,,,,U,12/22/2020,12/25/2020,3.0,Test Date: 20201225; Test Name: Covid test; Test Result: Positive  ; Comments: tested positive for Covid in 25Dec2020,PVT,,,,Comments: List of non-encoded Patient Relevant History: Patient Other Relevant History 1: none,,USPFIZER INC2021001595,2,01/06/2021,,,,,True
805,927687,01/08/2021,,,,,U,,"One of my partners was the same way, tested positive after getting the vaccine; One of my partners was the same way, tested positive after getting the vaccine; This is a spontaneous report from a contactable nurse. This nurse reported similar events for 2 patient. This is the second of 2 reports.   A patient of unspecified age and gender received bnt162b2 (BNT162B2, Pfizer biontech Covid-19 Vaccine, solution for injection, lot number and expiation date unknown), via an unspecified route of administration on an unspecified date at a single dose for covid-19 immunization. The patient's medical history and concomitant medications were not reported. On an unknown date, the patient was tested positive after getting the vaccine. The outcome of the event was unknown.  Information on Lot/batch number has been requested.; Sender's Comments: The association between the event lack of effect (SARS CoV2 test positive) with BNT162b2 can not be fully excluded.,Linked Report(s) : US-PFIZER INC-2020510419 same reporter/ drug/similar events, different patient",,,,,,,,,U,,,,Test Name: covid; Test Result: Positive,UNK,,,,,,USPFIZER INC2021001896,2,01/07/2021,,,,,True
807,927696,01/08/2021,FL,,,,F,,"she woke up sick and was having the same symptoms as her husband so she was positive; she woke up sick and was having the same symptoms as her husband so she was positive; This is a spontaneous report from a contactable pharmacist reported for herself.  A 31-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration in Dec2020 at single dose for COVID-19 immunization.  The patient medical history was not reported.  The patient's concomitant medications were not reported.  Caller stated that she was a pharmacist and on Tuesday last week that she received the Pfizer BioNTech Vaccine. Stated that her husband tested positive yesterday (on 29Dec2020). Stated that she was positive that she was positive because that was her husband. Stated that she woke up sick and was having the same symptoms as her husband so she was positive. Stated that she was due for second dose in 2 weeks. Stated that she received the vaccine last week and was negative. The patient underwent lab tests and procedures which included covid test: negative in Dec2020. The outcome of the events was unknown. Information about Batch/Lot number has been requested.; Sender's Comments: The information currently provided is too limited to make a meaningful medical assessment hence, the events are conservatively assessed as related to the suspect drug BNT162B2 until further information becomes available.",,,,,,,,,U,12/01/2020,12/01/2020,0.0,Test Date: 202012; Test Name: covid test; Test Result: Negative,OTH,,,,,,USPFIZER INC2021002413,2,01/07/2021,,,,,True
814,927734,01/08/2021,,,,,U,,"severe anaphylaxis; This is a spontaneous report from a non-contactable Consumer. This Consumer reported similar event for six patient. This is 6th of sixth reports.   A patient of unspecified age and gender received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiration date not reported), via an unspecified route of administration on an unspecified date a single dose for covid-19 immunization. The patient's medical history and concomitant medications were not reported. The patient experienced severe anaphylaxis on an unspecified date with outcome of unknown.  No follow-up attempts are possible. Information about batch number cannot be obtained.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021003207 same drug/event and different patients",,,,,,,,,U,,,,,UNK,,,,,,USPFIZER INC2021003212,2,01/07/2021,,,,,True
843,929048,01/08/2021,CA,31.0,,,M,,"infection of SARS-COV-2; infection of SARS-COV-2; This is a spontaneous report from a contactable healthcare professional.  A 31-year-old male patient started to receive received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number EL0140), intramuscular into the left arm on 18Dec2020, at 10:30 as single dose for covid-19 immunization.  There was no medical history and no concomitant medications.  The patient experienced infection of SARS-COV-2 on 25Dec2020. Details were as follows: The patient received the first dose of the two dose series. On 20Dec2020, he was exposed to COVID-19. Official positive diagnosis of COVID-19  was made on 25Dec2020. Patient had symptoms of fatigue, joint pain and a small fever on an unspecified date, and had been exposed to SARS-COV-2  on 20Dec2020, and the infection on 25Dec2020.  The patient underwent lab tests and procedures which included sars-cov-2 test which was positive on 25Dec2020.  The patient was scheduled to receive second dose of the vaccine; he will be out of quarantine around five to six days before that dose. The outcome of infection of SARS-COV-2 was recovering.; Sender's Comments: The efficacy of a drug varies from one patient to another and can be affected by different factors; however, a contributory role of the suspect drug BNT162B2 to the reported events drug ineffective and COVID-19 cannot be ruled out.",,,,,,,,,N,12/18/2020,12/25/2020,7.0,Test Date: 20201225; Test Name: Covid-19 test; Test Result: Positive,UNK,,,,Comments: List of non-encoded Patient Relevant History: Patient Other Relevant History 1: None,,USPFIZER INC2020518134,2,01/08/2021,,,,,True
844,929050,01/08/2021,NJ,,,,F,,"recipient of the covid 19 vaccine received a positive antigen test within 10 days of getting the vaccine; recipient of the covid 19 vaccine received a positive antigen test within 10 days of getting the vaccine; This is a spontaneous report from a contactable nurse. This nurse reported similar events for two patients. This is the second of 2 reports. A female patient of an unspecified age (Age: 30, Unit: Unknown) received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number and expiration date were not reported), via an unspecified route of administration on an unspecified date at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported.  The patient received a positive antigen test within 10 days of the vaccine and wanted to know if the vaccine could cause a positive antigen test. There was no mention of exposure to a positive person. Outcome of the events was unknown.  Information on lot/batch number has been requested.; Sender's Comments: Based on available information, a possible contributory role of the subject product, BNT162B2 vaccine, cannot be excluded for the reported events of COVID-19 antigen test positive and LOE due to temporal relationship.  There is limited information provided in this report.  Additional information is needed to better assess the case, including complete medical history, diagnostics, counteractive treatment measures and concomitant medications.   This case will be reassessed once additional information is available.  The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.,Linked Report(s) : US-PFIZER INC-2020519946 same reporter, drug, and events; different patients",,,,,,,,,U,,,,Test Name: antigen test; Test Result: Positive,UNK,,,,,,USPFIZER INC2020520414,2,01/08/2021,,,,,True
849,929064,01/08/2021,IA,,,,F,,"experienced loss of smell, taste and a headache/she came down with signs and symptoms/she got tested and got the results on Thursday that she was positive for covid 19 virus; experienced loss of smell, taste and a headache/she came down with signs and symptoms/she got tested and got the results on Thursday that she was positive for covid 19 virus; This is a spontaneous report from a contactable Other Health Professional (patient). A 45-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) Solution for injection, lot number, via an unspecified route of administration from 14Dec2020 at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient had the first dose of COVID vaccine on 14Dec2020. Eleven days following first dose, she experienced loss of smell, taste and a headache. She stated that she came down with signs and symptoms on 25Dec2020 and she got tested and got the results on Thursday that she was positive for Covid 19 virus. She was due for the 2nd dose of the COVID vaccine on the 6th of January. She asked what she should do about the second dose. She mentioned that her symptoms and positive test results were reported where she works in (State name). She wanted to know information as to whether she should get the second dose. Her second dose's scheduled was 6Jan2021. The event outcome was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.; Sender's Comments: Based on available information, a possible contributory role of the subject product, BNT162B2 vaccine, cannot be excluded for the reported events of suspected LOE and COVID 19 infection due to temporal relationship.  There is limited information provided in this report.  Additional information is needed to better assess the case, including complete medical history, diagnostics, counteractive treatment measures and concomitant medications.   This case will be reassessed once additional information is available. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.",,,,,,,,,U,12/14/2020,12/01/2020,,Test Date: 202012; Test Name: covid; Result Unstructured Data: Test Result:positive,UNK,,,,,,USPFIZER INC2021000566,2,01/07/2021,,,,,True
850,929065,01/08/2021,,,,,M,,"had a positive covid test results; had a positive covid test results; This is a spontaneous report from a contactable physician.  A male patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 17Dec2020 at a single dose for COVID-19 immunization.On 22Dec2020 he started to experience COVID like symptoms. On 26Dec2020, he had a positive COVID test results. On 28Dec2020, he received the Regeneron antibody infusion. Patient wants to know more about receiving the 2nd dose based on his positive diagnosis/antibody treatment. Outcome of the event was unknown.    Information on batch number has been requested.; Sender's Comments: Based on available information, a possible contributory role of the subject product, BNT162B2 vaccine, cannot be excluded for the reported events of SARS-CoV-2 test positive and suspected LOE due to temporal relationship.  There is limited information provided in this report.  Additional information is needed to better assess the case, including complete medical history, diagnostics, counteractive treatment measures and concomitant medications.   This case will be reassessed once additional information is available.  The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.",,,,,,,,,U,12/17/2020,12/22/2020,5.0,Test Date: 20201226; Test Name: Covid test; Result Unstructured Data: Test Result:positive,UNK,,,,,,USPFIZER INC2021000577,2,01/07/2021,,,,,True
852,929067,01/08/2021,TX,42.0,,,F,,"Chills; Soreness at the injection site; generalized body aches/Body aches; Shortness of breath; Asthma attack; Difficulty sleeping; Light headed and dizzy; Nausea; high BP 140's; HR 110's to 120s; Nasal congestion; Swelling of the face; Sore throat; This is a spontaneous report from a contactable nurse.  A 42-years-old female patient received her first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number EK5730, expiration date not reported), intramuscular on the right arm on 31Dec2020 at 10:15 AM, at a single dose for Covid-19 immunization.  Medical history included asthma, allergy, hypothyroidism, and some fish allergy. There were no concomitant medications (no other vaccine in four weeks and no other medications in two weeks). Patient previously took ibuprofen and experienced allergy. The patient is not pregnant. On 31Dec2020, after ten-15 minutes (10:30 AM) of receiving the vaccine, she was light headed and dizzy with some nausea. Monitored in the emergency room (ER) with high BP 140's and heart rate (HR) 110s to 120s. After an hour of saline bolus, she was better but she got nasal congestion and swelling of the face with sore throat. On 01Jan2021, after 24 hours, she got some soreness at the injection site with generalized body aches. Also she got some shortness of breath which lead to her asthma attack and difficulty sleeping. On 02Jan2021, after 48hours, she was feeling still light headed with some sore throat, chills, body aches and severe headache which lead her to go to the ER and got herself tested for flu, covid and strep, which came back all negative but her signs and symptoms (s/sx )still after discharge was getting worst especially the headache and generalized body aches. As well as congestion and sore throat. The patient had given ""Ivf"" for the events. The patient was not diagnosed with Covid prior to vaccination and was not Covid tested post vaccination. The outcome of the events was not recovered. The reporter assessed the events as non-serious.; Sender's Comments: A causal association between BNT162B2 and the reported events cannot be excluded based on a compatible temporal relation between vaccination and onset of events.  The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to RAs, Ethics Committees, and Investigators, as appropriate.",,,,,,,,,N,12/31/2020,12/31/2020,0.0,Test Name: BP; Result Unstructured Data: Test Result:high BP 140's; Test Name: HR; Result Unstructured Data: Test Result:110's to 120s; Test Name: flu; Result Unstructured Data: Test Result:negative; Test Name: covid; Result Unstructured Data: Test Result:negative; Test Name: strep; Result Unstructured Data: Test Result:negative,PVT,,,,Medical History/Concurrent Conditions: Allergy; Asthma; Fish allergy; Hypothyroidism,,USPFIZER INC2021000600,2,01/08/2021,,,Y,,True
854,929073,01/08/2021,CA,35.0,,,F,,"tingly feeling to my lips; some lip swelling; tightness in my throat.; This is a spontaneous report from a contactable Other HCP.   A 35-years-old female patient started to receive BNT162B2, via an unspecified route of administration from 30Dec2020 12:00 to 30Dec2020 12:00 at SINGLE DOSE for covid-19 immunisation.   Medical history included hypersensitivity from an unknown date and unknown if ongoing, gastritis from an unknown date and unknown if ongoing, anxiety from an unknown date and unknown if ongoing, depression from an unknown date and unknown if ongoing.   Concomitant medication included lorazepam (ATIVAN), ivermectin (IVERMECTIN), escitalopram oxalate (LEXAPRO), esomeprazole magnesium (NEXIUM [ESOMEPRAZOLE MAGNESIUM]), levocetirizine dihydrochloride (XYZAL).  The patient previously took tamiflu and experienced drug hypersensitivity.   The patient experienced tingly feeling to my lips (paraesthesia oral) (non-serious) on 30Dec2020 15:30 with outcome of recovered, some lip swelling (lip swelling) (non-serious) on 30Dec2020 15:30 with outcome of recovered, tightness in my throat. (throat tightness) (non-serious) on 30Dec2020 15:30 with outcome of recovered.   The action taken in response to the event(s) for BNT162B2 was not applicable.   Therapeutic measures were taken as a result of tingly feeling to my lips (paraesthesia oral), some lip swelling (lip swelling), tightness in my throat. (throat tightness).  This is a spontaneous report from a contactable other HCP. This 35-year-old female other HCP reported that:  Report about covid vaccine: Yes Reporter type: Patient   Age group: Adult (18-64 Years) Is pregnant: No Race: (race provided) Ethnicity: (ethnicity provided) Patient occupation: Other Health Professional  Covid vaccine details: product-COVID 19, Lot number-EL1284, Lot unknown-False, Administration date-30Dec2020, Administration time-12:00 PM, Vaccine location-Left arm, Dose number-1  Facility type vaccine: Hospital If other vaccine in four weeks: Yes Other vaccine 4weeks details: other vaccine 4weeks product -Allergy Immunotherapy injections , Other vaccine 4weeks vaccine date -07Dec2020, Other vaccine 4weeks dose number -2 , Other vaccine 4weeks vaccine location-Left and right arm. Other medications in two weeks: Nexium, xyzal, Ativan, Lexapro, Ivermectin Adverse event: At about almost 4 hrs after receiving the injection I started to experience a tingly feeling to my lips, some lip swelling and tightness in my throat. I had my epi pen on hand incase I needed it but I ended up taking 25mg of Benadryl, then 50 mg of Benadryl 5 hrs later. The following morning my lips where feeling tingly again so I took 25mg of Benadryl again and continued for the next 48 hrs at the advice of my doctor.   Adverse event start date: 30Dec2020 Adverse event start time: 3:30PM AE resulted in: None of the above  If patient recovered: Recovered   If treatment AE: Yes   AE treatment: Benadryl for 48 hrs   If covid prior vaccination: No   If covid tested post vaccination: No  Known allergies: Tamiflu  Other medical history: Chronic allergies, gastritis, anxiety, Depression   Identification of the case safety report  Serious: No Seriousness criteria-Results in death: No Seriousness criteria-Life threatening: No Seriousness criteria-Caused/prolonged hospitalization: No Seriousness criteria-Disabling/Incapacitating: No Seriousness criteria-Congenital anomaly/birth defect: No  VAERS Primary Reporter Addl Qualification: Patient     Relevant medical history and concurrent conditions:  Structured information (Patient episode name): Chronic allergies, gastritis, anxiety, depression     Reaction(s)/Event(s): Reaction/event as reported by primary source: At about almost 4 hrs after receiving the injection I started to experience a tingly feeling to my lips, some lip swelling and tightness in my throat. I had my epi pen on hand incase I needed it but I  Reaction/event in terminology (LLT) : At about almost 4 hrs after receiving the injection I started to experience a tingly feeling to my lips, some lip swelling and tightness in my throat. I had my epi pen on hand incase I needed it but I ended up taking 25mg of Benadryl, then 50 mg of B Date of start of reaction/event: 30Dec2020 Outcome of reaction/event at the time of last observation: RECOVERED/RESOLVED  Drug(s) Information: Characterization of drug role: Suspect Batch/lot number: EL1284     Date of start of drug:30Dec2020  Anatomical location: Arm left Dose number:1  Active drug substance information: Active drug substances name: COVID 19  Drug(s) Information: Characterization of drug role: CONCOMITANT  Proprietary medicinal product name: Allergy Immunotherapy injections   Date of start of drug:07Dec2020  Dose number:2  Narrative case summary and further information:  Case narrative  Age at vaccination: 35  Pregnant at the time of vaccination?: No Start Date/Time:30Dec2020 12:00 PM Facility where the most recent COVID-19 vaccine was administered: Hospital Did the patient receive any other vaccines within 4 weeks prior to the COVID vaccine: Yes List of any other medications the patient received within 2 weeks of vaccination: Nexium, xyzal, Ativan, Lexapro, Ivermectin   Reported Event: At about almost 4 hrs after receiving the injection I started to experience a tingly feeling to my lips, some lip swelling and tightness in my throat. I had my epi pen on hand incase I needed it but I ended up taking 25mg of Benadryl, then 50 mg of Benadryl 5 hrs later. The following morning my lips where feeling tingly again so I took 25mg of Benadryl again and continued for the next 48 hrs at the advice of my doctor. Was treatment received for the adverse event?: Yes: Benadryl for 48 hrs Prior to vaccination, was the patient diagnosed with COVID-19?:No Since the vaccination, has the patient been tested for COVID-19?:No Allergies to medications, food, or other products: Tamiflu Vaccine Facility information available. Ethnicity information is available. Race information is available. Location of injection information is available for other vaccines within 4 weeks PRIOR.; Sender's Comments: A causal association between BNT162B2 and the reported events cannot be excluded based on a compatible temporal relation between vaccination and onset of events. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to RAs, Ethics Committees, and Investigators, as appropriate.",,,,,,,,,Y,12/30/2020,12/30/2020,0.0,,PVT,,ATIVAN;  ; LEXAPRO; NEXIUM [ESOMEPRAZOLE MAGNESIUM]; XYZAL,,Medical History/Concurrent Conditions: Allergy; Anxiety; Depression; Gastritis,,USPFIZER INC2021001773,2,01/08/2021,,,,,True
857,929090,01/08/2021,LA,,,,F,,"TSH level has been borderline hypothyroidism; Almost feel like somebody is gently holding my throat, so I could still breathe, talk, eat but I had the feeling that my throat was being kind of squished; This is a spontaneous report from a contactable nurse. A 64-year-old female patient received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number EK5730), via an unspecified route of administration in right deltoid on an unspecified date at a single dose for covid-19 immunization. Medical history included hypertension and high cholesterol. Concomitant medication included evolocumab (REPATHA) for high cholesterol and two unspecified medications for hypertension. The got the first dose of Pfizer Vaccine for COVID, and for about 3 or 4 almost 5 days afterwards, she felt like somebody, it almost feel like somebody was gently holding her throat, so she could still breathe, talk, eat but had the feeling that throat was being kind of squished. The patient had her lipid panel liver and TSH level done because of the Repatha and TSH level has been borderline hypothyroidism, so she haven't really been on medicine for it but it might be. The patient added that the events had certainly correlated with the vaccine. She didn't have the events until she got the vaccine, so she feel like it was and then her concern was it wouldn't be safe to take the second one. The patient did not visit emergency room and physician office because of the issue 'feel like somebody was gently holding her throat' and all she did was take Benadryl at night. The outcome of the events was unknown.; Sender's Comments: The causal relationship between bnt162b2 and the event hypothyroidism cannot be excluded as the information available in this report is limited and does not allow a medically meaningful assessment. This case will be reassessed once additional information becomes available. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees, and Investigators, as appropriate.",,,,,,,,,U,,,,Test Name: TSH; Result Unstructured Data: Test Result:borderline hypothyroidism; Test Name: lipid panel liver; Result Unstructured Data: Test Result:Unknown Result,UNK,,REPATHA,,Medical History/Concurrent Conditions: High cholesterol; Hypertension,,USPFIZER INC2021002640,2,01/08/2021,,,,,True
858,929092,01/08/2021,MI,35.0,,,F,,"test positive for COVID-19/fever, chills, body aches, joint pain; test positive for COVID-19/fever, chills, body aches, joint pain; This is a spontaneous report from a contactable other HCP. A 35-year-old female patient received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EK5703), via an unspecified route of administration in left arm on 15Dec2020 17:30 at a single dose for covid-19 immunization. Administration was done in the hospital. Medical history included seronegative rheumatoid arthritis and allergies to latex and actemra. Concomitant medication included tofacitinib citrate (XELJANZ), and ibuprofen. Eight days after vaccination, on 23Dec2020 at 13:30, the patient came down with fever, chills, body aches, joint pain. The patient was initially tested negative for COVID (nasal swab) and influenza on 27Dec2020 but did test positive for COVID-19 on 29Dec2020 (nasal swab). The patient stated that she knew that the vaccine did not cause COVID however as she was on immunosuppressants (Xeljanz), she wanted to record this information. There was no treatment included for the events. The outcome of the events was recovering. Prior to vaccination, the patient was not diagnosed with COVID-19.; Sender's Comments: Based on the current available information and the plausible drug-event temporal association, a possible contributory role of the suspect product BNT162B2 to the development of events Drug ineffective and COVID-19 cannot be totally excluded.  The case will be reassessed if additional information becomes available.",,,,,,,,,N,12/15/2020,12/26/2020,11.0,Test Date: 20201227; Test Name: Influenza; Test Result: Negative  ; Comments: I initially tested negative for COVID and influenza.; Test Date: 20201227; Test Name: Nasal Swab; Test Result: Negative  ; Test Date: 20201229; Test Name: Nasal Swab; Test Result: Positive,PVT,,XELJANZ;,,Medical History/Concurrent Conditions: Latex allergy; Seronegative rheumatoid arthritis,,USPFIZER INC2021002658,2,01/08/2021,,,,,True
860,929103,01/08/2021,CA,43.0,,,F,,"When she went back to work on 25Dec2020 it was positive/On the weekend she had to come back to do a PCR test on28Dec2020 and it was positive.; When she went back to work on 25Dec2020 it was positive/On the weekend she had to come back to do a PCR test on28Dec2020 and it was positive.; This is a spontaneous report from a contactable nurse. A 43-year-old female patient receive bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/lot number: EH9899), via an unspecified route of administration given in the left arm on 22Dec2020 at a single dose for covid-19 immunization. The patient medical history included ""patient's a blood donor"" reported as, she donated blood on 12Sep2020 and it was negative for covid. The patient's concomitant medications were not reported. The patient experienced ""when she went back to work on 25Dec2020 it was positive/on the weekend she had to come back to do a pcr test on28dec2020 and it was positive"" on 25Dec2020 with an unknown outcome. It was further reported that the patient was a registered nurse that works night shift. She clarified that the rapid test was taken each time she goes to work. When she went to work on the night of 21Dec2020 the rapid test was negative.Then she got the Covid vaccine in the morning of 22Dec2020. When she went back to work the night of 22Dec2020 the rapid test was negative. When she went back to work on 25Dec2020 it was positive. On the weekend she had to come back to do a PCR test on28Dec2020 and it was positive. Caller clarifies that the rapid tests were Nasal Swabs. The patient's latest test was on 28Dec2020, she was told that when she comes back, they do not have to do the rapid test daily anymore, it will now be every 90 days. The patient did not have a test before the vaccine. She has had no issues with Vaccines in the past.; Sender's Comments: Based on the information available, a possible contributory role of the suspect BNT162B2 cannot be excluded for the reported event positive for corona virus infection based on the known safety profile. However given the short duration of 3 days since the vaccine first dose, it is unlikely patient would have fully developed immunity.",,,,,,,,,U,12/22/2020,12/25/2020,3.0,Test Date: 20200912; Test Name: covid; Test Result: Negative  ; Test Date: 20201228; Test Name: PCR test; Test Result: Positive  ; Test Date: 20201221; Test Name: rapid test/Nasal Swabs; Test Result: Negative  ; Test Date: 20201222; Test Name: rapid test/Nasal Swabs; Test Result: Negative  ; Test Date: 20201225; Test Name: rapid test/Nasal Swabs; Test Result: Positive,UNK,,,,Medical History/Concurrent Conditions: Blood donor,,USPFIZER INC2021002781,2,01/08/2021,,,,,True
863,929118,01/08/2021,NY,34.0,,,F,,"a left sided nystagmus; urgent MRI showing multiple brain lesions consistent with Acute disseminated encephalomyelitis; Patient developed paresthesias on entire right side of body / The paresthesias continued, not progressing; a brief headache; episode of dizziness / developed severe dizziness; This is a spontaneous report from a contactable physician (patient). A 34-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EK5730) intramuscularly at right arm on 21Dec2020 07:00 at single dose for COVID-19 immunization. Medical history included known allergies to sulfa meds. The patient's concomitant medications included multivitamins [vitamins nos] within 2 weeks of vaccination. Patient developed paresthesias on entire right side of body after a brief headache and episode of dizziness, all since 29Dec2020 15: 00. The paresthesias continued, not progressing, but patient was advised to obtain an MRI Brain and C spine as an outpatient. On 02Jan2021, the patient developed severe dizziness and a left sided nystagmus. She went to the ER and underwent urgent MRI showing multiple brain lesions consistent with acute disseminated encephalomyelitis. Lumbar puncture (LP) was performed, awaiting final results. Patient was admitted and was receiving IV steroids (solumedrol). Duration of hospitalization was 5 days since Dec2020. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient underwent lab tests and procedures, which included Nasal Swab and Rapid covid swab, both on 02Jan2020 with result of negative. The outcome of the events was recovering.; Sender's Comments: Based on temporal association and lack of other provided etiology, a possible contributory role of suspect BNT162B2 vaccine cannot be excluded for reported acute disseminated encephalomyelitis, paraesthesia, headache, dizziness and nystagmus. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.",,,,,Y,5.0,,,N,12/21/2020,12/29/2020,8.0,Test Name: LP; Result Unstructured Data: Test Result:Unknown results; Test Name: MRI; Result Unstructured Data: Test Result:Multiple brain lesions; Comments: MRI showing multiple brain lesions consistent with Acute disseminated encephalomyelitis.; Test Date: 20210102; Test Name: Nasal Swab; Test Result: Negative  ; Test Date: 20210102; Test Name: Rapid covid swab; Test Result: Negative,PVT,,MULTIVITAMINS [VITAMINS NOS],,Medical History/Concurrent Conditions: Sulfonamide allergy (Known allergies: Sulfa meds),,USPFIZER INC2021002897,2,01/07/2021,,,Y,,True
866,929126,01/08/2021,WV,59.0,,,M,,"Test positive for COVID-19/have symptoms on 26, 27 and 28Dec2020; Test positive for COVID-19/have symptoms on 26, 27 and 28Dec2020; This is a spontaneous report from a contactable physician (patient). A 59-year-old male patient started to receive first dose of BNT162B2 (Batch/lot number: EH9899) intramuscular into left deltoid on 15Dec2020 at single dose for covid-19 immunisation. Medical history included hypertension and the patient was on blood pressure (BP) medications. The patient received no other vaccines on the same day as the COVID Vaccine. The patient received first dose on 15Dec2020 and was exposed to someone with COVID on 24Dec2020 and tested positive for COVID 28Dec2020. The patient stated that he was wondering what the recommendations are for receiving the second dose of the product, if someone contracted COVID-19 after receiving the first dose. He tested Positive for COVID-19 on 28Dec2020 and he does not know if it is ongoing or not, as he does not re-test for COVID-19 until Wednesday (30Dec2020), but he currently has no symptoms. The patient stated that he did have symptoms on 26, 27 and 28Dec2020. The lab tests and included COVID-19 PCR test: positive on 28Dec2020. The outcome of events was unknown.; Sender's Comments: The association between the event lack of effect (COVID-19) with BNT162b2 can not be completely excluded.",,,,,,,,,U,12/15/2020,12/26/2020,11.0,Test Date: 20201228; Test Name: COVID-19 PCR test; Test Result: Positive,UNK,,,,Medical History/Concurrent Conditions: Hypertension,,USPFIZER INC2021002966,2,01/07/2021,,,,,True
867,929132,01/08/2021,NJ,25.0,,,M,,"Patient fainted in the ICU setting.; dizziness; hypotension; This is a spontaneous report from a contactable Other HCP. A 25-year-old male patient received BNT162B2 (Lot number: eh9899) via an unspecified route of administration on 24Dec2020 13:00 at single dose for covid-19 immunisation. The patient did not have any known allergies or medical history. Prior to vaccination, the patient was not diagnosed with COVID-19. There were no concomitant medications. On 24Dec2020, patient experienced dizziness and hypotension. Patient's blood pressure (BP) was 50/30 and heart rate (HR) 45. Patient fainted in the intensive care unit (ICU) setting. This happened during work hours while treating a patient. Patient was treated in the emergency department (ED). The adverse events resulted in emergency room/department or urgent care. It was unknown if treatment was received for the adverse event. Since the vaccination, the patient has not been tested for COVID-19. The outcome of events was recovered.; Sender's Comments: A possible contributory effect of suspect BNT162B2 on reported events cannot be excluded.  The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to regulatory authorities, Ethics Committees, and Investigators, as appropriate.",,,,,,,,,Y,12/24/2020,12/24/2020,0.0,Test Date: 20201224; Test Name: BP; Result Unstructured Data: Test Result:50/30; Test Date: 20201224; Test Name: HR; Result Unstructured Data: Test Result:45,PVT,,,,Comments: List of non-encoded Patient Relevant History: Patient Other Relevant History 1: none,,USPFIZER INC2021002997,2,01/08/2021,,,Y,,True
868,929136,01/08/2021,KY,26.0,,,F,,"temperature of 101 F; body aches; headache; nausea; chills; This is a spontaneous report from a contactable Other HCP (patient).  A 26-year-old female patient started to receive BNT162B2 (Batch/lot number: EK9231) at right deltoid via an unspecified route of administration on 03Jan2021 12:20 at single dose for covid-19 immunisation. Medical history was none. The patient's concomitant medications were not reported. The patient experienced temperature of 101 F, chills, body aches, headache and nausea on 04Jan2021 02:00. Patient stated for the second one, she was hoping for the best, but she got the vaccine yesterday (03Jan2021), at 12:20, and today (04Jan2021), at 2 AM, she had a temperature of 101, and chills, body aches, headaches, and nausea. She was out of it today, she was not feeling good, and was told to do this. Caller got the vaccine at Employee Health. After 4 hours of Tylenol (expiry is May2021, lot is P115252), her temperature went right back up. It was about 99 when she had Tylenol. Chills started late this morning (04Jan2021) and were ongoing when she was not on Tylenol, but her body aches were ongoing. 9AM was when her headache started, and she was intermittently on Tylenol, but if past the 4 hour mark, they were as bad as they were this morning, but with Tylenol they were better. Nausea was mostly this morning, and had gotten better. Patient stated that due to her current symptoms her employer had required her to be tested for COVID-19. She had not yet received the results of that test. Seriousness for events temperature of 101 F, chills, body aches, headache and nausea was Medically significant. Lab data included COVID test on 23Dec2020 was negative. The outcome of temperature of 101 F, headache and nausea was recovering; of body aches was not recovered; of chills was unknown.  Primary Source Reporter (Method of assessment was Global Introspection) considered the events were related to BNT162B2.; Sender's Comments: There is a reasonable possibility that the events reported were related to BNT162b2 based on known drug safety profile and close temporal relationship.  The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to regulatory authorities, Ethics Committees, and Investigators, as appropriate.",,,,,,,,,N,01/03/2021,01/04/2021,1.0,Test Date: 20210104; Test Name: Body Temp; Result Unstructured Data: Test Result:101 Fahrenheit; Test Date: 202101; Test Name: Body Temp; Result Unstructured Data: Test Result:99 Fahrenheit; Test Date: 20201223; Test Name: COVID test; Result Unstructured Data: Test Result:negative,UNK,,,,Comments: List of non-encoded Patient Relevant History: Patient Other Relevant History 1: None,,USPFIZER INC2021003012,2,01/08/2021,,,,,True
869,929139,01/08/2021,NV,43.0,,,F,,"Itching and redness over whole body/I turned all red and was itching all over my body by about 10:30- 10:45 am/I still have mild itching; Itching and redness over whole body/I turned all red and was itching all over my body by about 10:30- 10:45 am/I still have mild itching; Elevated heart rate and blood pressure; Elevated heart rate and blood pressure; Had an allergic reaction; This is a spontaneous report from a contactable nurse (patient). A 43-year-old female patient received the first dose of bnt162b2 (BNT162B2) lot no: EK9231, via an unspecified route of administration in left arm on 30Dec2020 09:00 at a single dose for COVID-19 immunization. Medical history HTN and exercise-induced asthma, both from an unspecified date and unknown if ongoing. The patient was not pregnant at the time of vaccination. The patient had no covid prior to vaccination and was not covid tested post vaccination. Concomitant medication included colecalciferol (VITAMIN D), montelukast sodium (SINGULAIR), and biotin. No other vaccines were administered in four weeks. Known allergies include tapendalol (NUCYNTA) and trimethoprim/sulfamethoxazole (BACTRIM). On 30Dec2020 09:30, the patient experienced itching and redness over whole body, elevated heart rate, and blood pressure. The patient was given IV diphenhydramine (BENADRYL) 50 mg, IV famotidine (PEPCID), IV methylprednisolone (SOLU MEDROL), ""flui"" as treatment for AEs. The patient further clarified that she received the COVID 19 vaccine on 30Dec2020 at 9:00 and she had an allergic reaction. She turned all red and was itching all over her body by about 10:30- 10:45 am and was at the ER by about 11am. She started on prednisone 40mg for 3 days and diphenhydramine every 6 hours, as needed on 30Dec2020. On Sunday (03Jan2021), she was still severely itching and turning red so prednisone was continued for an additional 3 days and was switched to cetirizine (ZYRTEC) because she can't function on diphenhydramine. Cetirizine was not helping so she had to take diphenhydramine yesterday morning (04Jan2021). Last night (04Jan2021), she was ok without any diphenhydramine but this morning (05Jan2021), she still have mild itching, and no redness. The redness comes and goes; it is on the face, chest, arms, legs. When it first started, it was whole body redness. Then it moved to different areas on different days; she don't have a rash or hives, just redness.  She had a 4 inch band of redness on both arms one day. The events were reported as non-serious. The patient had not recovered from the events.; Sender's Comments: A possible causal association between administration of BNT162B2 and the onset of allergic reactions cannot be excluded, considering the plausible temporal relationship and the known adverse event profile of the suspect product.  The underlying predisposing condition of drug allergies to multiple materials may put the patient at high risk of allergic reactions. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate",,,,,,,,,N,12/30/2020,12/30/2020,0.0,Test Date: 20201230; Test Name: blood pressure; Result Unstructured Data: Test Result:Elevated; Comments: elevated heart rate and blood pressure; Test Date: 20201230; Test Name: heart rate; Result Unstructured Data: Test Result:Elevated; Comments: elevated heart rate and blood pressure,WRK,,VITAMIN D [COLECALCIFEROL]; SINGULAIR;,,Medical History/Concurrent Conditions: Exercise induced asthma; Hypertension,,USPFIZER INC2021003028,2,01/08/2021,,,Y,,True
870,929140,01/08/2021,,,,,F,,"contracted Sars-Cov-2 in between her two doses; contracted Sars-Cov-2 in between her two doses; This is a spontaneous report from a Contactable Other HCP. A female patient of an unspecified age started to receive the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on unknown date at single dose for covid-19 immunisation. The patient medical history was not reported. The patient's concomitant medications were not reported. Patient was due for her 2nd dose of Pfizer-Biontech Covid19 vaccine on 06Jan2020. She contracted Sars-Cov-2 in between her two doses, want to know if she should receive her second dose as scheduled. Patient had COVID-19 test with unknown result. Outcome of events was unknown. Information about lot/batch number has been requested.; Sender's Comments: The association between the event lack of effect (contracted SARS CoV 2) with BNT162b2 cannot be completely excluded.",,,,,,,,,U,,,,Test Name: Sars-Cov-2; Result Unstructured Data: Test Result:unknown results,UNK,,,,,,USPFIZER INC2021003032,2,01/08/2021,,,,,True
872,929154,01/08/2021,AZ,67.0,,,M,,"I was pretty sick, I felt palsy; I was pretty sick, I felt palsy; I developed the fever for all about 30 hours after the vaccination; Headache; This is a spontaneous report from a contactable physician. This physician reported for himself that a 67-years-old male patient received BNT162B2 (BioNTech Covid 19 vaccine; Batch/lot number: EL1284), via an unspecified route of administration on 30Dec2020 at SINGLE DOSE for ""Because I am a physician, a healthcare provider"" (covid-19 immunization).  Medical history included had Covid back on the 4th of December.  There were no concomitant medications. Physician stated he was wondering he just took your Pfizer Covid vaccination, the first one. He took it couple of days ago. He took it on the 30th of this month, two days ago. Physician further stated he developed the fever for all about 30 hours after the vaccination. Just because he developed the fever with the first one, it was like a 101.7 that was about 36 hours. So the question was just because he developed the fever with the first one, he was pretty sick, he meant he felt palsy, you know headache and all that it was like probably developed the same with the second one? Patient weight was maybe 125 pounds. When probed if vaccine was prescribed by any Physician, Physician stated he went himself. Causality by physician stated as ""he think so"". Lab work reported as He did not have the results yet. He just look a Covid screening test because he had Covid back on the 04Dec. So, he just took a Covid screening test. Treatment received included aspirin. The outcome of all events was unknown.; Sender's Comments: The causal relationship between BNT162B2 and the event palsy cannot be excluded as the information available in this report is limited and does not allow a medically meaningful assessment. This case will be reassessed once additional information becomes available. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees, and Investigators, as appropriate.",,,,,,,,,U,12/30/2020,,,"Test Name: fever; Result Unstructured Data: Test Result:101.7; Test Name: Covid screening test; Result Unstructured Data: Test Result:Unknown result; Comments: I do not have the results yet. I just look a Covid screening test because I had Covid back on the 4th of December. So, I just took a Covid screening test; Test Name: Weight; Result Unstructured Data: Test Result:125 lbs; Comments: Maybe 125 pounds",PVT,,,,Medical History/Concurrent Conditions: COVID-19 (I had Covid back on the 4th of December.),,USPFIZER INC2021003106,2,01/08/2021,,,,,True
874,929157,01/08/2021,TN,31.0,,,F,,"blurriness on the right eye with consistent optic neuritis; read up on transverse myelitis that may be related to her condition; blurriness on the right eye with consistent optic neuritis; This is a spontaneous report from a contactable physician. This physician (patient) reported for self that the 31-year-old female patient received bnt162b2 (BNT162B2, PFIZER-BIONTECH COVID-19 VACCINE, lot: EK5730), via an unspecified route of administration on Deltoid, Left on 20Dec2020 13:00 at single dose for covid-19 immunisation. Medical history and concomitant medications were none. Reported she has a flu vaccine in Sep2020, and had no reaction to the flu vaccine. She clarified she has never had a reaction to a vaccination before. The patient received the vaccine last 20Dec2020 and has reported to have blurriness on the right eye with consistent optic neuritis since 24Dec2020. She has already consulted with an ophthalmologist who said her case was interesting and referred her to Pfizer. She is scheduled to have her second dose on 10Jan2021 and is asking if she should still take it. She also mentioned that she read up on transverse myelitis that may be related to her condition and is asking for any information we may have on this. Doctor reporting she is having a possible adverse event to the COVID-19 Vaccine. The patient clarified she received the COVID-19 Vaccine on Sunday, 20Dec2020 at approximately 1:00PM. Reported the COVID-19 Vaccine was administered at her employer. Doctor reported she is experiencing blurry vision in her right eye only, consistent with optic neuritis in Dec2020 (Medically significant). She said her right eye blurry vision gets worse after working out or showering. She said she has read some medical information that states some kind of autoimmune reaction, like transfer myelitis, may occur after receiving the COVID-19 Vaccine. The patient asked if she should get the second COVID-19 Vaccine, clarifying she is scheduled to receive her second dose on 10Jan2021. Clarified she started experiencing the right eye blurry vision on either 24Dec2020 or 25Dec2020. Treatment: Reported she saw an ophthalmologist, and the ophthalmologist said he didn't see anything concerning or not normal. She said the ophthalmologist referred her to see a neurologist, and to get a MRI of her head. She clarified her MRI appointment is on 19Jan2021. She clarified her ophthalmologist called her back 2 hours after she left her appointment. She said the ophthalmologist told her he found what she was experiencing to be interesting, as to when she received the COVID-19 Vaccine, and the start of her right eye blurry vision, and that he wanted her to get further evaluation. She said the ophthalmologist performed visual field testing, and took a fancy picture of her retina. No further details provided. Vaccination Facility Type was hospital. No Vaccine Administered at Military Facility. History of all previous immunization with the Pfizer vaccine considered as suspect (or patient age at first and subsequent immunizations if dates of birth or immunizations are not available) was none. Additional Vaccines Administered on Same Date of the Pfizer Suspect was none. No AE(s) required a visit to Emergency Room but AE(s) required a visit to Physician Office. Prior Vaccinations (within 4 weeks) was none. Patient's Medical History(including any illness at time of vaccination) was none. Family Medical History Relevant to AE(s) was not provided. Relevant Tests included Visual field test, and picture of her retina. The outcome of the events was not recovered.; Sender's Comments: Based on temporal association, the causal relationship between bnt162b2 and the events optic neuritis, vision blurred and myelitis transverse cannot be excluded. The information available in this report is limited and does not allow a medically meaningful assessment. This case will be reassessed once additional information becomes available. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees, and Investigators, as appropriate.",,,,,,,,,N,12/20/2020,12/01/2020,,Test Name: picture of her retina; Result Unstructured Data: Test Result:unknown results; Test Name: Visual field test; Result Unstructured Data: Test Result:unknown results,PVT,,,,Comments: List of non-encoded Patient Relevant History: Patient Other Relevant History 1: none,,USPFIZER INC2021003127,2,01/08/2021,,Y,,,True
882,929175,01/08/2021,OR,65.0,,,M,,"occipital neuralgia; left-side Bells Palsy; bilateral headache; This is a spontaneous report from a contactable physician (patient). A 65-year-old male patient received BNT162b2 (Lot/batch number and Expiration date were not provided), via an unspecified route of administration at right deltoid on 21Dec2020 19:00 at single dose for covid-19 immunization. The patient's medical history included low high density lipoprotein (HDL). There were no concomitant medications. The patient previously took influenza vaccine (longer than 4 weeks ago, and he did not have any reaction), pravastatin for low HDL. Reported 2 days ago (02Jan2021) he developed a bilateral headache. He stated he was asymptomatic until then. He said he now has Bells Palsy on 02Jan2021, clarified he has left-side Bells Palsy. He said it is unknown to him if the bilateral headache and Bells Palsy are related to taking the COVID-19 Vaccine. He stated he started wearing a N95 mask for the past 2 weeks. He said the N95 mask is very tight on the back of his head. He said he believes he is experiencing occipital neuralgia caused by wearing the N95 mask. He said studies show that the N95 mask can cause Bells Palsy, and the N95 mask maybe a confounding factor. He stated he doesn't have any further information on the N95 mask he was using. Initially he had a severe headache and administered to himself a sphenopalatine block of Lidocaine 1% in his nose. He stated being an ER doctor, he knows how to administer the sphenopalatine block to a patient. He went to the ER on 03Jan2021 to make sure he did not have a tumor or a stroke. He said the hospital performed a CT of his head, a MRA, labs, and a COVID-19 test (clarified as a PCR COVID-19 test) with a full viral count. He said all the tests were negative. His wife noticed his Bells Palsy yesterday, 03Jan2021. He said he thinks the Bells Palsy started the night before on 02Jan2021. He said he noticed on the night of 02Jan2021 when he was brushing his teeth, he hit a tooth on that side (clarified as left side) of his mouth with his tooth brush. He hasn't started taking steroids yet, but will be starting steroids real soon. He clarified his doctor prescribed a Medrol dose pack and Valtrex for the Bells Palsy. He stated he has not started the Medrol dose pack and Valtrex. He is ordering Lidocaine 1% viscous for himself, so he can do an internasal sphenopalatine block on himself. He does not know if the bilateral headache and Bells Palsy were caused by taking the COVID-19 Vaccine. The events required Emergency Room visit. The outcome of the event Bell's palsy was not recovered,  Headache was recovering, Occipital neuralgia was unknown.  Information on the Lot/Batch number has been requested.; Sender's Comments: A possible causal association between administration of BNT162b2 and the onset of Bell's palsy/Headache might not be excluded, considering the plausible temporal relationship.  The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.",,,,,,,,,N,12/21/2020,01/02/2021,12.0,Test Date: 20210103; Test Name: MRA; Test Result: Negative  ; Test Date: 20210103; Test Name: Head CT; Test Result: Negative  ; Test Name: HDL; Result Unstructured Data: Test Result:Low; Test Date: 20210103; Test Name: Lab test; Test Result: Negative  ; Test Date: 20210103; Test Name: COVID-19 PCR test negative; Test Result: Negative  ; Comments: full viral count,PVT,,,,Medical History/Concurrent Conditions: Low HDL,,USPFIZER INC2021003751,2,01/08/2021,,,Y,,True
884,929178,01/08/2021,UT,38.0,,,F,,"I was having trouble clearing my throat, felt like it was closing up; high heart rate/rapid heart rate agai; uncontrollable rigors; numb lips and hands; numb lips and hands; nausea; shortness of breath, difficulty catching my breath; This is a spontaneous report from a contactable Other Health Professional (patient). A 38-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) lot number: EJ1685, intramuscular in the left arm, on 30Dec2020 09:15 at a single dose for COVID-19 immunization. Medical history included bariatric surgery, had anterior vaginal repair and bladder sling, had her gall bladder and tonsils removed. Concomitant medication included rizatriptan and paracetamol (TYLENOL). The patient had no known allergies but mentioned that she cannot take the NSAIDs eventhough she was not allergic to them. She had no allergies to food or to other products. It was reported that within about 10 minutes of the injection of the vaccine, she had trouble clearing her throat, felt like it was closing up, had uncontrollable rigors, high heart rate, numb lips and hands, and nausea on 30Dec2020 at 09:30 AM. She was discharged from the ED (emergency department), went home and took a nap. Later that evening, she began to have a rapid heart rate again, began to had shortness of breath, difficulty catching her breath and she was admitted to the emergency department again and given more IV medications. The onset of the events was reported to be 30Dec2020 at 09:30 AM with outcome of recovering. As a result of the events, the patient visited that Emergency room/department or urgent care. Treatment received with IV medications (unspecified), breathing treatment, and epinephrine injection. The patient had no covid prior vaccination. She had not had Covid test post vaccination.; Sender's Comments: Based on temporal association, the causal relationship between BNT162B2 and the events throat tightness, heart rate increased, chills, hypoaesthesia oral, hypoaesthesia, nausea and dyspnoea cannot be excluded. The information available in this report is limited and does not allow a medically meaningful assessment. This case will be reassessed once additional information becomes available. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees, and Investigators, as appropriate.",,,,,,,,,N,12/30/2020,12/30/2020,0.0,Test Name: heart rate; Result Unstructured Data: Test Result:high,WRK,,; TYLENOL,,Medical History/Concurrent Conditions: Bariatric surgery; Bladder disorder; Tonsillar disorder; Vaginal disorder (had anterior vaginal repair and bladder sling),,USPFIZER INC2021004230,2,01/08/2021,,,Y,,True
888,929185,01/08/2021,,,,,U,,"What I believe may have triggered this reaction is that in October I had a carpal and ulnar tunnel release in the same extremity/affected the nerves; my entire upper arm began aching-pain from my trapezius down to my elbow; my index and middle finger began tingling; I am noting pain in each of the major joints of my arm-shoulder, elbow and wrist; I am noting pain in each of the major joints of my arm-shoulder, elbow and wrist.; I am noting pain in each of the major joints of my arm-shoulder, elbow and wrist.; This is a spontaneous report from a contactable nurse (patient).  A patient of unspecified age and gender received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), via an unspecified route of administration on the arm on 19Dec2020 as single dose for covid-19 immunization.  The patient's medical history and concomitant medications were not reported.  The patient experienced the following:  "" my entire upper arm began aching-pain from my trapezius down to my elbow "" in Dec2020 with outcome of unknown;  ""my index and middle finger began tingling ""  in Dec2020 with outcome of unknown;  "" I am noting pain in each of the major joints of my arm-shoulder, elbow and wrist "" in Dec2020 with outcome of unknown; "" what I believe may have triggered this reaction is that in October I had a carpal and ulnar tunnel release in the same extremity "" in Dec2020 with outcome of unknown.  Therapeutic measures were taken as a result of the events. Details were as follows: The injection itself was without any issues. However, 6-7 hours later, the patient described the following: patients entire upper arm began aching-pain from trapezius down to the elbow. This continued throughout the weekend and then Monday, patients index and middle finger began tingling (as if asleep). This symptom never subsided. The patient noted pain in each of the major joints of the arm shoulder, elbow and wrist. The patient tried trigger injections in the trapezius, ibuprofen, muscle relaxers, heat, exercises, and a steroid burst-all without relief of symptoms. Patient was able to move arm and had strength in the extremity. Patient saw a specialist in physical medicine and rehabilitation. The patient believed that what triggered this reaction is that in October the patient had a carpal and ulnar tunnel release in the same extremity. The patient wondered whether the medication affected the nerves that had been manipulated during surgery. The events outcome was unknown.   The batch/lot number for the vaccine, BNT162B2, was not provided and will be requested during follow-up .; Sender's Comments: Based on the time association, the possible contribution of suspect BNT 162B2 injection to the event Neuropathy peripheral cannot be excluded. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.",,,,,,,,,U,12/19/2020,12/01/2020,,,UNK,,,,,,USPFIZER INC2021006637,2,01/08/2021,,,,,True
890,929192,01/08/2021,,,,,F,,"Coughing so hard; coughed during COVID but not like this; Hard to stand up; Pain/body wrecking pains; Fever; Started heaving; Dizzy; Nauseous; Throwing up; Chills; Draining; This is a spontaneous report from a contactable consumer. An adult female patient (consumer's daughter) received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on an unspecified date at single dose for covid-19 immunization. Medical history included covid-19 from Nov2020. The patient had COVID in the middle of Nov2020 and her father and reporter had it two weeks before and then about two weeks later, she got it. She took her 14 days quarantine, she coughed and had some tummy issues. She had fever, the aches and pains with Covid, a little bit of dry cough. She did not feel good for probably about 5 days, after that she started working again. She had COVID and did not have to be hospitalized, any IV drip or anything before vaccination. 6 weeks later, she got the vaccine shot. The patient's concomitant medications were not reported. The vaccine came out on Wednesday (30Dec2020), the patient signed up at work to take it. Within about 12 hours  (unknown onset date), she did start to feel 'oily', and had started having aches, pains and very shortly after that she started running a fever, all of a sudden the cough came out of the blue, she started heaving, dizzy, nauseous and it's three days later, she was coughing so hard. She coughed during COVID but not like this, this was like COVID ten times over, same symptoms though, throwing up, throwing up, hard to stand up, aches, pains, fever, chills, body wrecking pains. The patient can hardly talk because she kept coughing and draining. The reporter asked that ""Should her daughter be given vaccine? Does her antibodies, daughter was asked - Did you have any severe case, and she told - No, I was able to stay home and just stay in bed, they said - Okay we'll give it to you. Should she have gotten so close to the signs that she had COVID? Why her daughter be asked that question? What is going on regarding the symptoms. What should we do about it?"" Consumer tried to get daughter to go to a COVID Clinic today (02Jan2021), and know she didn't have COVID, that's not how it worked, but normal doctors didn't want to see her daughter. Consumer called the COVID Clinic and they said ""Yes, we could probably see her"". The outcome of events was unknown.  Information about lot/batch number has been requested; Sender's Comments: A causal association between BNT162B2 and the reported events cough and difficulty standing cannot be excluded based on temporal relation of vaccination and onset of events. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to RAs, Ethics Committees, and Investigators, as appropriate.",,,,,,,,,U,,,,Test Name: FEVER; Result Unstructured Data: Test Result:fever,PVT,,,,"Medical History/Concurrent Conditions: COVID-19 (middle of Nov2020,coughed, fever, the aches and pains, a little bit of dry cough.); Tummy ache",,USPFIZER INC2021007572,2,01/08/2021,,,,,True
897,929428,01/08/2021,KY,55.0,,,F,,"felt the need to have a COVID test, which turned out positive; felt the need to have a COVID test, which turned out positive; felt the need to have a COVID test, which turned out positive; Chills; Fever; This is a spontaneous report from a contactable Other HCP. A 55-year-old female patient received frist dose of BNT162B2 (Batch/lot number: EK5730) via an unspecified route of administration on 21Dec2020 at single dose for covid-19 immunisation. The patient medical history was not reported. There were no concomitant medications.  The patient explained receiving the COVID-19 vaccine on the 21Dec2020 and experienced fever and some chills. She pursed explaining that she was fine afterwards but felt the need to have a COVID test, which turned out positive of the 31Dec2020. The patient stated that she only had chills and fever the evening of 29Dec2020 and had been fine every since. Her fever that night did not hit 100 degrees. She thought that it would be better if she did not go to work on that Wednesday since she had had a fever the night before. She called her doctor who told her to come into the office on 31Dec2020 to have a rapid COVID test done and it came back positive. She only had fever and chills that one night and has not had any other symptoms. She received no treatment and did not take anything for the fever. This all happened during the night. She felt fine when she got up the next morning. Because she had received the first dose of the COVID vaccine, she thinks that this helped her. She thinks if she had not had the vaccine, then the virus would have been a lot worse. She stated that her second dose of the vaccine is scheduled on the 11Jan2021, and asked if it is safe to get the second dose of the COVID-19 vaccine.  The outcome of events chills and fever was recovered; of other events was unknown.; Sender's Comments: The association between lack of effect (suspected COVID-19, SARS CoV2 test positive) with BNT162b2 can not be completely excluded.",,,,,,,,,Y,12/21/2020,12/29/2020,8.0,Test Date: 20201229; Test Name: Temperature; Result Unstructured Data: Test Result:fever that night did not hit 100 degrees; Test Date: 20201231; Test Name: COVID-19 Rapid Test; Test Result: Positive,UNK,,,,,,USPFIZER INC2021003009,2,01/08/2021,,,,,True
901,929437,01/08/2021,,,,,F,,"tested positive for covid ""yesterday""/asymptomatic; tested positive for covid ""yesterday""/asymptomatic; This is a spontaneous report from a contactable nurse (patient). A female patient of an unspecified age received 1st dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 21Dec2020 at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient received the first dose of the vaccine on 21Dec2020 and was scheduled for the second on 11Jan2021. The patient tested positive for COVID yesterday, 03Jan2021 and wanted to know what to do about her second dose. The patient added that she was asymptomatic at this point and not taking any medications. Outcome of the events was unknown. The events was assessed as non-serious.  Information on the lot/batch number has been requested.; Sender's Comments: The reported positive test with Covid-19 after COVID-19 immunization is considered ineffective of BNT162B2, and the Company cannot completely exclude the possible causality between the reported event and BNT162B2 administration.",,,,,,,,,U,12/21/2020,01/03/2021,13.0,Test Date: 20210103; Test Name: covid; Test Result: Positive,UNK,,,,,,USPFIZER INC2021003195,2,01/07/2021,,,,,True
907,929462,01/08/2021,CA,68.0,,,M,,"Tested positive for covid a week later after his first shot; Tested positive for covid a week later after his first shot; This is a spontaneous report from a contactable consumer. A 68-year-old male patient received the first dose of BNT162B2 (Pfizer-BIONTECH Covid-19 Vaccine), via an unspecified route of administration in the left arm on 28Dec2020 at 12:00 PM in a hospital at a single dose as a COVID vaccine. The patient's medical history and concomitant medications were not reported. The patient had no known allergies but had other medical history (unspecified). The patient did not receive any other vaccine within four weeks prior to the COVID vaccine, had other medications in two weeks (unspecified), and was not diagnosed with COVID-19 prior to the vaccination. The patient tested positive for COVID a week later after his first shot. The test used was via nasal swab on 04Jan2021. The patient did not receive any treatment for the events. Outcome of the events was reported as recovering. The case was reported as non-serious (did not result in death, was not life-threatening, did not cause/prolong hospitalization, was not disabling/incapacitating, and did not result to any congenital anomaly/birth defect).  Information on the lot/batch number has been requested.",,,,,,,,,N,12/28/2020,01/04/2021,7.0,Test Date: 20210104; Test Name: Covid test Nasal Swab; Test Result: Positive  ; Comments: Tested positive for covid a week later after his first shot,PVT,,,,,,USPFIZER INC2021003421,2,01/08/2021,,,,,True
911,929475,01/08/2021,NJ,35.0,,,F,,"received a covid positive diagnosis; received a covid positive diagnosis; This is a spontaneous report from a contactable nurse (patient). A 35-year-old non-pregnant female patient received 1st dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), intramuscular in the left arm on 21Dec2020 09:45 at a single dose for COVID-19 immunization at the hospital. The patient has no medical history. The patient has no known allergies. The patient's concomitant medications were not reported. The patient did not received any other vaccines within 4 weeks prior to the COVID vaccine and did not received other medications within 2 weeks of vaccination. The patient received a COVID positive diagnosis on 29Dec2020, 8 days later. The events led to a doctor or other healthcare professional office/clinic visit. The patient underwent COVID tests post vaccination on 29Dec2020 - Nasal Swab (NAA nasal swab) and Rapid COVID test, both showed positive test results. The patient was not diagnosed with COVID-19 prior to vaccination. Outcome of the events was recovering. No treatment was given for the events. The events were assessed as non-serious.   Information on the lot/batch number has been requested.; Sender's Comments: The efficacy of a drug varies from patient to patient and can be affected by different factors; however, a contributory role of the suspect product BNT162B2 to the reported drug ineffective and COVID-19 cannot be ruled out.",,,,,,,,,N,12/21/2020,12/29/2020,8.0,Test Date: 20201229; Test Name: Nasal Swab; Test Result: Positive  ; Comments: NAA nasal swab; Test Date: 20201229; Test Name: Other (Rapid covid test); Test Result: Positive,PVT,,,,Comments: List of non-encoded Patient Relevant History: Patient Other Relevant History 1: None,,USPFIZER INC2021003597,2,01/08/2021,,Y,,,True
912,929485,01/08/2021,NY,60.0,,,M,,"tested positive after taking the first dose of the vaccine; exposed to a family member with the virus/tested positive after taking the first dose of the vaccine; tested positive after taking the first dose of the vaccine; This is a spontaneous report from a Pfizer-sponsored program Pfizer First Connect. A contactable nurse reported for a 60-year-old male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 28Dec2020 at single dose for covid-19 immunization. The patient's medical history and concomitant medications were not reported. The patient who tested and was positive for the virus after being exposed to a family member with the virus after taking the first dose of the vaccine. Patient was asymptomatic. The Nurse asking if we have any recommendations for the 2nd dose. The outcome of the events was unknown. Information on the lot/batch number has been requested.; Sender's Comments: The association between the events lack of effect (suspected COVID-19, tested and was positive) with BNT162b2 can not be completely excluded.",,,,,,,,,U,12/28/2020,,,Test Name: tested; Test Result: Positive,UNK,,,,,,USPFIZER INC2021003790,2,01/08/2021,,,,,True
913,929486,01/08/2021,MA,46.0,,,M,,"contracted covid after getting the vaccine; contracted covid after getting the vaccine; This is a spontaneous report from a Pfizer-sponsored program. A contactable physician reported similar events for 4 patients. This is 1st of 4 reports. A 46-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/lot number: Unknown, does not have lot number to provide) via an unspecified route of administration on 24Dec2020 at single dose for covid-19 immunization. The patient medical history and concomitant medications were not reported. The patient contracted COVID after getting the vaccine on 01Jan2021. The outcome of the events was unknown.  Information on the Lot/Batch number has been requested; Sender's Comments: The association between the event lack of effect (contracted COVID) with BNT162b2 can not be completely excluded.,Linked Report(s) : US-PFIZER INC-2021003894 same reporter/drug/event, different patient;US-PFIZER INC-2021003893 same reporter/drug/event, different patient;US-PFIZER INC-2021003895 same reporter/drug/event, different patient",,,,,,,,,U,12/24/2020,01/01/2021,8.0,,UNK,,,,,,USPFIZER INC2021003873,2,01/08/2021,,,,,True
914,929487,01/08/2021,MA,,,,U,,"Contracted covid after getting the vaccine; Contracted covid after getting the vaccine; This is a spontaneous report from a Pfizer Sponsored Program. A contactable physician reported similar events for 4 patients. This is 2nd of 4 reports. A patient of unspecified age and gender received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot/batch number and expiration date not provided), via an unspecified route of administration on an unspecified date at single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient experienced contracted covid after getting the vaccine on an unspecified date. The report was non-serious per the reporter. The outcome of the events was unknown.  Information on Lot/Batch number has been requested.; Sender's Comments: The association between the event lack of effect (contracted COVID) with BNT162b2 can not be completely excluded.,Linked Report(s) : US-PFIZER INC-2021003873 same reporter/drug/event, different patient",,,,,,,,,U,,,,,UNK,,,,,,USPFIZER INC2021003893,2,01/08/2021,,,,,True
915,929488,01/08/2021,MA,,,,U,,"contracted covid after getting the vaccine; contracted covid after getting the vaccine; This is a spontaneous report from a Pfizer-sponsored program. A contactable Physician reported similar events for 4 patients. This is 3rd of 4 reports. A patient of an unknown age and gender received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/lot number: Unknown) via an unspecified route of administration on an unspecified date at single dose for COVID-19 immunization.  The patient medical history and concomitant medications were not reported. The patient contracted COVID after getting the vaccine. The outcome of the events was unknown.  Information on the Lot/Batch number has been requested.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021003873 same reporter/drug/event, different patient",,,,,,,,,U,,,,,UNK,,,,,,USPFIZER INC2021003894,2,01/08/2021,,,,,True
916,929489,01/08/2021,MA,,,,U,,"contracted covid after getting the vaccine; contracted covid after getting the vaccine; This is a spontaneous report from a Pfizer-sponsored program IBCC (Inbound Call Center for HCPs). A contactable physician reported similar events for 4 patients. This is 4th of 4 reports. A patient of unspecified age and gender received bnt162b2 (lot/batch number and expiration date not provided), via an unspecified route of administration, on an unspecified date, at single dose, for Covid-19 immunization. The patient medical history and concomitant medications were not reported. The patient contracted COVID after getting the vaccine. The outcome of the events was unknown.  Information on the lot/batch number has been requested.; Sender's Comments: The association between the event lack of effect (contracted COVID) with BNT162b2 can not be fully excluded.,Linked Report(s) : US-PFIZER INC-2021003873 same reporter/drug/event, different patient",,,,,,,,,U,,,,Test Name: covid; Result Unstructured Data: Test Result:contracted Covid after getting the vaccine,UNK,,,,,,USPFIZER INC2021003895,2,01/08/2021,,,,,True
918,929494,01/08/2021,CA,52.0,,,M,,"covid 19 test result came up positive; covid 19 test result came up positive; severe left arm pain; This is a spontaneous report from a contactable unspecified Healthcare professional reporting for himself. This 52-year-old male patient received on 20Dec2020 02:30 PM first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot EK5730) at single dose intramuscular in the left arm for COVID-19 immunization. No allergies to medications, food, or other products. Medical history was not reported. Prior to vaccination, the patient was not diagnosed with COVID 19. Concomitant medications (all started on an unknown date and received within 2 weeks of vaccination) included buspirone hydrochloride (BUSPIRON), atorvastatin (manufacturer unknown) and acetylsalicylic acid (BABY ASPIRIN). On 21Dec2020, 10 hours after getting vaccine the patient had body aches, cold and severe left arm pain. 4 days after getting vaccine again the patient had cold, body aches and sore throat for couple of days. On 28Dec2020, covid 19 test (nasal swab) result came up positive. The patient went to Emergency room. Outcome was recovered on an unknown date. It was unknown if a treatment was performed.; Sender's Comments: The association between the event lack of effect (COVID 19 nasal swab test result came up positive) with BNT162b2 can not be fully excluded.",,,,,,,,,Y,12/20/2020,12/21/2020,1.0,Test Date: 20201228; Test Name: Nasal Swab; Result Unstructured Data: Test Result:Positive,PVT,,BUSPIRON [BUSPIRONE HYDROCHLORIDE];  ; BABY ASPIRIN,,,,USPFIZER INC2021004287,2,01/08/2021,,,Y,,True
920,929532,01/08/2021,,,,,U,,"Tested positive for covid; Received first Pfizer covid vaccine on 23Dec, tested positive for covid; This is a spontaneous report from a contactable pharmacist.  A 75-year-old patient of an unspecified gender started to receive bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 23Dec2020 at SINGLE DOSE for COVID-19 immunization.  The patient medical history and concomitant medications were not reported.  The reporter stated ""75 year old patient with some comorbidities who received first Pfizer covid vaccine on 23Dec, tested positive for covid on 28Dec. Patient has been treated at home and is doing well. What is the protocol for their second dose of Pfizer covid vaccine due on 13Jan?"" The outcome of the events was unknown.  Information about lot/batch number has been requested.",,,,,,,,,U,12/23/2020,12/23/2020,0.0,Test Date: 20201228; Test Name: covid; Result Unstructured Data: Test Result:Positive,UNK,,,,,,USPFIZER INC2021005783,2,01/08/2021,,,,,True
924,929586,01/08/2021,MA,29.0,,,F,,"I tested positive for COVID-19; I tested positive for COVID-19; This is a spontaneous report from a contactable nurse. A 29-year-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EH9899), intramuscular in left arm on 17Dec2020 19:45 at single dose for covid-19 immunisation. Medical history was not reported. There were no concomitant medications. The patient tested positive for COVID-19 on 03Jan2021. Outcome of event was recovering. Patient has not been diagnosed with COVID-19 prior to vaccination.",,,,,,,,,N,12/17/2020,01/03/2021,17.0,Test Date: 20210103; Test Name: Nasal Swab; Result Unstructured Data: Test Result:Positive,PVT,,,,,,USPFIZER INC2021006479,2,01/08/2021,,,,,True
934,929943,01/08/2021,MD,61.0,61.0,,F,,"Received flu shot in Left arm and did not feel anything so very surprised to next get TDAP in Right arm and immediately experience ""fireworks"" pain at injection site radiating down arm. Looked at needle as it was withdrawn and appeared longer than expected (I used to be a nurse). Pharmacy tech said I could go but was nervous to leave store so walked around and felt my right arm grow heavy and difficult to raise. Eventually drove home using left arm to steer. Took tylenol with little result. Following day called pharmacy who said DTAP is known to be uncomfortable and they ""never use needles longer than 1 inch."" By Wed 9/23 arm was not improving so called insurance advice nurse who said go to urgent care but declined to avoid unnecessary covid exposure. She said to wear arm sling and use Voltaren gel because I cannot tolerate NSAIDS. Following morning I had a virtual appointment with my primary care physician who said to minimize use of sling to avoid frozen shoulder, keep using Voltaren and ask physical therapist currently treating me for rehab post back surgery 6/2020 to add shoulder exercises, and let her know if still not better in 4 weeks at which time she would refer me to Physical Medicine specialist for nerve testing. I found I had to wear sling at work (part time librarian) but was able to get by at home without it. By 4 weeks the pain and limited range of motion was improving, by then I could drive and dress myself, but it took a further 2-3 weeks to resolve fully. Primary care physician at checked with immunizations clinic supervisor who asked if the pharmacy tech had been standing (and if I were sitting) for the injection. Yes to both. Immunization clinic chief said this (bad) practice can sometimes direct the needle into the nerve or joint capsule, which may have happened in my case.  If you happen to follow this up with the pharmacy please note their paperwork has the injection sites reversed. I chose to have the flu shot in my left arm and the TDAP in my right arm.",,,,,,,,,Y,09/18/2020,09/18/2020,0.0,,PHM,,"Vitamin D, Magnesium, Flonase, Premarin cream",,,,,2,01/08/2021,,Y,,"Flagyl, Celebrex, Dermabond wound adhesive",True
944,930235,01/08/2021,CO,44.0,44.0,,M,,"Hospital on 1/2 - then again on 1/5, transferred and admitted to hospital, discharged 1/6 Abnormal reflex/weakness   back pain  paresthesia and weakness of legs abdominal pain  evaluation for possible GBS post covid 19 vaccine",,,,,Y,1.0,,,N,12/30/2020,01/02/2021,3.0,CT L-Spine *NSMC 01/02,OTH,,Multivitamin daily  Ambien 5mg daily/nighttime,,History of Bells Palsy,,,2,01/08/2021,,,Y,,True
957,930669,01/08/2021,AR,56.0,56.0,,M,,"patient begin to feel bad that night was admitted into hospital sometime in the next couple of days for dehydration, patient discharged home and then readmitted to hospital for positive covid testing after feeling very ill.",,,,,Y,3.0,,,,12/17/2020,12/17/2020,0.0,COVID-19 test positive,PVT,,none reported,none reported,none reported,,,2,01/08/2021,,,,none reported,True
991,956903,01/09/2021,,86.0,85.0,,M,,"mi Narrative: patient with asymptomatic covid 19, covid positive 12/10/2020.",Y,12/27/2020,,,,,,,U,12/22/2020,12/27/2020,5.0,,OTH,,,,,,,2,01/08/2021,,Y,Y,,True
1000,932091,01/10/2021,FL,50.0,50.0,,M,,"Started severe  belly pain  and went to Emergency room and diagnosed with mesenteric  vein thrombosis after the CT scan of the abdomen, treated with heparin drip, antibiotic and discharged with anticoagulant pills(Eliquis).  I am not sure that it is because of the vaccine my doctors are also not sure about it, but I am sure that I am a healthy person without any health issues . I am working as registered nurse, our unit is for covid-19 patient's since march 2020 and I had covid -19 on August month and recovered  after 3 weeks.",,,,,Y,5.0,,,Y,12/16/2020,01/05/2021,20.0,,WRK,,NO,NO,None,,,2,01/10/2021,,,,Simvastatin,True
1004,932346,01/10/2021,NC,66.0,66.0,,M,,"1/7-21 - Received second dose of pfizer covid-19 vaccine 1/8/21 - Fever, dizziness, headache 1/10/21 0250 was found not breathing.  EMS performed CPR and patient deceased",Y,01/10/2021,,,,,,,N,01/07/2021,01/08/2021,1.0,autopsy pending,PVT,,Unknown,none known,"hypertension, hyperlipidemia.",,,2,01/10/2021,,,,Statin - muscle aches,True
1010,932515,01/10/2021,OH,73.0,73.0,,M,,Resident appeared to be jaundice with yellow skin and eyes.  Resident also complained of not feeling well.  Urine was dark yellow.  Resident short of breath.  Resident was admitted to hospital and diagnosed with post-covid pneumonia.,,,,,Y,,,,Y,12/29/2020,12/31/2020,2.0,"CT Scan, Lab work,",SEN,,"Asprin, cyanacabalmin, dulpxetine, lasix, isosorbide, Slisinop","COPD, PTSD, CAD, BPH, Post COVID","CAD, COPD, PTSD, BPH",,,2,01/08/2021,,,Y,"PCN, Lactose intolerant",True
1045,933282,01/11/2021,,,,,F,,"vomited; diarrhea; a severe headache; severe muscle pain; severe fatigue like being ""beat up in a bar""; This is a spontaneous report from a contactable nurse (patient). A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot and expiry not reported), via an unspecified route of administration on 28Dec2020 at single dose for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. On 29Dec2020, patient experienced a severe headache, severe muscle pain and severe fatigue; further reported as like being ""beat up in a bar"" for over 1 week. It was also reported that the patient vomited and experienced diarrhea on an unspecified date. The patient was also inquiring if there is difference between the symptoms in dose 1 and 2. Outcome of events was unknown.  Information of lot and batch number has been requested.; Sender's Comments: Based on the available information and known BNT162B2 vaccine safety profile, a causal relationship between events severe headache, severe muscle pain and severe fatigue and BNT162B2 vaccine cannot be excluded. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.",,,,,,,,,U,12/28/2020,12/29/2020,1.0,,UNK,,,,,,USPFIZER INC2021003352,2,01/08/2021,,,,,True
1047,933284,01/11/2021,,,,,M,,"Tested positive with covid 19 with symptoms; Tested positive with covid 19 with symptoms; This is a spontaneous report from a contactable healthcare professional.  A male patient of an unspecified age received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiration date were not reported), via an unspecified route of administration on 22Dec2020 at single dose for COVID-19 immunisation.  The patient medical history and concomitant medications were not reported.  The patient stated, ""I received the covid 19 vaccine on 22Dec; was supposed to have 2nd dose on 12Jan2021. Tested positive with covid 19 on 01Jan2021 with symptoms. I want to know how long I need to wait to get the second dose"".The outcome of the events was unknown.   Information on the lot number has been requested.; Sender's Comments: Although, BNT162B2 vaccine immunogenicity is not in full effect after short time (10 days in this case) of first dose administration, a causal relationship between event ""Tested positive with covid 19 with symptoms"" (coded to Drug ineffective / COVID-19) and BNT162B2 vaccine cannot be completely excluded.",,,,,,,,,U,12/22/2020,01/01/2021,10.0,Test Date: 20210101; Test Name: covid 19; Test Result: Positive,UNK,,,,,,USPFIZER INC2021003374,2,01/08/2021,,,,,True
1048,933286,01/11/2021,AR,,,,M,,"received covid vaccine then contracted covid-19, 9 days after getting the vaccine; received covid vaccine then contracted covid-19, 9 days after getting the vaccine; This is a spontaneous report from a contactable physician.  A male patient of an unspecified age received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiration date were not reported), via an unspecified route of administration on Dec2021 at single dose for COVID-19 immunisation.  The patient medical history and concomitant medications were not reported.  It was stated, ""received covid vaccine then contracted covid-19, 9 days after getting the vaccine, should he get his 2nd dose which is on Friday? Tested positive on the 30th, received monoclonal antibody infusion on the 31st. Any information regarding this?"". The outcome of the event was unknown.   Information on the lot number has been requested.; Sender's Comments: Although, BNT162B2 vaccine immunogenicity is not in full effect after short time (9 days in this case) after first dose administration, a causal relationship between event ""received covid vaccine then contracted covid-19"" (coded to Drug ineffective / SARS-CoV-2 test positive) and BNT162B2 vaccine cannot be completely excluded.",,,,,,,,,U,12/01/2020,12/30/2020,29.0,Test Date: 20201230; Test Name: Covid; Test Result: Positive,UNK,,,,,,USPFIZER INC2021003482,2,01/08/2021,,,,,True
1050,933290,01/11/2021,,,,,U,,"memory care patients received Pfizer-BioNTech covid vaccine, and then were diagnosed with COVID, all three had COVID symptoms; memory care patients received Pfizer-BioNTech covid vaccine, and then were diagnosed; This is a spontaneous report from a contactable other health professional. This reporter reported same events for three patients. This is first of three reports. A patient of unspecified age and gender received BNT162B2 (Pfizer BioNTech COVID vaccine), via an unspecified route of administration on an unspecified date at single dose for Covid-19 immunization. The patient's medical history and concomitant medications were not reported. The memory care patient received Pfizer-Biontech Covid vaccine, and then was diagnosed with Covid and had Covid symptoms on an unspecified date, the patient was scheduled to receive monoclonal antibody. Event took place after use of product. The outcome of events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.; Sender's Comments: Based on the information available, a possible contributory role of the suspect products cannot be excluded for the reported event of positive for corona virus infection for the lack of efficacy of the vaccine. However, based on the mechanism of action of the vaccine, it is unlikely the patient would have fully developed immunity for the vaccine to be effective, due to possibly short number of days passed since the vaccine is given. Case will be reevaluated based on follow-up information,Linked Report(s) : US-PFIZER INC-2021004747 same reporter/product/event, different patient;US-PFIZER INC-2021004748 same reporter/product/event, different patient",,,,,,,,,U,,,,Test Name: Covid; Result Unstructured Data: Test Result:diagnosed with Covid and had Covid symptoms,UNK,,,,,,USPFIZER INC2021004746,2,01/08/2021,,,,,True
1090,934895,01/11/2021,MI,55.0,,,F,,"Numbness lips,mouth; Was feeling bad; leg numbness/numbness in head, face; pain in head; increased BP; blood pressure was up and down; This is a spontaneous report from a contactable consumer (patient). A 55-year-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/lot number: EL0140) via an unspecified route of administration in left arm on 29Dec2020 6 am at single dose for covid-19 immunisation. Co-suspected drug amoxicillin;clavulanic acid (AUGMENTIN, Batch/lot number: KN4291, Expiry Date: Mar2022) by mouth from Dec2020 to 28Dec2020 at 875mg, 1 tablet twice daily for pain or infection; MOXIFLOXACIN HYDROCHLORIDE (AVELOX, strength:400mg) by mouth from 29Dec2020 and ongoing at 400mg, 1 tablet once daily for infection; fluconazole (DIFLUCAN, strength:200mg) orally (by mouth) from unknown date and ongoing at 200mg, 1 tablet once daily for Infection.The patient's medical history was reported as ongoing high blood pressure, ongoing pains in her fingers and toes and they thought she had an infection from 02Dec2020, white count went down on 09Dec2020, ongoing pain was up and down. No other vaccines given at that time and none given 4 weeks prior. Had a Flu shot back in Oct2020, but no problems. None diagnosed allergies and family medical history relevant to adverse event. The concomitant medications included unspecified blood pressure medication by mouth daily for high blood pressure. She had also started 2 antibiotics around the same time that she received the vaccine.  No further details provided Was on antibiotics at the time she was given the Pfizer COVID-19 vaccine. Patient experienced increased BP/ high blood pressure, pain in head, and leg numbness; all started 2 days (on 31Dec2020) after receiving the vaccine and persisted for 48 hours. First her blood pressure was up and they had to get it stable and had numbness in her head, face, and mouth for 48 hours. Her blood pressure was up and down and she has history of blood pressure and takes medicine. Was taken off work for a few hours and went to the emergency department on Fri night about 2am. Her blood pressure was 170/92 on 01Jan2021. Not sure if this was related to the vaccine, but the numbness in her head started from her upper neck to face to the right side of her check and she also had leg numbness. Wanting to know if this was related because she was worried about getting the second dose. Had a hard time for 48 hours. Weight was between 150-155 pounds. Stated everything improved after 48 hours. Her lip was also just a little bit numb, but it is feeling better. Patient was feeling bad from 01Jan2021, all Fri and Sat and much better by Sun. Events of increased BP/ blood pressure up and down, leg numbness, numbness in lips, head, face, mouth with emergency room visiting. Wanted to know if she should have the second dose. The action taken in response to Augmentin was permanently discontinued on 28Dec2020, for Avelox and Diflucan was dose not changed. The outcome of events was recovering.",,,,,,,,,N,12/01/2020,12/31/2020,30.0,"Test Date: 20201231; Test Name: blood pressure; Result Unstructured Data: Test Result: increased; Comments: increased BP, all started 2 days after receiving the vaccine; Test Date: 20210101; Test Name: blood pressure; Result Unstructured Data: Test Result:170/92; Comments: blood pressure was up; it was up and down; Test Name: weight; Result Unstructured Data: Test Result:150-155 lbs; Test Date: 20201209; Test Name: white count; Result Unstructured Data: Test Result: went down",PVT,,AUGMENTINE [AMOXICILLIN;CLAVULANIC ACID]; AVELOX; Diflucan,Blood pressure high; Infection; Pain; Pain in fingers; Pain in toe,Medical History/Concurrent Conditions: White blood cell decreased,,USPFIZER INC2021003291,2,01/10/2021,,,Y,,True
1091,934896,01/11/2021,TX,36.0,,,F,,"eventually inability to move arm; pain; joint pain; tenderness at injection site; loss of strength; This is a spontaneous report from a contactable nurse. A 36-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/lot number: EJ1685) intramuscular at arm left, on 19Dec2020 06:45 at single dose for covid-19 immunisation. Medical history included ongoing acne. Patient had no known allergies. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Concomitant medication included isotretinoin (ACCUTANE). On 19Dec2020 11:30, approximate 5 hours after vaccine, the patient experienced pain, joint pain and tenderness at injection site, progressively loss of strength and eventually inability to move arm. Since the vaccination, the patient hasn't been tested for COVID-19. The outcome of events was recovered.; Sender's Comments: Based on the compatible temporal association, the vaccination with BNT162B2 might play a contributory role in triggering the onset of the reported events. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.",,,,,,,,,Y,12/19/2020,12/19/2020,0.0,,PVT,,ACCUTANE,Acne,,,USPFIZER INC2021005127,2,01/10/2021,,,,,True
1097,934903,01/11/2021,WA,34.0,,,F,,"Sudden and rapid onset of generalized Urticaria accompanied by dyspnea; sudden and rapid onset of generalized uritcaria accompanied by dyspnea; This is a spontaneous report from a contactable nurse (patient). A 34-year-old female patient (non-pregnant) received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/lot number: EH9899), intramuscular on 30Dec2020 11:00 at single dose at right arm for covid-19 immunization. Medical history included Grave's dse, psoriasis, bronchial asthma. Concomitant medication in two weeks included propranolol, methimazole, fluticasone furoate, vilanterol trifenatate (BREO ELLIPTA), colecalciferol (VITAMIN D). Patient didn't receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient previously took adalimumab and experienced drug allergies. The patient was not diagnosed with COVID-19 prior to vaccination. Since the vaccination, patient has not been tested for COVID-19. 9hrs post-vaccine, patient developed sudden and rapid onset of generalized uritcaria accompanied by dyspnea on 30Dec2020 20:00 with outcome of recovered with sequelae. Adverse events resulted in emergency room/department or urgent care. Patient received intramuscular epinephrine, intravenous solumedrol & benadryl, and oral prednisone x5 for events. This report is considered as non-serious.; Sender's Comments: Based on temporal association, the causal relationship between bnt162b2 and the events urticaria and dyspnoea cannot be excluded. The information available in this report is limited and does not allow a medically meaningful assessment. This case will be reassessed once additional information becomes available. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees, and Investigators, as appropriate.",,,,,,,,,N,12/30/2020,12/30/2020,0.0,,WRK,,; METHIMAZOLE; BREO ELLIPTA; VITAMIN D [COLECALCIFEROL],,Medical History/Concurrent Conditions: Bronchial asthma; Graves' disease (Grave's dse); Psoriasis,,USPFIZER INC2021005294,2,01/10/2021,,,Y,,True
1098,934904,01/11/2021,PR,42.0,,,F,,"Facial paralysis; stress; This is a spontaneous report from a contactable Nurse. A 42-year-old female patient received first dose of BNT162B2(PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on an unspecified date at single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The reporter felt worried about the patient(partner) that had facial paralysis and asked if they could administer the second dose of the vaccine of covid-19 from Pfizer. The paralysis it was previous from the fist dose of the vaccine, a consequences of the stress, the partner had 42 years. The reporter considered that the event was non-serious. The outcome of the event was unknown.  Information on the lot/batch number has been requested.; Sender's Comments: Based on temporal association, the causal relationship between BNT162B2and the event facial paralysis cannot be excluded. The information available in this report is limited and does not allow a medically meaningful assessment. This case will be reassessed once additional information becomes available. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees, and Investigators, as appropriate.",,,,,,,,,U,,,,,UNK,,,,,,USPFIZER INC2021005339,2,01/10/2021,,,,,True
1101,934909,01/11/2021,CO,59.0,,,F,,"soreness around the injection site; Had severe arm pain; Had a fever on the night of the 31Dec2020 of 101.3; I have painful lymph nodes/the swollen lymph nodes under her right arm, the armpit area had swollen and painful lymph nodes; I have painful lymph nodes/the swollen lymph nodes under her right arm, the armpit area had swollen and painful lymph nodes; had joint pains/knees and hip joint pain; severe fatigue; muscle pain; This is spontaneous report from a contactable nurse (patient). A 59-years-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EK9231), via an unspecified route of administration in right arm on 30Dec2020 14:15 at first single dose (0.3 cc, but really uncertain of dose) for covid-19 immunization. Medical history included COVID virus from Nov2020 to 2020 (The patient was not hospitalized. It was a mild case and lasted about 10 days. she had any positive antibodies at that time. Was off work for about 12 days and was very lucky to have had a very light case with fever, cough, cold, and super fatigue). The patient's concomitant medications were not reported. The patient did not receive any other vaccines at the same time or 4 weeks prior. No problems with vaccinations in past or events.  Caller reported she had the first injection of the Pfizer BioNTech COVID-19 vaccine on the 30Dec2020 and having some side effect symptoms and her supervisor recommended for her to report these things, they are not life threatening, obviously, but things were still lingering. Side effect of severe fatigue started on the 31Dec2020 and lasted for 72 hours. It was so severe, now it is mild. The patient reported soreness around the injection site. Had a fever on the night of the 31Dec2020 of 101.3 and had that for 6 hours then it dissipated and was gone. Had never had a fever after injections before. Had severe arm pain that usually goes along with an injection. It started also that night of 31Dec2020. She had rolled over in the middle of the night and it hurt. That lasted for about 48 hours, but it has improved. Had some muscle aches since 31Dec2020 but that had improved and had joint pains since 31Dec2020. What was worrisome was the swollen lymph nodes under her right arm, the armpit area had swollen and painful lymph nodes, since 31Dec2020. The patient was still having that and that is why she was so concerned because shouldn't that have gone away after a week. Had knee and hip joint pain, but that had improved. Again, mentioned she had never had that before with an injection. The patient received vaccine at her workplace. Some of her coworkers got it the same day and no one else has this. Mentioned she did have COVID virus back in Nov2020 and wonders if this correlates with her getting the vaccine. Was not hospitalized or notified she had any positive antibodies at that time. Was off work for about 12 days and was very lucky to have had a very light case with fever, cough, cold, and super fatigue. This is the same way she felt back when she had the virus back in November. The patient was concerned about having these side effects would it be okay for her to get the next injection in 3 weeks. AEs did not require a visit to emergency room and physician office. No further details provided. Outcome of the events Fever was recovered, of event swollen and painful lymph nodes was not recovered, of events knees and hip joint pain, fatigue, muscle pain, severe arm pain was recovering, of event soreness around the injection site was unknown.  The reporter considered the events severe fatigue, fever, swollen lymph nodes and pain under right arm, knees and hip joint pain as serious (medically significant). The reporter considered the events severe fatigue, fever, severe arm pain, muscle ache, swollen lymph nodes and pain under right arm, knees and hip joint pain as related to BNT162B2.; Sender's Comments: Based on the compatible temporal association, the vaccination with BNT162B2 might play a contributory role in triggering the onset of the reported events. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.",,,,,,,,,N,12/30/2020,12/31/2020,1.0,Test Date: 20201231; Test Name: body temperature; Result Unstructured Data: Test Result:101.3,PVT,,,,"Medical History/Concurrent Conditions: COVID-19 (The patient was not hospitalized. It was a mild case and lasted about 10 days. she had any positive antibodies at that time. Was off work for about 12 days and was very lucky to have had a very light case with fever, cough, cold, and super fatigue)",,USPFIZER INC2021005452,2,01/10/2021,,,,,True
1105,934915,01/11/2021,,,,,F,,"TB test; This is a spontaneous report from a contactable consumer. This female consumer (patient) reported that received received bnt162b2 (BNT162B2, PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 30Dec2020 at single dose for covid-19 immunisation. Medical history and concomitant medications were unknown. Certified Nursing Assistant got the first dose of the covid vaccine on January 2nd and also she needs to get her TB test. She was told to wait 2weeks between the application and the TB test but the 2 weeks period ends on January 15th and she needs to have the test before that day, so she was wondering if she could get the test done a couple of days early. The outcome of the event was unknown.   Information about lot/batch number has been requested.",,,,,,,,,U,01/02/2021,,,Test Name: TB test; Result Unstructured Data: Test Result:unknown results,UNK,,,,,,USPFIZER INC2021005525,2,01/10/2021,,,,,True
1111,934922,01/11/2021,TX,39.0,,,M,,"Followed by neurological symptoms staring day 4; parasthesias of both upper extremity; progression to muscle weakness of all four extremities/Currently with significant muscle weakness, Left hand weakness leading to dropping of objects and left foot drop; progression to muscle weakness of all four extremities/Currently with significant muscle weakness, Left hand weakness leading to dropping of objects and left foot drop; Flu like symptoms first 3 days; This is a spontaneous report from a contactable physician (patient). A 39-year-old male patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number: ek5730) at left arm, via an unspecified route of administration on 16Dec2020 at single dose for covid-19 immunisation. Medical history included hypertension, diabetes, migraines, Eosinophilic granulomatosis with polyangiitis (EGPA) remission. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not have any allergies to medications, food, or other products. The patient's concomitant medications were not reported. On 21Dec2020, the patient experienced flu like symptoms first 3 days. Followed by neurological symptoms staring day 4, parasthesias of both upper extremity with progression to muscle weakness of all four extremities. Leading to 2 ER visits and hospital admission. Evaluation by internal medicine, neurology and rheumatology. Currently with significant muscle weakness, Left hand weakness leading to dropping of objects and left foot drop. The events resulted in Doctor or other healthcare professional office/clinic visit, Emergency room/department or urgent care, Hospitalization, Disability or permanent damage. The treatment for events included High dose steroid. Covid test included Nasal Swab: negative on 19Dec2020. The outcome of events was not recovered.; Sender's Comments: Based on temporal association, the causal relationship between bnt162b2 and the events influenza like illness, neurological symptom, paraesthesia, muscular weakness and peroneal nerve palsy  cannot be excluded. The information available in this report is limited. This case will be reassessed once additional information becomes available. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees, and Investigators, as appropriate.",,,,,Y,3.0,,Y,N,12/16/2020,12/21/2020,5.0,Test Date: 20201219; Test Name: Nasal Swab; Test Result: Negative,PVT,,,,Medical History/Concurrent Conditions: Diabetes; Eosinophilic granulomatosis with polyangiitis; Hypertension; Migraine,,USPFIZER INC2021006226,2,01/10/2021,,Y,Y,,True
1112,934924,01/11/2021,OH,58.0,,,F,,"tired; no energy; low back pain; her fingers are hurting; passed out on toilet; Nauseated; hit head on wall, head just hurts; hit head on wall, head just hurts; Chills; she was very cold; could not sleep good; site of vaccine was sore; Muscle pain; Joint pain; This is a spontaneous report from a contactable consumer. A 58-year-old female patient started to receive first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/lot number: EK9231) by injection once to left arm, via an unspecified route of administration on 04Jan2021 12:30 at single dose for covid-19 immunisation. Medical history included thyroid disorder. Concomitant medication included levothyroxine sodium (SYNTHROID) for thyroid disorder; patient started it after she had her son, and her son is 18 years old. The patient had her vaccine yesterday (04Jan2021) at 12:30, and at nighttime, around 22:00, she started having chills, she was very cold, so she went to bed, she could not sleep good, she kept waking up, and the site of vaccine was sore, she had muscle pain, joint pain, she didn't have fever, but she got up late today (05Jan2021), around 11:00, and had breakfast and felt nauseated, so she stopped eating, and she went to the bathroom and passed out on the toilet, when she woke up, she had her nightgown inside the toilet, it was all wet, she felt better, so she stood up and then she woke up again, and was inside the tub, her legs were inside the basin, she was lying down with her back inside the tub, she thinks she hit her head on the wall, and it just hurts, it didn't bleed or nothing.  The patient stated she had the paper she was given. Again stated she can not even function. Patient still feels Chills a little bit, not as bad as last night. She is awake now, but she feels very very tired, like she has no energy, she is laying down on couch right now. She kept waking up and noticed this morning, she had low back pain, in the muscles, even her fingers are hurting. Regarding hitting her head on the wall, states she has a terrible headache, not a little pain, she thinks it is because she hurt her head. The patient is supposed to get second vaccination on 25Jan2021. The outcome of events Chills, Joint pain and nauseated was recovering; of events site of vaccine was sore and muscle pain was not recovered; of other events was unknown.",,,,,,,,,N,01/04/2021,01/04/2021,0.0,,UNK,,SYNTHROID,,Medical History/Concurrent Conditions: Thyroid disorder,,USPFIZER INC2021006428,2,01/10/2021,,,,,True
1113,934925,01/11/2021,,,,,U,,"Fainting; This is a spontaneous report from a non-contactable consumer. This consumer reported similar events for 2 patients. This is 2nd of 2 reports.   A patient of unspecified age and gender received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on an unspecified date at single dose for covid-19 immunisation. The patient medical history and concomitant medications were not reported.  The patient experienced fainting on an unspecified date with outcome of unknown.  The action taken in response to the event for bnt162b2 was not applicable.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021006219 same reporter/drug/event, different patient",,,,,,,,,U,,,,,UNK,,,,,,USPFIZER INC2021006463,2,01/10/2021,,,,,True
1116,934929,01/11/2021,VA,34.0,,,F,,"rash; All over rash with some itching; This is a spontaneous report from a contactable Nurse reported for self. This 34-year-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on 05Jan 2021 12:50 on right arm at single dose (Lot # EK4176, Expiration Date: Mar2021) for covid-19 immunisation. Medical history was not provided. Concomitant medications were none. Past drug history included the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on 15Dec2020 16:00 at age of 34 year old at single dose (Lot # EH9899) for covid-19 immunisation. About 30 minutes after being administered (05Jan2021 13:20) that second dose she developed all over rash with some itching. She took Benadryl and Pepcid in response. Today the all over rash with some itching came back at the same persistent level. She wants to know what kind of timeframe she can expect with the continued allergic reaction of all over rash with some itching. She was made to check into the emergency room for observation, but did not have any testing/lab work/investigations done and was not admitted to the hospital. Outcome of the events was not recovered. Reporter seriousness for All over rash with some itching was Medically significant. Drug result was related.; Sender's Comments: Based on the current available information and the plausible drug-event temporal association, a possible contributory role of the suspect product BNT162B2 to the development of events Rash and Itching cannot be totally excluded.  The case will be reassessed if additional information becomes available.  The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.",,,,,,,,,N,01/05/2021,01/05/2021,0.0,,PVT,,,,,,USPFIZER INC2021007528,2,01/11/2021,,,Y,,True
1117,934931,01/11/2021,AZ,45.0,,,F,,"Chills with no fever; Cramping in legs; super tired with no energy; Body aches; tiredness/Feeling super tired with no energy; This is a spontaneous report from a contactable consumer. This consumer (patient) reported for self that the 45-year-old female patient who receive first dose of bnt162b2 (BNT162B2, PFIZER-BIONTECH COVID-19 VACCINE, Batch/lot number: EH9899), via an unspecified route of administration on Saturday (02Jan2021) at single dose (once by injection in the right arm) for covid-19 immunisation. Medical history included ongoing Hypothyroidism from 2008. Concomitant medications included levothyroxine at 75 ug ongoing from 2008 for Hypothyroidism. Medical Professional and told by her work that she could get it because contact with COVID patients. The consumer calls for information about if the side effects she is experiencing after the administration of the COVID-19 vaccine will last for more days. The consumer reported tiredness and other side effects to DSU. A Consumer calls for information about if it would be appropriate the second dose of the COVID-19 vaccine is not administered considering that she had adverse reactions. Consumer calls for information about if the second dose of the COVID-19 vaccine would cause her more side effects than the first one. Received the vaccine on Saturday, 02Jan2021. The day she got it she did not feel anything at all. She was completely fine. She did not even have pain at the injection site. The next day, on Sunday she started feeling super tired with no energy, had body aches, and cramping in legs from 03Jan2021. She has had these for the past 3 days now. She also had chills with no fever from 03Jan2021 to 05Jan2021. She took Tylenol for the first 2 days, but it did not help her at all. She is feeling a little better today, but not much. Her question is, how long will these side effects last? Tylenol: She says it did help a little bit. She think she would just sleep because she was uncomfortable. The Tylenol just did not make her symptoms go away completely. LOT/Batch: AA46487, EXP: Apr2022 UPC: The consumer says the number under the barcode is: 5187536. Feeling super tired and body aches: Has improved about 20%. She says these are all medically significant as she is not able to do what she was able to do before getting the vaccine. She is super tired with no energy and she is confined to her bed most of the time. The consumer confirms this is her first dose of the COVID Vaccine. She thinks she got the standard dose. Vaccine card does not have the expiration date or NDC written on it. Unknown causality. She said that she could be positive for COVID. She is unsure. The outcome of the event Chills with no fever was recovered. The outcome of the event Cramping in legs was not recovered. The outcome of the other events was recovering.; Sender's Comments: Based on the current available information and the plausible drug-event temporal association, a possible contributory role of the suspect product BNT162B2 to the development of  reported events cannot be totally excluded.  The case will be reassessed if additional information becomes available.  The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.",,,,,,,,,N,01/02/2021,01/03/2021,1.0,,UNK,,,Hypothyroidism (Patient Medical comments; Verbatim: Hypothyroidism),,,USPFIZER INC2021007551,2,01/11/2021,,,,,True
1121,934939,01/11/2021,MI,53.0,,,F,,"severe muscle pain, diagnosis of polymyalgia rheumatica; This is a spontaneous report from a contactable other HCP (patient). A 53-year-old female patient received the first dose of BNT162b2 (Lot/batch number and Expiration date were not provided), at the age of 53-year-old, via an unspecified route of administration at right arm on 18Dec2020 08:30 at single dose for covid-19 immunization. Medical history included hypertension (htn), allergies: penicillin. Concomitant medication included cefatrizine propyleneglycolate (CEFTIN), lisinopril, levothyroxine sodium (SYNTHROID). The patient experienced severe muscle pain, diagnosis of polymyalgia rheumatica on an unspecified date. The patient was not pregnant at the time of vaccination. The patient underwent lab tests and procedures which included COVID test rapid (Nasal Swab): negative on 06Jan2021. The outcome of the event was unknown.  Information on the lot/batch number has been requested.; Sender's Comments: A possible contributory effect of suspect drug BNT162B2 on reported event cannot be excluded.  The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to regulatory authorities, Ethics Committees, and Investigators, as appropriate.",,,,,,,,,U,12/18/2020,,,Test Date: 20210106; Test Name: COVID test rapid (Nasal Swab); Test Result: Negative,PVT,,CEFTIN [CEFATRIZINE PROPYLENEGLYCOLATE];  ; SYNTHROID,,Medical History/Concurrent Conditions: Hypertension; Penicillin allergy,,USPFIZER INC2021007725,2,01/10/2021,,,,,True
1124,934943,01/11/2021,MO,75.0,,,F,,"Her arm is a little sore; the tissue paper is red after wiping her anal area/ reddish looking poop/ there are pieces of blood or something is different; This is a spontaneous report from a contactable other Health Professional (patient).  A 75-year-old female patient receive BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/lot number: EL0142), via an unspecified route of administration on 05Jan2021 at single dose for covid-19 immunization, also reported as for work. Medical history included ulcer (15 to 20 years before 06Jan2021). Concomitant medication included prasugrel from Apr2020 and ongoing as blood thinner, acetylsalicylic acid, ascorbic acid (ASPIRIN) from Apr2020 and ongoing as blood thinner. The patient went to the bathroom in the morning 06Jan2021, she had to poop. When she wiped, it was reddish looking. The patient stated her stool color was normal, but the tissue paper is red after wiping her anal area. At first she thought hm oh well. Then she had been to the bathroom a couple of times 06Jan2021, and that the same thing happened. She had never experienced that before. It seems to her that there were pieces of blood or something was different. She wasn't hurting or anything. She was not weak or anything at this time. Her arm was a little sore, but she expected that. She was concerned about the color. She worked in the mammography department. She didn't have a prescribing doctor. She got it at work. She had noticed a difference of color in her poop. It had been the same all day. The outcome of the reddish poop was not recovered, of sore arm was unknown. The patient asked would the vaccine cause rectal blood upon wiping after defecation?; Sender's Comments: Reported blood in stool is considered intercurrent and unrelated to BNT162B2. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to regulatory authorities, Ethics Committees, and Investigators, as appropriate.",,,,,,,,,N,01/05/2021,01/06/2021,1.0,,UNK,,; ASPIRIN [ACETYLSALICYLIC ACID;ASCORBIC ACID],,Medical History/Concurrent Conditions: Ulcer,,USPFIZER INC2021008194,2,01/11/2021,,,,,True
1125,934944,01/11/2021,CA,50.0,,,M,,"The subject experienced acute pericarditis on 27Dec2020; Other vaccine same date vaccine date= 23Dec2020; This is a spontaneous report from a contactable consumer. A 50-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 23Dec2020 at single dose for covid-19 immunization. The facility type vaccine was hospital. None medical history. The patient's concomitant medications were not reported. Other vaccine same date vaccine date on 23Dec2020. The patient experienced acute pericarditis on 27dec2020 with outcome of recovered. The adverse event resulted in Doctor or other healthcare professional office/clinic visit. It's unknown if treatment was received for the adverse event. The event was reported as non-serious.  Pfizer is a marketing authorization holder of [BNT162B2] in the country of incidence or the country where the product was purchased (if different). This may be a duplicate report if another marketing authorization holder of [BNT162B2] has submitted the same report to the regulatory authorities.  Information on the lot/batch number has been requested.",,,,,,,,,Y,12/23/2020,12/23/2020,0.0,,PVT,,,,Comments: List of non-encoded Patient Relevant History: Patient Other Relevant History 1: None,,USPFIZER INC2021008311,2,01/10/2021,,Y,,,True
1127,934947,01/11/2021,NY,31.0,,,F,,"it was debilitating for her at work; It even hurts to move the right eye in one direction and hurts to speak, the pain was so bad.; pain in right leg and bottom sole of right foot; hurts to speak; numbness right upper side of lip; pins and needle feeling right upper quadrant of face; pain and dull aching right upper side of face; right hand numbness, wasn't able to feel anything; generalized headache; generalized muscle weakness and pain; generalized muscle weakness and pain; This is a spontaneous report from a contactable other hcp (patient). A 31-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 03Jan2021 at single dose in deltoid right for covid-19 immunization. There were no medical history or concomitant medications. The patient received the vaccine on 03Jan2021 and within 15 minutes had a generalized headache. Later that night she had generalized muscle weakness and pain, but really didn't think too much about it. The next day at work (04Jan2021), she had numbness on the right upper side of her lip and a pins and needle feeling in the right upper quadrant of the face. Had a lot of pain in the area as well on the right upper side of the face as well as a dull aching pain that lasted for hours. Later that day when using the computer and she was trying to reach for her mouse she noticed her right hand wasn't able to feel anything and that lasted about 20-25 minutes. Kept slapping the mouse with her hand, but could not feel anything, her hand went numb. Yesterday (05Jan2021), she had the same pins and needle feeling in the same area of the face and that dull achy feeling and it occurred for hours and it was very kind of debilitating for her at work.  Later that night she had pain in her right leg and felt the same way, that very severe achiness, which was the pins and needles feeling up and down the leg and underneath the right foot. All these symptoms tend to be on her right side and it definitely lasted for hours. It started about 1 and didn't end until 6-7pm. It even hurts to move the right eye in one direction and hurts to speak, the pain was so bad. This morning (06Jan2021) she had to call out of work because at 3am the generalized headache, pain was unbearable. She was still experiencing the pain in right leg and bottom sole of right foot. She did not receive any vaccines the same day or 4 weeks prior. No problems with vaccines in past. She had made an appointment with a neurologist and will have a MRI done on Friday, 08Jan2021. No further details provided. All events required a visit to physician office. All events were reported as serious per medically significant. The outcome of all events was not resolved. The reporter considered all events were related to the vaccine.   Information about Lot/Batch number has been requested.; Sender's Comments: Based on a compatible temporal relationship, causality between reported events and BNT162B2 vaccine cannot be excluded. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.",,,,,,,,,N,01/03/2021,01/03/2021,0.0,,PVT,,,,Comments: List of non-encoded Patient Relevant History: Patient Other Relevant History 1: None,,USPFIZER INC2021008533,2,01/11/2021,,Y,,,True
1130,934951,01/11/2021,AZ,35.0,,,M,,"Acute demyelinating encephalomyelitis; Slurring his speech; Stroke; This is a spontaneous report from a contactable physician. A 35-year-old male patient received first dose bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), intramuscular in deltoid (unknown if right or left) on 17Dec2020 at 30 ug, single for 'Preventative'. Medical history included hypertension. There were no concomitant medications.(Physician) He is calling about the Pfizer Covid 19 vaccine. States what is going on with the patient may be associated as a side effect. The patient got the vaccine two to three weeks ago, he clarifies the patient received the vaccine on 17Dec2020 and the patient ended up acutely developing (states it is a presumptive diagnosis) Acute demyelinating encephalomyelitis, states it looks like a radiologic diagnosis. The patient is an employee at hospital. When querying seriousness states it is medically significant but could be disabling but he thinks the patient will recover. Reporter seriousness for acute demyelinating encephalomyelitis: Medically significant, Hospitalization. Patient was hospitalized on Sunday and he is still admitted at this time. Dates when patient was in hospital for acute demyelinating encephalomyelitis was from 03Jan2021 to ongoing. Caller thinks the patient was flown to (Place) yesterday. The patient's mother asked the caller if the caller thought the acute demyelinating encephalomyelitis was from the vaccine and the caller responded that he did not think it was from the vaccine. He confirms the patient is still admitted in the hospital and the patient's attending neurologist is doctor. The caller heard about the patient from doctor. When querying covid vaccine dose, the caller states the standard dose is 30 mcg. This was clarified and documented as provided. The patient has not received his second dose yet. He asks if the patient should receive the second dose. He asks a general question if a pregnant patient can be given the Pfizer covid vaccine. He heard the patient had a stroke then the CFO tried to talk to him and the patient was slurring his speech. Caller spoke to the patient's mother this morning and caller told the mother that he would try to find out what is going on with the patient.  He asked that the patient get an HIV test even though he does not think the patient is at risk. Vaccination facility type was Hospital. Vaccine administered at military facility was No. None additional vaccines administered on same date of the PFIZER suspect. AE acute demyelinating encephalomyelitis require a visit to Emergency Room, not visit to physician office. Prior Vaccinations (within 4 weeks) was none. He has heard of acute demyelinating encephalomyelitis being associated with vaccines in the past and states that it is rare and usually in kids. States he saw patients that may have had acute demyelinating encephalomyelitis back in the 80s and 90s. Therapeutic measures were taken as a result of acute demyelinating encephalomyelitis (Patient will get steroids tonight pending the review of the x-ray). The outcome of the events was unknown.   Information on the lot/batch number has been requested.; Sender's Comments: The reported stroke with speech slurred, and the presumptive diagnosis of acute demyelinating encephalomyelitis (looks like a radiologic diagnosis by the reporting physician), was most likely an intercurrent disease, and unlikely causally related to the first dose bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE).  The case will be reassessed should additional information become available.  The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.",,,,,Y,,,,U,12/17/2020,,,Test Name: HIV test; Result Unstructured Data: Test Result:Unknown results; Test Name: radiologic; Result Unstructured Data: Test Result:Acute demyelinating encephalomyelitis; Comments: states it looks like a radiologic diagnosis; Test Name: X-ray; Result Unstructured Data: Test Result:Unknown results,PVT,,,,Medical History/Concurrent Conditions: Hypertension,,USPFIZER INC2021008606,2,01/11/2021,,,Y,,True
1132,934954,01/11/2021,,,,,U,,"aware of 6 cases of Bell's Palsy by the companies making these vaccines; This is a spontaneous report from contactable Other HCP. This Other HCP reported same events for 6 patients. This report is for 2nd of 6 patients. A patient of unspecified age and gender received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on an unspecified date at single dose for covid-19 immunization. The patient medical history and concomitant medications were not reported. The other HCP was aware of 6 cases of Bell's Palsy by the companies making these vaccines since an unknown date. The event was reported as non-serious. The event outcome was unknown.  Information about lot/batch number has been requested.; Sender's Comments: Based on a compatible temporal relationship, causality between event Bell's Palsy and BNT162B2 vaccine cannot be excluded. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.,Linked Report(s) : US-PFIZER INC-2021007605 same reporter, same drug, same event, different patients.",,,,,,,,,U,,,,,UNK,,,,,,USPFIZER INC2021009408,2,01/11/2021,,,,,True
1133,934955,01/11/2021,,,,,U,,"aware of 6 cases of Bell's Palsy by the companies making these vaccines; This is a spontaneous report from a contactable other HCP. This Other HCP reported similar events for 6 patients. This report is for 3rd of 6 patient. A patient of unspecified age and gender received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on an unspecified date at SINGLE DOSE for covid-19 immunization.  The patient medical history and concomitant medications were not reported. The reporter reported since the use of modified RNA in covid vaccines, he/she had aware of 6 cases of Bell's Palsy by the companies making these vaccines since an unknown date. The outcome of the event was unknown.  Information about batch/lot number has been requested.; Sender's Comments: Based on a compatible temporal relationship, causality between event Bell's Palsy and BNT162B2 vaccine cannot be excluded. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.,Linked Report(s) : US-PFIZER INC-2021007605 Different patient, same drug/event.",,,,,,,,,U,,,,,UNK,,,,,,USPFIZER INC2021009409,2,01/11/2021,,,,,True
1134,934957,01/11/2021,,,,,U,,"aware of 6 cases of Bell's Palsy by the companies making these vaccines; This is Spontaneous report from a contactable Other HCP. This Other HCP reported similar events for 6 patients. This is 4th of six reports. A patient of unspecified age and gender received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot/batch number and expiration date not provided), via an unspecified route of administration on an unspecified date at single dose for covid-19 immunization. The patient medical history and concomitant medications were not reported. The reporter reported since the use of modified RNA in covid vaccines, he/she had aware of 6 cases of Bell's Palsy by the companies making these vaccines since an unknown date. The outcome of the event was unknown.  Information on the Lot/batch number has been requested.; Sender's Comments: Based on a compatible temporal relationship, causality between event Bell's Palsy and BNT162B2 vaccine cannot be excluded. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.,Linked Report(s) : US-PFIZER INC-2021007605 same reporter, same drug, same event, different patient",,,,,,,,,U,,,,,UNK,,,,,,USPFIZER INC2021009410,2,01/11/2021,,,,,True
1135,934958,01/11/2021,,,,,U,,"aware of 6 cases of Bell's Palsy by the companies making these vaccines; This is a spontaneous report from a contactable other health professional (HCP). This other HCP reported similar events for 6 patients. This is the 5th of 6 patient. A patient of unspecified age and gender received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot/batch number and expiration date not provided), via an unspecified route of administration on an unspecified date at single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The reporter reported since the use of modified RNA in covid vaccines, he/she had aware of 6 cases of Bell's Palsy by the companies making these vaccines since an unknown date. The outcome of the event was unknown.  Information about batch/lot number has been requested.; Sender's Comments: Based on temporal association, the causal relationship between bnt162b2 and the event facial paralysis cannot be excluded. The information available in this report is limited and does not allow a medically meaningful assessment. This case will be reassessed once additional information becomes available. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees, and Investigators, as appropriate.,Linked Report(s) : US-PFIZER INC-2021007605 Different patient, same drug/event.",,,,,,,,,U,,,,,UNK,,,,,,USPFIZER INC2021009411,2,01/11/2021,,,,,True
1136,934959,01/11/2021,CT,60.0,,,F,,"Looked like an encephalopathy; Face was all swollen; Head swelled; Glands swelled; Fatigue; Headache/ So much pain in my head; Couldn't talk; Complete brain fog; nausea; This is a spontaneous report from a contactable nurse. This 60-year-old female nurse (Patient) reported that received bnt162b2 (BNT162B2, Pfizer COVID-19 vaccine), via an unspecified route of administration on 30Dec2020 at single dose for covid-19 immunisation. Medical history included Atrial fibrillation, Chronic Lyme, Lupus and Autoimmune. Concomitant medications included Metoprolol at 12.5 mg for Atrial fibrillation and acetylsalicylic acid (BABY ASPIRIN). No diabetes, no hypertension. None of the usual common diseases. Registered Nurse stated, ""I received vaccine this past Wednesday. I was just talking to a couple of my colleagues and honestly I received the vac. at work. I did not really read through the paperwork and was 'weird' sharing reactions to the vaccine which for me was pretty bad reaction and thought like I need to go through your paperwork and report it. So I thought I should call and just give some information. The usual fatigue which I go to after being normal, my arm was not sore. However, as the week progressed into Friday I had a constant headache but it was manageable and then by Friday night my glands swelled, my nerves behind my ears, my neck and I was extremely fatigued, bad headache and went to bed and I had not gone out and finally I got out today I spoke with my Physician yesterday. What happened it looked like an encephalopathy but my head swelled, my face was all swollen, complete brain fog, fatigue and I couldn't talk. I was in so much pain in my head resulting in (incomplete sentence)."" Lab work included the only thing is the PCR swabbing. No blood test. Registered Nurse further stated, ""I don't know if that is important. But I will tell you and if it is you can send me the questions. I do have a history of Autoimmune. So my Physician thought that this was just like an enhancement of like my bodies reaction I have Chronic Lyme and I have lupus like my ANA has always been stressful. But we think that it is a family thing. No treatment for the Lyme. I did a lot of antibiotic and a lot of naturopathic stuff but that is in the past. But anyhow for anything else what I did was when I got the injection they said try and just take Tylenol not Ibuprofen but there was no way I was going to make it through with just that . So I took Ibuprofen. I called my Physician yesterday morning because I was not sure about what was is happening and I thought it might be secondary sinus infection or something else going on and it reassured me that it is definitely due to the vaccine. He said it is just your body's reaction, take the Ibuprofen, hydrate. Had me take what I had in my house Tigan for nausea. So I was extremely nauseous from the severity of the headache."" Registered Nurse stated, ""I just wanted to let you know what happened and the intensity of what it was because normally I would expect a headache. But this was a 'go dated'. Registered Nurse stated, ""I guess the only question that I have is so do my work has this question and I was going to call my doctor tomorrow may be might know it better. I know that I have to take the second dose. But I understand the second round can be worse than the first. Is there anything that they are recommending that I can do may be prior to ease the reaction?"" The outcome of the events was unknown.   Information on the Lot/Batch number has been requested.; Sender's Comments: The reported clinical manifestations including swelling face and head swelled, which was suspected as encephalopathy by the reporting nurse, was probably related to the bnt162b2 (BNT162B2, Pfizer COVID-19 vaccine), due to temporal relationship.  The subject's underlying Chronic Lyme, Lupus and Autoimmune were likely the risk factors to the onset of the events.  The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory authorities, Ethics committees and Investigators, as appropriate.",,,,,,,,,U,12/30/2020,,,Test Name: PCR swabbing; Result Unstructured Data: Test Result:Unknown results,WRK,,; BABY ASPIRIN,,Medical History/Concurrent Conditions: Atrial fibrillation (Verbatim: Atrial fibrillation); Autoimmune disorder (Autoimmune); Lupus syndrome (Verbatim: Lupus); Lyme disease (Verbatim: Chronic Lyme),,USPFIZER INC2021010167,2,01/09/2021,,,,,True
1142,934969,01/11/2021,,42.0,,,F,,"Acute appendicitis; Severe acute abdominal pain; Chills; Fever; This is a spontaneous report from a contactable Nurse (patient). A 42-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) (expiration date Mar2021, incomplete lot number L0140, not sure the first letter it is C or E), via an unspecified route of administration on 23Dec2020 at single dose for covid-19 immunization. None medical history. Concomitant medication included escitalopram oxalate (LEXAPRO). The patient experienced a little bit chills and fever she felt coming exactly on the 26th but she expected that and that was all fine but patient ended up in (Incomplete sentence). She went to work on 30th December and had some onset of severe acute abdominal pain and she ended up in an emergency appendectomy by 6 O'clock that evening. So she had an acute appendicitis and she did some research and it says that she can be listed in to the severe complications that the number in the vaccinated group was double back to the procedural group. The 26th it resided and patient felt better until the 30th when she have acute severe abdominal pain onset. She left work went for emergency room and she was in surgery within four hours. The outcome of events chills and fever was recovering, the other events was unknown. Because of the research that is on the website patient cannot help and think that it is related. Patient believed the relatedness of drug to events was related.  Information about lot/batch number has been requested.; Sender's Comments: A possible contributory effect of suspect BNT162B2 on reported events cannot be excluded.  The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to regulatory authorities, Ethics Committees, and Investigators, as appropriate",,,,,,,,,N,12/23/2020,12/26/2020,3.0,Test Date: 20201226; Test Name: Fever; Result Unstructured Data: Test Result:Fever,UNK,,LEXAPRO,,Comments: List of non-encoded Patient Relevant History: Patient Other Relevant History 1: None,,USPFIZER INC2021013424,2,01/11/2021,,,Y,,True
1173,936209,01/12/2021,NJ,59.0,,,F,,"tested positive for Covid-19 after receiving 1st dose; COVID-19 PCR test: positive on 31Dec2020, Covid-19 rapid test: positive on 31Dec2020; smell was gone/no sense of smell; no sense of taste; This is a spontaneous report from a contactable nurse (patient). A 59-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number EH9899, expiry date unknown) via unspecified route of administration in the left arm on 26Dec2020 at single dose for Covid-19 immunization. Medical history included cholesterol, blood pressure (controlled blood pressure), hypothyroidism. Concomitant medications included TELMISARTAN (MICARDIS) for blood pressure and ATORVASTATIN (LIPITOR) for cholesterol; both on unspecified date. The patient was asking if she was able to get the 2nd dose of vaccine, since she was tested positive for Covid-19 (31Dec2020) after receiving 1st dose. The patient was asking information about missing 2nd dose and when can she get it and wanted to know if it was still okay to get the second dose. The patient asked if she needed to have a test negative for covid-19 prior to receiving 2nd dose. The patient experienced no sense of taste and actually realized it on 29Dec2020 that her food was not tasting good. The patient didn't notice her smell was gone until she was cooking the chicken curry, she even tested it out by spraying some perfume, she has no sense of smell on 30Dec2020. The patient informed that both her taste and smell returned 02Jan2021 but was not recovered completely. The patient underwent lab tests and procedures which included A1C: 6.4 on 12Dec2020, COVID-19 PCR test: positive on 31Dec2020, Covid-19 rapid test: positive on 31Dec2020. The patient informed that she had no positive test before the Covid-19 vaccine, she took Covid-19 antibody test in Apr2020 and it was negative. The outcome of the events tested positive for Covid-19 after receiving 1st dose was unknown, no sense of taste and smell was gone/no sense of smell was recovered with sequel on 02Jan2021.; Sender's Comments: No effect of the suspect vaccine could be reasonably achieved to protect from the targeted infection/disease due to the very short time lag.  Instead, the positive COVID represents the pre-existing infection prior to vaccine use.",,,,,,,,,N,12/26/2020,12/29/2020,3.0,Test Date: 20201212; Test Name: A1C; Result Unstructured Data: Test Result:6.4; Test Date: 202004; Test Name: Covid-19 antibody test; Test Result: Negative  ; Test Date: 20201231; Test Name: COVID-19 PCR test; Test Result: Positive  ; Test Date: 20201231; Test Name: Covid-19 rapid test; Test Result: Positive,UNK,,MICARDIS; LIPITOR [ATORVASTATIN],,Medical History/Concurrent Conditions: Blood cholesterol abnormal; Blood pressure abnormal (controlled blood pressure); Hypothyroidism,,USPFIZER INC2021002938,2,01/10/2021,,,,,True
1177,936217,01/12/2021,CA,44.0,,,F,,"Patient complained of itching starting on her legs, which went upwards; Redness on her arms, neck, face; Redness on her arms, neck, face; Redness on her arms, neck, face; Itching up to her scalp; Dry cough; Rash; This is a spontaneous report from a contactable nurse (patient).   A 44-year-old non-pregnant female patient received the first dose of BNT162B2 (Pfizer-Biontech Covid-19 Vaccine) at single dose, in the left arm, on 26Dec2020, at 09:00 AM, for COVID-19 immunisation. COVID-19 vaccine was administered at hospital. The patient had not received any other vaccines within 4 weeks prior to the BNT162B2 vaccine. Relevant medical history included asthma, hypertension, hypothyroidism, penicillin allergy, food allergy (melon and pineapple) and latex allergy. Concomitant medications, received within 2 weeks of vaccination, included omalizumab (XOLAIR), levothyroxine sodium (LEVOXYL), levocetirizine dihydrochloride (XYZAL), losartan and formoterol fumarate, mometasone furoate (DULERA). After covid vaccination, the patient was advised to stay 30 minutes for observation. On 26Dec2020 at 09:15, less than 15 minutes later, the patient complained of itching starting on her legs, which went upwards. The patient took 25 mg oral diphenhydramine hydrochloride (BENADRYL). She noted to have redness on her arms, neck, face, itching up to her scalp. By then she started to have a dry cough, removed her mask, nurse who was with her called for a rapid response team. Patient's epi pen was used, they then started IV and pushed emergency meds and transported to ED. Emergency room/department or urgent care was required. Another dose of epinephrine IM and additional meds were given. Placed on oxygen via non-rebreather with albuterol. Epinephrine drip started. Stabilized after 3 hours, stayed in observation for 12 hours then discharged to home. Around the clock 50 mg diphenhydramine hydrochloride (BENADRYL) at home x 2 days, then levocetirizine (ZYXAL) thrice daily x 7 days to control itching and redness/rash. Other treatment included steroids, pepcid. Prior to vaccination, the patient was not diagnosed with COVID-19 and since the vaccination, the patient has been tested for COVID-19 (PCR, Nasal Swab) on 26Dec2020 and the result was negative. Clinical outcome of the adverse events was recovering at time of this report.   Information on the lot/batch number has been requested.; Sender's Comments: Based on a close temporal association, a causal relationship between reported events and BNT162B2 vaccine cannot be excluded. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.",,,,,,,,,N,12/26/2020,12/26/2020,0.0,"Test Date: 20201226; Test Name: COVID-19 PCR test; Test Result: Negative  ; Comments: COVID-19 (PCR, Nasal Swab): result was negative.",PVT,,XOLAIR; LEVOXYL; XYZAL;  ; DULERA,,Medical History/Concurrent Conditions: Asthma; Food allergy; Hypertension; Hypothyroidism; Latex allergy; Penicillin allergy,,USPFIZER INC2021003698,2,01/11/2021,,,Y,,True
1181,936244,01/12/2021,VA,,,,F,,"a little bit of a cough.; headache; runny nose; Aside from her taste and smell still being gone; Aside from her taste and smell still being gone/loss of taste; fogginess; Patient had since tested positive; Patient had since tested positive; patient likely had exposure on 22Dec2020; This is a spontaneous report from a contactable physician. A female patient of an unspecified age received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 21Dec2020 at single dose for covid-19 immunization. The patient's medical history and concomitant medications were not reported. The patient likely had exposure on 22Dec2020. She showed the first covid symptoms on 31Dec2020. Patient experienced loss of taste, headache, fogginess, runny nose, and a little bit of a cough on unspecified date. Patient received her first covid dose on 21Dec2020. The first dose likely helped her, she has rapidly gotten better and was feeling much better today. Aside from her taste and smell still being gone. The patient was scheduled to receive her second dose on 11Jan2021. Patient had since tested positive. Caller clarified that the patient didn't get a test until 03Jan2021. Outcome of events taste and smell still being gone was not recovered, and outcome of other events was unknown.   Information on batch/lot number was requested.; Sender's Comments: No effect of the suspect vaccine could be reasonably achieved to protect from the targeted infection/disease due to the very short time lag.  Instead, the positive COVID likely represents the pre-existing infection prior to vaccine use.  Further information like confirmative COVID 19 Nucleic acid/ PCR test together with any associated symptoms are needed for full medical assessment.",,,,,,,,,N,12/21/2020,12/22/2020,1.0,Test Date: 20210103; Test Name: test; Test Result: Positive,UNK,,,,,,USPFIZER INC2021005198,2,01/11/2021,,,,,True
1182,936245,01/12/2021,,,,,F,,"tested positive; tested positive; runny nose; headache; This is a spontaneous report from a Pfizer-sponsored program Pfizer First Connect. A contactable consumer reported that a 51-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on an unspecified date at single dose for covid-19 immunization. The patient's medical history and concomitant medications were not reported. The patient experienced tested positive, runny nose, headache after getting the vaccine on an unspecified date with outcome of unknown. This report is considered as non-serious.",,,,,,,,,U,,,,Test Name: tested positive; Test Result: Positive,UNK,,,,,,USPFIZER INC2021005201,2,01/10/2021,,,,,True
1183,936254,01/12/2021,OH,55.0,,,F,,"tested positive for COVID-19; tested positive for COVID-19; This is a spontaneous report from a contactable nurse (patient) from a Pfizer-sponsored program Pfizer First Connect. A 55-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/lot number: EK5730), via an unspecified route of administration in the right arm on 18Dec2020 at single dose for covid 19 immunisation as healthcare professional and husband was high risk. Medical history included hypertension from 2019 and ongoing. Concomitant medication included amlodipine besilate (NORVASC, 5 mg) from 2019 and ongoing for high blood pressure. The patient experienced tested positive for covid-19 on 03Jan2021 with outcome of not recovered, congestion and headache in Jan2021 with outcome of unknown. The patient underwent lab tests and procedures which included COVID test on 03Jan2021 and the results came back positive on 04Jan2021. The patient was scheduled to receive her second injection on 08Jan2021. Since her first injection she had tested positive for COVID-19. The second dose had to be given a certain amount of days after the first. She would be outside that window. She would like to know if there is any guidance regarding the if/when she should get the second dose. The reporter would like to know if she waits longer than the recommended 21 days to receive her second dose of the COVID-19 vaccine would she need to restart the vaccination series. The reporter said this was not serious as she only had congestion and headache with treatment: using over the counter stuff. Event relatedness with COVID vaccine was unknown.; Sender's Comments: Based on available information, a possible contributory role of suspect BNT162B2 vaccine cannot be completely excluded for reported ""tested positive for COVID-19"".",,,,,,,,,N,12/18/2020,01/03/2021,16.0,Test Date: 20210103; Test Name: COVID; Test Result: Positive,UNK,,NORVASC,Blood pressure high,,,USPFIZER INC2021005421,2,01/11/2021,,,,,True
1188,936266,01/12/2021,CA,65.0,,,F,,"received the vaccine on December 17th and tested positive for Covid on December 27th/COVID PCR (polymerase chain reaction) test: positive on 28Dec2020; received the vaccine on December 17th and tested positive for Covid on December 27th/COVID PCR (polymerase chain reaction) test: positive on 28Dec2020; This is a spontaneous report from a Pfizer sponsored program Pfizer First Connect. A contactable nurse (patient) reported that a 65-year-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/lot number: EK5730), via an unspecified route of administration on 17Dec2020 11:00 in left deltoid at single dose for covid-19 immunization. Medical history included thyroid cancer from an unknown date and unknown if ongoing, bilateral thyroidectomy in 2014. Family Medical History: Father died of lung cancer. Mother died of cardiac arrest in 1972. Concomitant medication included levothyroxine sodium (SYNTHROID) for bilateral thyroidectomy. The patient received the vaccine on 17Dec2020 and tested positive for covid on 27Dec2020. The adverse events resulted in emergency room visit. The patient underwent lab tests and procedures which included tested positive for COVID on 27Dec2020, COVID PCR (polymerase chain reaction) test: positive on 28Dec2020. Vaccination facility type was hospital. No additional vaccines administered on same date of Pfizer suspect. Received COVID Vaccine on 17Dec2020. Tested positive for COVID in emergency room on 27Dec2020. Tested positive on a COVID PCR test on 28Dec2020. Prior vaccinations within 4 weeks was none. Caller received the first dose of the COVID Vaccine. Tested positive for COVID on 27Dec2020. Is about to get the second dose of COVID Vaccine and would like to know if she should proceed or wait. Since quarantine, she has had no fever. Is slightly short of breath and has a headache. Works in COVID units in a hospital. Wants to make sure she can receive the second dose. Stated she had no adverse reaction to the COVID Vaccine unless an adverse reaction can occur two weeks after. Is attributing the shortness of breath and headache to testing positive for COVID. Shortness of breath and headache only occurred after testing positive for COVID. Reason she went to the hospital is because she lost her sense of smell. She got tested and was positive for COVID. Lost sense of smell, went to Emergency Room, and notified doctor of positive test the following day, 28Dec2020. Clarified she just went to the emergency department to get tested for COVID and then went home. Was called with positive results in an hour. Caller wanted to know when she should proceed with getting her second dose of Covid vaccine. She is supposed to receive her second dose tomorrow. She thought she was going to take second dose when I completely recovered. Caller asked if she waited until the 13th to receive second dose of Covid vaccine, would it be effective. She would feel more comfortable doing that. The outcome of events was unknown.; Sender's Comments: Based on the information available, a possible contributory role of the suspect BNT162B2 cannot be excluded for the reported COVID-19 based on the known safety profile. However the short duration of 9 days since the vaccine first dose is given it is unlikely patient would have fully developed immunity.",,,,,,,,,U,12/17/2020,12/27/2020,10.0,Test Date: 20201227; Test Name: COVID; Test Result: Positive  ; Comments: Tested positive for COVID on 27Dec2020; Test Date: 20201228; Test Name: COVID PCR test; Test Result: Positive  ; Comments: COVID test and COVID PCR test. Both resulted as positive,PVT,,SYNTHROID,,Medical History/Concurrent Conditions: Thyroid cancer; Thyroidectomy (Bilateral thyroidectomy in 2014),,USPFIZER INC2021005502,2,01/10/2021,,,Y,,True
1189,936269,01/12/2021,PA,30.0,,,M,,"Felt like he couldn't breath; He still has his sense of taste, but it is dulled; Recently got the vaccine and also came down with covid; Recently got the vaccine and also came down with covid; Exhaustion/feeling tired; Loss of smell; Mild congestion/The congestion went into full nasal drainage; This is a spontaneous report from a contactable pharmacist (patient). A 30-year-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/lot number: EL0140, Expiry Date: 31Mar2021), via an unspecified route of administration on 31Dec2020 13:00 at single dose for Covid-19 immunization. The patient had no relevant medical history and concomitant drug. The patient experienced recently got the vaccine and also came down with covid on 04Jan2021 00:30, mild congestion/the congestion went into full nasal drainage on 31Dec2020, loss of smell on 02Jan2021, exhaustion/feeling tired on 03Jan2021, felt like he couldn't breathe, he still has his sense of taste, but it is dulled on an unspecified date. He was a pharmacist. He received his first dose of the COVID vaccine on Thursday 31Dec2020 1pm. Shortly thereafter, he got the typical side effects of the vaccine that are posted. Then 2.5 days letter he no longer had a sense of smell. Everything he read said that he probably came in contact with COVID prior to administration. His questions was since he test positive for COVID, should he still get the second shot. He got it at a clinic. He did experience mild congestion which started by 6 o'clock. He started to notice slight congestion that kind of went away. Then, on Friday, about 24 hours later, he really noticed he had congestion. He took pseudoephedrine hydrochloride (SUDAFED) and paracetamol (TYLENOL). Then his sense of smell diminished with the congestion and felt like he couldn't breathe. On Saturday, he decided to not take medication. That was when he noticed he could not smell anything. He had full blown congestion. It probably took two days when he started to lose his sense of smell. He received the shot on Thursday. On Saturday, he lost his sense of smell. He still has his sense of taste, but it was dulled. Sunday, he was just exhausted and feeling tired. These were all listed as typical side effects except for the loss of smell. Saturday was the worst. The congestion went into full nasal drainage. On Sunday he had no sinus issues. He still hasn't gained his sense of smell back. The exhaustion set in Sunday 03Jan2020. He doesn't feel like any of the side effects are serious. The exhaustion has started to let up some so it is improving. He was pretty much back to normal. He just couldn't figure out why he had a loss of smell. He had a COVID rapid test on 04Jan2021 at 8:30 am (as reported). He received an alert and hour later that it was positive. He was wondering whether the loss of smell could be from the vaccine. The patient underwent lab tests and procedures which included COVID-19 rapid POC test: positive on 04Jan2021. The outcome of events for mild congestion/the congestion went into full nasal drainage was resolved on 03Jan2021, for loss of smell was not resolved, for exhaustion/feeling tired was resolving, for other events was unknown. The events were reported as non-serious.; Sender's Comments: Reported event ""recently got the vaccine and also came down with covid"" is considered possibly related to suspect BNT162B2 based on temporal association and known drug safety profile.",,,,,,,,,N,12/31/2020,12/31/2020,0.0,Test Date: 20210104; Test Name: COVID-19 rapid POC test; Test Result: Positive,UNK,,,,Comments: List of non-encoded Patient Relevant History: Patient Other Relevant History 1: none,,USPFIZER INC2021005518,2,01/10/2021,,,,,True
1192,936276,01/12/2021,AZ,47.0,,,F,,"she had COVID symptoms; she had COVID symptoms; chills; low grade fever; muscle joint pain; muscle joint pain; exhausted with a headache/ She doesn't want to get up she is tired; exhausted with a headache/slight headache; muscle joint pain which is a stabbing pain all over her body; feeling unwell; This is a spontaneous report from a contactable nurse (patient). A 47-year-old female patient receive first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/lot number: EH9899, manufacturer: Pfizer), via an unspecified route of administration on 04Jan2021 14:00 at single dose for Covid-19 immunization. Medical history included ongoing childhood asthma, COVID 19 positive from 07Dec2020 to an unknown date. There were no concomitant medications. The patient felt like she had covid symptoms, chills, low grade fever, muscle joint pain, exhausted with a headache/ she doesn't want to get up she was tired, muscle joint pain, which was a stabbing pain all over her body, feeling unwell, all on 05Jan2021 05:00. The events were reported as non-serious. Caller had Sars-COV-2 infection diagnosed 07Dec2020. Received first dose of vaccine 04Jan2021 at 14:00. She was experiencing chills, low grade fever, muscle joint pain, exhausted with a headache. Asking for information on efficacy of second dose. She didn't have any side effects or anything initially. Then, 12 hours later at 5- 6 am she felt like she had COVID symptoms. She already had COVID so she known what it feels like. She was wondering how long would last. It was almost like having real COVID. She didn't have a prescribing doctor. She had COVID 07Dec2020. She was currently experiencing Chills, fever low grade, muscle joint pain which was a stabbing pain all over her body, and she was feeling unwell. She didn't want to get up she was tired. She has a slight headache. This all started at 5 am on 05Jan2021. Even with medication. She has been taking paracetamol (TYLENOL) and excedrin. She cannot work if she wanted to, but these effects are not serious. Her fever has went down. The chills have stayed the same. She was diagnosed with childhood asthma. Caller asked about interval information between the SARS-COV-2 infection diagnosed 07Dec2020 and her first dose of vaccine 04Jan2021 at 14:00. The outcome of events for felt like she had covid symptoms was unknown, for low grade fever was resolving, for other events was not resolved.; Sender's Comments: There is not a reasonable possibility that event suspected COVID-19 is related to BNT162B2.  There is no test done to confirm whether patient got COVID-19 or not.  And symptoms that were suspected by reporter as due to COVID-19 occurred one after the vaccination, when vaccine was not expected to achieve the effect.",,,,,,,,,N,01/04/2021,01/05/2021,1.0,Test Date: 20210105; Test Name: fever; Result Unstructured Data: Test Result:Low grade; Test Date: 202101; Test Name: fever; Result Unstructured Data: Test Result:went down; Comments: Her fever has went down; Test Date: 20201207; Test Name: COVID 19; Test Result: Positive,UNK,,,Childhood asthma,Medical History/Concurrent Conditions: COVID-19 virus test positive,,USPFIZER INC2021005573,2,01/11/2021,,,,,True
1199,936288,01/12/2021,,,,,U,,"developed covid like symptoms a few days later/ tested positive on the 26th; developed covid like symptoms a few days later/tested positive on the 26th; This is a spontaneous report from a contactable physician. A patient of unspecified age and gender received the first dose bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 18Dec2020 at single dose for covid-19 immunization. The patient's medical history and concomitant medications were not reported. The patient received the vaccine on 18Dec2020 and developed covid like symptoms a few days later in Dec2020 and believed the patient was likely exposed. The patient was tested positive on 26Dec2020. The outcome of the events was unknown.   Information about Lot/Batch number has been requested.; Sender's Comments: The reported covid like symptoms a few days with  tested positive  after COVID-19 immunization is considered ineffective of BNT162B2, and the Company cannot completely exclude the possible causality between the reported event and BNT162B2 administration.",,,,,,,,,U,12/18/2020,12/01/2020,,Test Date: 20201226; Test Name: covid; Test Result: Positive  ; Comments: They tested positive on the 26th,UNK,,,,,,USPFIZER INC2021005851,2,01/10/2021,,,,,True
1203,936302,01/12/2021,,,,,U,,"Developed covid symptoms 21Dec, tested positive 26Dec; Developed covid symptoms 21Dec, tested positive 26Dec; This is a spontaneous report from a contactable physician reporting for a patient.  A patient of unspecified age and gender received BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), via an unspecified route of administration on 18Dec2020 as a single dose for COVID-19 immunization.  The patient's medical history and concomitant medications were not reported.  The patient developed COVID symptoms 21Dec2020, tested positive 26Dec2020. The outcome of the event was unknown.  The lot number for the vaccine, BNT162B2, was not provided and will be requested during follow up.; Sender's Comments: Based on the information currently available, a lack of efficacy with the suspected vaccine BNT162B2 in this patient cannot be completely excluded. However individuals may not be protected until at least 7 days after their second dose of the vaccine.",,,,,,,,,U,12/18/2020,12/21/2020,3.0,"Test Date: 20201226; Test Name: covid symptoms, tested positive; Test Result: Positive",UNK,,,,,,USPFIZER INC2021006339,2,01/10/2021,,,,,True
1205,936318,01/12/2021,AZ,30.0,,,F,,"within 6 hours experienced severe chills and covid-like symptoms, she also tested positive for COVID-19; within 6 hours experienced severe chills and covid-like symptoms, she also tested positive for COVID-19; This is a spontaneous report from a contactable nurse. A 30-year-old female patient received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiry date were not reported), via an unspecified route of administration in left arm on 04Jan2021 11:30 at a single dose for COVID-19 vaccination. Medical history included allergies to Sulfa diagnosed in 2008, Allergies to Strawberries diagnosed when she was very young, Diamox allergy diagnosed in 2008, dyslexic, and Obesity but never been treated. Concomitant medication included levothyroxine (LEVOTHYROXINE), ascorbic acid, betacarotene, calcium sulfate, colecalciferol, cyanocobalamin, ferrous fumarate, folic acid, nicotinamide, pyridoxine hydrochloride, retinol acetate, riboflavin, thiamine mononitrate, tocopheryl acetate, zinc oxide (PRENATAL VITAMINS), zinc (ZINC), nd cetirizine hydrochloride (ZYRTEC). The patient previously took diamox [acetazolamide] and experienced drug hypersensitivity.  Patient received first dose Monday, 04Jan2021, then she experienced severe chills and Covid like symptoms. Apparently, she tested positive for COVID 19. She ws not sure if it was a false positive or if she actually has COVID, but was concerned because her husband has cancer and was immunocompromised. Literally, she got the vaccine because her OB/GYN told her she needs to get it as soon as possible. She did blood work and she tested negative for pregnancy. There was no prescriber as it was given as part of her work. Fifteen minutes after receiving the vaccine, she had the worst headache she has ever had in her life. Six hours after that, she had such bad chills. That night, it worsened and it got better every hour when she took something. She said her congestion was still present. She stated she took Tylenol and hour later and it subsided. The outcome of the events was not recovered. The patient underwent laboratory date including negative antibodies on an unknown date, blood work on Mar2020 with unknown result, then on 05Jan2020 tested positive to COVID 19 by saliva test at 09:15 and nasal test at 11:30  Information about Lot/batch number has been requested.; Sender's Comments: Based on the current available information and the plausible drug-event temporal association, a possible contributory role of the suspect product BNT162B2 to the development of events Drug ineffective and COVID-19 cannot be totally excluded.  The case will be reassessed if additional information becomes available",,,,,,,,,N,01/04/2021,01/04/2021,0.0,Test Name: antibodies; Test Result: Negative  ; Test Date: 202003; Test Name: blood work; Result Unstructured Data: Test Result:Unknown results; Test Date: 20210105; Test Name: saliva test; Test Result: Positive  ; Comments: at 09:15; Test Date: 20210105; Test Name: nasal test; Test Result: Positive  ; Comments: at 11:30,PVT,,; PRENATAL VITAMINS [ASCORBIC ACID;BETACAROTENE;CALCIUM SULFATE;COLECALCIFEROL;CYANOCOBALAMIN;FERROUS ;  ; ZYRTEC [CETIRIZINE HYDROCHLORIDE],,Medical History/Concurrent Conditions: Dyslexia; Fruit allergy (diagnosed very young Allergies to Strawberries); Obesity (Obesity but never been treated); Sulfonamide allergy (diagnosed in 2008 allergies to Sulfa),,USPFIZER INC2021007366,2,01/11/2021,,,,,True
1207,936328,01/12/2021,CT,35.0,,,F,,"tested positive for covid; tested positive for covid; This is a spontaneous report from a contactable consumer. A 35-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration at the left upper arm on 18Dec2020 15:30 at a single dose for COVID-19 immunisation.  Medical history included high blood pressure and had electrocardiogram (EKG) unknown result a week before vaccination in Dec2020.  Concomitant medication included acetylsalicylic acid (ASPIRIN), lisinopril, and guaifenesin (MUCINEX).  It was reported that patient tested positive for COVID on 31Dec2020. She has not gotten her second dose but it was scheduled for 08Jan2021 for which will still be in quarantine then and requested guidance on when/if she should get the second dose. Patient explained her parents have COVID and that the rapid test for the COVID test was how she found out she had COVID. The patient has not recovered from the events.",,,,,,,,,N,12/18/2020,12/31/2020,13.0,Test Date: 20201231; Test Name: Covid-19; Test Result: Positive,UNK,,ASPIRIN (E.C.);  ; MUCINEX,,Medical History/Concurrent Conditions: Blood pressure high; EKG (unknown result),,USPFIZER INC2021007428,2,01/11/2021,,,,,True
1208,936337,01/12/2021,IN,31.0,,,F,,"Developing symptoms of covid/ symptoms of Covid after having the vaccine; Developing symptoms of covid/ symptoms of Covid after having the vaccine; This is a spontaneous report from a contactable consumer (patient) via a Pfizer-sponsored program. A 31-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection) lot number: EJ1688, via an unspecified route of administration in the left arm, on 21Dec2020 at a single dose for covid-19 immunisation as she works with disabled people and for general community health. Patient's medical history was none. Family history included her kids/children had covid (unknown if ongoing). There were no concomitant medications. It was reported that the patient had symptoms of covid after having the vaccine with outcome of recovering. The patient received the first dose of covid vaccine on 21Dec2020 and on the 02Jan2021 she started developing symptoms of covid. She mentioned that her children have virus and she had the covid test done. She wanted to know if she can get the second dose of the vaccine. She queried for her co-worker who has the Covid and was told to not take the vaccine yet and how long they need to wait. She was tested this morning. She has not gotten the results. Her kids had Covid and she felt certain she had it because she has symptoms. It comes and goes. It was better during the day and worse at night. She received the vaccine because she works with disabled people where there are extremely high numbers of the virus. She also got it for general community health. The Covid test was done on 06Jan2021 with unknown result.",,,,,,,,,N,12/21/2020,01/02/2021,12.0,Test Date: 20210106; Test Name: Covid test; Result Unstructured Data: Test Result:Unknown result,UNK,,,,Medical History/Concurrent Conditions: COVID-19 (her kids/children); Comments: List of non-encoded Patient Relevant History: Patient Other Relevant History 1: None,,USPFIZER INC2021007546,2,01/11/2021,,,,,True
1210,936366,01/12/2021,,,,,M,,"He tested positive last Tuesday for SARS-Cov-2; He tested positive last Tuesday for SARS-Cov-2; This is a spontaneous report from a Pfizer Sponsored Program, Pfizer First Connect via a contactable other health professional (HCP) (patient). A male patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 18Dec2020 at single dose for covid-19 immunization.  The patient medical history and concomitant medications were not reported. The patient tested positive last Tuesday (05Jan2021) for SARS-Cov-2 and the patient wanted to know if he could receive his second dose of vaccine. The outcome of the event was unknown.  Information on the lot/batch number has been requested.; Sender's Comments: Based on the information currently available, a lack of efficacy with the suspected vaccine BNT162B2 in this patient cannot be completely excluded. Further information like confirmative virus genome /nucleic acid detection is needed for meaningful medical assessment.",,,,,,,,,U,12/18/2020,01/05/2021,18.0,Test Date: 20210105; Test Name: SARS-Cov-2; Test Result: Positive,UNK,,,,,,USPFIZER INC2021007745,2,01/10/2021,,,,,True
1212,936379,01/12/2021,CA,37.0,,,F,,"chest tightness; palpitations; elevated heart rate; fatigue; This is a spontaneous report from a contactable Other HCP. A 37-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 31Dec2020 at single dose for covid-19 immunisation. Medical history included Dermatographia. The patient is allergic to Penicillin, lactose, Cephalosporins and Beepen-VK.  There were no concomitant medications. Seventy two hours after the vaccine was given the patient had an elevated heart rate, chest tightness and fatigue. Are this consistent with the vaccine. She does not have a history of elevated heart rate or palpitations. She checked her heart rate with her Apple watch and sent in a strip to the doctor. The doctor is concerned and is asking if this is related. She went to the ER to make sure she was ok but was not admitted. Outcome of event heart rate increased as recovered on 05Jan2021, of fatigue was not recovered, of others was recovering.   Information about Lot/batch number has been requested.; Sender's Comments: Based on available information, a possible contributory role of the subject product, BNT162B2 vaccine, cannot be excluded for the reported events of elevated heart rate, chest tightness, palpitations and fatigue due to temporal relationship.  There is limited information provided in this report.  Additional information is needed to better assess the case, including complete medical history, diagnostics including 12-lead EKG , counteractive treatment measures and concomitant medications. This case will be reassessed once additional information is available.  The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.",,,,,,,,,N,12/31/2020,01/02/2021,2.0,Test Name: heart rate; Result Unstructured Data: Test Result:elevated; Test Name: heart rate; Result Unstructured Data: Test Result:Unknown results,UNK,,,,Medical History/Concurrent Conditions: Dermatographia; Lactose intolerance; Penicillin allergy,,USPFIZER INC2021007850,2,01/11/2021,,Y,Y,,True
1214,936392,01/12/2021,PA,37.0,,,F,,"Angioedema; Tongue numb observer notified about 10 minutes after vaccine, then tongue and Lower lips numb; tachycardia with throat tightness; tachycardia with throat tightness.; This is a spontaneous report from a contactable nurse (patient).  The 37-years-old female patient received first dose of bnt162b2 (BNT162B2, Lot number: EK9231), unknown on 05Jan2021 07:45 at SINGLE DOSE on left arm for COVID-19 immunisation. The patient is not pregnant. No covid tested post vaccination. Medical history included Idiopathic angioedema, HTN, PCOS, Allergies to medications, food, or other products: Latex, penicillin, coconut. Prior to vaccination, the patient was diagnosed with COVID-19. Concomitant medication included spironolactone (ALDACTONE), fexofenadine hydrochloride (ALLEGRA), hydrochlorothiazide, amlodipine besilate (NORVASC). The patient did not take other vaccine in four weeks. The patient experienced Angioedema event occurred approximately 18 hrs later with repeat of treatment in ER on 06Jan2021, tongue numb observer notified about 10 minutes after vaccine, then tongue and lower lips numb on 05Jan2021 08:00, taken to ER became tachycardia with throat tightness on 05Jan2021 08:00. EPIPEN administered, benadryl and prednisone (steroids), and famotidine administered along with a saline bolus. The outcome of the events was recovered.  No follow-up attempts are needed.; Sender's Comments: Based on available information, a possible contributory role of the subject product, BNT162B2 vaccine, cannot be excluded for the angioedema and other reported events due to temporal relationship.  There is limited information provided in this report.  Additional information is needed to better assess the case, including complete medical history, diagnostics including complement levels, counteractive treatment measures and concomitant medications.  This case will be reassessed once additional information is available.  The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.",,,,,,,,,Y,01/05/2021,01/05/2021,0.0,,WRK,,ALDACTONE [SPIRONOLACTONE]; ALLEGRA;  ; NORVASC,,"Medical History/Concurrent Conditions: COVID-19 (Prior to vaccination, was the patient diagnosed with COVID-19?: Yes); Fruit allergy (Allergies to medications, food, or other products: Latex, penicillin, coconut); Hypertension; Idiopathic angioedema; Latex allergy (Allergies to medications, food, or other products: Latex, penicillin, coconut); Penicillin allergy (Allergies to medications, food, or other products: Latex, penicillin, coconut); Polycystic ovary",,USPFIZER INC2021007903,2,01/11/2021,,,Y,,True
1217,936417,01/12/2021,AZ,35.0,,,F,,"Left Bell's palsy/left side of face, inability to raise left eyebrow; numbness and paresthesia of tongue; numbness and paresthesia of tongue; pain in left upper arm between elbow and shoulder; tachycardia; elevated blood pressure; This is a spontaneous report from a contactable physician. A 35-year-old female patient (not pregnant at the time of vaccination) received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/lot number: EH9899), intramuscular at arm left on 31Dec2020 at single dose for covid-19 immunization. The vaccine was administered at other (as reported). Medical history included asthma (Allergy induced asthma). Concomitant medication within 2 weeks of vaccination included cetirizine hydrochloride (ZYRTEC) from Dec2020 at 10mg daily.  The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 31Dec2020, the patient experienced Left Bell's palsy, numbness and paresthesia of tongue, left side of face, inability to raise left eyebrow, pain in left upper arm between elbow and shoulder, tachycardia, elevated blood pressure.  The adverse events result in emergency room/department or urgent care. The patient received treatment for the adverse events which included Prednisone 20mg daily, Valacyclovir 1000mg twice a day. Prior to vaccination, the patient was not diagnosed with COVID-19 and since the vaccination, the patient was not been tested for COVID-19. The outcome of events was not recovered.; Sender's Comments: Based on available information, a possible contributory role of the subject product, BNT162B2 vaccine, cannot be excluded for the Bell's palsy and other reported events due to temporal relationship.  However, the Bell's palsy may possibly represent a concurrent medical condition.  There is limited information provided in this report.  Additional information is needed to better assess the case, including complete medical history, diagnostics including viral serologies, and concomitant medications.  This case will be reassessed once additional information is available.  The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.",,,,,,,,,N,12/31/2020,12/31/2020,0.0,Test Date: 20201231; Test Name: blood pressure; Result Unstructured Data: Test Result:Elevated,UNK,,ZYRTEC [CETIRIZINE HYDROCHLORIDE],,Medical History/Concurrent Conditions: Allergic asthma,,USPFIZER INC2021008026,2,01/11/2021,,,Y,,True
1218,936419,01/12/2021,AZ,51.0,,,F,,"Shortness of breath, stridor, migraine for 5 days and 10 days later cellulitis at injection site.; Shortness of breath, stridor, migraine for 5 days and 10 days later cellulitis at injection site.; Shortness of breath, stridor, migraine for 5 days and 10 days later cellulitis at injection site.; Shortness of breath, stridor, migraine for 5 days and 10 days later cellulitis at injection site.; This is a spontaneous report from a contactable Nurse (patient). A 51-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) (lot number EH9899), intramuscularly on 28Dec2020 14:30 at single dose for covid-19 immunization. Vaccine location was left arm and it was the first dose. The facility type vaccine was hospital. Medical history included migraine from an unknown date. Concomitant medication included erenumab aooe (AIMOVIG), estradiol, diphenhydramine hydrochloride (BENADRYL), trazodone hydrochloride (TRAZODON). No known allergies. Patient was not diagnosed with COVID-19 prior to vaccination nor tested for COVID-19 since the vaccination. The patient didn't receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient experienced shortness of breath, stridor, migraine for 5 days and 10 days later cellulitis at injection site on 28Dec2020 15:00. Patient received Antibiotics, steroids epi as treatment for the adverse events. The adverse events resulted in Doctor or other healthcare professional office/clinic visit. The outcome of event migraine was recovered in Jan2021, other events was recovered on an unknown date. The events were reported as non-serious.; Sender's Comments: Based on available information, a possible contributory role of the subject product, BNT162B2 vaccine, cannot be excluded for the reported events of Vaccination site cellulitis, shortness  of breath, stridor and migraine,  due to temporal relationship.  There is limited information provided in this report.  Additional information is needed to better assess the case, including complete medical history, diagnostics, and concomitant medications.  This case will be reassessed once additional information is available.  The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.",,,,,,,,,Y,12/28/2020,12/28/2020,0.0,,PVT,,AIMOVIG;  ; BENADRYL; TRAZODON,,Medical History/Concurrent Conditions: Migraine,,USPFIZER INC2021008029,2,01/11/2021,,Y,,,True
1219,936423,01/12/2021,FL,,,,F,,"to get Botox injection for her Dystonia; got her 1st dose of Covid vaccine last 04Jan and was scheduled to have her 2nd dose on 22Jan; This is a spontaneous report from a Pfizer-sponsored program. A contactable consumer(patient) reported that a 62-year-old female received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 04Jan2021 at single dose for covid-19 immunization. The patient medical history and concomitant medications were not reported. The patient got her 1st dose of Covid vaccine last 04Jan2021 and was scheduled to have her 2nd dose on 22Jan2021, but she had an appointment 2 days prior this to get botulinum toxin type a (BOTOX) injection for her Dystonia. The patient wanted to know if it's ok for her to get 2nd dose of Covid vaccine after getting botulinum toxin type A. Outcome of the events was unknown.",,,,,,,,,U,01/04/2021,,,,UNK,,,,,,USPFIZER INC2021008052,2,01/11/2021,,,,,True
1221,936446,01/12/2021,NY,,,,M,,"received first dose of covid vaccine on 19Dec2020 tested positive on 31Dec2020; received first dose of covid vaccine on 19Dec2020 tested positive on 31Dec2020; This is a spontaneous report from a contactable other HCP (patient). A male patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE) , via an unspecified route of administration on 19Dec2020 at the first single dose for covid-19 immunisation.  The patient medical history was not reported.  The patient's concomitant medications were not reported.  The patient received first dose of covid vaccine on 19Dec2020 tested positive on 31Dec2020.  The outcome of events was unknown.  Information about Lot/Batch has been requested.; Sender's Comments: A causal association between reported event and BNT162B2 cannot be excluded.",,,,,,,,,U,12/19/2020,12/31/2020,12.0,Test Date: 20201231; Test Name: Covid; Test Result: Positive,UNK,,,,,,USPFIZER INC2021008119,2,01/11/2021,,,,,True
1222,936452,01/12/2021,LA,,,,F,,"tested positive for covid19; tested positive for covid19; This is a spontaneous report from a contactable nurse (patient). A 22-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration on 21Dec2020 at single dose for COVID-19 immunization. The patient medical history and concomitant medications were not reported. The patient received vaccine 1st dose on 21Dec2020 and on 29Dec2020 she tested positive for covid19. She is coming up on 2nd dose on Friday (will be out of quarantine on the same day), she asked if she should get the vaccine. Her primary care physician advised her not to receive, within 30 days because there had been reports of people having reactions (ie: high fevers) to the vaccine. If she has a high fever she can't go to school. She asked if waiting 90 days make the vaccine not as effective and if she need to restart the series. The outcome of the events was unknown.  Information on the lot/batch number has been requested.; Sender's Comments: Test positive for covid19 found 7 day following the vaccination, no adequate effect of the suspect vaccine thus could be reasonably achieved to protect from the targeted infection/disease due to the very short time lag",,,,,,,,,U,12/21/2020,12/29/2020,8.0,Test Date: 20201229; Test Name: covid19; Test Result: Positive,UNK,,,,,,USPFIZER INC2021008163,2,01/10/2021,,,,,True
1226,936474,01/12/2021,,,,,F,,"she received the Pfizer-BioNTech Covid-19 Vaccine .She said she tested positive for Covid-19 after being exposed to someone infected with the virus last Christmas; she received the Pfizer-BioNTech Covid-19 Vaccine .She said she tested positive for Covid-19 after being exposed to someone infected with the virus last Christmas; after being exposed to someone infected with the virus; This is a spontaneous report from a contactable Physician (patient). A female patient of an unspecified age receive the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) , via an unspecified route of administration on 18Dec2020 at single dose for covid-19 immunization. The patient's medical history and concomitant medications were not reported.  The patient she received the Pfizer-BioNTech Covid-19 Vaccine on 18Dec2020. She said she tested positive for Covid-19 after being exposed to someone infected with the virus last Christmas (25Dec2020). Now, she wanted to know if she can still take the 2nd dose. The outcome of the events was unknown.  Information on the Lot/Batch number has been requested.; Sender's Comments: A causal association between reported event and BNT162B2 cannot be excluded.",,,,,,,,,U,12/18/2020,12/25/2020,7.0,Test Name: Covid-19; Test Result: Positive,UNK,,,,,,USPFIZER INC2021008283,2,01/11/2021,,,,,True
1227,936478,01/12/2021,MT,64.0,,,F,,"tested positive for covid; tested positive for covid; This is a spontaneous report from a contactable consumer received from a Pfizer-sponsored program Pfizer First Connect. A 64-years-old female patient  received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number EH9899, expiry date Mar2021, NDC 59267-1000-1), intramuscular in right arm on 18Dec2020 11:45 at a single dose as prevention. The vaccine was administered in the hospital. Medical history included ongoing cardiomyopathy diagnosed about 32 years ago  and had pacemaker defibrillator Placed about 12 years ago. There were no concomitant medications. She was supposed to get the second dose of the Covid vaccine but she was positive for Covid. She found out she was positive for covid on Monday 04Jan2021 after she had a nasal swab test on 02Jan2020.  The outcome of the event was unknown.",,,,,,,,,U,12/18/2020,01/04/2021,17.0,Test Date: 20210102; Test Name: covid/nasal swab test; Test Result: Positive,PVT,,,Cardiac pacemaker insertion (Placed about 12 years ago.); Cardiomyopathy (Diagnosed about 32 years ago.),,,USPFIZER INC2021008296,2,01/11/2021,,,,,True
1230,936525,01/12/2021,,,,,F,,"recently got vaccinated unwillingly knowing she had Covid; recently got vaccinated unwillingly knowing she had Covid; This is a spontaneous report from a contactable Other healthcare professional (HCP) reporting for herself. A female patient of an unspecified age received her first dose BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on an unspecified date at single dose for covid-19 immunization. The patient's medical history and concomitant medications were not reported. The patient recently got vaccinated unwillingly knowing she had covid on an unspecified date. The patient wanted to known if she should get her second dose still and in the same timely manner. The outcome of the events was unknown. Information on the lot/batch number has been requested.; Sender's Comments: Based on available information, a possible contributory role of suspect BNT162B2 cannot be completely excluded for reported event.",,,,,,,,,U,,,,,UNK,,,,,,USPFIZER INC2021008724,2,01/11/2021,,,,,True
1235,936582,01/12/2021,,,,,F,,"got Covid/She tested positive for SARS-Cov-2 04JAN2021; got Covid; This is a spontaneous report from a contactable other healthcare professional (patient). A female patient of an unspecified age received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 21Dec2020 at single dose for covid-19 immunization. The patient's medical history and concomitant medications were not reported. The patient indicated she received her first dose of vaccine 21Dec2020.  She tested positive for SARS-Cov-2 04Jan2021.  She was asking how she ""got Covid"" and if she should receive the second dose. The outcome of the event was unknown.   Information on Lot/Batch number has been requested.; Sender's Comments: The reported tested positive for SARS-Cov-2 after COVID-19 immunization is considered ineffective of BNT162B2, and the Company cannot completely exclude the possible causality between the reported event and BNT162B2 administration.",,,,,,,,,U,12/21/2020,01/04/2021,14.0,Test Date: 20210104; Test Name: SARS-Cov-2; Test Result: Positive,UNK,,,,,,USPFIZER INC2021010564,2,01/11/2021,,,,,True
1237,936612,01/12/2021,CA,51.0,,,F,,"anaphylaxis; throat tightening; throat tightening/tingling; throat tightening/tingling/soreness; dry wheezy cough a little dizziness; dizziness; tachycardia; Itching; chills; numb R foot; Low grade temp; h/a today; This is a spontaneous report from a contactable Nurse (patient). A 51-years-old female patient (no pregnant) started to receive bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number el3248), via an unspecified route of administration on 06Jan2021 11:00 at the first single dose at left arm for covid-19 immunisation.  Medical history included supraventricular tachycardia, adrenal insufficiency, hypothyroidism, attention deficit hyperactivity disorder, hypermobility syndrome, developmental hip.  Concomitant medication included hydrocortisone, trazodone, levothyroxine sodium (LEVOTHROID), bupropion hydrochloride (WELLBUTRIN).  The patient previously took erythromycin, morphine and experienced drug hypersensitivity.  The patient experienced anaphylaxis, throat tightening/tingling/soreness, dry wheezy cough a little dizziness and tachycardia. Itching, numb R foot, Low grade temp and chills and headache on 06Jan2021 11:15. Seriousness criteria reported as life threatening. Taken to ER had IV benadryl, solumedrol, pepcid for anaphylaxis. Placed on O2 and given albuterol nebulizer. Had IV fluid bolus. Now on benadryl and 5 days of prednisone. The patient felt completely fine prior to vaccine. The patient underwent lab tests and procedures which included sars-cov-2 test: negative on 06Jan2021.  The outcome of events was recovering. No other vaccine in four weeks; No covid prior vaccination.; Sender's Comments: A possible causal association between administration of BNT162B2 and the onset of anaphylaxis presented as throat tightening/tingling/soreness, dry wheezy cough a little dizziness and tachycardia. Itching, numb R foot, Low grade temp and chills and headache cannot be excluded, considering the plausible temporal relationship and the known adverse event profile of the suspect product.  The underlying predisposing condition of drug allergies may put the patient at high risk of anaphylactic reactions. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.",,,Y,,,,,,N,01/06/2021,01/06/2021,0.0,Test Date: 20210106; Test Name: Nasal Swab; Test Result: Negative,PVT,,;  ; LEVOTHROID; WELLBUTRIN,,Medical History/Concurrent Conditions: ADHD; Adrenal insufficiency; Congenital hip dislocation; Hypermobility syndrome; Hypothyroidism; Paroxysmal supraventricular tachycardia,,USPFIZER INC2021011058,2,01/11/2021,,,Y,,True
1240,936621,01/12/2021,MT,,,,U,,"patient with covid between their first and second doses of the covid vaccine; patient with covid between their first and second doses of the covid vaccine; This is a spontaneous report from a Pfizer sponsored program IBCC (Inbound Call Center for HCPs). A contactable pharmacist reported similar events for two patients. This is the first case out of 2 cases. A patient of unspecified age and gender received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EK9231, expiration date: Apr2021, NDC#59267-1000-1), via an unspecified route of administration on an unspecified date at single dose for covid-19 immunization. The patient's medical history and concomitant medications were not reported. The patient with Covid between the first and second doses of the Covid vaccine on an unspecified date. The reporting pharmacist wanted to know if the patients with covid between their first and second doses of the covid vaccine what their risk would be, Reportedly 2 different patient. The outcome of the events was unknown.; Sender's Comments: The association between the event lack of effect (COVID between first and second dose) with BNT162b2 can not be fully excluded.  The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to regulatory authorities, Ethics Committees, and Investigators, as appropriate.,Linked Report(s) : US-PFIZER INC-2021011471 same reporter/drug/event, different patient..",,,,,,,,,U,,,,,UNK,,,,,,USPFIZER INC2021011515,2,01/11/2021,,,,,True
1241,936625,01/12/2021,CA,,,,U,,"tested positive and also received the vaccine from COVID-19; tested positive and also received the vaccine from COVID-19; This is a spontaneous report from a Pfizer sponsored program. This contactable physician reported similar events for the physician herself and a patient. This is the second report, the patient report of 2 reports.  A patient of unspecified age and gender received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on an unspecified date at single dose for covid-19 immunization. The patient medical history and concomitant medications were not reported. The physician reported there was another person in her clinic that tested positive and also received the COVID vaccine on an unspecified date with outcome of unknown.    The information on the batch number has been requested.; Sender's Comments: Based on the information currently available, a lack of efficacy with the suspected vaccine BNT162B2 in this patient cannot be completely excluded.  Further information like confirmative virus genome /nucleic acid detection needed for meaningful medical assessment.,Linked Report(s) : US-PFIZER INC-2021000799 Same reporter, same drug, different patients",,,,,,,,,U,,,,Test Name: COVID; Test Result: Positive,UNK,,,,,,USPFIZER INC2021011634,2,01/10/2021,,,,,True
1242,936642,01/12/2021,,,,,U,,"did develop COVID that week probably symptoms in general by 25Dec/probably infected whenever got the vaccine; did develop COVID that week probably symptoms in general by 25Dec/probably infected whenever got the vaccine/I don't feel very well right now; This is a spontaneous report from a contactable consumer (patient). A patient of unspecified age and gender received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EJ1685), via an unspecified route of administration on 21Dec2020 at single dose for covid-19 immunization. The patient's medical history and concomitant medications were not reported. The patient received 1st vaccine on 21Dec2020. The patient did develop COVID that week probably symptoms in general by 25Dec2020. She was probably infected whenever she got the vaccine and the patient was scheduled to have second vaccine on 11Jan2021 which was next Monday and the patient was still sick, should the patient delayed that. The patient also did not feel very well on an unknown date (""right now""). The outcome of the events was not recovered.",,,,,,,,,N,12/21/2020,12/25/2020,4.0,,UNK,,,,,,USPFIZER INC2021012901,2,01/10/2021,,,,,True
1243,936647,01/12/2021,,,,,M,,"had covid after his first dose; had covid after his first dose; headaches; This is a spontaneous report from a Pfizer-sponsored program Pfizer First Connect from a contactable Physician. A male patient of an unspecified age received his first single dose of BNT162B2 (Pfizer/ BioNTech Covid-19 vaccine) on an unspecified date in Dec2020 for Covid-19 immunization. The patient previously had Covid in Apr2020. Concomitant medications were not reported. After his first dose of vaccine, in Dec2020, the patient had Covid and headaches. The outcome of the events was unknown. Information on the lot/batch number has been requested.; Sender's Comments: The reported ""had Covid"" after COVID-19 immunization is considered ineffective of BNT162B2, and the Company cannot completely exclude the possible causality between the reported event and BNT162B2 administration.",,,,,,,,,U,12/01/2020,12/01/2020,0.0,,UNK,,,,Medical History/Concurrent Conditions: COVID-19 (Caller mentioned he had covid last April.),,USPFIZER INC2021014039,2,01/11/2021,,,,,True
1280,938050,01/12/2021,PA,76.0,,,M,,"mild elevation of his sed rate and leukocytosis; mild elevation of his sed rate and leukocytosis; myalgia (was reported as worsened); Arthralgia; Ten days later and still having pain/started in neck and migrated to his back, the buttocks and gluteal and quadriceps area; Ten days later and still having pain/started in neck and migrated to his back, the buttocks and gluteal and quadriceps area; Ten days later and still having pain/started in neck and migrated to his back, the buttocks and gluteal and quadriceps area; Ten days later and still having pain/started in neck and migrated to his back, the buttocks and gluteal and quadriceps area; This is a spontaneous report from a contactable physician (patient). A 76-years-old male patient received bnt162b2 (Pfizer-Biontech Covid-19 Vaccine), via an unspecified route of administration on 23Dec2020 at single dose on deltoid Right for covid-19 immunisation. Medical history included ongoing type 2 diabetes mellitus (diagnosed about 8 years ago). There were no concomitant medications. Patient developed myalgia on 27Dec2020 and arthralgia on 28Dec2020. Patient also experience ten days later and still having pain/ started in neck and migrated to his back, the buttocks and gluteal and quadriceps area in Dec2020. He had labs a few days ago. He had a mild elevation of his sed rate and leukocytosis. Events myalgia and arthralgia considered serious due to medically significant. Outcome of events myalgia (was reported as worsened) and arthralgia was not recovered.   Information about batch/lot number has been requested.; Sender's Comments: Based on the time association, the events myalgia and arthralgia are possibly related to suspect bnt162b2 administration. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.",,,,,,,,,N,12/23/2020,12/01/2020,,Test Name: labs; Result Unstructured Data: Test Result:mild elevation of his leukocytosis; Test Name: labs; Result Unstructured Data: Test Result:Mild elevation,PVT,,,Type 2 diabetes mellitus (Diagnosed about 8 years ago),,,USPFIZER INC2021007413,2,01/12/2021,,,,,True
1281,938051,01/12/2021,IL,37.0,,,F,,"blood pressure increased and her pulse; blood pressure increased and her pulse; Chest pain; Numb fingers and later numb face; Mind fog; This is a spontaneous report from a contactable other HCP. This 37-year-old female other HCP (patient) reported that she received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: 1685), via intramuscular at left arm on 02Jan2021 08:15 AM at single dose for COVID-19 immunization. Facility type of vaccine was pharmacy or drug store. Medical history included panic disorder (last attack 2 years prior) and known allergies: latex, Iodine dye. Concomitant medications were not reported. No other vaccine in four weeks. No covid prior vaccination. No covid tested post vaccination. On 02Jan2021 08:15 AM, within a few minutes while still under observation at pharmacy, her blood pressure increased and her pulse. Numb fingers and later numb face. Chest pain presented. She went to ER (emergency room) 3hours later with ongoing symptoms that never resolved until 6 or 7 that evening while still in ER waiting room. Mind fog (02Jan2021 08:15 AM) was currently ongoing. The treatment for events included lorazepam (ADIVAN), diphenhydramine (BENADRYL), ibuprofen. Outcome of event mind fog was not recovered, and the rest of events was recovered/resolved with sequel.; Sender's Comments: Based on the compatible temporal association, the vaccination with BNT162B2 might play a contributory role in triggering the onset of the reported events. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.",,,,,,,,,N,01/02/2021,01/02/2021,0.0,Test Date: 20210102; Test Name: blood pressure; Result Unstructured Data: Test Result:increase; Test Date: 20210102; Test Name: pulse; Result Unstructured Data: Test Result:increase and my pulse,PHM,,,,Medical History/Concurrent Conditions: Iodine contrast media allergy; Latex allergy; Panic disorder (last attack 2 years prior),,USPFIZER INC2021007498,2,01/11/2021,,,Y,,True
1283,938053,01/12/2021,,,,,U,,"aware of 6 cases of Bell's Palsy by the companies making these vaccines; This is a spontaneous report from a contactable Other HCP. This Other HCP reported similar events for 6 patients. This is 1st of 6 reports.   A patient of unspecified age and gender received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on an unspecified date at single dose for covid-19 immunisation. The patient medical history was not reported. The patient's concomitant medications were not reported. The reporter reported since the use of modified RNA in covid vaccines,he/she had aware of 6 cases of Bell's Palsy by the companies making these vaccines since an unknown date. The event outcome was unknown.  Information on the lot/batch number has been requested.; Sender's Comments: Bell's Palsy is not uncommon in general population. The information provided in this case is limited and does not allow a full medically meaningful assessment. The case will be reassessed should additional information become available. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics committees and Investigators, as appropriate.,Linked Report(s) : US-PFIZER INC-2021009409 Different patient, same drug/event.;US-PFIZER INC-2021009412 Different patient, same drug/event.;US-PFIZER INC-2021009410 Different patient, same drug/event.;US-PFIZER INC-2021009411 Different patient, same drug/event.;US-PFIZER INC-2021009408 Different patient, same drug/event.",,,,,,,,,U,,,,,UNK,,,,,,USPFIZER INC2021007605,2,01/11/2021,,,,,True
1286,938056,01/12/2021,KS,64.0,,,F,,"Her INR was 5.8 (normal range 1 to 2)/increasing INR; Scratched arm; Scratched arm and bled through 3 shirts, it kept bleeding; This is a spontaneous report from a contactable nurse (patient). A 64-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) (lot number EC1284), via an unspecified route of administration administered to left arm/deltoid on 29Dec2020 13:15 at single dose for COVID-19 immunization at a research medical facility; and received warfarin sodium (COUMADIN, strength 2 mg), oral (by mouth) from an unspecified date in 2017 and ongoing at ""3 1/2 tablets once daily in the evening at 5:30pm (total 7mg)"" for metal heart valve. The patient's medical history included had the surgery (for her metal heart valve), about 01Mar in 2017 (about 4 years ago) and so she thought she had been on Coumadin for about 4 years, had been on the 7mg dose for over a year; and has a history of metal heart valve and takes Coumadin for the metal heart valve. Denied illness. Denied family medical history relevant to event. There were no concomitant medications. The patient previously received Shingrix vaccine in past and remenbered she had the usual side effects from it, had mild symptoms. History of all previous immunization with the Pfizer vaccine considered as suspect was none. The patient did not receive any other vaccines the same date of the Pfizer Suspect or 4 weeks prior. On Jan2021, the patient experienced scratched arm and bled through 3 shirts, it kept bleeding. On 04Jan2021, her international normalised ratio (INR) was 5.8 (normal range 1 to 2). The events did not lead to emergency room visit, however led to physician office visit. The events were reported as serious medically significant. The nurse got the first Pfizer COVID-19 shot on 29Dec2020 because she is a healthcare provider. She wanted information on increasing INR. The nurse has a history of metal heart valve and takes Coumadin. Her INR was typically 1.7 to 2.3. She reported her last INR, before the covid-19 vaccine was given, was ""some time ago"" but it had not varied much over the years. Normally she got her INR run and it was about 2.  She had to be scheduled for her INR on the 04Jan2021 and it was 5.8 (normal range 1 to 2) and they asked about anything that may have changed and the only thing was that she got her first shot. The nurse reported not having any changes in her medications, food, or life style to account for the change, other than receiving the COVID-19 vaccine. The patient stated that it could be a serious problem if she had an accident or fell and started bleeding. A normal person's lab result is between 1 and 2, but they like to keep people with the metal heart valves between 2 and 3. She had been bleeding. She had barely scratched her arm the other day and went through 3 shirts because she kept bleeding. This is more than unusual for her, it's kind of unusual.  Getting the vaccine is the only variant she has had since getting her last INR. The patient underwent lab tests and procedures which included INR (normal range 1 to 2): typically 1.7 to 2.3 on an unspecified date; it's about 2 on an unspecified date: and 5.8 on 04Jan2021. The action taken in response to the events for warfarin sodium was dose not changed. The outcome of the event INR was 5.8 was not recovered, for the other events was unknown. The nurse (patient) assessed the event ""INR was 5.8; it's normally about 2"" as related to the COVID-19 vaccine.; Sender's Comments: Based on available information, a possible contributory role of the subject product, BNT162B2 vaccine, cannot be excluded for the reported events of International normalised ratio increased and wound hemorrhage due to temporal relationship.  There is limited information provided in this report.  Additional information is needed to better assess the case, including complete medical history, diagnostics coagulation panel, counteractive treatment measures and concomitant medications.  This case will be reassessed once additional information is available.  The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.",,,,,,,,,N,12/29/2020,01/01/2021,3.0,Test Name: INR; Result Unstructured Data: Test Result:1.7 to 2.3; Comments: typically 1.7 to 2.3; Test Name: INR; Result Unstructured Data: Test Result:2; Comments: it's about 2; Test Date: 20210104; Test Name: INR; Result Unstructured Data: Test Result:5.8,UNK,,,,Medical History/Concurrent Conditions: Heart valve disorders (Coumadin for a metal heart valve); Heart valve operation (had the surgery (for her metal heart valve) on Coumadin for about 4 years),,USPFIZER INC2021008190,2,01/11/2021,,Y,,,True
1287,938057,01/12/2021,NY,37.0,,,F,,"Dizziness; palpitations; resting tachycardia that persisted for 3 days; muscles aches; Chills; Restlessness; feeling unwell; arm pain; This is a spontaneous report from a contactable physician reported for herself. This 37-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: Ek5730) via intramuscular on 23Dec2020 09:30 AM on left arm at single dose for COVID-19 immunisation. Medical history included chronic kidney disease, HTN (hypertension), persistent proteinuria. No known allergies. Concomitant medication included losartan. The patient did not have other vaccine in four weeks and did not diagnosed with COVID-19 prior to vaccination. The patient was not pregnant at the time of vaccination. On 24Dec2020, the patient experienced dizziness, palpitations, resting tachycardia that persisted for 3 days, muscles aches, chills, restlessness, feeling unwell and arm pain, and resulted in Emergency room/department or urgent care. Treatment included paracetamol (TYLENOL). The patient had COVID tested on 28Dec2020 post vaccination, covid test type post vaccination=Nasal Swab, covid test name post vaccination=PCR, covid test result=Negative. Outcome of events was recovered.; Sender's Comments: The reported events dizziness, palpitations, resting tachycardia that persisted for 3 days, muscles aches, chills, restlessness, feeling unwell and arm pain, were likely related to the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) due to temporal relationship and clinical course.  The case will be reassessed should additional information become available.  The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics committees and Investigators, as appropriate.",,,,,,,,,Y,12/23/2020,12/24/2020,1.0,Test Date: 20201228; Test Name: COVID tested/Nasal Swab/PCR; Test Result: Negative,PVT,,,,Medical History/Concurrent Conditions: Chronic kidney disease; Hypertension; Proteinuria,,USPFIZER INC2021008229,2,01/12/2021,,,Y,,True
1292,938062,01/12/2021,LA,39.0,,,F,,"The numbness began to intensify and I could not feel myself blinking or smiling on the left side of my face; pain and numbness to my left ear and left jaw that began to spread down my left jaw and upward across my left cheek, left eye, and left temple, and above my left eyebrow; pain and numbness to my left ear and left jaw that began to spread down my left jaw and upward across my left cheek, left eye, and left temple, and above my left eyebrow; pain and numbness to my left ear and left jaw that began to spread down my left jaw and upward across my left cheek, left eye, and left temple, and above my left eyebrow; pain and numbness to my left ear and left jaw that began to spread down my left jaw and upward across my left cheek, left eye, and left temple, and above my left eyebrow; pain and numbness to my left ear and left jaw that began to spread down my left jaw and upward across my left cheek, left eye, and left temple, and above my left eyebrow; This is a spontaneous report from a contactable nurse reported for herself. A 39-years-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) (lot number EL0142) via an unspecified route of administration on 07Jan2021 07:00 at single dose for covid-19 immunization. Vaccine location was left deltoid. The facility type vaccine was Workplace Clinic. Medical history included food allergy at shrimp. Concomitant medications were not reported. The patient did not received any other vaccines within 4 weeks prior to the COVID vaccine. On 07Jan2021 at 07:15 AM the patient notice pain and numbness to her left ear and left jaw that began to spread down left jaw and upward across left cheek, left eye, and left temple, and above left eyebrow. The numbness began to intensify and patient could not feel herself blinking or smiling on the left side of my face. The numbness slowly began improving over the next hour in the same order that it began, but she still have mild left ear and jaw pain and mild numbness. Events outcome are recovering. No treatment was received. The action taken was not applicable.; Sender's Comments: Based on the compatible time association, the facial palsy is possibly related to suspect BNT162B2 administration. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.",,,,,,,,,N,01/07/2021,01/07/2021,0.0,,WRK,,,,Medical History/Concurrent Conditions: Fish allergy,,USPFIZER INC2021010361,2,01/12/2021,,,,,True
1293,938063,01/12/2021,AZ,45.0,,,M,,"Burst blood vessel in left eye 24 hours after vaccine was given.; This is a spontaneous report from a contactable other-HCP. A 45-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) lot number not available, via an unspecified route of administration on 21Dec2020 07:45 AM  at single dose for covid-19 immunization. Vaccine location was left deltoid. The patient did not received any other vaccines within 4 weeks prior to the COVID vaccine. Medical history included morbid obesity and blood pressure high. No known allergies. Patient didn't do relevant test. Concomitant medication included amlodipine (AMLODIPINE) at 5mg daily. The patient experienced burst blood vessel in left eye 24 hours after vaccine was given (eye haemorrhage) on 22Dec2020 08:30 with outcome of recovered. No treatment received. The action taken in response to the event for BNT162B2 was not applicable. Information on the lot/batch number has been requested.; Sender's Comments: Based on the available information, the company considers that a causal relationship between the eye haemorrhage and vaccination with BNT162B2 cannot be excluded. The impact of this report on the benefit/risk profile of the Pfizer drug is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.",,,,,,,,,Y,12/21/2020,12/22/2020,1.0,,PUB,,,,Medical History/Concurrent Conditions: Blood pressure high; Morbid obesity,,USPFIZER INC2021010414,2,01/11/2021,,,,,True
1294,938064,01/12/2021,MT,54.0,,,M,,"Had ruptured blood vessels x 2 spontaneously in eyes; This is a spontaneous report from a contactable nurse reported for herself. A 54-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) (lot number EK5730), via an unspecified route of administration on 17Dec2020 03:00 P.M at single dose for covid-19 immunization. The facility type vaccine was: workplace clinic. Medical history included manifesting carrier BMD (Becker's muscular dystrophy). Allergies to medication: allergies rash on Sulfa. The patient did not received any other vaccines within 4 weeks prior to the COVID vaccine. Concomitant medication included pregabalin (LYRICA), duloxetine hydrochloride (DULOXETINE [DULOXETINE HYDROCHLORIDE]). The patient experienced ruptured blood vessels x 2 spontaneously in eyes (eye haemorrhage) on 18Dec2020 with outcome of recovered. No treatment received. The action taken in response to the event for BNT162B2 was not applicable.; Sender's Comments: Based on the available information, the company considers that a causal relationship between the eye haemorrhage and vaccination with BNT162B2 cannot be excluded. The impact of this report on the benefit/risk profile of the Pfizer drug is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.",,,,,,,,,Y,12/17/2020,12/18/2020,1.0,,WRK,,LYRICA; DULOXETINE [DULOXETINE HYDROCHLORIDE],,Medical History/Concurrent Conditions: Becker's muscular dystrophy,,USPFIZER INC2021010524,2,01/11/2021,,,,,True
1295,938065,01/12/2021,LA,62.0,,,F,,"some congestion that just came on; her arm was really aching after the injection; she started coughing; voice was hoarse; light wheeze; soles of her feet were hurting; pressure in bilateral groin; aching all over; very tired; balance issues; This is a spontaneous report from a contactable nurse (patient).  A 62-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/lot number: EK9231) intramuscularly in left upper arm on 05Jan2021 at single dose for covid-19 immunisation. The patient got her Covid vaccine yesterday (05Jan2021) around 11 or 11:30 am in her left upper arm. She had bilateral breast cancer and had lymph nodes removed in each arm but more removed from her Right, so she got the vaccine in the left arm. She also had some skin cancers removed, one would not heal properly on her left arm and formed a blister, and her dermatologist popped it and put a band aid on it. The vaccine was given 3 inches above it. The patient's concomitant medications were not reported.  The patient experienced pressure in bilateral groin, aching all over, very tired and balance issues on 05Jan2021; light wheeze on 06Jan2021. Seriousness for these events was medically significant. The patient stated she had some congestion that just came on. She felt fine yesterday (05Jan2021) right after getting the vaccine, that at work she did notice that there was something different feeling in the left side of her groin. She was not in direct patient care. She noticed on her left side in the groin, something felt different, then yesterday evening (05Jan2021) after work she was really tired in the evening, aching all over last night, even the soles of her feet were hurting, woke up like her balance was off, she would walk one way and go another, states it is not like an orthostatic issue, that she knows what that feels like. She stated that in her inguinal area she could feel pressure, bilaterally. Her arm was really aching after the injection. Her breathing, heard a light wheezing, was clearing her voice, and then she started coughing, voice was hoarse.  The outcome of events pressure in bilateral groin, very tired and light wheeze was not recovered; of events aching all over and balance issues was recovering; of other events was unknown.; Sender's Comments: The reported events bilateral groin, aching all over, very tired, balance issues and light wheeze were possibly related to the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), due to temporal relationship.  The case will be reassessed should additional information become available.  The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics committees and Investigators, as appropriate.",,,,,,,,,N,01/05/2021,01/05/2021,0.0,,UNK,,,,Medical History/Concurrent Conditions: Blister; Breast cancer female (she had bilateral breast cancer and had lymph nodes removed in each arm but more removed from her Right); Lymph node excision (she had bilateral breast cancer and had lymph nodes removed in each arm but more removed from her Right); Skin cancer excision (some skin cancers removed),,USPFIZER INC2021010550,2,01/12/2021,,,,,True
1298,938068,01/12/2021,CA,46.0,,,M,,"patient developed acute onset of right-sided facial palsy and pain; patient developed acute onset of right-sided facial palsy and pain; Brain MRI done showing T2 hyperintensity in the brainstem and basal ganglia, suspicious for inflammation; This is a spontaneous report from a contactable physician.   A 46-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), on 18Dec2020 at SINGLE DOSE for COVID-19 immunization. Medical history included psoriasis. No COVID prior vaccination. It was unknown if the patient received any other vaccines within 4 weeks prior to the COVID vaccine.No known allergies. Concomitant medications (received within 2 weeks of vaccination) included fluoxetine. days following vaccination,on 23Dec2020,the patient developed acute onset of right-sided facial palsy and pain. Brain MRI done showing T2 hyperintensity in the brainstem and basal ganglia, suspicious for inflammation. Work-up is ongoing. AE Resulted in: Doctor or other healthcare professional office/clinic visit, Emergency room/department or urgent care, Disability or permanent damage].It was unknown if the event was treated. The event was assessed as serious for Disabling/Incapacitating. The patient had been tested for COVID post vaccination (covid test result-Negative). The outcome of the events werenot recovered    Information about lot/batch number has been requested.; Sender's Comments: A possible causal relationship between acute onset of right-sided facial palsy and pain with MRI findings suspicious for brain inflammation and BNT162B2 cannot be completely ruled out considering the temporal relationship.  The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.",,,,,,,,Y,N,12/18/2020,12/23/2020,5.0,"Test Date: 20201223; Test Name: MRI; Result Unstructured Data: Test Result:T2 hyperintensity; Comments: Brain MRI done showing T2 hyperintensity in the brainstem and basal ganglia, suspicious for inflammation; Test Name: COVID-19; Result Unstructured Data: Test Result:Negative",UNK,,,,Medical History/Concurrent Conditions: Psoriasis,,USPFIZER INC2021010625,2,01/12/2021,,,Y,,True
1317,938097,01/12/2021,,,,,U,,"died; This is a spontaneous report from a non-contactable consumer via a Pfizer-sponsored program. A patient of unspecified age and gender received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, via an unspecified route of administration on an unspecified date at single dose for covid-19 immunisation. The patient medical history and concomitant medications were not reported. It was reported the patient was a doctor, died after the vaccine with no apparent disease. It was not reported if an autopsy was performed.  No follow-up attempts are possible. Information about lot/batch number cannot be obtained.; Reported Cause(s) of Death: Unknown cause of death",Y,,,,,,,,N,,,,,UNK,,,,,,USPFIZER INC2021017780,2,01/12/2021,,,,,True
1360,939398,01/13/2021,,,,,F,,"got the covid 19 vaccine on 29Dec2020 and tested positive for covid on 05Jan2021; got the covid 19 vaccine on 29Dec2020 and tested positive for covid on 05Jan2021; This is a spontaneous report from a contactable nurse (patient). A female patient of an unspecified age (reported as ""Age-48, Unit-Unknown"") received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 29Dec2020 at single dose for COVID-19 immunization. The patient medical history and concomitant medications were not reported. The patient stated she got the covid 19 vaccine on 29Dec2020 and tested positive for covid on 05Jan2021. She wanted to know what to do about the second dose of the vaccine.   Information about Lot/batch number has been requested.",,,,,,,,,U,12/29/2020,01/05/2021,7.0,Test Date: 20210105; Test Name: covid; Test Result: Positive,UNK,,,,,,USPFIZER INC2021008153,2,01/12/2021,,,,,True
1362,939401,01/13/2021,,53.0,,,F,,"anaphylactic reaction; arm was really sore; tiredness; dizzy; This is a spontaneous report from a contactable other health professional (patient). A 53-year-old female patient received bnt162b2 (Pfizer-biontech covid-19 vaccine), via an unspecified route of administration on 31Dec2020 at single dose for covid-19 immunization. Medical history included shellfish allergy. The patient's concomitant medications were not reported. The patient experienced anaphylactic reaction on an unspecified date, dizzy on 31Dec2020, arm was really sore on an unspecified date, tiredness on an unspecified date. Event details: She was dizzy that day especially with changing positions, she didn't need to go to the doctor or anything. It wasn't severe. She was just a little dizzy. It's probably just the vaccine and it did go away. Her arm was really sore and went away after a few days. the tiredness, it wasn't a big deal. She did feel better about. it wasn't a serious anaphylactic reaction. It didn't happen right away. She had arm soreness. it wasn't immediate. She usually didn't have. It was really weird. She thought she was well hydrated. The outcome of event was really sore was resolved, outcome of other events was unknown.   Information on the Lot/Batch number has been requested.; Sender's Comments: Based on available information, a possible contributory role of the subject product, BNT162B2 vaccine, cannot be excluded for the anaphylactic reaction and other reported events due to temporal relationship.  There is very limited information provided in this report.  Additional information is needed to better assess the case, including complete medical history, diagnostics, counteractive treatment measures and concomitant medications.  This case will be reassessed once additional information is available.  The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.",,,,,,,,,Y,12/31/2020,12/31/2020,0.0,,UNK,,,,Medical History/Concurrent Conditions: Shellfish allergy,,USPFIZER INC2021008243,2,01/11/2021,,,,,True
1370,939501,01/13/2021,,,,,F,,"positive with covid; positive with covid; sinus strainagned at the back of the throat.; sinus strainagned at the back of the throat.; This is a spontaneous report from a contactable nurse. A female patient of an unspecified age started to receive BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot# unknown), via an unspecified route of administration on an unspecified date single dose for COVID-19 immunisation. The patient medical history was not reported. The patient's concomitant medications were not reported. The patient experienced positive with COVID on an unspecified date, sinus strainagned at the back of the throat on an unspecified date. The outcome of the events was unknown. Information on the Batch/Lot number has been requested.; Sender's Comments: A causal association between reported ""positive with covid"" and suspect BNT162B2 cannot be excluded.",,,,,,,,,U,,,,Test Name: covid; Test Result: Positive,UNK,,,,,,USPFIZER INC2021010999,2,01/12/2021,,,,,True
1375,939629,01/13/2021,LA,79.0,79.0,,F,,"The patient presented to hospital on 1/6/2021 with a primary complaint of Fatigue (pt had covid vaccine yesterday. Now displaying increased weakness, blood in urine, increased confusion and urinated on herself today. Fever of 101.9 ) 79-year-old female presents to the emergency room with fatigue. The patient states yesterday she had the Moderna COVID-19 The patient states today she had a temperature 101.8 prior to arrival. Her son noted that she was having episodes of urinary frequency and also that she was profoundly weak and fatigued. They denied falling or hitting her head. The patient also states she been having nausea vomiting with diarrhea.",,,,,Y,1.0,,,Y,01/05/2021,01/06/2021,1.0,"Hgb 9.1, HCT 29.8, Gluc 113, K+ 5.4, Cr. 2.0, urine culture taken",PVT,,"Amlodipine 10mg/day, Eliquis 2.5mg/day, Cyanocobalamine 1000mg Gabapentin 300/day, Lisinopril, 40mg/day, Metformin 500mg XR/day, Lopressor 25mg/day, Zofran 4mg/day, Protonix 40mg/day","Anticoagulant use, arthritis, asthma, AFib, bacteremia, CHG, lLumbar fractures, COPD, DM, DVT, Abcess, lung CA, Lupus, MRSA, Osteoporosis, PVD, Psoriasis, Sjorgrens, stroke, venous insufficiency of leg",See extensive list,,,2,01/13/2021,,,,"Bactrim, Codeine, Methotrexate, PCN, Sulfamethox",True
1391,940791,01/13/2021,TX,39.0,,,M,,"severe stabbing-shooting lower back pain; severe stabbing-shooting lower back pain that radiated to both legs; Pricking, pins and needles sensations in the hands and feet; numbness; weakness to both legs but mostly the right leg; Coordination problems, unsteadiness; Coordination problems, unsteadiness; This is a spontaneous report from a contactable nurse (patient). A 39-year-old male patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/lot number: EL0140), intramuscular on 20Dec2020 08:00 at single dose at left arm for covid-19 immunization. Medical history included hypertension from an unknown date and unknown if ongoing. The patient's concomitant medications in two weeks included multivitamins. Patient didn't receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was not diagnosed with COVID-19 prior to vaccination. No known allergies to medications, food, or other products. On 22Dec2020 at approximately 19:15, the patient experienced sudden onset of severe stabbing-shooting lower back pain that radiated to both legs. Pricking, pins and needles sensations in the hands and feet. Coordination problems, unsteadiness, numbness, and weakness to both legs but mostly the right leg. The patient underwent lab tests and procedures post-vaccination which included nasal swab for covid test: negative on 30Dec2020 (Antigen Test). Adverse events resulted in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care, disability or permanent damage. Patient received pain medication, steroid dose pack, MRI (pending), and physical therapy (pending) as treatment. Outcome of all events was not recovered.; Sender's Comments: Based on the compatible temporal association, a contributory role of vaccination with BNT162B2 in the onset of the events cannot be excluded. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.",,,,,,,,Y,N,12/20/2020,12/22/2020,2.0,Test Date: 20201230; Test Name: nasal swab for covid test; Test Result: Negative  ; Comments: Antigen Test,PVT,,,,Medical History/Concurrent Conditions: Hypertension,,USPFIZER INC2021009989,2,01/12/2021,,Y,Y,,True
1393,940794,01/13/2021,VA,,,,F,,"First dose on 16Dec2020, second dose on 05Jan2021; Tinnitus; constant ringing in ears; louder this time; This is a spontaneous report from a contactable nurse (patient). A 51-year-old female patient (no pregnancy) received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), with first dose (lot number: EH9899) on 16Dec2020 via intramuscular route, with second dose (lot number: EK4176) on 05Jan2021 via an unspecified route of administration, both at single dose for covid-19 immunization. Medical history included allergies: penicillin. Concomitant medication included famotidine, ibuprofen (DUEXIS), iron (IRON) and multivitamins, all received within two weeks of vaccination. On 17Dec2020, the patient experienced tinnitus, constant ringing in ears that started 24 hours after first vaccine, lasted about 2-3 days and went away. Ringing in ears started again and is louder this time on 06Jan2021. Facility where the most recent COVID-19 vaccine was administered was in hospital. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. No treatment received for the adverse event. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The event was identified as serious and resulted in disability or permanent damage. The outcome of event tinnitus was not recovered. The outcome of the other event was unknown.; Sender's Comments: Based on the compatible temporal association with positive rechallenge result, the Company considers the event tinnitus is possibly related to vaccination with BNT162B2. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.",,,,,,,,Y,N,01/05/2021,12/17/2020,,,PVT,,DUEXIS;,,Medical History/Concurrent Conditions: Penicillin allergy,,USPFIZER INC2021010248,2,01/12/2021,,,,,True
1399,940809,01/13/2021,NY,61.0,,,M,,"left side will blur; Left side of face was sagging/ water leaking out of mouth/Progressive weakness on left side of face/ Swelling on lower left mandible/  diagnosed with Bell's Palsy.; Eye tearing; This is a spontaneous report from a contactable nurse who reported for himself. A 61-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Batch/lot number: EK5780) in  left arm on 26Dec2020 at 08:30 at single dose for covid-19 immunisation (worked in surgical ICU and was over 61 years old).  Medical history included Pre-diabetic. Family history included: mother died; mother's side had colon cancer and grandparents and uncles had cardiovascular diseases.Concomitant medication included exenatide (BYDUREON), amlodipine besilate (NORVASC), omeprazole (PROTONIX), hydrochlorothiazide, lisinopril and pneumococcal vaccine on 08Dec2020 and tetanus vaccine on 08Dec2020.  It was reported that on 31Dec2020 at 07:30, the patient had eye tearing and water leaking out of mouth, left side of face was sagging, swelling on lower left mandible (eye tearing was first, as reported); on 31Dec2020 he also experienced progressive weakness on left side of face; on 02Jan2021 the patient was diagnosed with Bell's Palsy. Then on an unknown date, left side will blur occurred. All events required emergency room visit and physician office visit. Diagnosis of  Bell's Palsy and event eye tearing were serious per disability; left side will blur was non serious. Patient described the events as follows: on 31Dec2020 he was brushing teeth and noticed the water was going everywhere. Left side of face was sagging, noticed some swelling and thought it was from a bug bite. He wasn't sure if it was a stroke or not. In the morning of 01Jan2021 noticed it was progressively causing a problem. Days before noticed tearing of left eye (as reported). On 31Dec2020 before midnight, something felt wrong. He saw four cases on clinical trial with similar side effects (he clarified he had no patient information for the four patients mentioned with similar side effects from Pfizer Clinical trial. He saw this information from a article; stated four from Pfizer and Moderna). In the morning of 02Jan202, he went to Emergency Room (ER) and was diagnosed with Bells Palsy. He was given prednisone 20mg to take 3 times by mouth every day for 5 days, tetracycline 100mg, at 1 capsule by mouth twice a day for 10 days and methylprednisolone (SOLU MEDROL; Lot: 9945776;Exp: Nov2021) 4mg dose pack, started with 6 tablets first day. It was told by doctor it might cause tick problems. He was waiting for results. On 04Jan2021 went to family doctor and more blood work was taken. Because he was taking prednisone, noticed his sugar was up a little bit (date unspecified). It was prescribed Glitizide extended release, 2.5mg one tablet twice a day with breakfast. Patient was checking sugar every 6 hours. It was also prescribed Acyclovir 400mg one tablet orally five times per day for 10 days. 08Jan2021 is last day of prednisone 5 day dose and will follow up with methylprednisolone tablets. Patient had an appointment with a neurologist on 13Jan2021. Patient was still having symptoms. It was really hard for him. Not hard to swallow. Face was still drooping. Eyes were still tearing. Could not work with eyes tearing all of the time. Needed to be alert. When driving, had to focus on the right side because his left side will blur. He had to chew only on the right side because food will be left behind in between his cheeks and gums. If he drank through a straw, he had to cover the left side of his lips so he was able to suck out fluids. He thought symptoms were progressively getting worse, he didn't see much improvement. He clarified swelling was on lower part of mandible on left side. It was slightly bigger than right. When looking at face, the lines on his forehead on the left side were down. If he smiled he cannot raise his left eye brow, when before the COVID-19 vaccine he could. Noticed left side of nose was lower than the right. Cannot raise left side of lips. Outcome of the event Eyes tearing and Bell's Palsy was not recovered; outcome of the other event was unknown. Information on the batch number has been requested.; Sender's Comments: Based on available information, a possible contributory role of the subject product, BNT162B2 vaccine, cannot be excluded for the reported events of Bell's palsy, Lacrimation increased  and vision blurred due to temporal relationship.  However,  the Bell's palsy may likely possibly  represent concurrent medical condition in this patient.  There is limited information provided in this report.  Additional information is needed to better assess the case, including complete medical history, diagnostics including head CT/MRI and viral serologies, counteractive treatment measures and concomitant medications.  This case will be reassessed once additional information is available.  The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.",,,,,,,,Y,N,12/26/2020,12/31/2020,5.0,Test Name: sugar; Result Unstructured Data: Test Result:was up a little bit; Test Date: 20210104; Test Name: blood work; Result Unstructured Data: Test Result:Unknown results,PVT,,BYDUREON; NORVASC; PROTONIX [OMEPRAZOLE];  ;,,"Medical History/Concurrent Conditions: Cardiovascular disease, unspecified (Grandparents and uncles); Colon cancer (Mother's side); Death of mother (Mother); Pre-diabetic",,USPFIZER INC2021013221,2,01/12/2021,,Y,Y,,True
1400,940810,01/13/2021,,,,,M,,"Bell's Palsy; This is a spontaneous report from a contactable nurse. A 33-year-old male patient received his first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on an unspecified date at single dose for covid-19 immunization. The patient medical history and concomitant medications were not reported. The reporter reported a patient developed Bell's Palsy after receiving the first dose of the vaccine. This patient was a physician, the reporter stated that the patient was scheduled to receive the second dose on Monday (unspecified date) and questioned if he should or should not get the second dose. The outcome of the event was unknown.  Information on the lot/batch number has been requested.; Sender's Comments: Based on temporal association, the causal relationship between bnt162b2 and the event facial paralysis cannot be excluded. The information available in this report is limited and does not allow a medically meaningful assessment. This case will be reassessed once additional information becomes available. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees, and Investigators, as appropriate.",,,,,,,,,U,,,,,UNK,,,,,,USPFIZER INC2021013352,2,01/13/2021,,,,,True
1401,940811,01/13/2021,CO,36.0,,,F,,"hearing loss; ringing and pulsating in her ears; Chills; Headache; This is a spontaneous report from a contactable consumer (patient). A 36-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/lot number: EK9231), via an unspecified route of administration in in the left arm on 04Jan2021 at single dose for covid-19 immunization. Medical history included ongoing acid reflux. The patient had no concomitant medications. The patient previous received the flu shot. The patient experienced hearing loss, ringing and pulsating in her ears on 05Jan2021, headache on 04Jan2021, chills on 05Jan2021. Treatment was none. She had the vaccine on Monday at work and some of the symptoms that she has had have not resolved. She was having ringing in her ears and hearing loss. Went to see them and had her ears looked at. Everything was normal. Got the vaccine on 04Jan2021. Ringing in ears and hearing loss: Had been very consistent with no improvement. If anything, it had worsened. She was going to re-contact her doctor. She was also going to ask, should she go on Prednisone or something. She was worried she was going to lose her hearing. Her doctor said that a hearing test may need to be done. History: Takes one medication that she has been taking for years. She has never had an adverse event to any vaccine before. She got the flu shot every year. She was expecting the chills and headache, but they resolved fast. The next vaccine was 25Jan2021, the patient was asked whether she should get the second dose. The outcome of events for hearing loss, ringing and pulsating in her ears was not resolved, for headache and chills was resolved on 06Jan2021.",,,,,,,,,N,01/04/2021,01/04/2021,0.0,,UNK,,,Acid reflux (esophageal),,,USPFIZER INC2021013829,2,01/13/2021,,,,,True
1405,940822,01/13/2021,GA,81.0,,,M,,"patient passed away after receiving the Covid vaccine; This is a spontaneous report from a contactable nurse.  An 81-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), intramuscular  into the right arm on 07Jan2021 at 0.3 mL, single for covid-19 immunization.  There was no medical history and no concomitant medications.  On 08Jan2021, the patient passed away after receiving the COVID vaccine.  The patient died on 08Jan2021.  An autopsy was not performed. Investigations indicate that unspecified labs were done, but nothing two weeks prior; no further details were provided. The patient received the first dose the day prior. The reporting nurse discussed it with the medical director, and he thought that he potentially passed away from the COVID vaccine. The relatedness of the event to the suspect vaccine was reported as related by the reporting nurse per The Agency.  The batch/lot number for the vaccine, BNT162B2, was not provided and will be requested during follow-up .; Sender's Comments: Based on the limited information available, it is medically not possible to make meaningful causality assessment, it is unlikely the vaccine could have contributed to the death of the patient based on the known safety profile. However case will be reevaluated when additional information is received during the follow-up  The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.; Reported Cause(s) of Death: Stated that the patient passed away after receiving the Covid vaccine",Y,01/08/2021,,,,,,,N,01/07/2021,01/08/2021,1.0,,UNK,,,,Comments: List of non-encoded Patient Relevant History: Patient Other Relevant History 1: None,,USPFIZER INC2021015752,2,01/12/2021,,,,,True
1408,940949,01/13/2021,WI,21.0,,,F,,"5 days after administration- heavy uterine bleeding; constipation; severe knee/shoulder joint pain; light sensitivity; dizziness/ light headedness; thigh numbness; pain when prodded on either sides of thighs; harsh headache; This is a spontaneous report from a contactable Other healthcare professional (patient). A 21-year-old female patient received BNT162B2 first dose on 31Dec2020 03:15 PM intramuscularly on left arm at single dose for COVID-19 immunization. Medical history included Depression, Anxiety, Factor V Leiden, Known allergies to Penicillin and Onion sensitivity. Patient is not pregnant. No other vaccine in four weeks. Concomitant medications in two weeks included unspecified medications. ""5 days after administration"" (also reported as 01Jan2021)- heavy uterine bleeding (resulting with trip to ER), constipation, severe knee/ shoulder joint pain, light sensitivity, dizziness/ light headedness, thigh numbness, pain when prodded on either sides of thighs, harsh headache. No treatment received for the events. Events resulted in ER and physician office visit. No covid prior vaccination. No covid tested post vaccination. The outcome of the events was not recovered. The seriousness was reported as no.   Information on the lot/batch number has been requested.; Sender's Comments: A possible contributory effect of suspect BNT162B2  on reported uterine bleeding cannot be excluded.  The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to regulatory authorities, Ethics Committees, and Investigators, as appropriate.",,,,,,,,,N,12/31/2020,01/01/2021,1.0,,UNK,,,,"Medical History/Concurrent Conditions: Anxiety; Depression; Factor V Leiden thrombophilia; Penicillin allergy (Allergies to medications, food, or other products:Penicillin and onion sensitivity); Vegetable allergy (Allergies to medications, food, or other products:Penicillin and onion sensitivity)",,USPFIZER INC2021010569,2,01/13/2021,,Y,Y,,True
1413,940955,01/13/2021,NY,66.0,,,F,,"Cardiac Arrest; Patient was found pulseless and breathless 20 minutes following the vaccine administration.; Patient was found pulseless and breathless 20 minutes following the vaccine administration.; This is a spontaneous report from a contactable other healthcare professional (HCP). A 66-year-old female patient (pregnant at the time of vaccination: no) received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL1284) via intramuscular at left arm on 11Jan2021 12:15 PM at single dose for COVID-19 immunization. Medical history included diastolic CHF, spinal stenosis, morbid obesity, epilepsy, pulmonary hypertension and COVID-19 (Prior to vaccination, the patient was diagnosed with COVID-19). The patient received medication within 2 weeks of vaccination included amiodarone, melatonin, venlafaxine hydrochloride (EFFEXOR), ibuprofen, aripiprazole (ABILIFY), lisinopril, cranberry capsules, diltiazem, paracetamol (TYLENOL), famotidine, furosemide (LASIX [FUROSEMIDE]), ipratropium bromide, salbutamol sulfate (IPRATROPIUM/ALBUTEROL), buspirone, senna alexandrina leaf (SENNA [SENNA ALEXANDRINA LEAF]), polyethylene glycol 3350 and morphine. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Patient used took Penicillin, propranolol, quetiapine, topiramate, Lamictal and had allergy to them. Patient used took the first dose of BNT162B2 (lot number: EJ1685) via intramuscular at right arm on 21Dec2020 12:00 PM at single dose for COVID-19 immunization. Since the vaccination, the patient been tested for COVID-19 (Sars-cov-2 PCR) via nasal swab on 06Jan2021, covid test result was negative. Patient was found pulseless and breathless 20 minutes following the vaccine administration (11Jan2021 12:30 AM). MD found no signs of anaphylaxis. Patient died on 11Jan2021 12:30 AM because of cardiac arrest. No treatment received for the events. Outcome of pulseless and breathless was unknown. the autopsy was performed, and autopsy remarks was unknown. Autopsy-determined cause of death was unknown.  It was reported as non-serious, not results in death, Life threatening, caused/prolonged hospitalization, disabling/Incapacitating nor congenital anomaly/birth defect.; Sender's Comments: Based on the available information this patient had multiple underlying medical conditions including morbid obesity, diastolic CHF, epilepsy, pulmonary hypertension and COVID-19 diagnosed prior to vaccination. All these conditions more likely contributed to patients cardiac arrest resulting in death. However, based on a close temporal association (""Patient was found pulseless and breathless 20 minutes following the second dose of BNT162B2 vaccine administration, contributory role of BNT162B2 vaccine to the onset of reported events cannot be completely excluded. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.; Reported Cause(s) of Death: Cardiac arrest; Autopsy-determined Cause(s) of Death: autopsy remarks was unknown. Autopsy-determined cause of death was unknown",Y,01/11/2021,,,,,,,N,01/11/2021,01/11/2021,0.0,Test Date: 20210111; Test Name: pulseless; Result Unstructured Data: Test Result:pulseless; Test Date: 20210111; Test Name: breathless; Result Unstructured Data: Test Result:breathless; Test Date: 20210106; Test Name: Covid-19 PCR; Result Unstructured Data: Test Result:Negative (Nasal Swab),OTH,,;  ; EFFEXOR;  ; ABILIFY;  ; CRANBERRY;  ; TYLENOL;  ; LASIX [FUROSEMIDE]; IPRATROPIUM/ALBUTEROL;  ; SENNA [SENNA ALEXANDRINA LEAF]; POLYETHYLENE GLYCOL 3350;,,"Medical History/Concurrent Conditions: COVID-19 (Prior to vaccination, the patient was diagnosed with COVID-19); Diastolic heart failure; Epilepsy; Morbid obesity; Pulmonary hypertension; Spinal stenosis",,USPFIZER INC2021018488,2,01/13/2021,,,,,True
1420,941205,01/13/2021,CA,32.0,,,M,,"Caller is a respiratory therapist who reports that he tested positive for covid after receiving the first dose of the vaccine on 17Dec; Caller is a respiratory therapist who reports that he tested positive for covid after receiving the first dose of the vaccine on 17Dec; This is a spontaneous report from a contactable consumer (patient) reported that a 32-year-old male patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/lot number: EH9899), via an unspecified route of administration from on 17Dec2020 at single dose (once by injection in the right arm/bicep) for COVID-19 immunization (Healthcare worker). There were no medical history and concomitant medications reported. The patient/caller is a respiratory therapist who reported that he tested positive for covid after receiving the first dose of the vaccine on 17Dec2020. He called to ask if he can get the second dose. He also wanted to ask if people experienced side effects or what side effects people experience after the second dose. He tested positive for Covid-19 on 21Dec2020, after receiving the first dose of the vaccine. He said it had been 14 days since he tested positive for COVID and he is if he can get the second dose. He says he is actually on his way to get the second dose right now, and thought he should call. The outcome of the event was unknown.",,,,,,,,,U,12/17/2020,12/21/2020,4.0,Test Date: 20201221; Test Name: Covid-19; Test Result: Positive,UNK,,,,Comments: List of non-encoded Patient Relevant History: Patient Other Relevant History 1: None,,USPFIZER INC2021007599,2,01/12/2021,,,,,True
1426,941401,01/13/2021,CA,99.0,99.0,,F,,"Patient is a 99yr old female who got a covid vaccine in the afternoon of 1/10/21 and woke up in the morning of 1/11/21 with altered mental status, weakness, and dysarthria. She was taken from her assisted living facility to the hospital and MRI showed a small stroke in the right medial thalamus. She was also found to have new onset atrial fibrillation. She was treated appropriately for both conditions and discharged to a skilled nursing facility on 1/13/21.",,,Y,,Y,2.0,,,Y,01/10/2021,01/11/2021,1.0,MRI 1/11/21: acute infarct in the right medial thalamus EKG 1/11/21: atrial fibrillation,SEN,,Levothyroxine,None,"hypothyroidism, secondary hyperparathyroidism, chronic kidney disease stage 3",,,2,01/13/2021,,,,None,True
1448,942029,01/13/2021,TN,43.0,43.0,,F,,"I received my covid vaccine on 12/29/2020 at 4:42pm. In 10 minutes after the shot,  I went into anaphylactic shock,  I broke out in hives, and my throat was closing",,,,,Y,3.0,,,N,12/29/2020,12/29/2020,0.0,,WRK,,"Zoloft, Valsartan, propranolol,  lasix,",None,"Htn, asthma, diabetes  environmental allergies",,,2,01/13/2021,,,Y,"Contrast dye, triptans, Topamax, imitrex,reception, pravastatin, CATS( HAIR AND DANDER, pfizer-biontech covid 19 vaccine",True
1454,942106,01/13/2021,CA,54.0,54.0,,M,,"54 y/o M with PMH of HTN, HLD, Alcoholic Cirrhosis, Aortic Valve Stenosis, and angina BIBA as a Medical Alert for cardiac arrest noted PTA. Per EMS, the patient called because he was having constant, diffuse abdominal pain x 1 day that radiated to his chest. On scene, the patient had a witnessed arrest with EMS starting CPR. He was given 3 rounds of epi without ROSC. Pt had no associated shockable rhythm. Of note, pt's wife, had noted pt had received covid vaccine the prior day.",Y,01/09/2021,,,,,,,N,01/08/2021,01/09/2021,1.0,,PVT,,,,,,,2,01/13/2021,,,,,True
1464,942602,01/14/2021,NJ,53.0,,,M,,"Headache; migraine; tenderness at injection site; Ten hours after injection he had shaking, sweats, hot and cold flashes, and augmentation of myalgias; Ten hours after injection he had shaking, sweats, hot and cold flashes, and augmentation of myalgias; Ten hours after injection he had shaking, sweats, hot and cold flashes, and augmentation of myalgias; Ten hours after injection he had shaking, sweats, hot and cold flashes, and augmentation of myalgias; Ten hours after injection he had shaking, sweats, hot and cold flashes, and augmentation of myalgias; Fatigue; This is a spontaneous report from a contactable physician (patient). A 53-year-old male patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EK9231), via an unspecified route of administration on right deltoid on 05Jan2021 07:45 at single dose for covid-19 immunization. Family history included migraine (other family members). Medical history included mild blood pressure and kidney stones, reactive airway disease. Concomitant medication included colecalciferol (VITAMIN D), potassium, allopurinol and hydrochlorothiazide/valsartan for mild blood pressure and kidney stones, fluticasone propionate, salmeterol xinafoate (ADVAIR) for reactive airway disease, atorvastatin, and multivitamins. The patient previously took fluticasone propionate, salmeterol xinafoate (ADVAIR) and experienced dry mouth and lost sense of taste. The patient also previously took Tdap booster on Aug2020, Shingrix on 10Aug2020, and influenza on 12Oct2020; all for immunization; and tetanus injections for immunization and experienced localized tenderness. The patient had the first dose of BNT162B2 (lot number: EH9899) for COVID-19 immunization on 15Dec2020 and experienced localized tenderness at injection point. The received his second dose of COVID vaccine on 05Jan2021. With the first dose he had increased localized tenderness at injection site on 15Dec2020, and he rated it mild to moderate. He would say it was 80% resolved in 24 hours. It had completely resolved in 36 hours. He would say that he has recovered completely form the localized tenderness with the first dose. Then he noted his second dose was yesterday, in the context of not having much sleep the night before. The actual injection was uncommonly eerily painless. The other folks in his department had similar experience. Maybe it was the nurse who gave the injection. Maybe it was because it was the same area and sensitivity was decreased. They had to check the Band-Aid to make sure blood was there. The administration was painless. He was relieved when the arm started getting sore to know he actually received it. He had increased arm tenderness at injection site which he rated as moderate which has now resolved. It got to moderate where lifting the arm up was sore. He definitely knew that he had been vaccinated. He got the vaccine at 7:45AM and now it is 16 to 17 hours later and he would say the pain is mild now. It did persist. The first vaccine hurt a little more. He expects this to go away. Ten hours after injection he had shaking, sweats, hot and cold flashes, and augmentation of myalgias. He had unrelenting headache over night that was moderate to severe. He said it kept him awake. It was exacerbated by lying down. Sitting up helped him. It became a migraine which is something he doesn't often experience. Migraines are pretty rare for him. He took 800mg of Advil at 6AM that helped for headache and migraine. The weight of the patient was 250 to 255 pounds. Shaking, sweats, hot and cold flashes, and augmentation of myalgias have resolved. Everything has resolved except for a little headache. In the background he literally had one or two hours of sleep. He thinks that likely precipitated a migraine was increased. Last night he slept literally an hour. He took 800mg of Advil and fell asleep. He is operating on 2 hours of sleep in 48 hours. Most of the stuff is gone except a little headache and expected fatigue. Headache Seriousness Criteria: he would say that it was relatively disabling. He would not have been able to carry on. He wouldn't have been able to operate last night. It would have interfered. It was dissimilar to others. He gets rare migraines. Everything was amplified with a migraine. He certainly felt that. It was fair to say the vaccine precipitated the migraine that was mild or severe. He doesn't want to falsely attribute these things to the vaccine. Causality Headache: precipitated by the vaccine. In the context that he had not slept the night before. He had a nasopharyngeal COVID test and it was negative. He has been in a COVID study where they are looking at combination. They developed a saliva test at (Name). There is a combination of saliva oropharyngeal and immunoglobins. He has been negative multiple times. The outcome of the events headache and fatigue was not recovered and recovered for the rest of the events.; Sender's Comments: A causal association between BNT162B2 and the reported event headache cannot be excluded based on a compatible temporal relation between vaccination and onset of events. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to RAs, Ethics Committees, and Investigators, as appropriate.",,,,,,,,Y,N,01/05/2021,01/01/2021,,Test Name: COVID test; Result Unstructured Data: Test Result:Negative; Comments: He had a nasopharyngeal COVID test and it was negative; Test Name: COVID test; Result Unstructured Data: Test Result:Negative; Comments: There is a combination of saliva oropharyngeal and immunoglobins. He has been negative multiple times.; Test Name: Weight; Result Unstructured Data: Test Result:250 to 255 lbs; Comments: Weight: 250 to 255 pounds,PVT,,VITAMIN D [COLECALCIFEROL];  ;  ; VALSARTAN & HCTZ; ADVAIR;,,Medical History/Concurrent Conditions: Airways obstruction; Blood pressure abnormal; Kidney stone; Migraine (he has other family members with history of migraines.),,USPFIZER INC2021007760,2,01/13/2021,,,,,True
1467,942620,01/14/2021,,27.0,,,M,,"diagnosed with covid 30Dec2020; diagnosed with covid 30dec2020; This is a spontaneous report from a contactable nurse (patient). A 27-year-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/lot number EK5730), via an unspecified route of administration in right deltoid on 21Dec2020 13:45 at single dose for Vaccination.  There were no medical history and concomitant medications.  The patient was diagnosed with covid on 30Dec2020 with outcome of recovering.  The patient underwent lab tests and procedures which included COVID test: positive on 30Dec2020. The patient received the first dose of the covid vaccine on 21Dec2020, and was diagnosed with covid on 30Dec2020. The patient had COVID test on 30Dec2020 and received positive result of COVID test on 31Dec2020. He was scheduled for the second dose between 08Jan2021 and 11Jan2021. He asked if he should continue to get the second dose as scheduled in relation to the diagnosis of COVID. COVID: the patient still had chest congestion, but no fever without medication, no cough anymore. He was having cough, fever, loss of taste and smell, fatigue and malaise. Reporter seriousness for COVID: Not serious. Relatedness of drug to reaction/event:  Reaction assessed: COVID, Source of assessment: Primary Source Reporter, Method of assessment: Global Introspection, Drug result: Unrelated. Verbatim event relatedness: Pfizer COVID-19 Vaccine: COVID-Unrelated.; Sender's Comments: The patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE) on 21Dec2020, and was diagnosed with COVID-19 on 30Dec2020.  No effect of the suspect vaccine could be reasonably achieved to protect from the targeted infection/disease due to the very short time lag.  Instead, the diagnosed COVID-19 likely represents the pre-existing infection prior to vaccine use, and unrelated to BNT162B2.",,,,,,,,,N,12/21/2020,12/30/2020,9.0,Test Date: 20201230; Test Name: COVID test; Test Result: Positive,UNK,,,,Comments: List of non-encoded Patient Relevant History: Patient Other Relevant History 1: None,,USPFIZER INC2021010406,2,01/13/2021,,,,,True
1468,942621,01/14/2021,OK,,,,F,,"she got Covid; she got Covid; This is a spontaneous report from a contactable physician. A female patient (Patient Age: 18; Unit: Unspecified) received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiry date were not reported), via an unspecified route of administration on an unspecified date t a single dose for covid-19 immunization. The patient's medical history and concomitant medications were not reported. The nurse that her first Pfizer Covid 19 vaccine and a couple of days later developed symptoms of Covid and tested positive. Stated that she recovered and had no symptoms.   Information on Lot/Batch number has been requested.; Sender's Comments: The reported symptoms of Covid with tested positive after COVID-19 immunization is considered ineffective of BNT162B2, and the Company cannot completely exclude the possible causality between the reported event and BNT162B2 administration.",,,,,,,,,Y,,,,Test Name: Covid 19; Test Result: Positive,UNK,,,,,,USPFIZER INC2021010420,2,01/12/2021,,,,,True
1469,942623,01/14/2021,IN,38.0,,,M,,"covid test result=Positive; covid test result=Positive; This is a spontaneous report from a contactable other healthcare professional (other HCP reporting for himself).  A 39-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE Solution for injection, batch/lot no. and expiry date unknown), via an unspecified route of administration on 16Dec2020 12:45 (1st dose) at a single dose on his left arm for COVID-19 immunization.  The patient medical history was not reported.  Concomitant medication included hydrochlorothiazide, losartan potassium (HYZAAR), omeprazole, and ibuprofen; all on unspecified dates for unspecified indications. The patient previously took amoxicillin and experienced allergies. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine, he was also not diagnosed with COVID-19 prior to vaccination. However, since the medication, the patient has been tested positive for COVID-19. Patient had his nasal swab on 22Dec2020, and it turned out positive (COVID test result=positive).  Outcome of the event drug ineffective and COVID-19 virus test positive was unknown. Facility where the most recent COVID-19 vaccine was administered at the hospital.  Information on the lot/batch number has been requested.; Sender's Comments: Based on the information currently available, a lack of efficacy with the suspected vaccine BNT162B2 cannot be completely excluded. However, it is unlikely that the patient would have fully developed immunity due to the very short time lag between the first vaccine dose and the event onset.",,,,,,,,,U,12/16/2020,12/22/2020,6.0,Test Date: 20201222; Test Name: Nasal Swab; Result Unstructured Data: Test Result:Positive,PVT,,HYZAAR;  ;,,,,USPFIZER INC2021010441,2,01/12/2021,,,,,True
1470,942624,01/14/2021,TX,37.0,,,F,,"covid test result=Positive; covid test result=Positive; nasal congestion; sneezing runny nose; sneezing runny nose; sinus pressure; dry cough; This is a spontaneous report from a contactable Nurse (patient herself).  This 37-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number EL0140), via an unknown route, on 19Dec2020 at 16:15 at single dose for COVID-19 immunisation. Vaccine location was arm left. The patient was not pregnant. The patient was vaccinated at hospital, age at vaccination was 37-year-old. No other vaccine was received in four weeks. No relevant medical history was provided. Relevant concomitant medications included amoxicillin sodium, clavulanate potassium (AUGMENTIN, formulation: tablet) at dose of 875 mg twice daily from an unknown.  Pre-vaccination COVID test was not performed. On 25Dec2020 at 20:00, the patient complained of nasal congestion, sneezing runny nose, sinus pressure, and cough. On 28Dec2020, COVID test Nasal Swab (SOFIA SARS ANTIGEN FIA/QUIDEL) was performed and resulted positive. She was given oral azithromycin 500 mg 1 tab Daily and oral benzonatate (TESSALON PERLES) 1 Capsule three times a day (TID). The symptoms of nasal congestion, sneezing runny nose, sinus pressure, and cough were improving. The outcome of 'COVID test result=Positive' was unknown.; Sender's Comments: The efficacy of a drug varies from patient to patient and can be affected by different factors; however, a contributory role of the suspect product BNT162B2 to the reported drug ineffective and SARS-CoV-2 test positive cannot be ruled out.",,,,,,,,,N,12/19/2020,12/25/2020,6.0,Test Date: 20201228; Test Name: covid test Nasal Swab; Test Result: Positive  ; Comments: SOFIA SARS ANTIGEN FIA/QUIDEL,PVT,,AUGMENTIN [AMOXICILLIN SODIUM;CLAVULANATE POTASSIUM],,,,USPFIZER INC2021010475,2,01/13/2021,,,,,True
1471,942626,01/14/2021,NY,,,,U,,"two staff members who tested positive for covid after receiving the first dose.; two staff members who tested positive for covid after receiving the first dose.; This is a spontaneous report from a Pfizer-sponsored program from a contactable pharmacist reported similar events for 2 patients. This is a first of two reports. A staff member of unknown age and gender received the first dose of BNT162B2 Pfizer-BioNTech COVID-19 Vaccine, via an unspecified route of administration on an unspecified date  at single dose for COVID-19 immunization. The patient's medical history and concomitant medication were unknown. The reporter stated that have a staff member took the first shot and afterward got a positive COVID test. He is asking about the recommendation regarding taking the second shot. The reporter explained he is the immunizer and 2.5 weeks ago he gave the employ at the facility the first does of the vaccine. He has very little information to provide on this event. He called to go over the procedure for administering the second dose and that is when in was inform. Information on the lot/batch number has been requested.; Sender's Comments: The efficacy of a drug varies from patient to patient and can be affected by different factors; however, a contributory role of the suspect product BNT162B2 to the reported drug ineffective and SARS-CoV-2 test positive cannot be ruled out.,Linked Report(s) : US-PFIZER INC-2021011912 Same reporter/ drug/ event for different patients.",,,,,,,,,U,,,,Test Name: COVID test; Test Result: Positive,UNK,,,,,,USPFIZER INC2021010495,2,01/12/2021,,,,,True
1474,942629,01/14/2021,NY,36.0,,,F,,"got the covid 19 vaccine on 21Dec2020 and tested positive for covid on 24Dec2020; got the covid 19 vaccine on 21Dec2020 and tested positive for covid on 24Dec2020; This is a spontaneous report from a contactable Nurse (patient) from a Pfizer-sponsored program Pfizer First Connect. A 36-year-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, batch/lot number: EK5730), via intramuscular in left deltoid  on 21Dec2020 10:00 at 0.3 ml, single for precaution as front line healthcare worker in hospital which is not a military facility.  Medical history included nonsmoker. She did not provide causality but stated that she probably already had COVID when she got the vaccine. It was unknown if the patient had SARS-CoV2 antibodies at diagnosis as she had never been tested. Other history was none. The patient did not have a history of hypertension, diabetes, heart disease, lung disease, liver disease, kidney disease, cancer, immunosuppressive disorder, obesity. There was not any pre-existing diseases worsened during the SARS-CoV2 infection. The patient hadn't been treated with immunomodulating or immunosuppressing medications or received any other vaccines around the time of COVID-19 vaccination. Concomitant medication included bupropion hydrochloride (WELLBUTRIN SR), sertraline hydrochloride (ZOLOFT), amfetamine aspartate, amfetamine sulfate, dexamfetamine saccharate, dexamfetamine sulfate (ADDERALL). Prior Vaccinations (within 4 weeks) were none. AE following prior vaccinations were none. There was no additional vaccines administered on Same Date (21Dec2020) of the Pfizer bnt162b2. The patient got the covid 19 vaccine on 21Dec2020 and tested positive for covid on 24Dec2020. The patient wanted guidance on receiving the 2nd dose of the vaccine. The reporter considered event was non-serious. The patient received the first dose of the vaccine on 21Dec2020, and after that on 24Dec2020, she tested positive for COVID . She was supposed to be revaccinated on 07Jan2021. She would like to know if she should she get this or does she need to be revaccinated. There is no prescriber. She received it through her work. She received the first dose on 21Dec2020, and assumed she was positive when she got it. She just had cough and muscle aches and a headache. Her dad was hospitalized. Hers was not that serious. She had not completely recovered yet. Her smell had not come back yet and she was just tired still. She said the headache was prior to getting vaccine. She did not provide causality but stated that she probably already had COVID when she got the vaccine. The cough occurred on 25Dec2020, muscle aches on 22Dec2020 at 08:00. There was no emergency room of or physician's office required for the events. The patient was not hospitalized or admitted to an ICU. Nasal swab test done. Imaging for COVID-Pneumonia, other radiological investigations, hematology, clinical chemistry, inflammatory markers, urinalysis, evidence of hypoxemia, other relevant test were none. The patient did not display clinical signs at rest indicative of severe systemic illness. The patient did not require supplemental oxygen (including high flow or ECMO) or receive mechanical ventilation. The patient did not receive any additional therapies for COVID-19. The event did not require the initiation of new medication or other treatment or procedure.  She did start taking extra vitamins on her own. The patient was recovered with some lasting effects such as not being able to smell and is tired still.; Sender's Comments: The Company cannot completely exclude the possible causality between the reported COVID with symptoms and the administration of COVID 19 vaccine, bnt162b2.  However, as the reporter claimed ""she probably already had COVID when she got the vaccine"", this may provide  an alternative explanation.",,,,,,,,,N,12/21/2020,12/24/2020,3.0,Test Date: 20201224; Test Name: SARS-CoV2; Test Result: Positive  ; Comments: test 24Dec2020 and got results at 27Dec2020 at 08:00 am.,PVT,,WELLBUTRIN SR; ZOLOFT; ADDERALL,Suspected COVID-19 (probably already had COVID when she got the vaccine),Medical History/Concurrent Conditions: Hospitalization (Her dad); Nonsmoker,,USPFIZER INC2021010551,2,01/12/2021,,,,,True
1484,942659,01/14/2021,WI,34.0,,,F,,"Idiopathic trigeminal neuralgia; This is a spontaneous report from a contactable nurse (patient).  A 34-year-old female patient started to receive BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number EL0140), intramuscular (right deltoid) first dose on 21Dec2020 at single dose for Covid-19 immunization. The patient's medical history included multiple sclerosis from 2015 (Diagnosed 5 year) and ear infection from 03Dec2020 prior to vaccination, she was seen in urgent care with an ear infection, states it was super painful and lasted about 7-10 days treated it with drops..  There were no concomitant medications. The patient requested guidance on whether or not she should get the second dose of the covid vaccine after being diagnosed with Trigeminal Neuralgia following the first dose. The patient stated that she received the first done on 21Dec2020 and on 27Dec2020 was diagnosed with Idiopathic trigeminal neuralgia. The patient was unclear if the vaccine played a part in the diagnosis and wonders if there is any data available about this as an adverse event as she read that Bells Palsy was reported and this was similar. The patient need guidance on whether to get second dose of the Covid vaccine scheduled for on Monday. Wondering if getting the second dose would be risking it flaring up, states she was now on anticonvulsant medication and gabapentin and they have increased the anticonvulsant medication. The patient experienced idiopathic trigeminal neuralgia (trigeminal neuralgia) (non-serious) on 27Dec2020 with outcome of not recovered.  The action taken in response to the event(s) for bnt162b2 was not applicable. The outcome of the event was not recovered.; Sender's Comments: Based on available information, a possible contributory role of the subject product, BNT162B2 vaccine, cannot be excluded for the reported event of  Trigeminal Neuralgia due to temporal relationship.  However,  the event may possibly  represent concurrent medical condition in this patient with medical history of multiple sclerosis.  There is limited information provided in this report.  Additional information is needed to better assess the case, including complete medical history, diagnostics including head CT/MRI and viral serologies, counteractive treatment measures and concomitant medications. This case will be reassessed once additional information is available.  The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.",,,,,,,,,N,12/21/2020,12/27/2020,6.0,,UNK,,,,Medical History/Concurrent Conditions: Ear infection; Multiple sclerosis,,USPFIZER INC2021011050,2,01/13/2021,,,,,True
1487,942730,01/14/2021,NY,,,,U,,"two staff members who tested positive for covid after receiving the first dose.; two staff members who tested positive for covid after receiving the first dose.; This is a spontaneous report from the Pfizer Sponsored Program called 'Pfizer First Connect' received by a contactable pharmacist. This pharmacist reported similar events for 2 staff members. This is 2nd of 2 reports.   A patient (demographics unknown) received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unknown route, in Dec2020 at single dose for COVID-19 immunisation. No relevant medical history and concomitant medications were provided. On unknown date, after first shot of vaccine, COVID test resulted positive. The reporting pharmacist is asking about the recommendation regarding taking the second shot. The outcome of the event was unknown.  Information about Batch/Lot number has been requested.; Sender's Comments: A causal association between reported event and suspect BNT162B2 cannot be excluded. ,Linked Report(s) : US-PFIZER INC-2021010495 Same reporter/ drug/ event for different patients.",,,,,,,,,U,12/01/2020,,,Test Name: COVID test; Test Result: Positive,UNK,,,,,,USPFIZER INC2021011912,2,01/13/2021,,,,,True
1518,944203,01/14/2021,NY,31.0,,,F,,"covid a week after the1st dose of the vaccine. When to get the 2nd dose?/tested positive for COVID; covid a week after the1st dose of the vaccine. When to get the 2nd dose?/tested positive for COVID; body aches; fever; Headache; This is a spontaneous report from a contactable physician.  A 31-year-old female patient (healthcare worker) received the 1st dose of bnt162b2 (BNT162B2) at single dose in Dec2020 (9 days before 07Jan2021) for Covid-19 immunisation.  The patient medical history and concomitant medications were not reported.  The patient received the 1st dose of the COVID vaccine 9 days before 07Jan2021 and got a headache afterward in Dec2020. After 6 days, in Jan2021 the patient had a worse headache, body aches, and fever. She was swabbed for COVID on 06Jan2021 and tested positive. The reporter wanted to know what to do about the 2nd dose. The outcome of events was unknown. A product complaint was filed.  information about lot and batch number was requested.",,,,,,,,,U,12/01/2020,12/01/2020,0.0,Test Date: 20210106; Test Name: swabbed for COVID; Result Unstructured Data: Test Result:Positive; Comments: She was swabbed for COVID yesterday and tested positive.,UNK,,,,,,USPFIZER INC2021010622,2,01/13/2021,,,,,True
1519,944204,01/14/2021,CA,47.0,,,F,,"tested positive for covid/headache, ever, cough, diarrhea; tested positive for covid/headache, ever, cough, diarrhea; This is a spontaneous report from a contactable consumer (patient) via a Pfizer Sponsored Program IBCC (Inbound Call Center for HCPs). A 47-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/lot number: EK5730, expiration date: 20Mar2021), via an unspecified route of administration on 19Dec2020 16:15 at left arm, at single dose for covid-19 immunization. Medical history included hysterectomy in 2010, pulmonary Embolism in 2010, gallbladder removed on an unknown date. There were no concomitant medications. The patient received 1st dose 19Dec2020, she was supposed to get her second dose, but tested positive for covid. She thought she had side effects after vaccine, she began with a headache, fever a week later and thought they were from the vaccine, but then her sister-in-law was positive for COVID, her sister-in-law passed away from covid virus. Then the patient, her mom, and husband tested positive for COVID. She tested positive for COVID on 27Dec2020. She developed symptoms of COVID on 27Dec2020. It was exactly one week after receiving the first dose. It was also reported that she got tested on the 30th (as reported) and received results on 31Dec2020 that she was positive. After she got sick she has taken Mucinex. Day eleven, she is doing ok, but has a little cough. No more fever. Sometimes she has diarrhea but today no diarrhea. The patient asked if she can get her second dose of the covid vaccine on day 24. The outcome of the events was recovering.",,,,,,,,,N,12/19/2020,12/27/2020,8.0,Test Date: 20201227; Test Name: Covid test; Result Unstructured Data: Test Result:positive,PVT,,,,Medical History/Concurrent Conditions: Gallbladder disorder (Gallbladder removed- unknown date); Hysterectomy; Pulmonary embolism,,USPFIZER INC2021010755,2,01/13/2021,,,,,True
1521,944210,01/14/2021,MA,34.0,,,F,,"The patient had an ongoing medical history of Crohn's disease/Concomitant medication included vedolizumab (ENTYVIO) for Crohn's disease; shortness of breath; difficulty swallowing; fever; headache; nausea; she was feeling as if her throat was closing; Chest tightness; This is a spontaneous report from a contactable physician reporting for a patient.  A 34-year-old female patient received the first dose of BNT162B2 (COIVD-19 Vaccine) , via an unspecified route of administration on 03Jan2021 at single dose for covid-19 immunisation.  Medical history included Crohn's disease from an unknown date and unknown if ongoing, COVID-19 in 2020 to an unknown date and unknown if ongoing.  Concomitant medication included vedolizumab (ENTYVIO) for Crohn's disease.  The reporter is a physician who is reporting and AE for a patient who received the vaccine and subsequently developed symptoms including short of breath, fever, headache, nausea, difficulty swallowing with seriousness criteria of Medically significant on 03Jan2021. The patient self-medicated with benadryl and symptoms resolved briefly but then went to urgent care with re-occurring symptoms and was prescribed prednisone. Caller states the patient's symptoms have resolved. She is calling to get more information to determine if the patient should receive the second dose. The reporter further stated that she has a patient who received her first shot, clarified as the COVID-19 Vaccine. About an hour and 45 minutes later, the patient had shortness of breath and then later had a fever, headache and nausea. It was later that night when the patient had a fever. The patient had difficulty swallowing which worsen; she was feeling as if her throat was closing. The patient is a nurse, so she self medicated with Benadryl. After taking the Benadryl, the patient was better in the early morning. When the doctor's office opened, the patient called and was having similar symptoms, clarified as all the symptoms mentioned above. The patient went to the urgent care where she received more Benadryl and was started on prednisone. Caller did not know the dose of prednisone the patient had received. After that, the patient started feeling better. The patient's second dose of the COVID19 Vaccine is due around 24 to 26Jan2021. The patient has not called the doctor/caller back. The caller assumes that the patient has recovered but could not be certain. Caller added that the patient also experienced chest tightness when she was having shortness of breath. The patient's fever was 101 on 03Jan2021. The patient was not drooling with her difficulty swallowing. Caller stated that the patient had a positive COVID test earlier, she thinks it was maybe 3 to 4 months ago (in 2020). The patient has not received another COVID test since she received the first dose of the COVID-19 vaccine to the caller's knowledge. Reporting physician is an internal medicine physician. Therapeutic measures were taken as a result of the events. The outcome of the events was unknown.   Information on the Batch/Lot number has been requested.; Sender's Comments: The Company cannot completely exclude the possible causality between the reported short of breath, fever, headache, nausea, difficulty swallowing, throat closing, chest tightness, and the administration of COVID 19 vaccine, BNT162B2, based on the plausible temporal association.   The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to RA, IEC, as appropriate.",,,,,,,,,U,01/03/2021,01/03/2021,0.0,"Test Date: 20210103; Test Name: body temperature; Result Unstructured Data: Test Result:101; Test Date: 2020; Test Name: COVID-19; Test Result: Positive  ; Comments: the patient had a positive COVID test earlier, she thinks it was maybe 3 to 4 months ago",UNK,,ENTYVIO,,Medical History/Concurrent Conditions: COVID-19; Crohn's disease,,USPFIZER INC2021011014,2,01/13/2021,,,Y,,True
1525,944229,01/14/2021,,,,,U,,"develops symptomatic covid; develops symptomatic covid; This is a spontaneous report from a contactable physician received via a Pfizer sales representative. This physician reported similar events for two patients. This is the first of two reports.  A patient of unspecified age and gender received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot/batch number and expiry date were not provided) solution for injection, via an unspecified route of administration on an unspecified date at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient developed symptomatic Covid on an unspecified date. The patient received dose #1 of a Covid-19 vaccine and contracted Covid-19 prior to dose #2. The patient underwent lab test which included Covid-19 test in which he/she developed a symptomatic Covid-19 on an unknown date. Outcome of the event was unknown.  Information about batch/lot number has been requested.; Sender's Comments: A causal association between BNT162B2 and the reported events cannot be excluded based on a compatible temporal relation between vaccination and onset of events. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to RAs, Ethics Committees, and Investigators, as appropriate. ,Linked Report(s) : US-PFIZER INC-2021014755 Same reporter/drug/event, different patient",,,,,,,,,U,,,,Test Name: Covid-19 test; Result Unstructured Data: Test Result:develops symptomatic covid; Comments: receives dose #1 and develops symptomatic covid-19 prior to dose #2,UNK,,,,,,USPFIZER INC2021012928,2,01/14/2021,,,,,True
1531,944257,01/14/2021,CA,41.0,,,F,,"took a rapid test and it came up positive; took a rapid test and it came up positive; fever 100.8; coughing; This is a spontaneous report from a contactable consumer (patient herself). A 41-year-old female patient (non-pregnant) received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, reported as Pfizer covid19 el1284), via an unspecified route of administration on 30Dec2020 14:30 in left arm at single dose for covid-19 immunisation. Medical history included asthma and arthritis. Concomitant medication included ibuprofen and paracetamol (TYLENOL). The most recent COVID-19 vaccine was administered in public health clinic/ veterans administration facility. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19. Patient got the vaccine on Wednesday 30Dec2020, and by Saturday (02Jan2021 22:30) she started with a little coughing that increase on Monday (04Jan2021), Monday afternoon she had fever 100.8. She thought she was experiencing side effects and reported to her supervisor and didn't work the 2 next days. She when back to work on Thursday (07Jan2021), she was sent to a covid clinic and took a rapid test and it came up positive.  The patient underwent lab tests and procedures which included nasal swab (rapid antigen testing - SARS-CoV-2): positive on 07Jan2021. The events were reported as non-serious. No treatment was received for the events. Outcome of events were recovering.   Information on the lot/batch number has been requested.",,,,,,,,,N,12/30/2020,01/02/2021,3.0,Test Date: 20210104; Test Name: fever; Result Unstructured Data: Test Result:100.8; Test Date: 20210107; Test Name: nasal swab (rapid antigen testing - SARS-CoV-2); Test Result: Positive,PUB,,; TYLENOL,,Medical History/Concurrent Conditions: Arthritis; Asthma,,USPFIZER INC2021013571,2,01/13/2021,,,,,True
1536,944270,01/14/2021,MA,58.0,,,M,,"He collapsed with left sided hemiparesis; Stroke; Rt basal ganglia hemorrhage w/ edema and mass effect.; Rt basal ganglia hemorrhage w/ edema and mass effect.; Low platelets, 114; His bp as high as 200s/100; Hand weakness; Myalgia; Fever; Severe fatigue; This is a spontaneous report from a contactable physician. A 58-year-old male patient received first dose of bnt162b2 (Pfizer BioNTech COVID vaccine), intramuscularly on 16Dec2020 at a single dose for COVID-19 immunization. Medical history included hypertension with reported med noncompliance in the last few months due to stress. Concomitant medication included hypertension medications in two weeks. The patient was presumed neg covid status prior to vaccine. He worked as a Pulm/critical care physician. He reported fever, myalgia, fatigue on 16Dec2020. Next day (17Dec2020), he took off from work due to his symptoms. The following day (18Dec2020), he came to work. He c/o ongoing severe fatigue & hand weakness in am. Staff noted him to be evaluating his hands during clinic. At 12:15, he collapsed with left sided hemiparesis. The reporter had suspicion for stroke. He was transported to the Emergency Room (ER), head CT showed Rt basal ganglia hemorrhage w/ edema and mass effect. Labs notable for Low platelets, 114 (unknown baseline) on 18Dec2020, normal coags on an unspecified date. BP recorded as 179/101, but it was noted in trauma room his bp as high as 200s/100. He had a history of hypertension with reported med noncompliance in the last few months due to stress. Patient was transferred for further care. Full course was unknown but had rebleed there with low plts. Adverse event (he collapsed with left sided hemiparesis) resulted in hospitalization (22 days), life threatening illness (immediate risk of death from the event), disability/incapacitating or permanent damage. Treatment was received for adverse events. Results of tests and procedures for investigation of the patient: on 18Dec2020, Nasal Swab test: negative. The outcome of events was not recovered.   Unknown if any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient was not tested for COVID-19.   Information on the lot/batch number has been requested.; Sender's Comments: Collapsed with left sided hemiparesis/suspicion for stroke are as consequences of basal ganglia hemorrhage with edema, which is caused by worsening of hypertension.  Low platelet also contributes to brain hemorrhage. All these serious events are unrelated to the vaccine use.  The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.",,,Y,,Y,22.0,,Y,N,12/16/2020,12/16/2020,0.0,Test Date: 20201218; Test Name: BP; Result Unstructured Data: Test Result:high as 200s/100; Test Date: 20201218; Test Name: BP; Result Unstructured Data: Test Result:179/101; Test Date: 20201218; Test Name: head CT; Result Unstructured Data: Test Result:Rt basal ganglia hemorrhage w/ edema and mass effe; Comments: Rt basal ganglia hemorrhage w/ edema and mass effect; Test Name: platelets; Result Unstructured Data: Test Result:normal coags; Test Date: 20201218; Test Name: platelets; Result Unstructured Data: Test Result:114 (unknown baseline); Test Date: 20201218; Test Name: platelets; Result Unstructured Data: Test Result:Low; Test Date: 20201218; Test Name: Nasal Swab; Result Unstructured Data: Test Result:Negative,PVT,,,,Medical History/Concurrent Conditions: Hypertension; Stress,,USPFIZER INC2021014540,2,01/13/2021,,,Y,,True
1537,944272,01/14/2021,TX,35.0,,,F,,"Sore throat, severe chest tightness and pressure, very hard to breathe in, more than 30 minutes after covid vaccine, dizziness, headache, lightheadedness; severe chest tightness and pressure; very hard to breathe in, more than 30 minutes after covid vaccine; Dizziness /lightheadedness; headache; This is a spontaneous report from a contactable consumer (patient).  A 35-year-old female (not pregnant at the time of vaccination) patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) (lot number EL0142), via an unspecified route of administration at left arm on 09Jan2021 10:30 at single dose for COVID-19 immunization at a hospital. The patient's medical history included migraines, asthma, diabetes, sleep apnea, low immune system, post-traumatic stress disorder (PTSD), depression, panic attacks, insomnia, borderline personality disorder, and known allergies to medications, food, or other product (10 total). Concomitant medications included adult tetanus vaccine on 04Jan2021 received at right arm, for immunization (within 4 weeks prior to the COVID vaccine); first dose of botulinum toxin type a (BOTOX) on 06Jan2021 at single (31 shots in 7 muscle groups) for migraines (within 4 weeks prior to the COVID vaccine); and clindamycin antibiotic for infection in finger (took within in two weeks). The patient was not diagnosed with COVID-19 prior to vaccination, and had not been tested for COVID-19 since the vaccination. On 09Jan2021 11:00, the patient experienced sore throat, severe chest tightness and pressure, very hard to breathe in, more than 30 minutes after COVID vaccine, ""dizziness/lightheadedness"", and headache. The above mentioned events resulted in emergency room/department or urgent care visit, and patient received breathing treatment, oxygen for over an hour for these events. The outcome of the events was unknown. The reporter considered the events as non-serious.",,,,,,,,,U,01/09/2021,01/09/2021,0.0,,PVT,,BOTOX;,,"Medical History/Concurrent Conditions: Asthma; Borderline personality disorder; Depression; Diabetes; Immune system disorder; Insomnia; Migraine; Multiple allergies (known allergies to medications, food, or other product (10 total)); Panic attacks; Post-traumatic stress disorder; Sleep apnea",,USPFIZER INC2021014594,2,01/14/2021,,,Y,,True
1538,944275,01/14/2021,MI,72.0,,,M,,"complete hearing loss at the right ear, 5 hours post injection, continued till now 3 days past injection, not resolved yet prior to report; This is a spontaneous report from a contactable physician. A 72-years-old male patient started to receive bnt162b2 (BNT162B2) Lot number# ek9231 intramuscularly on 06Jan2021 12:00 at single dose for covid-19 immunisation. Anatomical Location: Arm Right. Facility where the most recent COVID-19 vaccine was administered: Hospital. Medical history included diabetes mellitus, hypertension. The patient did not received any other vaccines within 4 weeks prior to the COVID vaccine. Concomitant medication included alprazolam (AZOR [ALPRAZOLAM]), metformin hydrochloride, sitagliptin phosphate monohydrate (JANUMET [METFORMIN HYDROCHLORIDE;SITAGLIPTIN PHOSPHATE MONOHYDRATE]), atorvastatin calcium (LIPITOR [ATORVASTATIN CALCIUM]). The patient on 06Jan2021 18:00 reported complete hearing loss at the right ear, 5 hours post injection, continued till now 3 days past injection, not resolved yet prior to report. The action taken was not applicable.; Sender's Comments: A possible contributory effect of suspect BNT162B2 on reported hearing loss cannot be excluded.  The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to regulatory authorities, Ethics Committees, and Investigators, as appropriate.",,,,,,,,,N,01/06/2021,01/06/2021,0.0,,PVT,,AZOR [ALPRAZOLAM]; JANUMET [METFORMIN HYDROCHLORIDE;SITAGLIPTIN PHOSPHATE MONOHYDRATE]; LIPITOR [ATORVASTATIN CALCIUM],,Medical History/Concurrent Conditions: Blood pressure high; Diabetes,,USPFIZER INC2021015709,2,01/14/2021,,,,,True
1539,944277,01/14/2021,HI,45.0,,,F,,"Allergic reaction to vaccine; tingling to upper lip and face; tingling to upper lip and face; red rash on bilateral forearms; Patient developed Bell's Palsy 2-3 days later; This is a spontaneous report from a contactable consumer. A 45-year-old non-pregnant female patient received the first dose bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/lot number: EL1284), via an unspecified route of administration on 23Dec2020 at 14:30 at single dose in left arm for covid-19 immunization. Medical history included mitral valve prolapse from an unknown date, and allergies: Cephalosporins and nut (peanut derived). Concomitant medication included epinephrine (EPIPEN) 0.3MG/0.3ML, fluticasone propionate 50MCG/ACT nasal spray. On 23Dec2020 at 14:45, the patient experienced allergic reaction to vaccine, tingling to upper lip and face, red rash on bilateral forearms. Reactions resolved with no treatment. The patient developed Bell's Palsy 2-3 days later in Dec2020. Currently being treated with high dose steroids and acyclovir. All events required emergency room visit and physician office visit. All events were reported as non-serious by reporter. The outcome of event Bell's Palsy was not resolved, outcome of other events was resolved on an unspecified date. The patient was not diagnosed with COVID-19 prior to vaccination, and it was unknown if the patient has been tested for COVID-19 since the vaccination.",,,,,,,,,N,12/23/2020,12/01/2020,,,PVT,,EPIPEN;,,Medical History/Concurrent Conditions: Allergic reaction to antibiotics; Mitral valve prolapse; Peanut allergy,,USPFIZER INC2021015741,2,01/14/2021,,Y,Y,,True
1541,944280,01/14/2021,IL,25.0,,,F,,"Heart rate shot up to 170 with numbness of feet.; Heart rate shot up to 170 with numbness of feet.; Chest pain; feeling like I was going to vomit and faint; feeling like I was going to vomit and faint; This is a spontaneous report from a contactable other hcp (patient). A 25-year-old non-pregnant female patient received the first dose bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 06Jan2021 at 11:45 at single dose in left arm for covid-19 immunization. There was no medical history. Concomitant medication included valaciclovir hydrochloride (VALTREX), topiramate (TOPAMAX), lamotrigine (LAMICTAL), duloxetine hydrochloride (CYMBALTA), ziprasidone hydrochloride (GEODON). On 06Jan2021 at 12:30, The patient experienced heart rate shot up to 170 with numbness of feet, started to feel chest pain, and feeling like she was going to vomit and faint. The events required emergency room visit and were reported as serious per hospitalization. Heart rate at the hospital was 135-140 where two EKG were done and fluids were given. An x-ray of the heart was done and blood work was completed. The patient didn't receive treatment for the events. The patient didn't receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was not diagnosed with COVID-19 prior to vaccination, and has not been tested for COVID-19 since the vaccination. The outcome of the events was resolved in Jan2021.   Information on batch/lot number has been requested.; Sender's Comments: There is a reasonable possibility that the event ""feeling like she was going to vomit"" was related to BNT162b2 based on known drug safety profile. Based on the temporal relationship, the association between the other reported serious events with BNT 162b2 can not be completely excluded.  The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to regulatory authorities, Ethics Committees, and Investigators, as appropriate.",,,,,Y,,,,Y,01/06/2021,01/06/2021,0.0,Test Date: 202101; Test Name: Blood work; Result Unstructured Data: Test Result:Unknown results; Test Date: 202101; Test Name: Xray of heart; Result Unstructured Data: Test Result:Unknown results; Test Date: 202101; Test Name: EKG; Result Unstructured Data: Test Result:Unknown results; Test Date: 20210106; Test Name: Heart rate; Result Unstructured Data: Test Result:170; Comments: up to 170 with numbness of feet; Test Date: 202101; Test Name: Heart rate; Result Unstructured Data: Test Result:135-140; Comments: Heart rate at the hospital was 135-140,PVT,,VALTREX; TOPAMAX; LAMICTAL; CYMBALTA; GEODON [ZIPRASIDONE HYDROCHLORIDE],,Comments: List of non-encoded Patient Relevant History: Patient Other Relevant History 1: None,,USPFIZER INC2021016080,2,01/14/2021,,,Y,,True
1543,944283,01/14/2021,IL,34.0,,,F,,"Saturday had. Sweating. Chills. Headache. Nausea.; Saturday had. Sweating. Chills. Headache. Nausea.; Saturday had. Sweating. Chills. Headache. Nausea.; Saturday had. Sweating. Chills. Headache. Nausea.; Sunday had emergency appendectomy for actuate appendicitis.; Friday at 3pm, the patient had numbness and tingling to left hand, lips and throat; Friday at 3pm, the patient had numbness and tingling to left hand, lips and throat; Friday at 3pm, the patient had numbness and tingling to left hand, lips and throat; Friday at 3pm, the patient had numbness and tingling to left hand, lips and throat; Friday at 3pm, the patient had numbness and tingling to left hand, lips and throat; Friday at 3pm, the patient had numbness and tingling to left hand, lips and throat; Post surgery had allergic reaction unknown reason with head to toe rash; Post surgery had allergic reaction unknown reason with head to toe rash; This is a spontaneous report from a contactable nurse (patient). A 34-year-old female patient (pregnant: No) received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) via intramuscular (lot number: EL1283) on left arm on 08Jan2021 at 6:30 AM at single dose for covid-19 immunisation. The relevant medical history included celiac, anemia, known allergies: Sulfa and Gluten. Concomitant medications were not reported. The patient received first dose of BNT162B2 via intramuscular (lot number: Ek5730) on left leg on 18Dec2020 at 11:00 AM at single dose for covid-19 immunisation. The patient previously took Codeine, fish oil and experienced allergies. Friday at 3pm, the patient had numbness and tingling to left hand, lips and throat. On Saturday the patient had sweating, chills, headache, nausea. On Sunday had emergency appendectomy for actuate appendicitis. Post surgery had allergic reaction unknown reason with head to toe rash. It was also reported that the adverse event started on 08Jan2021 at 03: 15 PM (as reported). The patient had 1-day hospitalization. The patient received treatment for the events. The adverse events resulted in Emergency room/department or urgent care. The events were reported as serious due to life threatening and hospitalization. The most recent COVID-19 vaccine was administered at hospital. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The outcome of the events was recovering.; Sender's Comments: A causal association between BNT162B2 and the reported events cannot be excluded based on a compatible temporal relation between vaccination and onset of events. Medications administered during appendectomy may confound reactions experienced post-surgery. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to RAs, Ethics Committees, and Investigators, as appropriate.",,,Y,,Y,1.0,,,N,01/08/2021,01/01/2021,,,PVT,,,,Medical History/Concurrent Conditions: Anemia; Celiac disease; Gluten sensitivity (known allergies); Sulfonamide allergy (known allergies),,USPFIZER INC2021017248,2,01/14/2021,,,Y,,True
1544,944285,01/14/2021,,,,,F,,"passing out sensation; heart palpitations; sweating; diarrhea; This is a spontaneous report from a contactable consumer (patient's boyfriend). A female patient of an unspecified age received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on an unspecified date at single dose for covid-19 immunization. The patient's medical history and concomitant medications were not reported. The reporter reported that symptoms were related to the use of Covid 19 vaccine. The patient received the first dose on 15Jan (as reported) and the day after developed sweating, passing out sensation, heart palpitations and this morning on 11Jan2021 when she woke up she had the same symptoms plus diarrhea. The outcome of the events was unknown.  Information on the lot number/batch number was requested.",,,,,,,,,U,,01/11/2021,,,UNK,,,,,,USPFIZER INC2021017718,2,01/14/2021,,,,,True
1546,944287,01/14/2021,MO,66.0,,,M,,"he was in AFIB for about 3 hours after receiving his first dose of the COVID19 Vaccine; he noticed the rest of the day, right up to going to bed that he felt cold; This is a spontaneous report from a contactable consumer. A 66-year-old male patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot Number: EL1284) at arm, left upper, via an unspecified route of administration on 29Dec2020 06:15 at single dose for covid-19 immunisation. Medical history included atrial fibrillation (Afib) formally diagnosed around Jan2020. There were no concomitant medications. The patient reported he got the COVID-19 Vaccine at 06:15 on 29Dec2020 and had to sit for 15 minutes afterwards before he could leave. He said everything was fine, and he walked out to the hospital lobby, and was speaking with a work associate for 10 minutes before he headed to his car. When he got ready to leave, he got in his car, and started his car. He started driving home, and realized he was in AFIB. He did have an AFIB issue. His AFIB has been pretty well controlled for a year now, as long as, he didn't do something stupid. He had a moderately aggressive run of AFIB. He said his ""smart"" watch told him his heart rate was 117. His normal heart rate is around 60-70. He was in AFIB for about 3 hours. His typical runs of AFIB are considerably shorter. He only had a total of 2 episodes of AFIB in the last year. His prior AFIB episodes would have been about 4-5 minutes. The last time he had AFIB that lasted any length of time was when he was hospitalized for AFIB around Jan2020. He said at that time, he was hospitalized overnight for observation. He received medication during the hospitalization and his AFIB broke. He didn't remember what medications were given to him during the hospitalization. He said he had flutters before that hospitalization, but the flutters were always gone after a few minutes, so he never sought treatment because there would be nothing to treat. The patient reported he noticed the rest of the day on 29Dec2020, right up to going to bed that he felt cold. His house wasn't cold, and he didn't have a fever. He said the cold feeling went away during the night while he was sleeping. He said the cold feeling easily lasted for a 12 hours. He said the cold feeling could have been something else. The outcome of ""he was in afib for about 3 hours after receiving his first dose of the covid19 vaccine"" was recovered on 29Dec2020; of ""he noticed the rest of the day, right up to going to bed that he felt cold"" was recovered on 30Dec2020.",,,,,Y,,,,Y,12/29/2020,12/29/2020,0.0,Test Name: heart rate; Result Unstructured Data: Test Result:117; Comments: watch told him his heart rate was 117,PVT,,,,Medical History/Concurrent Conditions: AFib (formally diagnosed around Jan2020),,USPFIZER INC2021018815,2,01/14/2021,,,,,True
1547,944289,01/14/2021,NJ,22.0,,,F,,"she was diagnosed with bilateral deep vein thrombosis (DVT) and pulmonary embolism (PE); she was diagnosed with bilateral deep vein thrombosis (DVT) and pulmonary embolism (PE); This is a spontaneous report from a contactable nurse (patient). A 22-year-old female patient received 2nd dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot# EK9231), via an unspecified route of administration in left arm on 06Jan2021 13:45 at single dose for COVID-19 immunisation. Medical history included allergy to all fish, and clots. The patient was not pregnant. There were no concomitant medications. The patient previously received 1st dose of BNT162B2 (lot numer: EH9899) in left arm on 16Dec2020 13:45 for COVID-19 immunisation and experienced left sided lower back pain on 20Dec2020. No other vaccine received in four weeks. It was reported that the patient had the first covid vaccine on 16Dec2020 and on 20Dec2020 started with left sided lower back pain and then received the second on 06Jan2021 and then on 09Jan2021 11:00 her legs became blue and swollen and she was diagnosed with bilateral deep vein thrombosis (DVT) and pulmonary embolism (PE). The patient otherwise healthy and had never had covid. Other than the clots, she had no other health issues. The patient underwent lab tests and procedures which included nasal swab: negative on 09Jan2021. Events resulted in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care, hospitalization, and life threatening illness (immediate risk of death from the event), hospitalized for 2 days (in Jan2021). Adverse event treatment: heparin drip and xarelto at home. Recovered with lasting effects on an unspecified date of Jan2020. This case was reported as serious, serious criteria was life threatening, caused/prolonged hospitalization.; Sender's Comments: The underlying risk factors/predisposing condition of thrombotic diathesis have been assessed to have played a contributory role toward the events.",,,Y,,Y,2.0,,,N,01/06/2021,01/09/2021,3.0,Test Date: 20210109; Test Name: Nasal Swab; Test Result: Negative,PVT,,,,Medical History/Concurrent Conditions: Clot blood; Fish allergy,,USPFIZER INC2021023309,2,01/14/2021,,Y,Y,,True
1552,944512,01/14/2021,IL,39.0,,,F,,"felt kind of tired; Tested positive for COVID after receiving the first dose of the COVID Vaccine; Tested positive for COVID after receiving the first dose of the COVID Vaccine; slight fever; body aches; headache; This is a spontaneous report from a Pfizer-sponsored program. A contactable nurse (the patient) reported that a 39-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/lot number: EK5730) via unspecified route of administration on the left arm/shoulder on 22Dec2020 at single dose for COVID-19 immunisation.  Medical history included gained weight since the pandemic started. The patient's concomitant medications were not reported.  Patient received first dose of the vaccine. She had symptoms right after she got the vaccine the next day, on 23Dec2020. She had a slight fever, body aches, and a headache, which she never gets. She had these for about 2-3 days, they lingered around, and kicked back up around 26Dec2020/27Dec2020. She also felt kind of tired. She got covid 19 infection tested on 02Jan2021 and the results came back positive on 03Jan2021. Patient was calling to report this and see what to do about the second dose. She was supposed to get her second dose next Tuesday. The outcome of events was unknown.; Sender's Comments: Based on the information currently available, a lack of efficacy with the suspected vaccine BNT162B2 cannot be completely excluded. However, individuals may not be protected until at least 7 days after their second dose of the vaccine. It is unlikely that the patient would have fully developed immunity due to the very short time lag between the first vaccine dose and the event onset.",,,,,,,,,U,12/22/2020,12/23/2020,1.0,Test Date: 20210102; Test Name: Covid 19 infection tested; Test Result: Positive,UNK,,,,Medical History/Concurrent Conditions: Weight increase,,USPFIZER INC2021013329,2,01/13/2021,,,,,True
1553,944525,01/14/2021,OH,,,,U,,received the first dose of the vaccine on 21Dec2020 and tested positive for Covid-19; received the first dose of the vaccine on 21Dec2020 and tested positive for Covid-19; This is a spontaneous report from a contactable consumer. A patient of unspecified age and gender received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number and expiration date was not provided) via an unspecified route of administration on 21Dec2020 at single dose for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient received the first dose of the vaccine on 21Dec2020 and tested positive for covid-19 on 07Jan2021. The patient was isolated for 10 days. Outcome of event was unknown.  Information on the lot/batch number has been requested.,,,,,,,,,U,12/21/2020,01/07/2021,17.0,Test Date: 20210107; Test Name: Covid-19; Test Result: Positive,UNK,,,,,,USPFIZER INC2021013475,2,01/14/2021,,,,,True
1582,945504,01/14/2021,CA,36.0,36.0,,F,,"After first vaccine i experienced fatigue, body aches, headache and nausea for 2 days and injection site pain for two weeks. After second Vaccine given at 9:55am. tingling of feet for about 20 mins, 30 mins after the vaccine. Two hours later fatigue, body aches, headache and nausea began. At 0030 1/12/2021 I woke up with severe chills and left chest pain, temp was 101.6 and heart rate was 160. I began to see black and chest pain was severe feeling like i was having a heart atack and was going to pass out so i called 911. I then began to get short of breath and got numbess on my legs, left arm and left side of neck. Chest pressure/pain radiated to left arm and neck. I was taken by the ambulance to hospital. Arrived around 0130. My heart rate sustained at 140s in the ER so I was admitted at 0530 am. My D Dimer was a bit elevated as well as my lactic so I was given a bolus of fluids plus maintenance. I had a CXR done, CTA chest(negative for PE), UA, Labs, entire cardiac workup including an ECHO during my admission. I also began to have loose stools and wrist joint pain. MY heart rate sustained at 125-147 for about 30 hours. Fevers on and off. After everthing was negative we determined this was secondary to the covid 19 vaccine. I was discharged 1/13/2021 at around 1:30 pm. My heart rate is still not at baseline which is 87-90. I'm 100-130 and still get very fatigued with a simple slow walking. Still having tachycardia, fevers, body aches, joint wrist pain, chest discomfort and headaches. My potassium was 3.0 at discharge so will be needing labs in a week. Also bruised a little different than I usually do with lab draws so keeping an eye on them and will be checking my platelets again in a week. Ive been taking tylenol for my fever and pain and ativan for any anxiety when my heart rate goes up. (treatment during  hospital stay was normal saline bolus, nomal saline maintenance fluids at 150 cc/hr, tylenol, ativan, ice packs, rest)",,,,,Y,2.0,,,N,01/11/2021,01/12/2021,1.0,"CTA chest with contrast, chest xray, urinalysis, echocardiogram, blood labs",PVT,,"Vitamin D 50,000 IUs weekly, Ditropan 10mg daily, flexiril 10 mg PRN, melatonin 5mg at bedtime, multivitamins, Alani Nu Balance daily, probiotic",None,"Interstitial cystitis, Vertigo, migraines",,,2,01/14/2021,,,Y,No allergies,True
1591,963168,01/14/2021,,80.0,79.0,,M,,"shaking, altered consciousness Narrative:  One day after pt received his first covid vaccine, pt experienced upper extremity shaking leading to ED visit and subsequent hospitalization with concern for seizure. Examination and labs were not consistent with seizure. He had features of lewy body disease and parkinsonism. Labs were significant for leukocytosis, but pt had no other signs/symptoms of infection or findings to indicate a source of infection. Pt referred to Neurology.",,,,,Y,,,,N,01/05/2021,01/06/2021,1.0,,OTH,,,,,,,2,01/13/2021,,Y,Y,,True
1593,945917,01/15/2021,,,,,F,,"Caller received the first dose of covid 19 vaccine and tested positive for covid.; Caller received the first dose of covid 19 vaccine and tested positive for covid.; Caller received the first dose of covid 19 vaccine and tested positive for covid.; This is a spontaneous report from a Pfizer-sponsored program Pfizer First Connect. A contactable other health professional (patient) reported that a female (age: 22; unit: not reported) patient of an unspecified age received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on an unspecified date at single dose for covid-19 immunization. The patient's medical history and concomitant medications were not reported. The patient received the first dose of COVID 19 vaccine and tested positive for COVID on an unspecified date. She was under quarantine and wanted to know when and if she should get the second dose. Due date for second dose is 11Jan2021. The patient underwent lab tests and procedures which included Covid-19: positive on an unspecified date. The outcome of event was unknown.  Information on the lot/ batch number has been requested.; Sender's Comments: The association between the event lack of effect (Covid-19 test positive) with BNT162b2 can not be completely excluded.",,,,,,,,,U,,,,Test Name: Covid-19; Test Result: Positive,UNK,,,,,,USPFIZER INC2021013785,2,01/14/2021,,,,,True
1595,945934,01/15/2021,,,,,M,,"It felt like a viral meningitis; arm soreness; feel some tension; migraine headache; body started shaking; chills/Rigors; temperature 104; I had sensitivity that I never had; headache; photophobia; Sinophobia; paresthesia/tingling sensation along my upper extremity; I felt like I was freezing; I didn't feel comfortable; vertigo; nausea; hard time to focus; This is a spontaneous report from a contactable other health professional (patient himself). A male patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration in Jan2021 at single dose for covid-19 immunization. The patient's medical history and concomitant medications were not reported.  He didn't have any allergies. He was in good health, no underlying issue. He never had a surgery. In Jan2021, patient got the vaccine last night around. It started with arm soreness. Around 10:00 am he started to feel some tension, migraine headache. Around 11:00 he felt his body started shaking. He had chills, rigors and temperature 104. For 5-6 hours he had sensitivity that he never had. Patient had a headache, photophobia, sinophobia, paresthesia and tingling sensation along his upper extremity. he felt like he was freezing. He didn't feel comfortable. It resolved afterwards, he felt no weakness, no facial paralysis. It felt like a viral meningitis. He also had vertigo, nausea and hard time to focus. Outcome of events were unknown.   Information about lot/batch number has been requested.; Sender's Comments: Based on the temporal relationship, the association between the event viral meningitis with BNT162b2 can not be fully excluded.  The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to regulatory authorities, Ethics Committees, and Investigators, as appropriate.",,,,,,,,,U,01/01/2021,01/01/2021,0.0,Test Date: 202101; Test Name: temperature; Result Unstructured Data: Test Result:104,UNK,,,,,,USPFIZER INC2021013911,2,01/14/2021,,,,,True
1596,945942,01/15/2021,,,,,F,,"I have latent TB and am diagnosed with herpes 1 and 2; I have latent TB and am diagnosed with herpes 1 and 2; This is a spontaneous report from a contactable other health professional. A female patient of an unspecified age received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 11Jan2021 at single dose for covid-19 immunization. Patient had the first dose of the vaccine on 11Jan2021 and she/he had pre-existing conditions. A long time ago, she/he had 2 tachycardia episodes and was sensitive to epinephrine. Patient had latent TB and was diagnosed with herpes 1 and 2 in Jan2021. Outcome of events were unknown.  Information about lot/batch number has been requested.; Sender's Comments: The association between the events ""latent PTB and Herpes 1 and 2"" with BNT162b2 can not be completely excluded.  The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to regulatory authorities, Ethics Committees, and Investigators, as appropriate.",,,,,,,,,U,01/11/2021,01/01/2021,,,UNK,,,,Medical History/Concurrent Conditions: Tachycardia,,USPFIZER INC2021013926,2,01/14/2021,,,,,True
1597,945956,01/15/2021,WI,57.0,,,F,,"difficulty breathing and stridor; difficulty breathing and stridor; noises on inspiration; dizziness; headache; sore throat; Anaphylaxis developed within 2 hours of injection; This is a spontaneous report from a contactable other health professional (patient).  A 57-year-old female patient (not pregnant) received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) (lot number EL0142), via an unspecified route of administration in arm left on 08Jan2021 09:00 at single dose for covid-19 immunisation.  Medical history included Idiopathic Angioedema, Hypothyroidism. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient did not have COVID tested post vaccination and did not have COVID prior vaccination. The patient's concomitant medications were not reported.  Reported Event: Anaphylaxis developed within 2 hours of injection. 9:00 am injection;  9:05 am Developed sore throat, 9:20 am Developed dizziness and headache, 10:00 am developed noises on inspiration, 10:20 am Presented to Emergency Services, 10:40 am IV (intravenous) diphenhydramine (BENADRYL) and dexamethasone (DECADRON), 10:45 am difficulty breathing and stridor, 11:00 am intramuscular Epinephrine, 11:10 am Racemic Epi Nebulizer, 11:20 am Breathing improved, 14:00 Discharged home. The adverse events result in Emergency room/department or urgent care. The outcome of all the events was recovering.; Sender's Comments: A possible causal association between administration of BNT162B2 and the onset of anaphylaxis reactions considering the plausible temporal relationship and the known adverse event profile of the suspect product.  The underlying predisposing condition included Idiopathic Angioedema. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.",,,,,,,,,N,01/08/2021,01/08/2021,0.0,,PVT,,,,Medical History/Concurrent Conditions: Hypothyroidism; Idiopathic angioedema,,USPFIZER INC2021014072,2,01/14/2021,,,Y,,True
1598,945970,01/15/2021,,,,,U,,"Receives dose #1 of the covid vaccine and contracts covid prior to dose #2; Receives dose #1 of the covid vaccine and contracts covid prior to dose #2; This is a spontaneous report from a contactable physician via Pfizer sales representative. This physician reported similar events for two patients. This is 2nd of two reports.   A patient of unspecified age and gender received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot/batch number and expiry date were not provided) solution for injection, via an unspecified route of administration on an unspecified date at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. It was reported that patient received dose #1 of the COVID vaccine and contracts COVID prior to dose #2 on an unspecified date. The patient underwent lab test which included Covid-19 test in which he/she tested positive on an unknown date. Outcome of the events was unknown.  Information about batch/lot number has been requested.; Sender's Comments: A causal association between BNT162B2 and the reported events cannot be excluded based on a compatible temporal relation between vaccination and onset of events. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to RAs, Ethics Committees, and Investigators, as appropriate. ,Linked Report(s) : US-PFIZER INC-2021012928 Same reporter/drug/event, different patient",,,,,,,,,U,,,,Test Name: COVID; Test Result: Positive,UNK,,,,,,USPFIZER INC2021014755,2,01/14/2021,,,,,True
1600,946018,01/15/2021,CA,,,,F,,"received the vaccine on 17Dec2020 the next dose is today but during this time she was positive for covid; received the vaccine on 17Dec2020 the next dose is today but during this time she was positive for covid; This is a spontaneous report from a Pfizer-sponsored program, Pfizer First Connect. A contactable nurse reported for herself, a female patient of an unspecified age who received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiration date unknown), via an unspecified route of administration on 17Dec2020 at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. It was reported that patient received the vaccine on 17Dec2020, the next dose is today (07Jan2021) but during this time she was positive for covid since an unspecified date. She was asking if she would take the second vaccine or if she needed to be revaccinated with the first dose. She was also asking what should she do. The outcome of the events was unknown.  Information on the lot/batch number has been requested.; Sender's Comments: The association between the event lack of effect (positive for COVID) with BNT162b2 can not be fully excluded.",,,,,,,,,U,12/17/2020,,,Test Name: covid; Test Result: Positive,UNK,,,,,,USPFIZER INC2021015982,2,01/14/2021,,,,,True
1605,946082,01/15/2021,,51.0,,,F,,"positive for covid19; positive for covid19; got or felt sick; This is a spontaneous report from a contactable physician reported for self and consumer. This 51-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on Dec2020 at single dose for covid-19 immunisation. As soon as patient got vaccine she got or felt sick  in Dec2020 and had the test and finds out she was positive, so she stays home two weeks and doesn't have no symptom at all and wants to know when has to take a test. The day after the patient developed symptoms thought it was the vaccine, but the symptoms continued for 2-3 days, the 3rd day the patient got herself tested. The patient was positive for covid19 at the time had the shot/ as soon as she got vaccinated she became positive. The patient hasn't had any symptoms for the past 2 weeks. The patient was scheduled to get retested. The patient was scheduled for 2nd dose of vaccine. The patient asked if there are any risks since developed covid the day after getting the vaccine. What if miss today. The patient wanted to know time after having no symptoms past two weeks, when she has to take a test. Outcome of the events was unknown.  Information on the lot/batch number has been requested.; Sender's Comments: Test positive for covid19 found as soon as following the vaccination, no adequate effect of the suspect vaccine thus could be reasonably achieved to protect from the targeted infection/disease due to the very short time lag.",,,,,,,,,U,12/01/2020,12/01/2020,0.0,Test Date: 202012; Test Name: covid test; Test Result: Positive,UNK,,,,,,USPFIZER INC2021018164,2,01/14/2021,,,,,True
1610,946096,01/15/2021,NJ,22.0,,,F,,"started with left sided lower back pain; This is a spontaneous report from a contactable Nurse (patient). A 22-year-old female patient received the first dose of BNT162B2 (lot number: EH9899), via an unspecified route of administration at left arm on 16Dec2020 13:45 at single dose for covid-19 immunization. Medical history included allergies for All fish. The patient's concomitant medications were not reported. The patient had the first covid vaccine on 16Dec2020 and on 20Dec2020 started with left sided lower back pain. The event resulted in Doctor or other healthcare professional office/clinic visit, Emergency room/department or urgent care, Hospitalization (2 days), Life threatening illness (immediate risk of death from the event). The patient received the Heparin drip and xarelto at home for the event. The patient was not pregnant. The patient received the covid test post vaccination on 09Jan2021. Test type was Nasal Swab. The result was negative. The outcome of the event was recovered with sequel on unspecified date.; Sender's Comments: From the information provided it is unclear what is the nature of the reported event and what are the reasons that have put the subject at immediate risk of death. The event is considered possibly related to the suspect product based on the positive temporal association.",,,Y,,Y,2.0,,,N,12/16/2020,12/20/2020,4.0,Test Date: 20210109; Test Name: covid test; Test Result: Negative,PVT,,,,Medical History/Concurrent Conditions: Fish allergy,,USPFIZER INC2021021415,2,01/14/2021,,Y,Y,,True
1611,946098,01/15/2021,MD,44.0,,,F,,"throat closing up; struggled the breath; This is a spontaneous report from a contactable consumer (patient). A 44-year-old female patient (non-pregnant) received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/lot number: Pfizer EL 3302), via an unspecified route of administration on 09Jan2021 07:30 am at single dose at left arm for covid-19 immunization. Medical history included diabetes, high blood pressure, allergies. The patient's concomitant medications were not reported. Patient didn't receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was not diagnosed with COVID-19 prior to vaccination. Since the vaccination, patient has not been tested for COVID-19. On 10Jan2021 14:30, patient woke up with throat closing up and struggled the breath. Patient immediately drank a dose of diphenhydramine hydrochloride (BENADRYL). Patient did that two more time in the evening of 10Jan2021. Patient called the doctor in the morning. Events were considered serious per life-threatening. The adverse events resulted in doctor or other healthcare professional office/clinic visit, life threatening illness (immediate risk of death from the event). Patient received treatment liquid diphenhydramine hydrochloride, epinephrine (EPI-PEN) for events. Outcome of events was recovered in Jan2021.",,,Y,,,,,,Y,01/09/2021,01/10/2021,1.0,,WRK,,,,Medical History/Concurrent Conditions: Allergy; Blood pressure high; Diabetes,,USPFIZER INC2021021602,2,01/14/2021,,Y,,,True
1612,946103,01/15/2021,IL,46.0,,,F,,"chills; body aches; fever; flu like symptoms; headache; was drenched in sweat; This is a spontaneous report from a contactable nurse (patient). A 46-year-old female patient received the second dose of BNT162b2 (lot: EL1283), via an unspecified route of administration in left deltoid on 09Jan2021 15:30 at single dose for covid-19 immunization. Medical history included asthma from Dec2019 and ongoing, insomnia, hypertension. Concomitant medication included ongoing hydrochlorothiazide, metoprolol tartrate (LOPRESSOR HCT) for Hypertension. The patient previously took lopressor and experienced edema. The patient previously received the first dose of BNT162b2 (Lot number: EK5730), intramuscularly in right deltoid at single dose on 19Dec2020 for covid-19 immunization. The patient experienced fever, chills, flu like symptoms, headache all day long on 10Jan2021. The above events were reported as serious as medical significant. No nausea or diarrhea. She had chills and was drenched in sweat on 10Jan2021. She woke up at 10:30 am with chills, body aches on 10Jan2021. Last night at 10 pm she finally fell asleep. She woke up this morning (11Jan2021) and felt fine. The outcome of the event sweating was unknown, other events was recovered on 11Jan2021.; Sender's Comments: Based on a close temporal relationship there is a reasonable possibility of an association between the events and the product. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to regulatory authorities, Ethics Committees, and Investigators, as appropriate.",,,,,,,,,Y,01/09/2021,01/10/2021,1.0,,PVT,,LOPRESSOR HCT,Asthma,Medical History/Concurrent Conditions: Hypertension; Insomnia,,USPFIZER INC2021021984,2,01/14/2021,,,,,True
1629,946978,01/15/2021,FL,49.0,49.0,,M,,"Onset of shortness of breath and cough on 1/3 that progressively got worse. Clinical diagnosis of pneumonia without fever was made, patient started azithromycin on 1/5 and albuterol treatments every 4-6 hrs. Initially he improved, but then worsened.  chest xray on 1/6 was negative for pneumonia, PCR covid test was negative, albuterol treatment did not bring much relief. He started respiratory distress on 1/10 and was taken by car to the local ER where another covid test was negative and chest CT revealed multiple bilateral pulmonary emboli. The leg US revealed blood clots in both of his legs. He had an emergency catheter-delivered thrombolysis and was discharged home from the ICU on 1/12 on oral anticoagulants. He is gradually improving, but very weak. He tires easily and gets a drop in oxygen to 90- 93%, as well as an increase in the heart rate to 120  when walking less than half a mile. He runs out of breath with exertion.",,,Y,,Y,3.0,,Y,N,12/29/2020,01/03/2021,5.0,"PCR covid test 1/4/21 negative Chest Xray 1/6/21 negative  at the ER at the Medical Center on 1/10/21 d-dimer levels were very high, chest CT showed multiple bilateral pulmonary emboli, leg US revealed bilateral emboli",PVT,,"lexothyroxine, vitamin D, montelukast, manesium citrate",Sinus infection at the beginning of December treated with augmentin,"hypothyroidism, allergic rhinitis",,,2,01/15/2021,,,Y,NKDA,True
1634,947480,01/15/2021,NC,22.0,,,F,,"fainting spell; almost passed out; dizzy spells; weak; This is a spontaneous report from a contactable consumer (patient herself). A 22-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot: EL3246), via an unspecified route of administration on 07Jan2021 in right upper arm shoulder area at single dose for prevent covid. Medical history included ongoing acne. Concomitant medication included doxycycline from 2020 (taking it 6 months ago) and ongoing for acne. Patient stated that she got the Covid vaccine yesterday 07Jan2021 and almost passed out in her kitchen after a couple hours. Patient stated got in shower had dizzy spells and was weak 07Jan2021, she felt better now. Patient stated that she was a small girl of 105 pounds and the dose could have made her sick. She wanted to make sure she did not need to go and be seen. Patent had another spell in shower this morning and stated that the fainting spell and feeling weak started at 9:00 yesterday evening on 07Jan2021. Outcome of dizzy spells was recovering, and outcome of other events were unknown.",,,,,,,,,N,01/07/2021,01/07/2021,0.0,,UNK,,,Acne,,,USPFIZER INC2021013720,2,01/15/2021,,,,,True
1640,947501,01/15/2021,TN,50.0,,,F,,"old scar that I forgot that I have there, it just swelled up really bad; The injection site looked like ""a small pox vaccine,"" in which appear red and scabby with a blue dot in the middle; The injection site looked like ""a small pox vaccine,"" in which appear red and scabby with a blue dot in the middle; The injection site looked like ""a small pox vaccine,"" in which appear red and scabby with a blue dot in the middle; The injection site looked like ""a small pox vaccine,"" in which appear red and scabby with a blue dot in the middle; Injection site began to itch; Injection site soreness; This is a spontaneous report from a contactable nurse (patient). A 50-year-old female patient received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL0142 (also reported as EL0140, pending clarification), expiry date: 03Mar2021 (also reported as 31Mar2021, pending clarification), intramuscular on the right arm on 08Jan2021 06:30 at a single dose for covid-19 immunisation. Medical history included heartburn, hot flashes, Grave's disease (father also has Grave's disease), had a thyroidectomy in Dec2015, menopause, weight loss, and appetite control, allergies, compromised immune status (brother and father side with autoimmune), respiratory illness, genetic/chromosomal abnormalities, endocrine abnormalities (including diabetes) and obesity, and diabetes type 2 diagnosed in 2019 (both parents and brother also with diabetes). Concomitant medications included levothyroxine sodium (SYNTHROID) in Dec2015 for Grave's disease and had a thyroidectomy, esomeprazole sodium (NEXIUM [ESOMEPRAZOLE SODIUM]) on 02Jan2021 for heartburn, phentermine for weight loss and appetite control, estradiol on 02Jan2021 for hot flashes and menopause, medroxyprogesterone acetate (PROVERA) on 02Jan2021 for hot flashes and menopause, prednisone for unexplained whelps (pending clarification), and cimicifuga racemosa (also reported as black cohosh) for hot flashes. The patient previously took metformin and experienced GI upset (she quit taking metformin/it was causing GI upset because they increased dose/current dose is 1,000mg twice daily increased from 500 mg twice daily) and generic levothyroxine sodium and experienced feels like crap. The patient had no previous history of immunization with the Pfizer vaccine. No additional vaccines administered on same date of the bnt162b2. No prior vaccinations within four weeks. The patient wanted to know if she can receive the second dose of the Covid vaccine after experiencing adverse events. On 08Jan2021, the patient experienced some injection site soreness, in which she took TYLENOL for. Around 14:30, she noticed that the injection site began to itch. Around 16:00, the injection site looked like ""a small pox vaccine,"" in which appear red and scabby with a blue dot in the middle. The patient also reported, ""scar that I have on my arm, it is not a reaction, it is an old scar that I forgot that I have there, it just swelled up really bad."" Event injection site looked like a smallpox vaccine was assessed as serious-other medically important condition. No emergency room or physician's office required. Therapeutic measure was taken as a result of injection site soreness. Outcome of the event injection site looked like a smallpox vaccine was not recovered. Outcome of the events injection site soreness, injection site began to itch, vaccination site erythema, vaccination site scab, vaccination site discoloration, and old scar that I forgot that I have there, it just swelled up really bad was unknown.; Sender's Comments: Based on the time association, the possible contribution of suspect BNT162B2 to the event vaccination site discomfort cannot be excluded. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.",,,,,,,,,N,01/08/2021,01/08/2021,0.0,,PVT,,SYNTHROID; NEXIUM [ESOMEPRAZOLE SODIUM];  ;  ; PROVERA;  ;,,Medical History/Concurrent Conditions: Allergy; Appetite suppression; Chromosome abnormality; Endocrine disorder; Graves' disease (Father has Graves disease.); Heartburn; Hot flashes; Immunocompromised (brother and father side with autoimmune); Menopause; Obesity; Respiratory disorder; Thyroidectomy; Type II diabetes mellitus (both parents and brother also with diabetes); Weight loss,,USPFIZER INC2021013881,2,01/15/2021,,,,,True
1641,947506,01/15/2021,PA,44.0,,,F,,"Dizzy; headaches; flu feeling; side effects she had were like the COVID symptoms she had, like the chills and everything; lethargic feeling; weak; Nausea; the whole left side of her body went numb including even her vagina; left side of her body was so numb and weird and tingly feeling/left leg went numb; whole left side of face swelled up; left eye turned red; pressure in head; felt like someone squeezing her eyeball out; eye went black/left eye looked bruised/blackness around the eyes; whole face went numb/left side of face slightly numb; bells palsy; allergic reaction; This is a spontaneous report from a contactable consumer (patient).  A 44-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration in arm left on 05Jan2021 at single dose for COVID-19 immunization.  Medical history included cutaneous t-cell lymphoma from 2017 and ongoing, ongoing cholesterol, ongoing thyroid, covid-19 from Nov2020 to an unknown date not ongoing (lasted about 1-1.5 months; she did not have any breathing problems) and blood cancer. Concomitant medication included bexarotene ongoing for cutaneous T-cell lymphoma, rosuvastatin ongoing for cholesterol, levothyroxine ongoing for thyriod. The patient underwent lab tests and procedures which included COVID 19: positive in Nov2020, found out tested positive around holiday. Clinical course: onset about 26 hours after administered the first dose; onset as soon as she got back to work next day: 06Jan2021. The side effects were at their worst for at least 24-48 hours. Further described as all side effects occurred only on left side of her body: whole left side of face swelled up on 06Jan2021; left eye turned red on 06Jan2021; whole face went numb/left side of face slightly numb on 05Jan2021; eye went black/left eye looked bruised on 05Jan2021; pressure in head on 06Jan2021; felt like someone squeezing her eyeball out on 06Jan2021, within the first 24-48 hours, her 'left leg went numb'. She called to talk to physician and nurse who advised her to take Benadryl; which she did take and the Benadryl stopped the side effects; but she could not take a lot of Benadryl or anything because she was at work. She stayed at work because at least there were healthcare professionals, adults in case she passed out; at home she has 7 young children and is also raising her grandchild. The side effects did not completely go away. The arm thing was normal; The next day she was at work and had the swelling on left side of face; blackness around the eyes; arriving home she had headaches on 07Jan2021 and then her leg went numb for like 20 mins; the whole left side of her body went numb including even her vagina; left side of her body was so numb and weird and tingly feeling that she started panicking because she was driving on 06Jan2021. She calmed herself down thinking it's only the left side; you can drive with your right side to get home and be fine. It was more like left side of her body was asleep, tingling, she has never had that happen before. Everything else like the headache, flu feeling was about 48 hours later (on 07Jan2021). She had COVID already back in Nov2020 for about 1-1.5 months; the next side effects she had were like the COVID symptoms she had, like the chills and everything on 06Jan2021. She had the lethargic feeling again, her head was hurting, she felt extremely weak on 06Jan2021. Patient also felt nausea on 06Jan2021, Dizzy on 08Jan2021. Another doctor said it sounded like the side effects she experienced with the vaccine sounded like allergic reaction or Bell's palsy. Patient was asking the doctor if she could get like an Epi-pen or prescription Benadryl or something because she is afraid to get the second dose of Pfizer COVID-19 Vaccine and not have something to respond to side effects with. The outcome of event whole face went numb/left side of face slightly numb was recovered on 07Jan2021, for headaches was recovering, chills and nausea was recovered on 08Jan2021. Outcome of other events was unknown. Information about lot/batch number has been requested.",,,,,,,,,N,01/05/2021,01/01/2021,,Test Date: 202011; Test Name: COVID 19; Test Result: Positive  ; Comments: Found out tested positive around the holidays,PVT,,;  ;,Cholesterol; Cutaneous T-cell lymphoma; Thyroid disorder,Medical History/Concurrent Conditions: Blood disorder; COVID-19 (Lasted about 1-1.5 months; she did not have any breathing problems),,USPFIZER INC2021013904,2,01/15/2021,,,,,True
1642,947507,01/15/2021,,,,,F,,"felt like she had Covid; felt like she had Covid; stomach cramps; chills; aches; not feeling good; temp was around 101- 101.6/fever 102; Icy hot sensation; lethargy; arm was red and swollen; arm was red and swollen; This is a spontaneous report from a non-contactable nurse (patient). A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on an unspecified date at single dose for covid-19 immunization. Medical history included covid-19 from Jul2020. The patient's concomitant medications were not reported. The patient got her injection on Tuesday (specified date unknown) at 3pm. Felt good but then woke up with stomach cramps. She went to work and at around 1pm she started having chills, aches and not feeling good at 4:30 pm her temp was around 101- 101.6 so she took Tylenol went to bed. She woke up with fever 102 and felt like she had Covid all over again reporting that she had covid in Jul. Having what she has heard described as ""Icy hot sensation"" and lethargy and not feeling good with chills aches. Then on Thursday her arm was red and swollen with the redness expanding swelling and her fever was going back up. The outcome of the events was unknown.  No follow-up attempts are possible. Information about lot/batch number cannot be obtained. No further information is expected.; Sender's Comments: Based on the information currently available, the local reactions and flu like symptoms following vaccination with BNT162B2 are more likely attributed to the vaccine use.  Further information like diagnostic detection of virus genetic material or virus protein antigen needed for meaningful medical assessment on protective effects with the vaccine.",,,,,,,,,U,,,,Test Name: temp; Result Unstructured Data: Test Result:101- 101.6; Test Name: temp; Result Unstructured Data: Test Result:102,UNK,,,,Medical History/Concurrent Conditions: COVID-19 (she had covid in Jul),,USPFIZER INC2021013905,2,01/15/2021,,,,,True
1643,947511,01/15/2021,NY,54.0,,,F,,"convulsive chills, fever- (high); convulsive chills; fever- (high); all of my muscles and joints were flaring in extreme pain; all of my muscles and joints were flaring in extreme pain; I could NOT move my vaccine  arm more than 3 inches and my whole body hurt; my vision was extremely blurry; When I tried to walk, it was slow; achy/whole body hurt; tired, and took a nap; This is a spontaneous report from a contactable consumer (patient).  A 54-year-old female patient (no pregnant) received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/lot number: EL0142) via an unspecified route of administration on the left arm on 05Jan2021 11:00 AM at single dose for COVID-19 immunisation.  Medical history included having Covid the 3rd week in Mar2020, Positive for Antibodies in early May2020. Fairly sick but not emergency situation ""Long haulers"" covid symptoms that continued through Nov2020. Patient still had skin pain. Other medical history included hashimoto's. Past drug event included known allergy to codeine. The patient's concomitant medications included 25 mg of Levothyroxine in two weeks. No other vaccine in four weeks. On 05Jan2021 at 12:30, patient felt achy, tired, and took a nap. By 2:00ish. The patient's vision was extremely blurry and continued for 2 days. At 05Jan2021 8 pm- 6 hours later of convulsive chills, fever- (high) and all of her muscles and joints were flaring in extreme pain. Patient could not move vaccine arm more than 3 inches and whole body hurt as if she had been hit by a train. When patient tried to walk, it was slow. Patient groped walls for support. Patient had a televisit with a doctor friend who said this was not a normal side effect and go to emergency room (ER). Doctor or other healthcare professional office/clinic visit. Covid test post vaccination included nasal swab, Covid -19 diagnostic on 08Jan2021 with pending result. No treatment received for events. The outcome of convulsive chills fever was unknown. The outcome of other events was recovered in Jan2021.",,,,,,,,,Y,01/05/2021,01/05/2021,0.0,Test Date: 20210108; Test Name: Nasal Swab; Result Unstructured Data: Test Result:Result Unknown; Comments: Result: Pending,PVT,,,,"Medical History/Concurrent Conditions: COVID-19 (Covid the 3rd week in March ""Long haulers"" covid symptoms that continued through Nov2020); COVID-19 antibody test positive; Hashimoto's disease; Sickness; Skin pain",,USPFIZER INC2021013943,2,01/14/2021,,Y,Y,,True
1644,947518,01/15/2021,OR,34.0,,,F,,"tunnel vision; experienced a sudden onset of vertigo; presyncope; My hands became cold and numb; My hands became cold and numb; fatigue; sore arm, leg/thigh aching; sniffles; sore throat; brief dry cough; slight headache; neck ache; This is a spontaneous report from a contactable Nurse (patient). A 34-year-old non-pregnant female patient received the first dose bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), intramuscular on 05Jan2021 at 12:30 at single dose in left arm for covid-19 immunization. Medical history included Mild ADHD/ADD. The patient's concomitant medications were not reported. Approximately 5 minutes after receiving vaccination, she was standing in the observation room (where they had all of them stay for at least 15 minutes to ensure no severe reactions) and experienced a sudden onset of vertigo, tunnel vision and pre-syncope. Her hands became cold and numb and she was trying to talk to another staff member who was arranging/scheduling her second vaccination dose at the same time when this event occurred, but it subsided quickly and she started to feel normal again. All these events occurred at 12:45 on 05Jan2021. She reported this event right away and they had her stay in the room longer. She was stable at that point but experienced these symptoms again but very mildly twice more while she walked back to her car to go home. Other side effects on 05Jan2021 that started in the evening and for the following 2-3 days included fatigue, sore arm, leg/thigh aching, sniffles/sore throat, brief dry cough and slight headache/neck ache. Very mild and tolerable symptoms. All events were reported as non-serious by reporter. The patient did not receive treatment for the events. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was not diagnosed with COVID-19 prior to vaccination, and the patient has not been tested for COVID-19 since the vaccination. The outcome of all events was resolved in Jan2021.   Information on the lot/batch number has been requested.; Sender's Comments: Based on temporal association, a possible contributory role of BNT162B2 cannot be excluded for reported events. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.",,,,,,,,,Y,01/05/2021,01/05/2021,0.0,,PVT,,,,Medical History/Concurrent Conditions: Attention deficit hyperactivity disorder (Mild ADHD/ADD),,USPFIZER INC2021014145,2,01/14/2021,,,,,True
1645,947528,01/15/2021,MA,,,,F,,"Experienced vasovagal syncope after standing, resulting in fall; Experienced vasovagal syncope after standing, resulting in fall; Awoke with severe chills; nausea; body/muscle aches; body/muscle aches; left arm pain; extreme thirst; fatigue; This is a spontaneous report from a contactable consumer. A 44-year-old female patient (non-pregnant) received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot: EK9231), via an unspecified route of administration on 08Jan2021 14:30 in left arm at single dose for covid-19 immunization. There was no medical history and concomitant medications. Allergies to medications, food, or other products was no. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The most recent COVID-19 vaccine was administered was in hospital. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 09Jan2021 01:30 am, patient woke with severe chills, nausea, body/muscle aches, left arm pain, nausea, extreme thirst. Patient experienced vasovagal syncope after standing, resulting in fall. Worst symptoms were lasted about 30 minutes, muscle aches and fatigue continue about 16 hours later. All events were reported as non-serious. No treatment was received for these events. Outcome of all events were recovering.",,,,,,,,,N,01/08/2021,01/09/2021,1.0,,PVT,,,,Comments: List of non-encoded Patient Relevant History: Patient Other Relevant History 1: None,,USPFIZER INC2021014581,2,01/14/2021,,,,,True
1652,947559,01/15/2021,WI,33.0,,,F,,"had a metallic taste; turned to swollen tongue; hives around chest and neck; difficult to breathe; tachycardia; This is a spontaneous report from a contactable other HCP (Patient). A 33-year-old non-pregnant female received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number=EL 3248), via an unspecified route of administration at right arm on 07Jan2021 16:15 at single dose for covid-19 immunization. Vaccine was administered at hospital. Known allergies included cyclobenzaprine and dairy latex. Concomitant medication included amfetamine aspartate, amfetamine sulfate, dexamfetamine saccharate, dexamfetamine sulfate (ADDERALL) 10 mg, gabapentin 300 mg, venlafaxine 150 mg. No other vaccine in four weeks. Three minutes after vaccination the patient had a metallic taste, turned to swollen tongue, hives around chest and neck, difficult to breathe, and tachycardia on 07Jan2021 16:18. The events resulted in Emergency room/department or urgent care. Treatment received included Epinephrine, methylprednisolone sodium succinate (SOLU-ME dork) and famotidine (PEPCID) also diphenhydramine HCl (BENADRYL). The outcome of the events was unknown.; Sender's Comments: Based on temporal association, a possible contributory role of suspect BNT162B2 cannot be excluded for events metallic taste, swollen tongue, hives, difficulty breathing and tachycardia. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.",,,,,,,,,U,01/07/2021,01/07/2021,0.0,,PVT,,ADDERALL;  ;,,Medical History/Concurrent Conditions: Latex allergy; Milk allergy,,USPFIZER INC2021016363,2,01/14/2021,,,Y,,True
1655,947589,01/15/2021,NY,64.0,,,F,,"tested positive for COVID; tested positive for COVID; This is a spontaneous report from a contactable nurse (patient). A 64-year-old female patient received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EK5730, expiration date: 31Mar2021), via intramuscular on 21Dec2020 at 0.3 mL single in left deltoid for preventative. Medical history included she only had one kidney from 25Feb2020. There were no concomitant medications. It was reported that the patient was supposed (was scheduled) to get her second dose today (11Jan2021) but this past weekend she tested positive for COVID on 09Jan2021. The patient wanted to know if it would affect getting the second dose of the vaccine. The patient supposed to be quarantining right now and she was not symptomatic. On 09Jan2021 she found out she was positive for covid. The outcome of the event was unknown.; Sender's Comments: A causal association between reported event and suspect BNT162B2 cannot be excluded.",,,,,,,,,U,12/21/2020,01/09/2021,19.0,Test Date: 20210109; Test Name: Covid-19; Test Result: Positive,UNK,,,,Medical History/Concurrent Conditions: Kidney disorder (Patient Medical comments: Only has one kidney),,USPFIZER INC2021017654,2,01/15/2021,,,,,True
1658,947595,01/15/2021,,60.0,,,M,,"got the first dose of the vaccine and on 25Dec2020, he started getting symptoms of possible covid; got the first dose of the vaccine and on 25Dec2020, he started getting symptoms of possible covid; This is a spontaneous report from a contactable pharmacist.  A 7-decade-old (65 years or 66 years) male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 25Dec2020 at single dose for COVID-19 immunisation.  The patient medical history and concomitant medications were not reported.  The stated, ""my uncle got the first dose of the vaccine and on 25Dec2020, he started getting symptoms of possible Covid. He got tested for covid today (11Jan2021). He's supposed to get the second dose on 15Jan2021. If he is positive for covid, what does that mean for his second dose?  If he is positive, and waits for quarantine, then he wouldn't be able to get the second dose until day 36.""  The outcome of the events was unknown.   Information on the Lot/Batch Number has been requested.; Sender's Comments: A causal association between reported event and suspect BNT162B2 cannot be excluded.",,,,,,,,,U,12/25/2020,,,Test Date: 20210111; Test Name: covid; Result Unstructured Data: Test Result:Unknown results,UNK,,,,,,USPFIZER INC2021017793,2,01/15/2021,,,,,True
1671,947620,01/15/2021,,,,,U,,"13 people, who were applied the vaccine previously, were corona positive after a week; 13 people, who were applied the vaccine previously, were corona positive after a week; This is a spontaneous report from a non-contactable consumer. This consumer reported similar events for 13 patient. This is the 13th of 13 report.  A patient of unspecified age and gender received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection, batch/lot number unknown), via an unspecified route of administration on an unspecified date at a single dose for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. It was reported that 13 people, who were applied the vaccine previously, were corona positive after a week. on an unspecified date. The outcome of the events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021018407 same reporter, similar suspect drug and event; different patient",,,,,,,,,U,,,,Test Name: corona; Test Result: Positive  ; Comments: after a week,UNK,,,,,,USPFIZER INC2021018419,2,01/14/2021,,,,,True
1672,947622,01/15/2021,,,,,F,,"She tested positive for Covid-19 a week later after receiving the first dose of the vaccine; She tested positive for Covid-19 a week later after receiving the first dose of the vaccine; This is a spontaneous report from a Pfizer-sponsored program IBCC (Inbound Call Center for HCPs) received from a contactable consumer (patient). A female patient of an unspecified age received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot/batch number unknown), via an unspecified route of administration on 29Dec2020 at a single dose for covid-19 immunization. The patient's medical history and concomitant medications were not reported.  The patient took the first dose of Covid-19 vaccine on 29Dec2020. She tested positive for Covid-19 a week later after receiving the first dose of the vaccine. She is scheduled to get the second dose on 19Jan2021 and she was asking what to do. The outcome of the event was unknown.  Information about lot/batch number has been requested.",,,,,,,,,U,12/29/2020,,,Test Name: positive for Covid-19; Result Unstructured Data: Test Result:positive,UNK,,,,,,USPFIZER INC2021018622,2,01/15/2021,,,,,True
1673,947625,01/15/2021,CA,,,,F,,"tested positive for COVID; tested positive for COVID/fatigue, headache, body aches again; allergies were flaring up; Coughing; congestion; body aches; This is a spontaneous report from a Pfizer-sponsored program IBCC (Inbound Call Center for HCPs). A contactable nurse (female) reported that a female patient of an unspecified age received first dose of bnt162b2, via an unspecified route of administration on 21Dec2020 at single dose for covid-19 immunization. The patient's medical history and concomitant medications were not reported. The patient experienced tested positive for covid on 31Dec2020, coughing, congestion, body aches on 24Dec2020, fatigue, headache, allergies were flaring up on 28Dec2020. The caller got her first COVID-19 injection on 21Dec2020. She didn't have symptoms until 2 days after the vaccine. She then experienced coughing, congestion, body aches, but no fever. Then the next day, she felt fine. On 28Dec2020, she thought her allergies were flaring up. She started to feel fatigue, headache, body aches again. She went and got tested for the virus. She tested positive on 31Dec2020. Caller was due for a second vaccine on 11Jan2021. She was to remain in quarantine until 10Jan2021. Caller wanted to know should she get her second shot on 11Jan2021 or should she wait. The patient underwent lab tests and procedures which included Covid-19: positive on 31Dec2020. The outcome of events for tested positive for covid, fatigue, headache and allergies were flaring up was unknown, for other events was resolving.  No further information was obtained. Information on lot/batch number has been requested.; Sender's Comments: A causal association between BNT162B2 and the events drug ineffective and COVID-19 cannot be excluded based on a compatible temporal relation between vaccination and onset of events.",,,,,,,,,N,12/21/2020,12/24/2020,3.0,Test Date: 20201231; Test Name: COVID; Test Result: Positive,UNK,,,,,,USPFIZER INC2021018649,2,01/15/2021,,,,,True
1683,947867,01/15/2021,,,,,M,,"received first dose of bnt162b2/by the 3rd (03Jan2021), he was diagnosed as covid positive; received first dose of bnt162b2/by the 3rd (03Jan2021), he was diagnosed as covid positive; patient lost his sense of smell and taste; patient lost his sense of smell and taste; This is a spontaneous report from a contactable nurse (patient). A male patient of an unspecified age received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number and expiration date not provided), via an unspecified route of administration on 17Dec2020 at SINGLE DOSE for COVID-19 immunisation. Patient's medical history and concomitant medications were not reported. The patient reported he needs advice on the second dose of the vaccine. Patient stated he is an ER nurse and received the first dose of the vaccine on 17Dec2020. On 31Dec2020, patient lost his sense of smell and taste and by the 3rd (03Jan2021), he was diagnosed as covid positive. The patient underwent lab tests and procedures which included Covid test: positive on 03Jan2021. The patient is asking how safe it is to get the second dose now and if there's a time period that he should wait so that he can get the second dose. Outcome of the events was unknown.  Information about lot/batch number has been requested.; Sender's Comments: Based on the information currently available, a lack of efficacy with BNT162B2 in this patient cannot be completely excluded.  Further information like diagnostic detection of virus genetic material or virus protein antigen needed for meaningful medical assessment.",,,,,,,,,U,12/17/2020,12/31/2020,14.0,Test Date: 20210103; Test Name: COVID test; Test Result: Positive,UNK,,,,,,USPFIZER INC2021014026,2,01/15/2021,,,,,True
1781,951972,01/18/2021,KY,69.0,,,F,,"I felt quite sick, like I had the flu; became very lightheaded and dizzy; passed out; felt quite sick; This is a spontaneous report from a contactable consumer (patient). A 69-year-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 08Jan2021 at 12:30 at single dose in left arm for covid-19 immunization. Medical history included R.A.D., osteopenia, migraine with aura, the patient had previously suffered episodes of vasal vagal syncopy when she got the flu or other severe illnesses, and the patient was diagnosed with COVID-19 prior to vaccination. Concomitant medication included atenolol, atorvastatin, azelastine, and fluticasone. The patient previously took gramicidin, neomycin sulfate, polymyxin b sulfate (NEOSPORIN) and experienced allergies. The morning after receiving the vaccine, she felt quite sick, like she had the flu. When she got up from bed and went to the bathroom to urinate, she became very lightheaded and dizzy. She attempted to return to bed, but passed out on the bedroom floor before she could get to the bed, and seized while she was unconscious. Once she came to, she was helped to bed and, after about 90 minutes, felt much better, and got up, and ate food and had coffee. All events occurred at 07:30 AM on 09Jan2021. All events were reported as non-serious by reporter. The patient did not receive treatment for the events. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient has not been tested for COVID-19 since the vaccination. The outcome of the events was resolved in Jan2021.   Information on the lot/batch number has been requested.",,,,,,,,,Y,01/08/2021,01/09/2021,1.0,,UNK,,;  ;  ;,,Medical History/Concurrent Conditions: COVID-19; Flu; Migraine with aura; Osteopenia; Reactive attachment disorder of infancy or early childhood (R.A.D.); Syncope vasovagal,,USPFIZER INC2021014461,2,01/15/2021,,,,,True
1782,951973,01/18/2021,VA,30.0,,,F,,"Blacked out; Fainted; Felt very unwell; Nauseous; Chills; Fell; Knocked out, hit her nose, started to bleed; Humongous scar on her nose; In her hand there's a rash with different dots/red; She has petechiae/rash on the forearm; hit her face; knocked out, hit her nose; This is a spontaneous report from a contactable physician. This physician reported that a 30-year-old female patient (daughter) received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 08Jan2021 at single dose for covid-19 immunization. The patient's medical history and concomitant medications were not reported. The patient experienced blacked out, fainted, felt very unwell, nauseous, chills, fell, knocked out, hit her nose, started to bleed, humongous scar on her nose, in her hand there's a rash with different dots/red, she has petechiae/rash on the forearm, all on an unspecified date in Jan2021. The Caller wanted information on side effects specifically looking at platelet or clotting or bleeding issues. Her daughter, (female, age 29 date of birth) received the 2nd dose of Pfizer vaccine, received it at the (State name), last night. She felt very unwell, nauseous, chills, and then blacked out, fell, knocked out, hit her nose, started to bleed; fainted and hit her face, didn't stop bleeding for 2 hours. There's a humongous scar on her nose. It took 2 hours to stop bleeding. She's going to urgent care today. Her daughter was healthy, yesterday was 2nd dose. In her hand, there's a rash with different dots/red. She has petechiae/rash on the forearm. Thankfully it (bleeding) did stop. The outcome of events for 'knocked out, hit her nose, started to bleed' was resolved on an unspecified date, for other events was unknown. The case was reported as non-serious.  Information on the Batch/Lot number has been requested.; Sender's Comments: Based solely on a chronological association a causal relationship between events blacked out  and fainted and BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), cannot be completely excluded. The case will be reevaluated should additional information become available. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.",,,,,,,,,Y,01/08/2021,01/01/2021,,,UNK,,,,,,USPFIZER INC2021014489,2,01/15/2021,,,,,True
1803,952497,01/18/2021,IL,40.0,40.0,,M,,"Patient with PMH of depression and GERD who presented 1/8 with constipation, abdominal discomfort and worsening dyspnea. Symptoms began around 12/29. COVID vaccine 12/19. Previously quite active, marathon runner, gained some weight over last couple years but was still in good enough shape to complete 10K in New Orleans in early February. In late February, had a flu-like illness, as did one of his friends from church. 2020 was hard on him - weight gain, decreased activity, stress, overall deconditioning. No issues apart from sore arm after COVID vaccine 12/19 but then starting getting abdominal fullness/discomfort around 12/29, which steadily worsened, also develop worsening dyspnea on slight exertion. No known sick contacts.. Work-up notable for pericardial effusion, pleural effusions. Echo with severe diffuse LV hypokinesis, concern raised for myocarditis. COVID PCR negative, serology negative. RVP negative. . Concern raised that COVID vaccine may have played a role in myocarditis. He was found to have the following conditions Acute heart failure with reduced EF NYHA FC II,  non-ischemic cardiomyopathy. Myocarditis appears subacute per MRI hypertension obesity small pericardial effusion- asysmptomatic no pericarditis suspected obstructive sleep apnea.   .Started on the following medications. Continue Carvedilol 12.5mg BID, Farxiga 5mg daily, Digoxin 0.125mg daily, Entresto 97-103mg BID, and Spironolactone 25mg daily.   Per MD note.  While it remains uncertain, team is doubtful COVID vaccine played a role in his cardiac issues. Given the MRI findings are not acute, more likely that the cardiac insult occurred weeks to months ago - potentially in the setting of the February 2020 illness. Perhaps his ""deconditioning"" in 2020 was related to worsening cardiac function. Nevertheless, will hold on 2nd COVID vaccine dose given absence of a clear explanation for his myocarditis. conversation with team will continue to determine if candidate for second covid vaccine. If consensus is that myocarditis pre-dated vaccine, might be able to proceed with dose 2 of vaccine.",,,,,Y,5.0,,,N,12/19/2020,01/08/2021,20.0,"Echo with severe diffuse LV hypokinesis 1/12 Hepatitis panel negative, EBV/CMV IgG positive/IgM negative,  1/12 COVID antibody: negative 1/9 RVP negative 1/8 COVID PCR negative RADIOLOGY:  MRI cardiac 1/11:  1. There is linear mid myocardial late gadolinium enhancement in the inferoseptal wall of the left ventricle in a nonischemic pattern. This may represent sequela of myocarditis.  Findings do not appear to be acute. 2. The left ventricle is dilated with global hypokinesis and significantly reduced LV systolic function. The calculated left ventricular ejection fraction is 25%. There is also diastolic dysfunction. 3. The right systolic function is also reduced with ejection fraction of 30%. 4. There is a moderate-sized pericardial effusion without evidence of pericarditis or constrictive physiology.   CT chest 1/8: 1.  No evidence of pulmonary embolism. 2.  Mild cardiomegaly with small/moderate-sized pericardial effusion that appears mildly increased in size from the earlier abdominal CT. There are findings of mild pulmonary edema which are greatest in the lung bases and are new from the earlier abdominal CT. 3.  Small/moderate right and small left pleural effusions which have mildly increased in size from the earlier abdominal CT. 4.  Nonspecific mediastinal and right hilar lymphadenopathy   CT A/P 1/8: 1.  No evidence of acute abdominal/pelvic abnormality. 2.  Small/moderate-sized pericardial effusion. 3.  Small right and trace left pleural effusions.",PVT,,Nexium 20mg po daily Duloxetine 60mg po daily Ibuprofen as needed Vitamin D,,none,,,2,01/18/2021,,,Y,NKDA,True
1809,952707,01/18/2021,NH,38.0,38.0,,M,,"Anaphylaxis (urticaria, tongue swelling, subjective difficulty breathing) starting approx. 24hrs first moderna dose. No prior episodes of anaphylaxis/allergic rxn. Treated with Benadryl 100mg PO (prior to arrival, pt administered), famotidine 20mg IV, Epinepherine 0.3mg IM. Monitored in ED, complete resolution of symptoms, discharged home.",,,Y,,,,,,Y,01/14/2021,01/15/2021,1.0,,PVT,,colchicine,None,Gout,,,2,01/18/2021,,,Y,NKDA,True
1815,952872,01/18/2021,IL,80.0,80.0,,M,,"80YO male who htn, cva, epilepsy, ckd, cerebral avm s/p repair, cad s/p cab, cva (left sided hemiplegia) , hx of prostate cancer recent admission for pna on abx presents to ED on 1/11 with dizziness, hypoxia. CT with Bilateral PE  ""Large bilateral pulmonary artery emboli in the right and left main pulmonary artery extending into the right and left main pulmonary artery branches bilaterally. Findings are associated with right-sided heart strain."" ""Patchy alveolar airspace disease within the lungs highly suspicious for COVID pneumonia"" Covid negative. Patients wife recovered from Covid-19 infection within last month. Patent thus far has tested negative. Doppler lower extremity revealed Acute occlusive vein thrombosis of the entire course of the gastrocnemius vein and soleal vein. Patient received covid vaccine on 1/4/21. Patient has several risk factors for clot - age, previous CVA, hx of prostate cancer. Also had positive covid exposure though tested negative",,,,,Y,8.0,,,N,01/04/2021,01/11/2021,7.0,"Xray Chest Single View  Result Date: 1/11/2021 IMPRESSION: Cardiomegaly with borderline pulmonary vascularity. Persistent left lower lobe consolidation associated with a small left-sided pleural effusion. Minimal right basilar subsegmental atelectasis is present.  Ct Chest (pe Protocol)  Result Date: 1/11/2021 IMPRESSION: 1. Large bilateral pulmonary artery emboli in the right and left main pulmonary artery extending into the right and left main pulmonary artery branches bilaterally. Findings are associated with right-sided heart strain. 2. Patchy alveolar airspace disease within the lungs highly suspicious for COVID pneumonia. 3. Reflux of contrast into the inferior vena cava as well as the hepatic veins which can be seen in the setting of right-sided cardiac insufficiency.  Echo 1/12/21 Conclusions:  1. Normal LV ejection fraction of 66 %.  2. Septal motion is right ventricular volume overload.  3. Borderline concentric left ventricular hypertrophy.  4. The left ventricular cavity size is decreased.  5. Mild aortic insufficiency.  6. Moderate calcification in the aorta.  7. Severely enlarged right ventricle.  8. Severely reduced RV systolic function.  9. The right atrial area is mildly dilated.  10. Mild tricuspid valve regurgitation.  11. Left atrial pressure is normal.  12. The left atrial volume index is normal at 18 ml/m.  13. Moderate PHTN with PA systolic pressure estimated at 49 mmHg.  14. Compare to prior study, RV is larger, RV systolic function is worse, LV is smaller.   LE doppler 1/12/21: FINDINGS:  Right Lower Extremity:  Acute occlusive vein thrombosis of the entire course of the gastrocnemius vein and soleal vein. Incompressible entire course of the gastrocnemius vein and soleal vein. Fully compressible entire course of the femoral vein, common femoral vein, deep  femoral vein, popliteal vein, posterior tibial vein, peroneal vein, saphenofemoral junction, saphenopopliteal junction, great saphenous vein and small saphenous vein.    Left Lower Extremity:  The left common femoral, femoral, profunda femoris, popliteal and calf veins were examined. The veins are easily compressible and appear normal. There is normal spontaneous and phasic flow. The left great saphenous and small saphenous veins also appear  normal.   IMPRESSION:  1. Right: Acute occlusive vein thrombosis of the entire gastrocnemius vein and soleal vein.  2. No acute deep vein thrombosis or superficial vein thrombosis seen in the left leg.",SEN,,aspirin 81mg daily Vitamin B-1 100mg daily  Escitalopram 20mg daily gabapentin 100mg daily Levetiracetam 1000mg BID and 500mg qhs Pantoprazole 20mg daily Phenytoin 250mg qhs rosuvastatin 20mg daily Tamsulosin 0.4mg daily MVI daily  Vitamin,pneumonia treated with vantin (1/10),"hx of HTN, epilepsy, CKD, cerebral AVM s/p repair, CAD, CVA (left sided hemiplegia), ischemic heart disease s/p CABG",,,2,01/18/2021,,,,nsaids  -patient reports contribute to seizures,True
1818,953065,01/18/2021,MN,29.0,,,F,,"a low grade fever; cough; doesn't feel very well; feeling yucky; soreness in the arm where vaccine was given; This is a spontaneous report from a contactable Nurse (reporting for herself).  A 29-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE solution for injection, bacth/lot no: EK9231 while expiry date was unknown), intramuscular on left deltoid on 07Jan2021 16:45 at a single dose for covid-19 immunization.  There were no medical history and concomitant medications reported. Patient has no prior vaccination within 4 weeks.The patient got her first dose of the  COVID 19 vaccine yesterday (07Jan2021) from her employer.  She started ""feeling yucky"" today (08Jan2021) around noon with a low grade fever,and developed a cough that was not persistent. Patient has soreness in the arm where vaccine was given. She was asking what should she do about it? Outcome of the events low grade fever, cough, feeling unwell, feeling abnormal were not recovered while vaccination site pain was unknown. The events low grade fever, cough, feeling unwell were considered serious medically significant and related to vaccine.; Sender's Comments: Based on the time association, the events fever, cough and malaise are possibly related to suspect BNT162B2 administration. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.",,,,,,,,,N,01/07/2021,01/08/2021,1.0,,PVT,,,,Comments: List of non-encoded Patient Relevant History: Patient Other Relevant History 1: None,,USPFIZER INC2021013928,2,01/15/2021,,,,,True
1830,953086,01/18/2021,TN,31.0,,,F,,"I had a very early miscarriage at five weeks; I had a very early miscarriage at five weeks; I had a very early miscarriage at five weeks; This is a spontaneous report from a contactable Physician (patient). A 31-year-old female patient received BNT162B2 first dose of (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EJI685) intramuscular at arm right on 19Dec2020 06:30 at single dose for covid-19 immunization. Facility type vaccine was hospital. Medical history was none. The patient had no known allergies or other medical history. There were no concomitant medications. No other vaccine in four weeks and no other medications in two weeks. The patient experienced a very early miscarriage at five weeks on 01Jan2021. The event result in doctor or other healthcare professional office/clinic visit. No treatment received. The outcome of the event miscarriage was recovered in Jan2021. No covid prior vaccination and no covid tested post vaccination.; Sender's Comments: All pregnancies have a risk of birth defect, loss, or other adverse outcomes. The data on BNT162B2 administered to pregnant women is insufficient to make a meaningful medical assessment hence, the events are conservatively assessed as related to the suspect drug BNT162B2 until further information becomes available.  The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to RAs, Ethics Committees, and Investigators, as appropriate.",,,,,,,,,Y,12/19/2020,12/19/2020,0.0,,PVT,,,,Comments: List of non-encoded Patient Relevant History: Patient Other Relevant History 1: None,,USPFIZER INC2021014948,2,01/18/2021,,Y,,,True
1831,953087,01/18/2021,PA,24.0,,,F,,"almost pass out; Chills; nausea; diarrhea; abdominal pain; clammy; elevated heart rate; dizzy; This is a spontaneous report from a contactable consumer (patient's parent). A 24-year-old female patient (pregnant: No) received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EK9231) via an unspecified route of administration on left arm on an unspecified date in Dec2020 at single dose for COVID-19 immunization. The relevant medical history included asthma, migraines and anxiety all from an unspecified date. Concomitant medications included ethinylestradiol, etonogestrel (NUVARING), topiramate (TOPAMAX), verapamil and sertraline hydrochloride (ZOLOFT). The patient experienced chills, nausea, diarrhea, abdominal pain, clammy, elevated heart rate, almost pass out, dizzy, all on 05Jan2021. The patient had no treatment for the events. No covid prior vaccination. The patient underwent lab test included heart rate showed elevated on 05Jan2021, Nasal Swab showed negative on 06Jan2021. The outcome of the events was not recovered.",,,,,,,,,N,12/01/2020,01/05/2021,35.0,Test Date: 20210105; Test Name: heart rate; Result Unstructured Data: Test Result:elevated; Test Date: 20210106; Test Name: Nasal Swab; Test Result: Negative,PVT,,NUVARING; TOPAMAX;  ; ZOLOFT,,Medical History/Concurrent Conditions: Anxiety; Asthma; Migraine,,USPFIZER INC2021015025,2,01/17/2021,,,,,True
1832,953089,01/18/2021,TN,21.0,,,F,,"Rash on lower legs similar to that seen with Thrombocytopenia.; Rash on lower legs similar to that seen with Thrombocytopenia.; This is a spontaneous report from a contactable Other HCP (patient). A 21-year-old female patient (not pregnant) received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number= EJ1686), via an unspecified route of administration at Left arm on 05Jan2021 10:00 AM at single dose for covid-19 immunization. The COVID-19 vaccine was administered at Hospital. The patient's medical history and concomitant medications were unknown. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient experienced rash on lower legs similar to that seen with thrombocytopenia on 09Jan2021 at time of 12:00 PM. No treatment received for the events. Prior to vaccination, the patient was not diagnosed with COVID-19 and since the vaccination, the patient was not been tested for COVID-19. The outcome of the events was not recovered.; Sender's Comments: A possible contributory effect of suspect drug on reported thrombocytopenia cannot be excluded.  The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to regulatory authorities, Ethics Committees, and Investigators, as appropriate.",,,,,,,,,N,01/05/2021,01/10/2021,5.0,,PVT,,,,,,USPFIZER INC2021015112,2,01/18/2021,,,,,True
1834,953092,01/18/2021,WY,48.0,,,F,,"tingling sensation in right eye and mid cheek area,Unable to wink, or scrunch right eye; muscles on the right side of my face were noticeably weaker; This is a spontaneous report from a contactable nurse (patient).  This 48-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot # EH9899), via an unspecified route of administration, on 23Dec2020 at 04:00 PM at single dose for COVID-19 immunisation. Vaccine location was right arm.  The patient was vaccinated at Public Health Clinic/Veterans Administration facility, age at vaccination was 48-years-old. No other vaccine was received in four weeks. Medical history included gastrooesophageal reflux disease (GERD). Known allergies included levofloxacin (LEVOFLOXACIN), pethidine hydrochloride (DEMEROL), phenobarbital, cefalexin monohydrate (KEFLEX), charithromycin (BIAXIN). Concomitant medications included dexlansoprazole (DEXILANT), estradiol, phentermine, ergocalciferol (VIT D), calcium. The patient was not tested for covid prior or post vaccination.  On 23Dec2020 at 04:45 PM, after leaving the clinic, the patient felt tingling sensation in right eye and mid cheek area. Within 1.5 hours, muscles on the right side of her face were noticeably weaker. Unable to wink, or scrunch right eye. The events resulted in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient was treated with prednisone. Outcome was recovering.; Sender's Comments: Based on a close temporal relationship causality between events ""tingling sensation in right eye and mid cheek area"" and ""muscles on the right side of her face were noticeably weaker"" and BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) cannot be excluded. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.",,,,,,,,,N,12/23/2020,12/23/2020,0.0,,PUB,,DEXILANT;  ;  ; VIT D;,,Medical History/Concurrent Conditions: GERD,,USPFIZER INC2021015717,2,01/18/2021,,Y,Y,,True
1838,953098,01/18/2021,,,,,F,,"Stevens Johnson Syndrome; rash was starting to peel; developed a rash all over her neck/ the rash has spread to face eyes, cheek; developed a rash all over her neck, ""looks like its peeling and taut""; developed a rash all over her neck, ""looks like its peeling and taut""; This is a spontaneous report from a contactable nurse (patient). A female patient of an unspecified age (Age: 48, Unit unknown) received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 10Jan2021 at single dose for covid-19 immunization. Medical history included she had an allergic reaction to sulfa and developed Stevens Johnson syndrome from an unknown date and unknown if ongoing. The patient's concomitant medications were not reported. The patient experienced Stevens Johnson Syndrome, developed a rash all over her neck/ the rash has spread to face eyes, cheek; ""looks like its peeling and taut""; and the rash was starting to peel, all in Jan2021. The patient received 1st dose of vaccine on 10Jan2021, developed a rash all over her neck, ""looks like its peeling and taut"". She had an allergic reaction to sulfa and developed Stevens Johnson syndrome, this looks similar to that (Experience of Stevens Johnson Syndrome). The patient was asking if she did take the steroid dose pack from her dermatologist for the skin rash will it prohibit her from taking the second dose of the vaccine. She called yesterday and reported a rash after receiving the first dose of the COVID-19 vaccine. She stated that she went to her Dermatologist this morning because the rash has spread to face eyes, cheek and the rash was starting to peel. She stated that the dermatologist wanted to know if it was safe to treat her with a prednisone dose pack after receiving the vaccine. Her rash was worsening so she went to her dermatologist for treatment. She was asking if she should get the second dose. The outcome of events for developed a rash all over her neck/ the rash has spread to face eyes, cheek was not resolved, for other events was unknown.  Information about lot/batch number has been requested.; Sender's Comments: A possible causal association between administration of BNT162B2 and the onset of suspect Stevens Johnson Syndrome presented as skin reactions cannot be excluded, considering the plausible temporal relationship.  Severe allergic reaction is the known risk for the vaccine. The underlying predisposing condition of an allergic reaction to sulfa developed Stevens Johnson syndrome may put the patient at high risk of the similar occurrence. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate",,,,,,,,,N,01/10/2021,01/01/2021,,,UNK,,,,,,USPFIZER INC2021017792,2,01/16/2021,,,,,True
1839,953099,01/18/2021,MI,31.0,,,F,,"following day around 7pm lip swelling; tongue tingling; body hives; chills; After first dose of Covid vaccine face flushing; increased HR about 45 mins. went away on its own; hours later left eye swollen; This is a spontaneous report from a contactable Nurse (patient). A 31-years-old female patient received first dose of bnt162b2 (BNT162B2, Lot number: EK9231), via an unspecified route of administration on 06Jan2021 15:00 at single dose on Left arm for covid-19 immunisation. Medical history included Known allergies: Shellfish, IV contrast dye, Penicillin. There were no concomitant medications. No other vaccine in four weeks. No other medications in two weeks. The patient experienced after first dose of covid vaccine face flushing; increased hr about 45 mins. went away on its own since 06Jan2021 16:00; hours later left eye swollen on 06Jan2021; following day around 7pm lip swelling, tongue tingling, body hives, chills on 07Jan2021 19:00. The patient underwent lab tests and procedures which included heart rate: increased on Jan2021. Ae resulted in: Doctor or other healthcare professional office/clinic visit, Emergency room/department or urgent care. Ae treatment: Steroids, IV fluids, Benadryl. No COVID prior vaccination. No COVID tested post vaccinate. This report was reported non-serious. The event outcome of increased hr about 45 mins. went away on its own was recovered on 06Jan2021 16:45, outcome of other events were not recovered.; Sender's Comments: Based on the compatible time association, the serious events are possibly related to suspect BNT162B2 administration. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.",,,,,,,,,N,01/06/2021,01/06/2021,0.0,Test Date: 202101; Test Name: HR; Result Unstructured Data: Test Result:increased,PVT,,,,Medical History/Concurrent Conditions: Contrast media allergy; Penicillin allergy; Shellfish allergy,,USPFIZER INC2021017865,2,01/16/2021,,Y,Y,,True
1843,953107,01/18/2021,,36.0,,,F,,"Slight left sided facial weakness/droop 4 days post vaccination; Slight left sided facial weakness/droop 4 days post vaccination; Tingling in injected arm and facial tingling in cheeks/lips same day of vaccination/Tingling to lower extremities; Tingling in injected arm and facial tingling in cheeks/lips same day of vaccination; Tingling in injected arm and facial tingling in cheeks/lips same day of vaccination; This is a spontaneous report from a contactable consumer (patient herself).  A 36-year-old female patient received her first dose of bnt162b2 (BNT162B2 also reported as COVID 19 brand Pfizer, lot EK9231), via an unspecified route of administration in the left arm on 04Jan2021 13:00 at single dose, for Covid-19 immunisation. The vaccine was given in a Nursing Home/Senior Living Facility. Medical history was none. No known drug allergies. No other vaccine in four weeks. No Covid-19 prior vaccination. Concomitant medication included naproxen sodium (ALEVE). The patient experienced tingling in injected arm and facial tingling in cheeks/lips same day of vaccination (04Jan2021). Tingling to lower extremities the day after vaccination (still continuing). Slight left sided facial weakness/droop 4 days post vaccination (04Jan2021). Tingling to left arm continuing on and off. No treatment reported. On 04Jan2021, she was negative to PCR covid test post vaccination. She went to the Emergency room/department or urgent care. The outcome of events was not recovered.",,,,,,,,,N,01/04/2021,01/04/2021,0.0,"Test Date: 20210104; Test Name: COVID-19; Result Unstructured Data: Test Result:Negative, PCR",OTH,,ALEVE,,Comments: List of non-encoded Patient Relevant History: Patient Other Relevant History 1: none,,USPFIZER INC2021018877,2,01/16/2021,,,Y,,True
1844,953109,01/18/2021,AL,36.0,,,M,,"slurring speech; rash around his neck and upper chest; his earlobes were bright red, as was his nose; mouth was dry; nose was dry; dry throat; almost ""drunk""; Only abnormal finding was BP 159/94; This is a spontaneous report from contactable pharmacist. A 36-year-old male patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number=EL1283 and Expiration Date unknown) via Intramuscular on 08Jan2021 11:25 at single dose for COVID-19 immunisation. The patient's medical history was reported toradol made him feel lightheaded and foggy (similar to his first Pfizer BioNTech covid vaccine), Attention deficit hyperactivity disorder (ADHD). History vaccine included first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number =EK5730 and Expiration Date unknown) via Intramuscular on 18Dec2020 at single dose for COVID-19 immunisation. Patient did report that on first vaccine it made him feel a little sluggish, tired and foggy minded. The concomitant medications were reported as amfetamine aspartate, amfetamine sulfate, dexamfetamine saccharate, dexamfetamine sulfate (Adderall XR) at 25mg twice a day (BID) and escitalopram oxalate (LEXAPRO) oral (PO) at 10mg every day. No other vaccine in four weeks. Patient was vaccinated at 11:25. Patient was observed for 30 minutes. Pharmacist checked on patient at 17 minutes after vaccination - he was fine able to communicate and showed no signs of distress. Pharmacist came back and checked on patient at 25 minutes after vaccination (11:50)  and patient was slurring speech, had developed rash around his neck and upper chest, his earlobes were bright red, as was his nose - mouth was dry, reported dry throat - no visible swelling of the lips or tongue. Patient was transported to ED (2 min) Home meds: Adderall XR 25mg BID [Twice a day], Lexapro 10mg Q [every]PM. Only abnormal finding was BP 159/94 - after initial workup patient was noted to be almost ""drunk"" as reported by Emergency Room (ER Doc). Patient was offered diphenhydramine declined several times but eventually agreed. Approx 30 min after diphenhydramine patient fully recovered and stated ""I'm back"". The second dose reaction was much more exaggerated and lasted much longer. No COVID prior vaccination and no COVID tested post vaccination. The adverse event result in Emergency room/department or urgent care. The outcome of events was recovered in Jan2021 after treatment was given.; Sender's Comments: Based on the time association, all events are possibly related to suspect BNT162B2 administration. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.",,,,,,,,,Y,01/08/2021,01/08/2021,0.0,Test Date: 20210108; Test Name: BP; Result Unstructured Data: Test Result:159/94,PVT,,LEXAPRO; ADDERALL,,Medical History/Concurrent Conditions: ADHD,,USPFIZER INC2021018900,2,01/16/2021,,,Y,,True
1859,953587,01/18/2021,NJ,55.0,,,M,,"severe body aches; severe chills; night sweats; Fatigue; This is a spontaneous report from a contactable Physician (patient). A 55-year-old male patient received the second dose bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 06Jan2021 at 12:00 at single dose in left arm for covid-19 immunization. The patient's medical history and concomitant medications were not reported. The patient previously received the first dose bnt162b2 in Dec2020 three weeks ago at 12:00 noon in the left arm for covid-19 immunization and experienced mild pain at the injection site which lasted two days and then was gone. The patient experienced severe body aches, severe chills, night sweats, and fatigue on 07Jan2021. Event details: The patient reported that he received the first dose of the Pfizer COVID 19 vaccine three weeks ago at 12:00 noon in the left arm. He did not know the exact date. After the first dose there was mild pain at the injection site which lasted two days and then was gone. He received the second dose of the Pfizer COVID 19 vaccine on 06Jan2021 at 12:00 noon in the left arm. He noticed 12 hours later severe body aches, severe chills, and night sweats. He also felt fatigue. Everything had mostly resolved except for the night sweats and they were still pretty severe. All events were reported as serious by reporter per medically significant. The outcome of event night sweats was not resolved, outcome of other events was resolved on 10Jan2021.  Information about lot/batch number has been requested.; Sender's Comments: The Company cannot completely exclude the possible causality between the reported severe body aches, severe chills, fatigue and night sweats, and the administration of the COVID 19 vaccine, bnt162b2, based on the reasonable temporal association.   The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to RA, IEC, as appropriate.",,,,,,,,,N,01/06/2021,01/07/2021,1.0,,PVT,,,,,,USPFIZER INC2021024849,2,01/16/2021,,,,,True
1863,953596,01/18/2021,,,,,U,,"Congestion in my lungs; I am coughing up junk; This is a spontaneous report from a contactable consumer (patient). A patient of unspecified age and gender received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number and expiry date was not reported) via an unspecified route of administration on an unspecified date at single dose for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient experienced congestion in lungs and was reportedly coughing up ""junk"" on an unspecified date. It was also reported that the patient woke up this morning with a pretty bad side effect. Outcome of events was unknown.  Information on the lot/batch number has been requested.",,,,,,,,,U,,,,,UNK,,,,,,USPFIZER INC2021031208,2,01/18/2021,,,,,True
1883,954265,01/18/2021,DE,27.0,27.0,,F,,"Received shot Wednesday night, developed arm soreness and mild flu like symptoms on left side of my body and facial paresthesias on the left side of my face. Twelve hours later, after waking up those same symptoms were only on the right side of my body. Friday morning, mostly normal physically just with some overall fatigue. Friday afternoon I started to get hives on my chest and overnight into Saturday they were on my lower back, sides, and legs. I took 50 mg of Benadryl every 6-12 hours until Monday mid-day when Benadryl was not helping reduce the hives and so I had full body hives. I did try an drugstore cortisone cream which did not help.  Sought treatment at an urgent care as I was feeling anxious and could not control the itching. I and was diagnosed with likely allergic reaction to the covid-19 vaccine.",,,Y,,,,,,N,01/13/2021,01/15/2021,2.0,"None, just vital signs at clinic. I did take a blood pressure at home and it was stable and my pulse was high normal for me. (80s)",WRK,,Adderall 15 mg xr,"ADD, gastric sleeve surgery, chronic sinusitis","Chronic sinusitis, ADD, history of diabetes but no longer diabetic (as of 2019)",,,2,01/18/2021,,,Y,None,True
1885,954305,01/19/2021,TX,64.0,,,F,,"She woke up soaking wet. She had sweats kind of.; Tested positive for COVID; Tested positive for COVID; This is a spontaneous report from a Pfizer-sponsored program Pfizer First Connect. A contactable nurse (patient herself) reported that a 64-year-old female patient received her first dose of bnt162b2 (BNT162B2 also reported as PFIZER-BIONTECH COVID-19 VACCINE, lot EK5730, expiry date not reported), via an unspecified route of administration in the upper left arm on 21Dec2020 17:00 at SINGLE DOSE for Covid-19 immunisation. Medical history included ongoing hypertension (blood pressure high). She was a former smoker, a teenage smoker. She has not smoked since the age of 19 years old. Concomitant medication included amlodipine for high blood pressure. The patient informed that she was vaccinated on 21Dec2020. On 05Jan2021, she had a positive COVID Test and she was wondering when she should have the second dose of the COVID Vaccine. She thought initially she just had a cold. She took the COVID test as a precaution. It started out with a stuffy nose. She had a congested cough, upper airway cough, nothing deep in the lungs. She had a low grade fever. It was like 99.9. It was possible it was higher, but she had taken Ibuprofen at night. She woke up soaking wet. She had sweats kind of. Her temperature however never registered a true fever if a fever  was considered 100.4. She was not really having body aches any more unusual than one would have for a 64 year old. She has a very mild sore throat. Her stuffy nose had improved, it's still there slightly, but not like it was the first few days. The outcome of events was unknown.; Sender's Comments: Test positive for covid19 found 14 day following the first dose of COVID-19 vaccination, bnt162b2, no adequate effect of the suspect vaccine thus could be reasonably achieved to protect from the targeted infection/disease due to the very short time lag.",,,,,,,,,U,12/21/2020,01/05/2021,15.0,Test Name: temperature; Result Unstructured Data: Test Result:99.9.; Test Date: 20210105; Test Name: COVID Test; Test Result: Positive,PVT,,,,Medical History/Concurrent Conditions: Hypertension; Smoker,,USPFIZER INC2021013267,2,01/17/2021,,,,,True
1891,954325,01/19/2021,CA,48.0,,,M,,"Fevers; Chills; he is suspecting that he got infected with the Covid-19 though he already received the 1st dose; he is suspecting that he got infected with the Covid-19 though he already received the 1st dose; Body aches; Patient suspected that he has gotten infected also from his spouse; This is a spontaneous report from a contactable physician (patient). A 48-year-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 05Jan2021 (Tuesday) at single dose for covid-19 immunization. The patient medical history and concomitant medications were not reported. Patient reported body aches developing the evening of receiving the vaccine, and it has persisted for three days. Patient started to get the chills on Wednesday (06Jan2021). Patient said his wife has been tested positive after he took the 1st dose and he is suspecting that he got infected with the Covid-19 though he already received the 1st dose. Patient thought that he may have been infected by his spouse. He got the vaccine on Tuesday and on Wednesday had fever and chills and still has them. Stated that his spouse lost her sense of smell and taste and tested positive for Covid on Wednesday. Patient stated that this was the day after he received his vaccine. Patient suspected that he has gotten infected also from his spouse and was not aware when he got the vaccine. Stated that now that he is having expected side effects of fever and chills. The outcome events was not recovered. This case was reported as non-serious.  Information on the lot/batch number has been requested.; Sender's Comments: The subject received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE) on 05Jan2021, and suspected got COVID-19 infection via exposure to COVID-19 living with his wife, who lost her sense of smell and taste and tested positive for COVID on 06Jan2021.  No effect of the suspect vaccine could be reasonably achieved to protect from the targeted infection/disease due to the very short time lag.  Further information is needed for full medical assessment.",,,,,,,,,N,01/05/2021,01/01/2021,,Test Date: 20210106; Test Name: body temperature; Result Unstructured Data: Test Result:fever,UNK,,,,,,USPFIZER INC2021013751,2,01/16/2021,,,,,True
1894,954353,01/19/2021,,,,,F,,"the symptoms as ""having Covid all over again""; the symptoms as ""having Covid all over again""; headache; nausea; severe joint and body pain; body pain; coughing; fever; This is a spontaneous report from a contactable other healthcare professional (HCP) reporting for herself. A female patient of an unspecified age received  BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on an unspecified date at single dose for covid-19 immunization. Medical history included covid-19 from an unknown date. The patient's concomitant medications were not reported. The patient just got the Covid vaccine and was experiencing side effects. She described the symptoms as ""having Covid all over again"", mentioned headache, nausea, severe joint and body pain, coughing and fever on an unknown date. Want to see how long these side effects last. The outcome of the events was unknown. Information regarding lot/batch number has been requested.; Sender's Comments: Based on the information currently available, a lack of efficacy with the suspected vaccine BNT162B2 in this patient cannot be completely excluded. Further information like confirmative virus genome /nucleic acid detection is needed for meaningful medical assessment.",,,,,,,,,U,,,,,UNK,,,,Medical History/Concurrent Conditions: COVID-19,,USPFIZER INC2021014487,2,01/16/2021,,,,,True
1896,954362,01/19/2021,,,,,F,,"got a positive test on 31Dec2020. Her 2nd dose is due on Wed and she is currently symptomatic.; got a positive test on 31Dec2020. Her 2nd dose is due on Wed and she is currently symptomatic.; This is a spontaneous report from a contactable consumer via Pfizer-sponsored program . A female patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, batch/lot and expiration date unknown), via an unspecified route of administration on an unspecified date at a single dose for covid-19 immunization. The patient's medical history and concomitant medications were not reported. On 31Dec2020, the patient got a positive test. Her 2nd dose was due on wed and she was currently symptomatic. Patent would to know if she should get second dose on her scheduled date even though she still was feeling unwell. The outcome of the events was unknown.  Information about batch/lot number has been requested.",,,,,,,,,U,,12/31/2020,,Test Date: 20201231; Test Name: covid test; Test Result: Positive  ; Comments: she is currently symptomatic,UNK,,,,,,USPFIZER INC2021014519,2,01/18/2021,,,,,True
1910,954479,01/19/2021,CA,51.0,,,F,,"Tested positive for COVID; Tested positive for COVID; Phlegm in throat; Cough; Runny nose; cold; Sneezing; Body aches; Nausea; Chills; Headache; This is a spontaneous report from a contactable consumer (patient). A 51-year-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 29Dec2020 14:50 at single dose at right arm for covid-19 immunization. No additional vaccines administered on the same date. Patient didn't receive any other vaccines within 4 weeks prior to the COVID vaccine. Medical history included ongoing migraine. Concomitant medication included acetylsalicylic acid, caffeine, paracetamol (EXCEDRIN EXTRA STRENGTH) for migraine, patient had been alternating this with paracetamol (TYLENOL) while she has been recovering. She clarified the symptoms she experienced as the same day she got the vaccine that evening she had a headache on 29Dec2020. It eventually became a migraine and she left work early. On 30Dec2020 she had body aches, little nausea, and chills. On 31Dec2020, she had more chills, a runny nose, she felt like she was coming down with a cold. She was sneezing, had more chills, more body aches. On 01Jan2021 she felt like she noticed she had phlegm in her throat, but she did not have any pain. The phlegm was causing her to cough more. She had a runny nose the next morning as well. She did the rapid test for COVID on 02Jan2021 evening, and it was positive. She had a headache almost every day. The body aches had pretty much worn off. Runny nose and sneezing resolved in Jan2021. Phlegm in throat confirmed with no pain. This also resolved, as well as coughing. Outcome of event tested positive for COVID was unknown, outcome of event headache was not recovered. outcome of event nausea was recovered on 07Jan2021, event chills was recovered on 08Jan2021, outcome of other events was recovered on unspecified date in Jan2021. The adverse events resulted in neither doctor or other healthcare professional office/clinic visit, nor emergency room/department or urgent care.  Information of lot/batch number has been requested.",,,,,,,,,N,12/29/2020,12/29/2020,0.0,Test Date: 20210102; Test Name: Tested for COVID; Test Result: Positive,OTH,,EXCEDRIN EXTRA STRENGTH,Migraine,,,USPFIZER INC2021018819,2,01/16/2021,,,,,True
1913,954489,01/19/2021,TN,27.0,,,F,,"tested positive after receiving the vaccine; tested positive after receiving the vaccine; she did not think symptoms were related to COVID like leg pain. She noticed that it was a lot worst; she did not think symptoms were related to COVID like leg pain. She noticed that it was a lot worst; This is a spontaneous report from a contactable consumer (patient herself).  A 27-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE Solution for injection, batch/lot no. EH9899 and expiry date Mar2021), via an unspecified route of administration on 05Jan2021 on her left arm at a single dose for covid-19 immunization. Medical history included leg pain. There was no reported concomitant medications. On an unspecified date, patient received COVID vaccine. She stated that she was symptomatic during the vaccine and somewhere after confirmed that she was COVID-positive. She wanted to know if there are any health concerns with getting the vaccine while COVID positive. She added that this was her first dose. she did not think symptoms were related to COVID like leg pain. She noticed that it was a lot worst but did not think that it was a symptom. She stated that she does not recall the first time ever that she had leg pain but stated that the leg pain was really bad the night before the vaccine. She added that she was isolated until 14Jan2021. Outcome of the events drug ineffective, COVID-19 virus test positive and leg pain were unknown.; Sender's Comments: Leg pain is considered intercurrent and unrelated to suspect BNT162B2.",,,,,,,,,U,01/05/2021,01/05/2021,0.0,Test Name: Covid; Test Result: Positive,UNK,,,,Medical History/Concurrent Conditions: Leg pain,,USPFIZER INC2021018998,2,01/16/2021,,,,,True
1916,954511,01/19/2021,,,,,F,,"tested positive for covid; tested positive for covid; This is a spontaneous report from a contactable consumer (patient) via a Pfizer sponsored program Pfizer Connect.  A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number and expiry date not reported), via an unspecified route of administration on an unspecified date at single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient works for a hospital. Said had 1st dose of vaccine. Had tested positive for covid on an unspecified date and is under quarantine. The patient would like to know when she should get 2nd dose. The patient underwent lab tests and procedures which included sars-cov-2 test: positive on an unspecified date. The outcome of the events was unknown.  Information on the lot/Batch number has been requested.",,,,,,,,,U,,,,Test Name: covid Test; Test Result: Positive,UNK,,,,,,USPFIZER INC2021019386,2,01/16/2021,,,,,True
1917,954512,01/19/2021,SC,,,,U,,"got sick and tested positive with COVID; got sick and tested positive with COVID; This is a spontaneous report from a contactable consumer via Pfizer Sponsored Pfizer First Connect. A contactable consumer reported similar events for four patients. This is second of four reports.  A patient of unspecified age and gender received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, batch/lot and expiration date unknown), via an unspecified route of administration on an unspecified date at a single dose for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. It was reported that the patient got sick and tested positive with covid on an unspecified date. It was further reported that patient who received the COVID vaccine, tested positive for COVID, and experienced side effects afterwards. The outcome of the events was unknown.  Information about batch/lot number has been requested.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021013589 same drug, similar events, different patient",,,,,,,,,U,,,,Test Name: COVID; Test Result: Positive,UNK,,,,,,USPFIZER INC2021019513,2,01/16/2021,,,,,True
1918,954514,01/19/2021,SC,,,,U,,"got sick and tested positive with COVID; got sick and tested positive with COVID; This is a spontaneous report from a contactable consumer via Pfizer Sponsored Pfizer First Connect. A contactable consumer reported similar events for four patients. This is fourth of four reports.  A patient of unspecified age and gender received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, batch/lot and expiration date unknown), via an unspecified route of administration on an unspecified date at a single dose for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient got sick and tested positive with covid on an unspecified date and experienced side effects afterwards. The outcome of the events was unknown.  Information about batch/lot number has been requested.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021013589 same drug, similar events, different patient",,,,,,,,,U,,,,Test Name: Covid; Test Result: Positive,PVT,,,,,,USPFIZER INC2021019534,2,01/16/2021,,,,,True
1920,954520,01/19/2021,CA,,,,F,,caller tested positive on covid a week after taking the 1st dose of vaccine; caller tested positive on covid a week after taking the 1st dose of vaccine; This is a spontaneous report from a contactable consumer (patient) via Pfizer-sponsored program Pfizer First Connect.   A female patient of an unspecified age received the 1st dose of bnt162b2 (BNT162B2) at single dose on an unspecified date for Covid-19 immunisation.  The patient medical history was and concomitant medications were not reported.  The patient was tested positive for Covid a week after taking the 1st dose of vaccine on an unspecified date. The outcome of events was unknown. Patient wanted to know if she can get the second dose.  Information on the lot/batch number has been requested.,,,,,,,,,U,,,,Test Name: Covid; Test Result: Positive  ; Comments: a week after taking the 1st dose of vaccine,UNK,,,,,,USPFIZER INC2021020360,2,01/15/2021,,,,,True
1922,954540,01/19/2021,,,,,F,,"Got the first dose and was contracted with COVID; Got the first dose and was contracted with COVID; This is a spontaneous report from a contactable consumer (patient) from a Pfizer-sponsored program IBCC (Inbound Call Center for HCPs). A female patient of an unspecified age received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 20Dec2020 at single dose for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. The patient was contracted with covid on an unspecified date in Dec2020 (27Dec2020 or 28Dec2020) with outcome of unknown.    Information about lot/batch number has been requested.",,,,,,,,,U,12/20/2020,12/01/2020,,,UNK,,,,,,USPFIZER INC2021021133,2,01/15/2021,,,,,True
1923,954541,01/19/2021,CO,,,,F,,"throat swelling; headache; Pain; little bit of chills; GI upset; This is a spontaneous report from a contactable nurse. A 48-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot: EK9231, expiry: 30Apr2021), via an unspecified route of administration on an unspecified date at 0.3 mL, single dose for covid-19 immunization. The patient's medical history and concomitant medications were not reported. The patient received her first dose of bnt162b2 on an unknown date for covid-19 immunization and experienced pain at the injection site. On an unspecified date, the patient experienced head ache, throat swelling, gastrointestinal (GI) upset, pain, and little bit of chills (don't believe to have had fever). It was clarified that the event took place after use of product. The outcome of the events was unknown.; Sender's Comments: The information in this report is limited, and does not allow a full medically meaningful assessment of the case.   Considering temporal relationship, a causal relationship between the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE) and the reported events including throat swelling cannot be excluded.  The case will be reassessed should additional information become available.  The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.",,,,,,,,,U,,,,,UNK,,,,,,USPFIZER INC2021021164,2,01/18/2021,,,,,True
1934,954620,01/19/2021,KY,,,,U,,"diagnosed with Covid; diagnosed with Covid; This is a spontaneous report from contactable other healthcare professional via a Pfizer sales representative. A patient of unspecified age and gender received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number and expiry date was not reported) via an unspecified route of administration on 04Jan2021 at single dose for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. It was reported that the patient received the vaccine on 04Jan2021 and was diagnosed with COVID on 07Jan2021. Outcome of the event was unknown.  Information about Lot/Batch number has been requested.; Sender's Comments: Although, BNT162B2 vaccine immunogenicity is not in full effect after short time (3 days in this case) from the first dose administration, a causal relationship between event ""diagnosed with COVID"" (coded to Drug ineffective / COVID-19) and BNT162B2 vaccine cannot be completely excluded.",,,,,,,,,U,01/04/2021,01/07/2021,3.0,Test Date: 20210107; Test Name: Covid; Result Unstructured Data: Test Result:diagnosed with Covid,OTH,,,,,,USPFIZER INC2021025370,2,01/18/2021,,,,,True
1949,955231,01/19/2021,CO,89.0,89.0,,M,,"After receiving Moderna vaccine, pt became increasingly tired, withdrawn, and confused, refusing to walk at home.  He has begun to have mild memory changes after suspected COVID illness (covid testing negative) in November, but daughter of patient, with whom he lives, states that his memory and orientation now significantly changed- he seems to have forgotten the last ""3 years"" of memory.  Presented to ER 1/16/21 as she checked his O2 and found him to be hypoxic in 60s. He is being treated for possible CAP with underlying perviously undiagnosed ILD vs post-covid lung changes (per pulmonology), and his energy and ability to walk have returned but memory is significantly impaired, confabulating and oriented only to self despite good oxygenation on 5L O2 by NC.",,,,,Y,3.0,,,U,01/12/2021,01/13/2021,1.0,"COVID negative, BCx negative, Mild AKI resolving, Mild anemia of chronic disease. TSH/B12/folate normal.   borderline low vitD. MRI brain- chronic  small vessel changes CTA chest- . No evidence of pulmonary embolism.  2. Patchy areas of ground-glass opacity in the bilateral lungs with subpleural reticulation and mild honeycombing along bases. Appearance is suggestive of UIP type interstitial lung disease. Component of superimposed acute pneumonia is possible.  3. Mediastinal adenopathy, reactive versus malignant.",PVT,,"Metformin, glyburide, actos, losartan, simvastatin",,"Diabetes, uncontrolled Suspected COVID infection (but testing Negative) in November- febrile illness with diarrhea/fatigue/cough/hypoxia requiring 2 L O2- treated w/ steroids and abx for possible pneumonia.  O2 requirement lasted 2 weeks",,,2,01/19/2021,,,,none,True
1965,955758,01/19/2021,,,,,F,,"right sided weakness with numbness from her face down her entire body; right sided weakness with numbness from her face down her entire body; right sided weakness with numbness from her face down her entire body; bad headache; pain at the injection site; This is a spontaneous report from a contactable consumer (patient). A female patient of an unspecified age (reported as 41 unknown unit) received the first dose of bnt162b2 (BNT162B2) via an unspecified route of administration on an unspecified date at a single dose for covid-19 immunization. The patient's medical history and concomitant medications were not reported. The patient wanted to know how long side effects last after receiving the first dose of the Covid vaccine. The patient received first dose of Covid vaccine on Thursday (unspecified date) and reported side effects. She reported side effects of right sided weakness with numbness from her face down her entire body. She describes the feeling as if she's been ""shot up with novocaine on the right side of her body."" She was also experiencing a really bad headache and pain at the injection site. She reported that the side effects do not seem to be wearing off. She wanted to know if this has been reported as a common side effect. Outcome of the events was unknown.  Information on the lot/batch number has been requested.",,,,,,,,,U,,,,,UNK,,,,,,USPFIZER INC2021015038,2,01/19/2021,,,,,True
1966,955759,01/19/2021,,27.0,,,F,,"Severe headache from 12-36h post administration impairing ability to perform ADLs with inability to turn head from side to side or to change positions without lancing temporal pain and a/w photophobia; Severe headache from 12-36h post administration impairing ability to perform ADLs with inability to turn head from side to side or to change positions without lancing temporal pain and a/w photophobia; Severe malaise; Severe headache from 12-36h post administration impairing ability to perform ADLs with inability to turn head from side to side or to change positions without lancing temporal pain and a/w photophobia; loss of appetite; Transient dysgeusia; Mild nausea; Pleuritic chest pain; This is a spontaneous report from a non-contactable physician. This 27-year-old female physician (patient) reported that she received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number=E15249), via unspecified route at left arm on 08Jan2021 07:30 AM at single dose for COVID-19 immunization. Medical history was none. Concomitant medication was not reported. The historical vaccine included the first dose of BNT162B2 for COVID-19 immunization. Facility type of vaccine was hospital. No other vaccine in four weeks. No Covid prior vaccination. No covid tested post vaccination. On 08Jan2021 06:00 PM, patient experienced severe headache from 12-36h post administration (as reported), impairing ability to perform ADLs with inability to turn head from side to side or to change positions without lancing temporal pain and a/w photophobia (nearly meningeal signs); mild nausea; pleuritic chest pain; severe malaise; transient dysgeusia; loss of appetite. Treatment for events included initially NSAIDs until had difficulty tolerating was received. Outcome of events was recovering.  No follow-up attempts are possible. No further information is expected.; Sender's Comments: Based on the time association, the possible contribution of suspect BNT162B2 to the events cannot be excluded. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.",,,,,,,,,N,01/08/2021,01/08/2021,0.0,,PVT,,,,Comments: List of non-encoded Patient Relevant History: Patient Other Relevant History 1: None,,USPFIZER INC2021015134,2,01/19/2021,,,,,True
1972,955872,01/19/2021,,,,,U,,"throat and tongue started to feel weird and tight/throat got to the point of so swollen and itchy I couldn't swallow; throat and tongue started to feel weird and tight/throat got to the point of so swollen and itchy I couldn't swallow; throat and tongue started to feel weird and tight/throat got to the point of so swollen and itchy I couldn't swallow; throat and tongue started to feel weird and tight/throat got to the point of so swollen and itchy I couldn't swallow; This is a spontaneous report from a non-contactable consumer (patient) via a Pfizer-sponsored program Corporate (Pfizer) Social Media Platforms.   This patient of unspecified age and gender received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration at single dose on an unspecified date for covid-19 immunisation. The patient medical history and concomitant medications were not reported.  On an unspecified date, the patient experienced throat and tongue started to feel weird and tight/throat got to the point of so swollen and itchy I couldn't swallow. The patient condition was life threatening. The patient described the events as follows: 40 min after injection my throat and tongue started to feel weird and tight. Pharmacy at my work hospital  gave me 25 mg Benadryl and 650mg Tylenol. At about 1 hr 45 min after injection my throat got to the point of so swollen and itchy I couldn't  swallow. I went to nearest  emergency room hospital they  administered Decadron orally, Pepcid  P.O. (orally), and Toradol via IM (Intramuscular). The outcome of the events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.",,,,,,,,,U,,,,,UNK,,,,,,USPFIZER INC2021028284,2,01/19/2021,,,Y,,True
1974,955876,01/19/2021,PA,52.0,,,F,,"Possible Bells Palsy; Arm/neck soreness; Arm/neck soreness/ neck are painful; travel up neck to side of face/around temple/ Side of head/face/cheeks/jaw; travel up neck to side of face/around temple/ Side of head/face/cheeks/jaw; travel up neck to side of face/around temple/ Side of head/face/cheeks/jaw; Feel numb; Sore-all on same side as injection; This is a spontaneous report from a contactable consumer (patient).  A 52-year-old female patient received first dose of bnt162b2 (Pfizer COVID 19 vaccine, lot number: EL3246) , via an unspecified route of administration on 13Jan2021 17:00 at single dose on left arm for covid-19 immunisation .  The patient medical history was not reported.  Concomitant medication included fluticasone propionate (FLONASE), pantoprazole.  The patient experienced arm/neck soreness, travel up neck to side of face/around temple; side of head/face/cheeks/jaw, neck are painful, feel numb, and sore-all on same side as injection; and possible Bells Palsy on 14Jan2021 02:00. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. No allergies to medications, food, or other products. No treatment was received for the events. The outcome of the events was not recovered.",,,,,,,,,N,01/13/2021,01/14/2021,1.0,,PVT,,FLONASE [FLUTICASONE PROPIONATE];,,,,USPFIZER INC2021029117,2,01/19/2021,,,,,True
1992,956365,01/19/2021,CA,81.0,81.0,,F,,"12/28/2020: generalized weakness and fell twice at home, cough, nausea,1/04/2021: cough, nausea, fever and chronic pain when she fell from being weak. admitted to hospital with Covid pneumonia, shortness of breath, covid postive, 1/09/2021: pt on bipap, 1/15/2021: pt was intubated, on TPN, pt DNR, 1/18/2021: was extubated and put on comfort measures and passed away",Y,01/18/2021,,,,,,,,12/21/2020,01/04/2021,14.0,,PVT,,,,,,,2,01/19/2021,,,,,True
2013,956962,01/19/2021,NY,74.0,74.0,,M,,"COVID 19 vaccine, unknown which company  Chronically ill in a skilled nursing facility found diaphoretic, hypotensive, hypoxia to 85% arrived to Emergency dept in cardiac arrest Died within 65 minutes of nursing finding patient in distress Wife felt it may have been related to vaccine date of vaccination 1/6/20 hx covid 19  PNA in April 2020",Y,01/19/2021,,,,,,,N,01/06/2021,01/19/2021,13.0,none,PVT,,Unavail,CVA seizure disorder all chronic HTN CAD had COVID 19 in April 2020,as above  PAtient had accute respiratory distress followed prolptly by cardiac arrest,,,2,01/19/2021,,,,NKDA,True
2024,959927,01/19/2021,,78.0,77.0,,M,,"short of breath Narrative: patient complained of shortness of breath prior to getting covid vaccine, patient and wife stating it was his norm. After vaccine he complained of increasing shortness of breath, and hypoxic with bluish nail beds, lips, and greyish in color. Applied O2 via mask, and nail beds, lips, and facial color returned, sent patient to local ER for treatment and evaluation.",,,,,Y,,,,N,01/19/2021,01/19/2021,0.0,,OTH,,,,,,,2,01/19/2021,,Y,Y,,True
2029,957416,01/20/2021,TX,40.0,,,F,,"Hypertensive Emergency (BP 219/114) with no previous blood pressure issues; Radiating chest pain, left arm pain; jaw pain; This is a spontaneous report from a contactable other Health Professional (patient). A 40-year-old non-pregnant female patient received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EX5170), via an unspecified route of administration on 16Dec2020 15:00 at single dose in left arm for covid-19 immunization. Medical history included symptomatic PVC's (Premature ventricular contractions), tachycardia, bradycardia, CVA (cerebrovascular accident) from 2018 to an unknown date, asthma and rhythm. Concomitant medication included flecainide, spironolactone, metoprolol for rhythm. The patient had known allergies included hydrocodone bitartrate, paracetamol (VICODIN), eletriptan and adhesive. Prior vaccination, the patient had no covid. On 22Dec2020 18:00, the patient experienced hypertensive Emergency (BP 219/114) with no previous blood pressure issues. Radiating chest pain, left arm pain, and jaw pain. Admitted to the hospital where an echocardiogram and angiogram was performed showing clear coronary arteries and no hypertensive remodeling of the heart. Issue has been ongoing since, despite interventions. The events result in emergency room/department or urgent care and hospitalization from an unspecified date for 1 day. The patient received the treatment for the events included frequent nitroglycerin, hydralazine and metoprolol. The patient underwent curative-SARS-Cov-2 Assay RT-PCR on 01Jan2021 with negative result. The outcome of the events was not recovered.; Sender's Comments: Based on the information available, contributory role of BNT162B2 ((PFIZER-BIONTECH COVID-19 VACCINE,) to event ""hypertensive emergency (BP 219/114) with no previous blood pressure issues"" cannot be excluded. The events chest pain and pain in jaw are attributed to underlying medical conditions and assessed unrelated. BNT162B2 ((PFIZER-BIONTECH COVID-19 VACCINE,). The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.",,,,,Y,1.0,,,N,12/16/2020,12/22/2020,6.0,Test Date: 20201222; Test Name: angiogram; Result Unstructured Data: Test Result:clear coronary arteries and no hypertensive; Comments: clear coronary arteries and no hypertensive remodeling of the heart.; Test Date: 20201222; Test Name: blood pressure/BP; Result Unstructured Data: Test Result:219/114; Test Date: 20201222; Test Name: echocardiogram; Result Unstructured Data: Test Result:clear coronary arteries and no hypertensive; Comments: clear coronary arteries and no hypertensive remodeling of the heart.; Test Date: 20210101; Test Name: Curative-SARS-Cov-2 Assay RT-PCR; Test Result: Negative,PVT,,;  ;,,Medical History/Concurrent Conditions: Adhesive tape allergy; Asthma; Bradycardia; CVA; Heart rate abnormal; Premature ventricular contractions; Tachycardia,,USPFIZER INC2021015767,2,01/19/2021,,,Y,,True
2030,957428,01/20/2021,MO,,,,F,,"having symptoms, tested covid+(positive); having symptoms, tested covid+(positive); This is a spontaneous report from a contactable consumer (patient).  This 57-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unknown route, on 17Dec2020 at single dose for COVID-19 immunization. No relevant medical history and concomitant medications were provided. The patient started having symptoms on 23Dec2020 and she was tested for COVID 19 on 27Dec2020 and resulted positive. The outcome of the event was unknown.  Information on the batch/lot number has been requested.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021015240 Same patient/reporter, 2nd dose of drug, different AE",,,,,,,,,U,12/17/2020,12/27/2020,10.0,Test Date: 20201227; Test Name: covid; Test Result: Positive,UNK,,,,,,USPFIZER INC2021021949,2,01/19/2021,,,,,True
2032,957454,01/20/2021,LA,82.0,,,M,,"I still have uncomfortable feeling in my arm/I was finally able to raise it above my head, my left arm, after two days but it was not comfortable to do it, it was painful; I have severe pain in my arm/it started hurting and then it continued to get worse and worse and it was severe; It was the worst pain I have ever had and I could not move my arm; It continued to get worse and that night I went to bed and I cannot sleep, it hurts so bad/I could not sleep on the right side or on a left side; This is a spontaneous report from a contactable consumer (patient). An 82-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiration date was not provided), via an unspecified route of administration (left arm) first dose on 30Dec2020 10:30 at single dose for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient stated that I had the vaccine back a week and half ago on 30Dec2020 and was due to get the booster this month and wanted to report severe pain arm for two days. The patient stated that he had many vaccine (Unspecified Vaccine) over the years and have never had anything that hurts so bad after about six hours. The patient just wanted to know that was that normal. Consumer further stated, ""I took the vaccine about 10:30 in the morning and about four hours later, it started getting sore but that thing was normal you know some vaccines (Unspecified Vaccine) do that but along with that it started hurting about four hours after the vaccine and it continued to get worse and that night I went to bed and I cannot sleep, it hurts so bad. The patient even have thoughts about getting up and go in to the emergency room. It was the worst pain I have ever had and I could not move my arm. I could not sleep on the right side or on a left side and all I did was take Tylenol as prescribed and that helped a little bit but not much but I did not go to the emergency room, I am not going to do that but I felt like it because it hurts so bad but I made it through the night and next day it continued to hurt really bad. I just keep taking Tylenol every four hours and that continued for two days and then finally I was able to raise my arm up above my head without little pain, it was discomfort, but it was not hurting so bad."" The patient stated that the event started about two hours later it started, it started hurting and then it continued to get worse and worse and it was severe, that is the reason why I am calling that it was severe. I wanted a shot or morphine to relieve myself that how bad it was."" (no clarified further). The patient stated that the vaccine was given in my left arm only about one inch below the top of my shoulder which I think that might have been the problem, I don't know if you can answer that or not but I have never received the vaccine or shot anywhere near that area, it is always three or four inches down in my muscle, on my arm either on left or right, this was given in my left arm but this was given almost in my joint I am wondering if that would cause pain."" The patient stated it was given only one inch below the tip above shoulder may be that is causing so much pain."" The patient just wanted to report the severe pain, that was for two whole days and then it was subsided and it lasted for four days and I still have uncomfortable feeling in my arm. I was finally able to raise it above my head, my left arm, after two days but it was not comfortable to do it, it was painful."" The outcome of the events was unknown.  Information on the lot/batch number has been requested.",,,,,,,,,U,12/30/2020,12/30/2020,0.0,,PVT,,,,,,USPFIZER INC2021036159,2,01/19/2021,,,,,True
2059,958838,01/20/2021,PR,36.0,,,F,,"sinus arrhythmia; Night sweats; Heart rate low; Dyskinesia; This is a spontaneous report from a contactable nurse (patient).   This 36-year-old female patient the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), intramuscular at single dose in the left arm on 07Jan2021 10:00 for covid-19 immunisation. Medical history included hypotension, rheumatoid arthritis, asthma. Concomitant medication included clonazepam, methylprednisolone. On 07Jan2021 21:00, the patient experienced sinus arrhythmia, night sweats, heart rate low, dyskinesia, all with outcome of recovered with sequelae. Therapeutic measures were taken as a result of the events included Inderal 10mg. The events were assessed as congenital anomaly. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was not diagnosed with COVID-19 prior to vaccination. The patient had not been tested for COVID-19 since the vaccination. The patient was not pregnant at the time of vaccination.  Information on the lot/batch number has been requested.; Sender's Comments: A possible contributory effect of suspect BNT162B2 on reported events cannot be excluded.  The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to regulatory authorities, Ethics Committees, and Investigators, as appropriate.",,,,,,,,,N,01/07/2021,01/07/2021,0.0,Test Date: 20210107; Test Name: Heart rate; Result Unstructured Data: Test Result:Low,UNK,,CLONAZEPAN;,,Medical History/Concurrent Conditions: Asthma; Hypotension; Rheumatoid arthritis,,PRPFIZER INC2021018863,2,01/20/2021,Y,,,,True
2060,958840,01/20/2021,CA,28.0,,,M,,"postural dizziness; dyspnea; paresthesia; This is a spontaneous report from a contactable Physician. This Physician reported for a 28-year-old male patient received 2nd dose of BNT162B2 Intramuscular on 10Jan2021 07:30 on Left arm for covid-19 immunization. Medical history and concomitant drug were not reported. No other-vaccine-in-four weeks. No other-medications-in-two weeks. Historical Vaccine was first dose of BNT162B2 on an unspecific date. Patient experienced Moderate reaction: postural dizziness, dyspnea, and paresthesia on 10Jan2021 09:00 AM that resolved with H1 and H2 antagonists and IV hydration. AE-resulted-in Emergency room/department or urgent care. Outcome of the event was recovered. No covid-prior-vaccination. No covid-tested-post-vaccination.  Information on the lot/batch number has been requested.; Sender's Comments: A causal association between BNT162B2 and the reported events cannot be excluded based on a compatible temporal relation between vaccination and onset of events. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to RAs, Ethics Committees, and Investigators, as appropriate.",,,,,,,,,Y,01/10/2021,01/10/2021,0.0,,PVT,,,,,,USPFIZER INC2021015111,2,01/20/2021,,,Y,,True
2075,959017,01/20/2021,VT,41.0,41.0,,F,,Patient got her 2nd dose of Pfizer covid vaccine on 1/8.  On 1/11 she had intermittent chest pain that lasted a few days and started to notice small purpura rash on left breast.  She didn't think much of it but noticed the same type of rash on her pant line and then right thigh.  On 1/15 she called Occupational Health who advised her to go straight to the ED.,,,Y,,Y,2.0,,Y,Y,01/08/2021,01/15/2021,7.0,"Upon arrival to ED on 1/15 patient had CXR and blood work ordered.  CXR showed hilar prominence and thickening paratracheal strip - recommended to get chest CT.  Labwork revealed extremely low level of platelets, 11,000.  Discussed with hematology who concurred it was probably ITP. Advised to admit patient, start prednisone 1 mg/kg/day and IVIG 1 g/kg/day x 2 days.  On 1/16 platelets increased to 42,000 and on 1/17 they were 104,000.  Patient responded well to treatment and was discharged on 1/17.  At discharge plan for a slow taper of prednisosone over 4-6 weeks, weekly CBC's and PCP prophylaxis with Bactrim.  She was advised to f/u with PCP in 1 week and should consider getting lung lesion biopsy when platelet count allows.",PVT,,"melatonin 3mg daily, magnesium 500mg daily, gabapentin 300mg BID",none known.,lower extremity neuropathy,,,2,01/20/2021,,Y,Y,meperidine = hives/dyspnea,True
2108,960001,01/20/2021,LA,70.0,70.0,,F,,"Patient came to ED at 1600 with right upper lip swelling and finger swelling after getting covid vaccine earlier. Angioedema of lips, initial encounter; History of allergic reaction; Lip swelling; Vaccination side effects, initial encounter. Pt has history of rheumatoid arthritis. Was treated & discharged home on 1/12/21",,,,,Y,,,,Y,01/10/2021,01/10/2021,0.0,,PVT,,,,Gastroesophageal reflux disease without esophagitis; History of allergic reaction; Lip swelling; Rheumatoid arthritis involving multiple sites with positive rheumatoid factor,,,2,01/20/2021,,,Y,ACE INHIBITORS; AZITHROMYCIN; CIPROFLOXACIN; CODEINE; CYCLOBENZAPRINE; ERYTHROMYCIN; HYDROCODONE BITARTRATE; HYDROCODONE-ACETAMINOPHEN; SULFA (SULFONAMIDE ANTIBIOTICS); TRAMADOL,True
2117,960426,01/21/2021,OH,,,,U,,"expired before receiving the second dose; This is a spontaneous report from a contactable nurse. This nurse reported similar death events for 8 patients. This report is for 1st of 8 patient.  A patient of unspecified age and gender received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 22Dec2020 at single dose for covid-19 immunisation. The patient medical history was and concomitant medications were not reported. The patient expired before receiving the second dose on an unspecified date. It was not reported if an autopsy was performed.  Information about Lot/Batch number is requested.; Sender's Comments: Current information is very limited for full assessment. The patient died following the vaccine use; further information such as patient demographics, complete medical history, concomitant medications, concurrent illness and event term details especially death cause and autopsy results are needed for meaningful evaluation.   The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.,Linked Report(s) : US-PFIZER INC-2021034597 same  drug, reporter and event but different patient;US-PFIZER INC-2021034598 same  drug, reporter and event but different patient;US-PFIZER INC-2021034599 same  drug, reporter and event but different patient;US-PFIZER INC-2021034600 same  drug, reporter and event but different patient;US-PFIZER INC-2021034601 same  drug, reporter and event but different patient;US-PFIZER INC-2021034603 same  drug, reporter and event but different patient;US-PFIZER INC-2021034596 same drug, reporter and event but different patient.; Reported Cause(s) of Death: expired before receiving the second dose",Y,,,,,,,,N,12/22/2020,,,,UNK,,,,,,USPFIZER INC2021034595,2,01/20/2021,,,,,True
2118,960427,01/21/2021,OH,,,,U,,"expired before receiving the second dose; This is a spontaneous report from a contactable nurse. This nurse reported similar events for 8 patients. This report is for 2nd of 8 patients.  A patient of unspecified age and gender received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 22Dec2020 at single dose for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient expired before receiving the second dose on an unspecified date. It was not reported if an autopsy was performed.  Information about Lot/Batch number is requested.; Sender's Comments: Current information is very limited for full assessment. The patient died following the vaccine use; further information such as patient demographics, complete medical history, concomitant medications, concurrent illness and event term details especially death cause and autopsy results are needed for meaningful evaluation.   The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.; Reported Cause(s) of Death: expired before receiving the second dose",Y,,,,,,,,N,12/22/2020,,,,UNK,,,,,,USPFIZER INC2021034596,2,01/20/2021,,,,,True
2119,960428,01/21/2021,OH,,,,U,,"expired before receiving the second dose; This is a spontaneous report from a contactable nurse. This nurse reported similar events for 8 patients. This report is for 3rd of 8 patients.  A patient of unspecified age and gender received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 22Dec2020 at single dose for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient expired before receiving the second dose on an unspecified date. It was not reported if an autopsy was performed.  Information about Lot/Batch number is requested.; Sender's Comments: Based on the reasonable temporal association, the Company cannot completely exclude the possible causality between the reported death and the administration of COVID 19 vaccine, bnt162b2.  However, more information on the patient's underlying medical condition, concomitant medications, patient's age group, clinical course and relevant lab tests would be helpful for the Company to make a more meaningful causality assessment.   The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to RA, IEC, as appropriate.; Reported Cause(s) of Death: expired before receiving the second dose",Y,,,,,,,,N,12/22/2020,,,,OTH,,,,,,USPFIZER INC2021034597,2,01/19/2021,,,,,True
2120,960429,01/21/2021,OH,,,,U,,"expired before receiving the second dose; This is a spontaneous report from a contactable nurse. This nurse reported similar events for 8 patients. This report is for 4th of 8 patient. A patient of unspecified age and gender received the first dose bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 22Dec2020 at single dose for covid-19 immunization. The patient's medical history and concomitant medications were not reported. The patient expired before receiving the second dose on an unspecified date. The patient died on an unspecified date. It was not reported if an autopsy was performed.  Information about Lot/Batch number has been requested.; Sender's Comments: Current information is very limited for full assessment. The patient died following the vaccine use; further information such as patient demographics, complete medical history, concomitant medications, concurrent illness and event term details especially death cause and autopsy results are needed for meaningful evaluation.   The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.,Linked Report(s) : US-PFIZER INC-2021034595 same  drug, reporter and event but different patient; Reported Cause(s) of Death: expired before receiving the second dose",Y,,,,,,,,N,12/22/2020,,,,OTH,,,,,,USPFIZER INC2021034598,2,01/20/2021,,,,,True
2121,960430,01/21/2021,OH,,,,U,,"7 residents expired before receiving the second dose; This is a spontaneous report from a contactable nurse. This nurse reported similar events for 8 patients. This report is for 6th of 8 patients.  A patient of unspecified age and gender received first dose bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on an unspecified date at SINGLE DOSE for covid-19 immunisation. The patient's medical history and concomitant medications were not reported.  The patient expired before receiving the second dose on an unspecified date. It was not reported if an autopsy was performed. Information on the lot/batch number has been requested.; Sender's Comments: The event death is assessed as related to BNT162b2 vaccine and documented as such in the  global safety database until sufficient information is available to allow an unrelated causality assessment.  The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to regulatory authorities, Ethics Committees, and Investigators, as appropriate.,Linked Report(s) : US-PFIZER INC-2021034595 same  drug, reporter and event but different patient; Reported Cause(s) of Death: 7 residents expired before receiving the second dose",Y,,,,,,,,N,,,,,OTH,,,,,,USPFIZER INC2021034600,2,01/20/2021,,,,,True
2122,960431,01/21/2021,OH,,,,U,,"expired before receiving the second dose; This is a spontaneous report from a contactable nurse. This nurse reported similar death events for 8 patients. This report is for 7th of 8 patient.  A patient of unspecified age and gender received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 22Dec2020 at single dose for covid-19 immunisation. The patient medical history was and concomitant medications were not reported. The patient expired before receiving the second dose on an unspecified date. It was not reported if an autopsy was performed.  Information about Lot/Batch number is requested.; Sender's Comments: Current information is very limited for full assessment. The patient died following the vaccine use; further information such as patient demographics, complete medical history, concomitant medications, concurrent illness and event term details especially death cause and autopsy results are needed for meaningful evaluation.   The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.,Linked Report(s) : US-PFIZER INC-2021034595 same  drug, reporter and event but different patient; Reported Cause(s) of Death: expired before receiving the second dose",Y,,,,,,,,N,12/22/2020,,,,OTH,,,,,,USPFIZER INC2021034601,2,01/20/2021,,,,,True
2123,960437,01/21/2021,NJ,,,,M,,"platelets dropped so low/thrombocytopenia; Hemorrhagic stroke/brain hemorrhage; This is a spontaneous report from a contactable nurse. A 56-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration on 18Dec2020 at single dose for covid-19 immunisation. Medical history and concomitant medications were unknown. The reporter read about the doctor that died that developed thrombocytopenia after taking the vaccine, stated it was in the news yesterday. The patient received the Pfizer Covid vaccine on 18Dec2020, and he died 16 days later from a brain hemorrhage. Autopsy stated that said he had a hemorrhagic stroke on 03Jan2021. His platelets dropped so low that he had specialists that tried to get his platelet count back up again and they could not get his platelets back up again and he ended up having the hemorrhagic stroke.  The reporter already had thrombocytopenia and she was debating what she should do about getting vaccine. Outcome of the events was fatal.   Information on the lot/batch number has been requested.; Sender's Comments: Very limited information is currently available.  Lacking patient's underlying medical conditions, clinical course, relevant lab data, the Company cannot make a meaningful causality assessment.  The reported hemorrhagic stroke following low platelet count are managed as related to the suspect, BNT162B2, for reporting purpose only.   The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to RA, IEC, as appropriate.; Reported Cause(s) of Death: Hemorrhagic stroke/brain hemorrhage; platelets dropped so low/thrombocytopenia",Y,01/03/2021,,,,,,,N,12/18/2020,01/03/2021,16.0,Test Name: platelet count; Result Unstructured Data: Test Result:dropped so low,UNK,,,,,,USPFIZER INC2021035530,2,01/20/2021,,,,,True
2135,961848,01/21/2021,,76.0,,,M,,"Narrative: Was pt previously covid positive?- Yes. Initial- 10/27/2020, 11/29/2020, 12/22/2020 Are there any predisposing factors for patient experiencing adverse drug event?- Yes, patient had multiple co-morbidities including GI bleed, hepatitis congestion due to cardiac issues, treatment for PE, NSTEMI, or antibiotics for PNA, also on concurrent medications APAP, Atorvastatin, Mirtazapine and Duloxetine. Pt with 2 doses of covid-19 vaccine, second one on 01/08/2021, 2 days pre-death Any occurrence of an ADR at time of administration? Did not specify injection site issues, per RN admin note- Vaccine ""administered without complications."" Did patient recover from event? Not s/p dose on 01/08/2021. First dose given on 12/21/2021, LFTS increased ~01/01/2021, peaked on 01/03/2021 and were decreasing on 01/07/2021 Was there an ADR between observation period and date of death? No Did patient recover from event? No (01/08/2021 event, died 01/10/2021) Was patient hospitalized prior to vaccination? Yes, in between inpatient and nursing home Was patient hospitalized prior to death--was hospitalization attributable to ADE? Yes re-admitted to inpatient on 12/31/2020. GI bleed Is there an alternative cause of death? Yes, as noted above. Quite a complicated case with many comorbidities/concurrent medications as noted above. Primary Diagnosis: Upper GI Bleed in the death note from 01/10/2021",Y,01/10/2021,,,,,,,N,,01/09/2021,,"AST 1826, ALT 1462 (01/09/2021) up from 01/07/2021 when it was downtrading to AST 52, ALT 193. Initially increased from 12/28/2020 AST 28, ALT 24. 01/01/2021 up to AST 134, ALT 130, increasing and then trending down.",OTH,,,,,,,2,01/21/2021,,Y,Y,,True
2136,962307,01/21/2021,SD,93.0,,,M,,"tired; legs felt heavy; stopped breathing; This is a spontaneous report from a Pfizer-sponsored program a non-contactable consumer. A 93-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 04Jan2021 11:00 at single dose for covid-19 immunisation. The patient medical history and concomitant medications were not reported.  Patient received vaccine around 11:00 a.m. About two hours later, he said he was tired and couldn't continue with the physical therapy he was doing. He was taken back to his room, where he said his legs felt heavy. Soon after, he stopped breathing. A nurse declared a do-not-resuscitate order. The patient died on 04Jan2021. It was not reported if an autopsy was performed. Outcome of stopped breathing was fatal. Outcome of tired and legs felt heavy was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.; Reported Cause(s) of Death: stopped breathing",Y,01/04/2021,,,,,,,N,01/04/2021,01/04/2021,0.0,,UNK,,,,,,USPFIZER INC2021045398,2,01/21/2021,,,,,True
2137,962308,01/21/2021,UT,,,,F,,"died; This is a spontaneous report from a Pfizer-sponsored program. A contactable consumer reported that an 83-year-old female patient (reporter mother) received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection), via an unspecified route of administration on an unspecified date at single dose for covid-19 immunization. Medical history included hospice care and dementia. The patient's concomitant medications were not reported. The patient died one day after getting vaccine. She was reportedly in good health the day before receiving vaccine. She was on hospice, frail, but in good condition and checked by a hospice nurse the day before which she reported her in good health considering. She was with dementia but stable in her health. The reporter read investigating 23 deaths of people receiving vaccine in similar conditions. The patient died on an unspecified date.  It was not reported if an autopsy was performed.; Reported Cause(s) of Death: died",Y,,,,,,,,N,,,,,UNK,,,,"Medical History/Concurrent Conditions: Dementia; Hospice care (on hospice, frail, but in good condition)",,USPFIZER INC2021045659,2,01/21/2021,,,,,True
